<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://www.wikidoc.org/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Gonzalo+Romero</id>
	<title>wikidoc - User contributions [en]</title>
	<link rel="self" type="application/atom+xml" href="https://www.wikidoc.org/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Gonzalo+Romero"/>
	<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php/Special:Contributions/Gonzalo_Romero"/>
	<updated>2026-04-15T16:43:17Z</updated>
	<subtitle>User contributions</subtitle>
	<generator>MediaWiki 1.45.1</generator>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=WBR0026&amp;diff=956657</id>
		<title>WBR0026</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=WBR0026&amp;diff=956657"/>
		<updated>2014-03-15T21:25:58Z</updated>

		<summary type="html">&lt;p&gt;Gonzalo Romero: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{WBRQuestion&lt;br /&gt;
|QuestionAuthor=Raviteja Reddy Guddeti MBBS, Aarti Narayan MBBS (Reviewed by Gonzalo Romero)&lt;br /&gt;
|ExamType=USMLE Step 2 CK&lt;br /&gt;
|MainCategory=Pharmacology, Internal medicine&lt;br /&gt;
|SubCategory=Cardiology, Cardiovascular&lt;br /&gt;
|MainCategory=Pharmacology, Internal medicine&lt;br /&gt;
|SubCategory=Cardiology, Cardiovascular&lt;br /&gt;
|MainCategory=Pharmacology, Internal medicine&lt;br /&gt;
|SubCategory=Cardiology, Cardiovascular&lt;br /&gt;
|MainCategory=Pharmacology, Internal medicine&lt;br /&gt;
|MainCategory=Pharmacology, Internal medicine&lt;br /&gt;
|SubCategory=Cardiology, Cardiovascular&lt;br /&gt;
|MainCategory=Pharmacology, Internal medicine&lt;br /&gt;
|SubCategory=Cardiology, Cardiovascular&lt;br /&gt;
|MainCategory=Pharmacology, Internal medicine&lt;br /&gt;
|SubCategory=Cardiology, Cardiovascular&lt;br /&gt;
|MainCategory=Pharmacology, Internal medicine&lt;br /&gt;
|SubCategory=Cardiology, Cardiovascular&lt;br /&gt;
|MainCategory=Pharmacology, Internal medicine&lt;br /&gt;
|MainCategory=Pharmacology, Internal medicine&lt;br /&gt;
|SubCategory=Cardiology, Cardiovascular&lt;br /&gt;
|Prompt=A 35-year-old female presents to the ER with fever, weakness and pleuritic chest pain. The pain is relieved by sitting up and leaning forward.  The patient states &#039;&#039;this pain gets worse when I take a deep breath, I try not to breath as much&#039;&#039;. Upon physical examination, her vital signs are within normal range.  Auscultation of the heart reveals a friction rub. An EKG is performed and is depicted below: &amp;lt;br&amp;gt; [[File:PtaDepressionPericarditis.png|700px]]  &amp;lt;br&amp;gt; What is the best initial therapy for this patient?&lt;br /&gt;
|Explanation=This patient;s presentation is classic for acute pericarditis. NSAIDs, such as ibuprofen, naproxen or indomethacin, are the best initial therapy for acute pericarditis.  Management requires treatment for the underlying cause.  The majority of cases, the specific cause of pericarditis is not identified, therefore they are assumed to be caused by Coxsackie B virus and treated with NSAIDs.  Colchicine has been proved to decreased the recurrences.&lt;br /&gt;
|AnswerA=Colchicine&lt;br /&gt;
|AnswerAExp=[[Colchicine]] may be used to prevent recurrences.  This pharmacological agent is used for the treatment of acute gout.  It binds to tubulin  inhibiting microtubule polymerization.&lt;br /&gt;
|AnswerB=NSAIDs&lt;br /&gt;
|AnswerBExp=NSAIDs is the correct answer.  NSAIDs, such as ibuprofen, naproxen or indomethacin, are the best initial therapy for acute pericarditis.&lt;br /&gt;
|AnswerC=Morphine&lt;br /&gt;
|AnswerCExp=[[Morphine]] is not the first drug of choice for acute pericarditis.  &lt;br /&gt;
|AnswerD=Prednisone&lt;br /&gt;
|AnswerDExp=Oral [[prednisone]] is used in acute pericarditis in addition to NSAIDs when pain persists, but is not the best initial therapy to use.&lt;br /&gt;
|AnswerE=Diuretics&lt;br /&gt;
|AnswerEExp=[[Diuretics]] are used in the initial management of patients with chronic constrictive pericarditis, prior to surgical management.&lt;br /&gt;
|EducationalObjectives=NSAIDs, such as indomethacin and aspirin, are the best initial therapy for acute pericarditis.&lt;br /&gt;
Colchicine decreases recurrences.&lt;br /&gt;
|References=Master the Boards for Step 2CK, 2013 edition, page 99&lt;br /&gt;
|RightAnswer=B&lt;br /&gt;
|WBRKeyword=NSAIDs, Pericarditis, Cardiology, Pharmacology&lt;br /&gt;
|Approved=Yes&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Gonzalo Romero</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=WBR0026&amp;diff=956638</id>
		<title>WBR0026</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=WBR0026&amp;diff=956638"/>
		<updated>2014-03-15T20:57:14Z</updated>

		<summary type="html">&lt;p&gt;Gonzalo Romero: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{WBRQuestion&lt;br /&gt;
|QuestionAuthor=Raviteja Reddy Guddeti MBBS, Aarti Narayan MBBS (Reviewed by Gonzalo Romero)&lt;br /&gt;
|ExamType=USMLE Step 2 CK&lt;br /&gt;
|MainCategory=Pharmacology, Internal medicine&lt;br /&gt;
|SubCategory=Cardiology, Cardiovascular&lt;br /&gt;
|MainCategory=Pharmacology, Internal medicine&lt;br /&gt;
|SubCategory=Cardiology, Cardiovascular&lt;br /&gt;
|MainCategory=Pharmacology, Internal medicine&lt;br /&gt;
|SubCategory=Cardiology, Cardiovascular&lt;br /&gt;
|MainCategory=Pharmacology, Internal medicine&lt;br /&gt;
|MainCategory=Pharmacology, Internal medicine&lt;br /&gt;
|SubCategory=Cardiology, Cardiovascular&lt;br /&gt;
|MainCategory=Pharmacology, Internal medicine&lt;br /&gt;
|SubCategory=Cardiology, Cardiovascular&lt;br /&gt;
|MainCategory=Pharmacology, Internal medicine&lt;br /&gt;
|SubCategory=Cardiology, Cardiovascular&lt;br /&gt;
|MainCategory=Pharmacology, Internal medicine&lt;br /&gt;
|SubCategory=Cardiology, Cardiovascular&lt;br /&gt;
|MainCategory=Pharmacology, Internal medicine&lt;br /&gt;
|MainCategory=Pharmacology, Internal medicine&lt;br /&gt;
|SubCategory=Cardiology, Cardiovascular&lt;br /&gt;
|Prompt=A 35-year-old female presents with fever, weakness and pleuritic chest pain. The pain is relieved by sitting up and leaning forward. Auscultation reveals friction rub. Her EKG is depicted below: &amp;lt;br&amp;gt; [[File:PtaDepressionPericarditis.png|700px]]  &amp;lt;br&amp;gt; What is the best initial therapy in this patient?&lt;br /&gt;
|Explanation=This patients presentation is classic for acute pericarditis. NSAIDs, such as ibuprofen, naproxen or indomethacin, are the best initial therapy for acute pericarditis.  Management requires treatment for the underlying cause.  The majority of cases, the specific cause of pericarditis is not identified, therefore they are assumed to be caused by Coxsackie B virus and treated with NSAIDs.  Colchicine has been proved to decreased the recurrences.&lt;br /&gt;
|AnswerA=Colchicine&lt;br /&gt;
|AnswerAExp=[[Colchicine]] may be used to prevent recurrences.&lt;br /&gt;
|AnswerB=NSAIDs&lt;br /&gt;
|AnswerBExp=NSAIDs is the correct answer.  NSAIDs, such as ibuprofen, naproxen or indomethacin, are the best initial therapy for acute pericarditis.&lt;br /&gt;
|AnswerC=Morphine&lt;br /&gt;
|AnswerCExp=[[Morphine]] is not the first drug of choice for acute pericarditis.&lt;br /&gt;
|AnswerD=Prednisone&lt;br /&gt;
|AnswerDExp=Oral [[prednisone]] is used in acute pericarditis in addition to NSAIDs when pain persists, but is not the best initial therapy to use.&lt;br /&gt;
|AnswerE=Diuretics&lt;br /&gt;
|AnswerEExp=[[Diuretics]] are used in the initial management of patients with chronic constrictive pericarditis, prior to surgical management.&lt;br /&gt;
|EducationalObjectives=NSAIDs, such as indomethacin and aspirin, are the best initial therapy for acute pericarditis.&lt;br /&gt;
Colchicine decreases recurrences.&lt;br /&gt;
|References=References: Master the Boards for Step 2CK, 2013 edition, page 99&lt;br /&gt;
|RightAnswer=B&lt;br /&gt;
|WBRKeyword=NSAIDs, Pericarditis,&lt;br /&gt;
|Approved=Yes&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Gonzalo Romero</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=WBR0026&amp;diff=956637</id>
		<title>WBR0026</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=WBR0026&amp;diff=956637"/>
		<updated>2014-03-15T20:56:37Z</updated>

		<summary type="html">&lt;p&gt;Gonzalo Romero: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{WBRQuestion&lt;br /&gt;
|QuestionAuthor=Raviteja Reddy Guddeti MBBS, Aarti Narayan MBBS (Reviewed by Gonzalo Romero)&lt;br /&gt;
|ExamType=USMLE Step 2 CK&lt;br /&gt;
|MainCategory=Pharmacology, Internal medicine&lt;br /&gt;
|SubCategory=Cardiology, Cardiovascular&lt;br /&gt;
|MainCategory=Pharmacology, Internal medicine&lt;br /&gt;
|SubCategory=Cardiology, Cardiovascular&lt;br /&gt;
|MainCategory=Pharmacology, Internal medicine&lt;br /&gt;
|SubCategory=Cardiology, Cardiovascular&lt;br /&gt;
|MainCategory=Pharmacology, Internal medicine&lt;br /&gt;
|MainCategory=Pharmacology, Internal medicine&lt;br /&gt;
|SubCategory=Cardiology, Cardiovascular&lt;br /&gt;
|MainCategory=Pharmacology, Internal medicine&lt;br /&gt;
|SubCategory=Cardiology, Cardiovascular&lt;br /&gt;
|MainCategory=Pharmacology, Internal medicine&lt;br /&gt;
|SubCategory=Cardiology, Cardiovascular&lt;br /&gt;
|MainCategory=Pharmacology, Internal medicine&lt;br /&gt;
|SubCategory=Cardiology, Cardiovascular&lt;br /&gt;
|MainCategory=Pharmacology, Internal medicine&lt;br /&gt;
|MainCategory=Pharmacology, Internal medicine&lt;br /&gt;
|SubCategory=Cardiology, Cardiovascular&lt;br /&gt;
|Prompt=A 35-year-old female presents with fever, weakness and pleuritic chest pain. The pain is relieved by sitting up and leaning forward. Auscultation reveals friction rub. Her EKG is depicted below: &amp;lt;br&amp;gt; [[File:PtaDepressionPericarditis.png|700px]]  &amp;lt;br&amp;gt; What is the best initial therapy in this patient?&lt;br /&gt;
|Explanation=This patients presentation is classic for acute pericarditis. NSAIDs, such as ibuprofen, naproxen or indomethacin, are the best initial therapy for acute pericarditis.  Management requires treatment for the underlying cause.  The majority of cases, the specific cause of pericarditis is not identified, therefore they are assumed to be caused by Coxsackie B virus and treated with NSAIDs.  Colchicine has been proved to decreased the recurrences.&lt;br /&gt;
|AnswerA=Colchicine&lt;br /&gt;
|AnswerAExp=[[Colchicine]] may be used to prevent recurrences.&lt;br /&gt;
|AnswerB=NSAIDs&lt;br /&gt;
|AnswerBExp=NSAIDs is the correct answer.  NSAIDs, such as ibuprofen, naproxen or indomethacin, are the best initial therapy for acute pericarditis.&lt;br /&gt;
|AnswerC=Morphine&lt;br /&gt;
|AnswerCExp=[[Morphine]] is not the first drug of choice for acute pericarditis.&lt;br /&gt;
|AnswerD=Prednisone&lt;br /&gt;
|AnswerDExp=Oral [[prednisone]] is used in acute pericarditis in addition to NSAIDs when pain persists, but is not the best initial therapy to use.&lt;br /&gt;
|AnswerE=Diuretics&lt;br /&gt;
|AnswerEExp=[[Diuretics]] are used in the initial management of patients with chronic constrictive pericarditis, prior to surgical management.&lt;br /&gt;
|EducationalObjectives= NSAIDs, such as indomethacin and aspirin, are the best initial therapy for acute pericarditis.&lt;br /&gt;
Colchicine decreases recurrences&lt;br /&gt;
|References=References: Master the Boards for Step 2CK, 2013 edition, page 99&lt;br /&gt;
|RightAnswer=B&lt;br /&gt;
|WBRKeyword=NSAIDs, Pericarditis,&lt;br /&gt;
|Approved=Yes&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Gonzalo Romero</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=WBR0026&amp;diff=956633</id>
		<title>WBR0026</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=WBR0026&amp;diff=956633"/>
		<updated>2014-03-15T20:50:51Z</updated>

		<summary type="html">&lt;p&gt;Gonzalo Romero: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{WBRQuestion&lt;br /&gt;
|QuestionAuthor=Raviteja Reddy Guddeti MBBS, Aarti Narayan MBBS (Reviewed by Gonzalo Romero)&lt;br /&gt;
|ExamType=USMLE Step 2 CK&lt;br /&gt;
|MainCategory=Pharmacology, Internal medicine&lt;br /&gt;
|SubCategory=Cardiology, Cardiovascular&lt;br /&gt;
|MainCategory=Pharmacology, Internal medicine&lt;br /&gt;
|SubCategory=Cardiology, Cardiovascular&lt;br /&gt;
|MainCategory=Pharmacology, Internal medicine&lt;br /&gt;
|SubCategory=Cardiology, Cardiovascular&lt;br /&gt;
|MainCategory=Pharmacology, Internal medicine&lt;br /&gt;
|MainCategory=Pharmacology, Internal medicine&lt;br /&gt;
|SubCategory=Cardiology, Cardiovascular&lt;br /&gt;
|MainCategory=Pharmacology, Internal medicine&lt;br /&gt;
|SubCategory=Cardiology, Cardiovascular&lt;br /&gt;
|MainCategory=Pharmacology, Internal medicine&lt;br /&gt;
|SubCategory=Cardiology, Cardiovascular&lt;br /&gt;
|MainCategory=Pharmacology, Internal medicine&lt;br /&gt;
|SubCategory=Cardiology, Cardiovascular&lt;br /&gt;
|MainCategory=Pharmacology, Internal medicine&lt;br /&gt;
|MainCategory=Pharmacology, Internal medicine&lt;br /&gt;
|SubCategory=Cardiology, Cardiovascular&lt;br /&gt;
|Prompt=A 35-year-old female presents with fever, weakness and pleuritic chest pain. The pain is relieved by sitting up and leaning forward. Auscultation reveals friction rub. Her EKG is depicted below: &amp;lt;br&amp;gt; [[File:PtaDepressionPericarditis.png|700px]]  &amp;lt;br&amp;gt; What is the best initial therapy in this patient?&lt;br /&gt;
|Explanation=The correct answer is NSAIDs. This patients presentation is classic for acute pericarditis. NSAIDs, such as indomethacin and aspirin, are the best initial therapy for acute pericarditis.&lt;br /&gt;
|AnswerA=Colchicine&lt;br /&gt;
|AnswerAExp=Colchicine may be used to prevent recurrences.&lt;br /&gt;
|AnswerB=NSAIDs&lt;br /&gt;
|AnswerBExp=NSAIDs is the correct answer.&lt;br /&gt;
|AnswerC=Morphine&lt;br /&gt;
|AnswerCExp=Morphine is not the first drug of choice for acute pericarditis.&lt;br /&gt;
|AnswerD=Prednisone&lt;br /&gt;
|AnswerDExp=Oral prednisone is used in acute pericarditis in addition to NSAIDs when pain persists, but is not the best initial therapy to use.&lt;br /&gt;
|AnswerE=Diuretics&lt;br /&gt;
|AnswerEExp=Diuretics are used in the initial management of patients with chronic constrictive pericarditis, prior to surgical management.&lt;br /&gt;
|RightAnswer=B&lt;br /&gt;
|Approved=Yes&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Gonzalo Romero</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=WBR0025&amp;diff=956630</id>
		<title>WBR0025</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=WBR0025&amp;diff=956630"/>
		<updated>2014-03-15T20:46:39Z</updated>

		<summary type="html">&lt;p&gt;Gonzalo Romero: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{WBRQuestion&lt;br /&gt;
|QuestionAuthor=Raviteja Reddy Guddeti MBBS, Aarti Narayan MBBS (Reviewed by Gonzalo Romero)&lt;br /&gt;
|ExamType=USMLE Step 2 CK&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|Prompt=A 62-year-old male presents to the ER with fever, fatigue, and sharp chest pain. The pain is relieved by sitting up and leaning forward. The patient describes the pain as &amp;quot;sharp and short&amp;quot;. Auscultation reveals a friction rub. What is the most specific EKG finding in this patient?&lt;br /&gt;
|Explanation=The correct answer is PR depression, as the patient has acute pericarditis. PR depression is an EKG finding which is more specific in acute pericarditis.  Although diffuse ST elevations are seen in multiple leads, ST segment elevation is seen in other cardiac conditions such as STEMI, pulmonary embolism, therefore this finding is not specific.&lt;br /&gt;
Pericarditis presents with sharp chest pain, which changes with respiration and position. The pain intensifies in a supine position and decreases when sitting up.  This may be due to the stretching of the pericardium.&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
[[File:PtaDepressionPericarditis.png|700px]]&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Please see more [[Pericarditis EKG examples]] here.&lt;br /&gt;
|AnswerA=Universal ST segment elevation&lt;br /&gt;
|AnswerAExp=Although universal ST segment elevation is commonly seen in acute pericarditis, it is not a specific finding.&lt;br /&gt;
|AnswerB=T wave inversion and poor R wave progression.&lt;br /&gt;
|AnswerBExp=T wave inversion and poor R wave progression suggests ischemia, and is not specific for acute pericarditis.&lt;br /&gt;
|AnswerC=PR depression&lt;br /&gt;
|AnswerCExp=PR depression is the correct answer.&lt;br /&gt;
|AnswerD=Presence of a Q wave&lt;br /&gt;
|AnswerDExp=Presence of a Q wave suggests an old infarct, and is not specific for acute pericarditis.&lt;br /&gt;
|AnswerE=Poor R-wave progression&lt;br /&gt;
|AnswerEExp=Poor R-wave progression can imply an old anterior MI.&lt;br /&gt;
|EducationalObjectives=The EKG in pericarditis shows ST segment elevation in all leads.  The most specific finding is the PR segment depression.&lt;br /&gt;
|References=Master the Boards for Step 2CK, 2013 edition, page 100&lt;br /&gt;
|RightAnswer=C&lt;br /&gt;
|WBRKeyword=Pericarditis, EKG, Pericarditis EKG examples&lt;br /&gt;
|Approved=Yes&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Gonzalo Romero</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=WBR0025&amp;diff=956628</id>
		<title>WBR0025</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=WBR0025&amp;diff=956628"/>
		<updated>2014-03-15T20:45:09Z</updated>

		<summary type="html">&lt;p&gt;Gonzalo Romero: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{WBRQuestion&lt;br /&gt;
|QuestionAuthor=Raviteja Reddy Guddeti MBBS, Aarti Narayan MBBS (Reviewed by Gonzalo Romero)&lt;br /&gt;
|ExamType=USMLE Step 2 CK&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|Prompt=A 62-year-old male presents to the ER with fever, fatigue, and sharp chest pain. The pain is relieved by sitting up and leaning forward. The patient describes the pain as &amp;quot;sharp and short&amp;quot;. Auscultation reveals a friction rub. What is the most specific EKG finding in this patient?&lt;br /&gt;
|Explanation=The correct answer is PR depression, as the patient has acute pericarditis. PR depression is an EKG finding which is more specific in acute pericarditis.  Although diffuse ST elevations are seen in multiple leads, ST segment elevation is seen in other cardiac conditions such as STEMI, pulmonary embolism, therefore this finding is not specific.&lt;br /&gt;
Pericarditis presents with sharp chest pain, which changes with respiration and position. The pain intensifies in a supine position and decreases when sitting up.  This may be due to the stretching of the pericardium.&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
[[File:PtaDepressionPericarditis.png|700px]]&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Please see more [[Pericarditis EKG examples]] here&lt;br /&gt;
|AnswerA=Universal ST segment elevation&lt;br /&gt;
|AnswerAExp=Although universal ST segment elevation is commonly seen in acute pericarditis, it is not a specific finding.&lt;br /&gt;
|AnswerB=T wave inversion and poor R wave progression.&lt;br /&gt;
|AnswerBExp=T wave inversion and poor R wave progression suggests ischemia, and is not pathognomonic for acute pericarditis.&lt;br /&gt;
|AnswerC=PR depression&lt;br /&gt;
|AnswerCExp=PR depression is the correct answer.&lt;br /&gt;
|AnswerD=Presence of a Q wave&lt;br /&gt;
|AnswerDExp=Presence of a Q wave suggests an old infarct, and is not specific for acute pericarditis.&lt;br /&gt;
|AnswerE=Poor R-wave progression&lt;br /&gt;
|AnswerEExp=Poor R-wave progression can imply an old anterior MI.&lt;br /&gt;
|EducationalObjectives=The EKG in pericarditis shows ST segment elevation in all leads.  The most specific finding is the PR segment depression.&lt;br /&gt;
|References=Master the Boards for Step 2CK, 2013 edition, page 100&lt;br /&gt;
&lt;br /&gt;
|RightAnswer=C&lt;br /&gt;
|WBRKeyword=Pericarditis, EKG, Pericarditis EKG examples&lt;br /&gt;
|Approved=Yes&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Gonzalo Romero</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=WBR0025&amp;diff=956625</id>
		<title>WBR0025</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=WBR0025&amp;diff=956625"/>
		<updated>2014-03-15T20:40:09Z</updated>

		<summary type="html">&lt;p&gt;Gonzalo Romero: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{WBRQuestion&lt;br /&gt;
|QuestionAuthor=Raviteja Reddy Guddeti MBBS, Aarti Narayan MBBS (Reviewed by Gonzalo Romero)&lt;br /&gt;
|ExamType=USMLE Step 2 CK&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|Prompt=A 62-year-old male presents to the ER with fever, fatigue, and sharp chest pain. The pain is relieved by sitting up and leaning forward. The patient describes the pain as &amp;quot;sharp and short&amp;quot;. Auscultation reveals a friction rub. What is the most specific EKG finding in this patient?&lt;br /&gt;
|Explanation=The correct answer is PR depression, as the patient has acute pericarditis. PR depression is an EKG finding which is more specific in acute pericarditis.  Although diffuse ST elevations are seen in multiple leads, ST segment elevation is seen in other cardiac conditions such as STEMI, pulmonary embolism, therefore this finding is not specific.&lt;br /&gt;
Pericarditis presents with sharp chest pain, which changes with respiration and position. The pain intensifies in a supine position and decreases when sitting up.  This may be due to the stretching of the pericardium.&lt;br /&gt;
|AnswerA=Universal ST segment elevation&lt;br /&gt;
|AnswerAExp=Although universal ST segment elevation is commonly seen in acute pericarditis, it is not a specific finding.&lt;br /&gt;
|AnswerB=T wave inversion and poor R wave progression.&lt;br /&gt;
|AnswerBExp=T wave inversion and poor R wave progression suggests ischemia, and is not pathognomonic for acute pericarditis.&lt;br /&gt;
|AnswerC=PR depression&lt;br /&gt;
|AnswerCExp=PR depression is the correct answer.&lt;br /&gt;
|AnswerD=Presence of a Q wave&lt;br /&gt;
|AnswerDExp=Presence of a Q wave suggests an old infarct, and is not specific for acute pericarditis.&lt;br /&gt;
|AnswerE=Poor R-wave progression&lt;br /&gt;
|AnswerEExp=Poor R-wave progression can imply an old anterior MI.&lt;br /&gt;
|EducationalObjectives=The EKG in pericarditis shows ST segment elevation in all leads.  The most specific finding is the PR segment depression.&lt;br /&gt;
|References=Master the Boards for Step 2CK, 2013 edition, page 100&lt;br /&gt;
|RightAnswer=C&lt;br /&gt;
|WBRKeyword=Pericarditis, EKG, &lt;br /&gt;
|Approved=Yes&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Gonzalo Romero</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=WBR0017&amp;diff=956621</id>
		<title>WBR0017</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=WBR0017&amp;diff=956621"/>
		<updated>2014-03-15T20:38:05Z</updated>

		<summary type="html">&lt;p&gt;Gonzalo Romero: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{WBRQuestion&lt;br /&gt;
|QuestionAuthor=Raviteja Reddy Guddeti MBBS, Aarti Narayan MBBS (Reviewed by Gonzalo Romero)&lt;br /&gt;
|ExamType=USMLE Step 2 CK&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|Prompt=A-65-year old male presents to the ER due to a crushing retrosternal chest pain, which started 20 minutes ago.  Additionally, he has nausea and diaphoresis. Following 2 hours of ER arrival, percutaneous coronary intervention is performed; he recovers over the next 5 days. 6 weeks following discharge, he returns to the office due to a mild retrosternal chest pain, which is aggravated when lying flat, and relieved when sitting up.  Concomitantly, he has a mild cough and runny nose consistent with a recent upper respiratory tract infection.  Complete blood count is within normal limits.  What is the most likely diagnosis?&lt;br /&gt;
|Explanation=This patient is returning to the office due to [[Dressler syndrome]], which is a post myocardial infarction syndrome.  It is a form of fibrinous pericarditis that occurs in the setting of injury to the heart (myocardial infarction). Typically, it occurs 2 to 10 weeks following a myocardial infarction.  It is usually treated with aspirin.  &lt;br /&gt;
* [[Acute pericarditis]] presents between 6 weeks to 6 months of the disease onset.  Acute pericarditis is more common than chronic pericarditis, and often occurs as a complication of viral infections, immunologic conditions, or as a result of a heart attack (myocardial infarction). &lt;br /&gt;
* Subacute pericarditis presents within 6 weeks to 6 months of the disease onset&lt;br /&gt;
* Chronic pericarditis manifests after 6 months of the disease onset. Chronic pericarditis is less common. It may manifest as scarring of the pericardium, which is a condition known as constrictive pericarditis.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;table&amp;gt;&lt;br /&gt;
&amp;lt;tr class=&amp;quot;Diagnosis&amp;quot;&amp;gt;&amp;lt;td&amp;gt; &amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;&#039;&#039;&#039;Typical Presentation&#039;&#039;&#039;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;&#039;&#039;&#039;Diagnostic Tests&#039;&#039;&#039; &amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&#039;&#039;&#039;Pericarditis&#039;&#039;&#039;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Pain aggravated supine and inspiration,  alleviated when sitting, friction rub&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;EKG with diffuse ST elevation and PR depressions followed by T-wave inversions &amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&#039;&#039;&#039;Costochondritis&#039;&#039;&#039;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Localized chest tenderness to palpation, localized&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Physical examination&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&#039;&#039;&#039;Aortic dissection&#039;&#039;&#039;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Acute onset, tearing pain radiated to the back, asymmetric pulses and BP between upper extremities, chronic hypertension&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;CXR with mediastinal widening, chest CT angiogram, MRI or TEE&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&#039;&#039;&#039;Pulmonary embolus&#039;&#039;&#039;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Sudden onset dyspnea, tachycardia and tachypnea&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Spiral CT, V/Q scan&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&#039;&#039;&#039;Pneumothorax&#039;&#039;&#039;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Pleuritic pain, shortness of breath, deviated trachea, trauma&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;CXR&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&#039;&#039;&#039;Pneumonia&#039;&#039;&#039;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Productive cough, hemoptysis, fever&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;CXR&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&#039;&#039;&#039;GERD&#039;&#039;&#039;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Acidic taste, chronic cough, hoarsenss&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Response to PPIs and antiacids&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&#039;&#039;&#039;PUD&#039;&#039;&#039;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Burning pain, change with eating&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Upper endoscopy&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;/table&amp;gt;&lt;br /&gt;
|AnswerA=Viral pericarditis&lt;br /&gt;
|AnswerAExp=Viral pericarditis is commonly caused by different virus such as:  Coxsackie B, Echovirus, HIV or Adenovirus.  It typically presents as an acute pericarditis with unspecific symptoms&lt;br /&gt;
It is important to consider the timeline of the chest pain occurring after the MI, which is 6 weeks in this case.  The history of this patient is consistent with Dressler&#039;s syndrome.&lt;br /&gt;
|AnswerB=Tuberculous pericarditis&lt;br /&gt;
|AnswerBExp=[[Tuberculous pericarditis]] usually presents with night sweats, weight loss and fever.  Pericardial fluid with an interferon-γ level greater than 50 pg/mL is highly specific for tuberculous pericarditis.  There is nothing else in the patient history to suggest a past medical history of [[tuberculosis]].&lt;br /&gt;
|AnswerC=Post-cardiac injury pericarditis&lt;br /&gt;
|AnswerCExp=Post-cardiac injury pericarditis, also known as post-myocardial infarction pericarditis has similar clinical presentation, but it occurs 2-4 days following an MI.  The pathophysiology is thought to be of autoimmune origin due to a reaction to the myocardial neo-antigens.&lt;br /&gt;
|AnswerD=Dressler’s syndrome&lt;br /&gt;
|AnswerDExp=This patient is returning to the office due to [[Dressler syndrome]], which is a post myocardial infarction syndrome.  It is a form of pericarditis that occurs in the setting of injury to the heart (myocardial infarction). Typically, it occurs 2 to 10 weeks following a myocardial infarction.&lt;br /&gt;
|AnswerE=Aortic dissection&lt;br /&gt;
|AnswerEExp=The history of MI suggests that [[myocardial infarction]] is the inciting factor for the pericarditis.&lt;br /&gt;
|EducationalObjectives=#[[Dressler syndrome]] is a form of pericarditis that presents 2 to 10 weeks following a myocardial infarction.  &lt;br /&gt;
# The symptoms of pericarditis include:  retrosternal chest pain aggravated when lying down and alleviated by sitting up.  The EKG may show diffuse ST segment elevations and PR interval depression.&lt;br /&gt;
Remember the causes of pericarditis using this mnemonic &#039;&#039;&#039;CARDIAC RIND&#039;&#039;&#039;, which stands for:  &lt;br /&gt;
* Collagen vascular disease&lt;br /&gt;
* Aortic dissection&lt;br /&gt;
* Radiation&lt;br /&gt;
* Drugs&lt;br /&gt;
* Infections&lt;br /&gt;
* Acute renal failure&lt;br /&gt;
* Cardiac (MI)&lt;br /&gt;
* Rheumatic fever&lt;br /&gt;
* Injury&lt;br /&gt;
* Neoplasms&lt;br /&gt;
* Dressler&#039;s syndrome&lt;br /&gt;
|References=Master the Boards for Step 2 CK, 2013 edition, page 54&lt;br /&gt;
&amp;lt;br&amp;gt; Read more here:  http://www.ncbi.nlm.nih.gov/pubmed/20194155&lt;br /&gt;
|RightAnswer=D&lt;br /&gt;
|WBRKeyword=MI, Pericarditis, Chest pain, Dressler syndrome&lt;br /&gt;
|Approved=Yes&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Gonzalo Romero</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=WBR0017&amp;diff=956620</id>
		<title>WBR0017</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=WBR0017&amp;diff=956620"/>
		<updated>2014-03-15T20:37:43Z</updated>

		<summary type="html">&lt;p&gt;Gonzalo Romero: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{WBRQuestion&lt;br /&gt;
|QuestionAuthor=Raviteja Reddy Guddeti MBBS, Aarti Narayan MBBS (Reviewed by Gonzalo Romero)&lt;br /&gt;
|ExamType=USMLE Step 2 CK&lt;br /&gt;
|Prompt=A-65-year old male presents to the ER due to a crushing retrosternal chest pain, which started 20 minutes ago.  Additionally, he has nausea and diaphoresis. Following 2 hours of ER arrival, percutaneous coronary intervention is performed; he recovers over the next 5 days. 6 weeks following discharge, he returns to the office due to a mild retrosternal chest pain, which is aggravated when lying flat, and relieved when sitting up.  Concomitantly, he has a mild cough and runny nose consistent with a recent upper respiratory tract infection.  Complete blood count is within normal limits.  What is the most likely diagnosis?&lt;br /&gt;
|Explanation=This patient is returning to the office due to [[Dressler syndrome]], which is a post myocardial infarction syndrome.  It is a form of fibrinous pericarditis that occurs in the setting of injury to the heart (myocardial infarction). Typically, it occurs 2 to 10 weeks following a myocardial infarction.  It is usually treated with aspirin.  &lt;br /&gt;
* [[Acute pericarditis]] presents between 6 weeks to 6 months of the disease onset.  Acute pericarditis is more common than chronic pericarditis, and often occurs as a complication of viral infections, immunologic conditions, or as a result of a heart attack (myocardial infarction). &lt;br /&gt;
* Subacute pericarditis presents within 6 weeks to 6 months of the disease onset&lt;br /&gt;
* Chronic pericarditis manifests after 6 months of the disease onset. Chronic pericarditis is less common. It may manifest as scarring of the pericardium, which is a condition known as constrictive pericarditis.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;table&amp;gt;&lt;br /&gt;
&amp;lt;tr class=&amp;quot;Diagnosis&amp;quot;&amp;gt;&amp;lt;td&amp;gt; &amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;&#039;&#039;&#039;Typical Presentation&#039;&#039;&#039;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;&#039;&#039;&#039;Diagnostic Tests&#039;&#039;&#039; &amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&#039;&#039;&#039;Pericarditis&#039;&#039;&#039;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Pain aggravated supine and inspiration,  alleviated when sitting, friction rub&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;EKG with diffuse ST elevation and PR depressions followed by T-wave inversions &amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&#039;&#039;&#039;Costochondritis&#039;&#039;&#039;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Localized chest tenderness to palpation, localized&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Physical examination&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&#039;&#039;&#039;Aortic dissection&#039;&#039;&#039;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Acute onset, tearing pain radiated to the back, asymmetric pulses and BP between upper extremities, chronic hypertension&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;CXR with mediastinal widening, chest CT angiogram, MRI or TEE&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&#039;&#039;&#039;Pulmonary embolus&#039;&#039;&#039;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Sudden onset dyspnea, tachycardia and tachypnea&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Spiral CT, V/Q scan&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&#039;&#039;&#039;Pneumothorax&#039;&#039;&#039;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Pleuritic pain, shortness of breath, deviated trachea, trauma&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;CXR&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&#039;&#039;&#039;Pneumonia&#039;&#039;&#039;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Productive cough, hemoptysis, fever&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;CXR&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&#039;&#039;&#039;GERD&#039;&#039;&#039;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Acidic taste, chronic cough, hoarsenss&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Response to PPIs and antiacids&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&#039;&#039;&#039;PUD&#039;&#039;&#039;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Burning pain, change with eating&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Upper endoscopy&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;/table&amp;gt;&lt;br /&gt;
|AnswerA=Viral pericarditis&lt;br /&gt;
|AnswerAExp=Viral pericarditis is commonly caused by different virus such as:  Coxsackie B, Echovirus, HIV or Adenovirus.  It typically presents as an acute pericarditis with unspecific symptoms&lt;br /&gt;
It is important to consider the timeline of the chest pain occurring after the MI, which is 6 weeks in this case.  The history of this patient is consistent with Dressler&#039;s syndrome.&lt;br /&gt;
|AnswerB=Tuberculous pericarditis&lt;br /&gt;
|AnswerBExp=[[Tuberculous pericarditis]] usually presents with night sweats, weight loss and fever.  Pericardial fluid with an interferon-γ level greater than 50 pg/mL is highly specific for tuberculous pericarditis.  There is nothing else in the patient history to suggest a past medical history of [[tuberculosis]].&lt;br /&gt;
|AnswerC=Post-cardiac injury pericarditis&lt;br /&gt;
|AnswerCExp=Post-cardiac injury pericarditis, also known as post-myocardial infarction pericarditis has similar clinical presentation, but it occurs 2-4 days following an MI.  The pathophysiology is thought to be of autoimmune origin due to a reaction to the myocardial neo-antigens.&lt;br /&gt;
|AnswerD=Dressler’s syndrome&lt;br /&gt;
|AnswerDExp=This patient is returning to the office due to [[Dressler syndrome]], which is a post myocardial infarction syndrome.  It is a form of pericarditis that occurs in the setting of injury to the heart (myocardial infarction). Typically, it occurs 2 to 10 weeks following a myocardial infarction.&lt;br /&gt;
|AnswerE=Aortic dissection&lt;br /&gt;
|AnswerEExp=The history of MI suggests that [[myocardial infarction]] is the inciting factor for the pericarditis.&lt;br /&gt;
|EducationalObjectives=#[[Dressler syndrome]] is a form of pericarditis that presents 2 to 10 weeks following a myocardial infarction.  &lt;br /&gt;
# The symptoms of pericarditis include:  retrosternal chest pain aggravated when lying down and alleviated by sitting up.  The EKG may show diffuse ST segment elevations and PR interval depression.&lt;br /&gt;
Remember the causes of pericarditis using this mnemonic &#039;&#039;&#039;CARDIAC RIND&#039;&#039;&#039;, which stands for:  &lt;br /&gt;
* Collagen vascular disease&lt;br /&gt;
* Aortic dissection&lt;br /&gt;
* Radiation&lt;br /&gt;
* Drugs&lt;br /&gt;
* Infections&lt;br /&gt;
* Acute renal failure&lt;br /&gt;
* Cardiac (MI)&lt;br /&gt;
* Rheumatic fever&lt;br /&gt;
* Injury&lt;br /&gt;
* Neoplasms&lt;br /&gt;
* Dressler&#039;s syndrome&lt;br /&gt;
|References=Master the Boards for Step 2 CK, 2013 edition, page 54&lt;br /&gt;
&amp;lt;br&amp;gt; Read more here:  http://www.ncbi.nlm.nih.gov/pubmed/20194155&lt;br /&gt;
|RightAnswer=D&lt;br /&gt;
|WBRKeyword=MI, Pericarditis, Chest pain, Dressler syndrome&lt;br /&gt;
|Approved=Yes&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Gonzalo Romero</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=WBR0025&amp;diff=956618</id>
		<title>WBR0025</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=WBR0025&amp;diff=956618"/>
		<updated>2014-03-15T20:37:09Z</updated>

		<summary type="html">&lt;p&gt;Gonzalo Romero: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{WBRQuestion&lt;br /&gt;
|QuestionAuthor=Raviteja Reddy Guddeti MBBS, Aarti Narayan MBBS (Reviewed by Gonzalo Romero)&lt;br /&gt;
|ExamType=USMLE Step 2 CK&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|Prompt=A 62-year-old male presents to the ER with fever, fatigue, and sharp chest pain. The pain is relieved by sitting up and leaning forward. The patient describes the pain as &amp;quot;sharp and short&amp;quot;. Auscultation reveals a friction rub. What is the most specific EKG finding in this patient?&lt;br /&gt;
|Explanation=The correct answer is PR depression, as the patient has acute pericarditis. PR depression is an EKG finding which is more specific in acute pericarditis.  Although diffuse ST elevations are seen in multiple leads, ST segment elevation is seen in other cardiac conditions such as STEMI, pulmonary embolism, therefore this finding is not specific.&lt;br /&gt;
Pericarditis presents with sharp chest pain, which changes with respiration and position. The pain intensifies in a supine position and decreases when sitting up.  This may be due to the stretching of the pericardium. &lt;br /&gt;
|AnswerA=Universal ST segment elevation&lt;br /&gt;
|AnswerAExp=Although universal ST segment elevation is commonly seen in acute pericarditis, it is not a specific finding.&lt;br /&gt;
|AnswerB=T wave inversion and poor R wave progression.&lt;br /&gt;
|AnswerBExp=T wave inversion and poor R wave progression suggests ischemia, and is not pathognomonic for acute pericarditis.&lt;br /&gt;
|AnswerC=PR depression&lt;br /&gt;
|AnswerCExp=PR depression is the correct answer.&lt;br /&gt;
|AnswerD=Presence of a Q wave&lt;br /&gt;
|AnswerDExp=Presence of a Q wave suggests an old infarct, and is not pathognomonic for acute pericarditis.&lt;br /&gt;
|AnswerE=Poor R-wave progression&lt;br /&gt;
|AnswerEExp=Poor R-wave progression can imply an old anterior MI, and is not pathognomonic for acute pericarditis.&lt;br /&gt;
|RightAnswer=C&lt;br /&gt;
|Approved=Yes&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Gonzalo Romero</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=WBR0021&amp;diff=956615</id>
		<title>WBR0021</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=WBR0021&amp;diff=956615"/>
		<updated>2014-03-15T20:28:52Z</updated>

		<summary type="html">&lt;p&gt;Gonzalo Romero: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{WBRQuestion&lt;br /&gt;
|QuestionAuthor=Aarti Narayan MBBS, Raviteja Reddy Guddeti MBBS (Reviewed by Gonzalo Romero)&lt;br /&gt;
|ExamType=USMLE Step 2 CK&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Oncology, Cardiovascular, Oncology&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Oncology, Cardiovascular, Oncology&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Oncology, Cardiovascular, Oncology&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Oncology, Cardiovascular, Oncology&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Oncology, Cardiovascular, Oncology&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Oncology, Cardiovascular, Oncology&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Oncology, Cardiovascular, Oncology&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Oncology, Cardiovascular, Oncology&lt;br /&gt;
|Prompt=A 50-year-old male presents to the clinic due to fatigue, weakness and weight gain.  Upon interrogration, he  has orthopnea, paroxysmal nocturnal dyspnea, abdominal swelling and lower extremity edema. His past medical history is significant for lymphoma treatment with radiotherapy. On physical examination, his vitals are:  BP 100/60 mmHg, RR 15/min and HR 100bpm. He has distant heart sounds and a prominent x and y descent on jugular examination. Abdominal examination shows hepatomegaly and ascites. EKG shows low voltage QRS complexes and flattened T waves.  What is the most likely diagnosis?&lt;br /&gt;
|Explanation=The correct answer is constrictive pericarditis. The history of radiation for lymphoma treatment, likely caused pericardial scarring. Signs of right heart failure (hepatomegaly, ascitis, lower extremity edema) along with characteristic JVP findings suggest chronic constrictive pericarditis.&lt;br /&gt;
|AnswerA=Constrictive pericarditis&lt;br /&gt;
|AnswerAExp=Constrictive pericarditis is caused by calcification and fibrosis of the pericardium, which prevents the filling of the right heart.  Signs of right heart failure include: JVD, Kussmal sign, a knock heard in diastole, ascites, edema and hepato-splenomegaly.  A CXR shows calcification of the pericardium.  The best initial test is a CXR.  CT and MRI are more accurate.  Echocardiogram is used to exclude other causes of right heart failure, the myocardium moves normally in constrictive pericarditis.   It is treated with diuretics and surgery.&lt;br /&gt;
|AnswerB=Acute pericarditis&lt;br /&gt;
|AnswerBExp=Acute [[pericarditis]] is associated with severe retrosternal chest pain aggravated with supine position and inspiration and alleviated when sitting. The history of increased abdominal girth, edema and hepatomegaly are findings of chronic pericarditis, rather than acute.&lt;br /&gt;
|AnswerC=Cardiac tamponade&lt;br /&gt;
|AnswerCExp=[[Cardiac tamponade]] is a life threatening condition, which presents with distant heart sounds, hypotension and jugular veins distention, a triad called [[Beck&#039;s triad]]. It is caused by the presence of  fluid in the &#039;&#039;virtual&#039;&#039; pericardial space, which compresses the heart chambers causing hypotension due to [[cardiogenic shock]]. Cold clammy skin, cyanotic extremities and decreased urine output can be noted. The history of increased abdominal girth, edema, and hepatomegaly are not characteristic findings of cardiac tamponade.&lt;br /&gt;
|AnswerD=Cor pulmonale&lt;br /&gt;
|AnswerDExp=The absence of history of a chronic pulmonary disease makes [[cor pulmonale]] a less likely diagnosis. [[Right heart failure]] is also used interchangeably with cor pulmonale when the pathology is caused by an underlying lung disease, such as emphysema or chronic bronchitis.&lt;br /&gt;
|AnswerE=Hypertrophic cardiomyopathy&lt;br /&gt;
|AnswerEExp=[[Hypertrophic cardiomyopathy]] generally presents with dyspnea, palpitations, chest pain and fatigue. Hypertrophic cardiomyopathy can cause sudden cardiac death in young adolescents and adults due to cardiac arrhytmias. A past history of irradiation, distant heart sounds on auscultation, and prominent x and y descent on JVP are more consistent with the diagnosis of constrictive pericarditis.&lt;br /&gt;
|EducationalObjectives=[[Constrictive pericarditis]] can be caused by radiation therapy to the chest in a patient with lymphoma.  It typically presents with distant heart sounds and fatigue and signs and symptoms of chronic right heart failure, such as:  jugular veins distention, hepatomegaly, ascites and lower extremity edema.&lt;br /&gt;
|References=Master the Boards for Step 2CK, 2013 edition, page 101&lt;br /&gt;
|RightAnswer=A&lt;br /&gt;
|WBRKeyword=Constrictive pericarditis, Pericarditis, Pericardium, right heart failure&lt;br /&gt;
|Approved=Yes&lt;br /&gt;
}}&lt;br /&gt;
{{WBRImage}}&lt;/div&gt;</summary>
		<author><name>Gonzalo Romero</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=WBR0021&amp;diff=956606</id>
		<title>WBR0021</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=WBR0021&amp;diff=956606"/>
		<updated>2014-03-15T20:16:21Z</updated>

		<summary type="html">&lt;p&gt;Gonzalo Romero: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{WBRQuestion&lt;br /&gt;
|QuestionAuthor=Aarti Narayan MBBS, Raviteja Reddy Guddeti MBBS (Reviewed by Gonzalo Romero)&lt;br /&gt;
|ExamType=USMLE Step 2 CK&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Oncology, Cardiovascular, Oncology&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Oncology, Cardiovascular, Oncology&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Oncology, Cardiovascular, Oncology&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Oncology, Cardiovascular, Oncology&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Oncology, Cardiovascular, Oncology&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Oncology, Cardiovascular, Oncology&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Oncology, Cardiovascular, Oncology&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Oncology, Cardiovascular, Oncology&lt;br /&gt;
|Prompt=A 50-year-old male presents to the clinic due to fatigue, weakness and weight gain.  Upon interrogration, he  has orthopnea, paroxysmal nocturnal dyspnea, abdominal swelling and lower extremity edema. His past medical history is significant for lymphoma treatment with radiotherapy. On physical examination, his vitals are:  BP 100/60 mmHg, RR 15/min and HR 100bpm. He has distant heart sounds and a prominent x and y descent on jugular examination. Abdominal examination shows hepatomegaly and ascites. EKG shows low voltage QRS complexes and flattened T waves.  What is the most likely diagnosis?&lt;br /&gt;
|Explanation=The correct answer is constrictive pericarditis. The history of radiation for lymphoma treatment, likely caused pericardial scarring. Signs of right heart failure (hepatomegaly, ascitis, lower extremity edema) along with characteristic JVP findings suggest chronic constrictive pericarditis.&lt;br /&gt;
|AnswerA=Constrictive pericarditis&lt;br /&gt;
|AnswerAExp=Constrictive pericarditis &lt;br /&gt;
|AnswerB=Acute pericarditis&lt;br /&gt;
|AnswerBExp=Acute [[pericarditis]] is associated with severe retrosternal chest pain aggravated with supine position and inspiration and alleviated when sitting. The history of increased abdominal girth, edema and hepatomegaly are findings of chronic pericarditis, rather than acute.&lt;br /&gt;
|AnswerC=Cardiac tamponade&lt;br /&gt;
|AnswerCExp=[[Cardiac tamponade]] is a life threatening condition, which presents with distant heart sounds, hypotension and jugular veins distention. It is caused by the presence of  fluid in the virtual pericardial space, which compresses the heart causing cardiogenic shock and hypotension. Cold clammy skin, cyanotic extremities and decreased urine output can be noted. The history of increased abdominal girth, edema, and hepatomegaly are not characteristic findings of cardiac tamponade.&lt;br /&gt;
|AnswerD=Cor pulmonale&lt;br /&gt;
|AnswerDExp=The absence of history of a chronic pulmonary disease makes cor pulmonale a less likely diagnosis. Right heart failure is also used interchangeably with cor pulmonale when the pathology is caused by an underlying lung disease, such as emphysema or chronic bronchitis.&lt;br /&gt;
|AnswerE=Hypertrophic cardiomyopathy&lt;br /&gt;
|AnswerEExp=[[Hypertrophic cardiomyopathy]] generally presents with dyspnea, palpitations, chest pain and fatigue. Hypertrophic cardiomyopathy can cause sudden cardiac death in young adolescents and adults due to cardiac arrhytmias. A past history of irradiation, distant heart sounds on auscultation, and prominent x and y descent on JVP are more consistent with the diagnosis of constrictive pericarditis.&lt;br /&gt;
|RightAnswer=A&lt;br /&gt;
|Approved=Yes&lt;br /&gt;
}}&lt;br /&gt;
{{WBRImage}}&lt;/div&gt;</summary>
		<author><name>Gonzalo Romero</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=WBR0018&amp;diff=956595</id>
		<title>WBR0018</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=WBR0018&amp;diff=956595"/>
		<updated>2014-03-15T19:58:10Z</updated>

		<summary type="html">&lt;p&gt;Gonzalo Romero: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{WBRQuestion&lt;br /&gt;
|QuestionAuthor=Aarti Narayan MBBS, Raviteja Reddy Guddeti MBBS (Reviewed by Gonzalo Romero)&lt;br /&gt;
|ExamType=USMLE Step 2 CK&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|Prompt=A-52-year old female undergoes percutaneous coronary intervention at a local community hospital.  5 weeks following discharge, she presents to her primary care physician complaining of sharp retrosternal chest pain, aggravated when lying flat and inspiration, and relieved when sitting up.  What is the treatment of choice of the most likely diagnosis?&lt;br /&gt;
|Explanation=This patient is returning to the office due to [[Dressler&#039;s syndrome]], which is a post myocardial infarction syndrome. It is a form of fibrinous pericarditis that occurs in the setting of injury to the heart (myocardial infarction). Typically, it occurs 2 to 10 weeks following a myocardial infarction. This differentiates Dressler&#039;s syndrome from the much more common post myocardial infarction pericarditis that occurs in 17 to 25% of cases of acute myocardial infarction between days 2 and 4 after the myocardial infarction. Dressler&#039;s syndrome also needs to be differentiated from pulmonary embolism, another identifiable cause of pleuritic (and non-pleuritic) chest pain in people who have been hospitalized and/or undergone surgical procedures within the preceding weeks.&lt;br /&gt;
It is believed to result from an autoimmune inflammatory reaction to myocardial neo-antigens.&lt;br /&gt;
&lt;br /&gt;
Dressler&#039;s syndrome is typically treated with high dose (up to 650 mg PO q 4 to 6 hours) enteric-coated [[aspirin]].  Acetominophen can be added for pain management as this does not affect the coagulation system.  Anticoagulants should be discontinued if the patient develops a pericardial effusion. &lt;br /&gt;
&lt;br /&gt;
[[Non-steroidal_anti-inflammatory_drug|NSAIDs]] such as [[ibuprofen]] should be avoided in the peri-infarct period as they:&lt;br /&gt;
#Increase the risk of [[reinfarction]] &lt;br /&gt;
#Adversely impact left ventricular remodeling&lt;br /&gt;
#Block the effectiveness of [[aspirin]]&lt;br /&gt;
|AnswerA=Corticosteroids&lt;br /&gt;
|AnswerAExp=Corticosteroids are not the treatment of choice in Dressler&#039;s syndrome.  Glucocorticoids and nonsteroidal antiinflammatory drugs are potentially harmful for treatment of pericarditis after STEMI.&lt;br /&gt;
|AnswerB=Aspirin&lt;br /&gt;
|AnswerBExp=Is the treatment of choice to treat Dressler&#039;s syndrome.&lt;br /&gt;
|AnswerC=Morphine&lt;br /&gt;
|AnswerCExp=Administration of [[acetaminophen]], [[colchicine]], or narcotic analgesics may be reasonable if aspirin, even in higher doses, is not effective.&lt;br /&gt;
|AnswerD=Colchicine&lt;br /&gt;
|AnswerDExp=Administration of acetaminophen, colchicine, or narcotic analgesics may be reasonable if aspirin, even in higher doses, is not effective.&lt;br /&gt;
|AnswerE=Rest&lt;br /&gt;
|AnswerEExp=Rest alone will not treat Dressler&#039;s syndrome.  Pharmacological therapy with aspirin is the recommended drug of choice.&lt;br /&gt;
|EducationalObjectives=Dressler&#039;s syndrome is a form of [[pericarditis]] that presents 2 to 10 weeks following a myocardial infarction.&lt;br /&gt;
The treatment of choice is high dose enteric coded aspirin.&lt;br /&gt;
Administration of acetaminophen, colchicine, or narcotic analgesics may be reasonable if aspirin, even in higher doses, is not effective.&lt;br /&gt;
|References=O&#039;Gara PT, Kushner FG, Ascheim DD, et al. (December 2012). &amp;quot;2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive Summary: A Report of the American College of Cardiology&lt;br /&gt;
|RightAnswer=B&lt;br /&gt;
|WBRKeyword=MI, Pericarditis, Aspirin, NSAIDs, Dressler&#039;s syndrome&lt;br /&gt;
|Approved=Yes&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Gonzalo Romero</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=WBR0018&amp;diff=956594</id>
		<title>WBR0018</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=WBR0018&amp;diff=956594"/>
		<updated>2014-03-15T19:55:11Z</updated>

		<summary type="html">&lt;p&gt;Gonzalo Romero: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{WBRQuestion&lt;br /&gt;
|QuestionAuthor=Aarti Narayan MBBS, Raviteja Reddy Guddeti MBBS (Reviewed by Gonzalo Romero)&lt;br /&gt;
|ExamType=USMLE Step 2 CK&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|Prompt=A-52-year old female undergoes percutaneous coronary intervention at a local community hospital.  5 weeks following discharge, she presents to her primary care physician complaining of sharp retrosternal chest pain, aggravated when lying flat and inspiration, and relieved when sitting up.  What is the treatment of choice of the most likely diagnosis?&lt;br /&gt;
|Explanation=This patient is returning to the office due to [[Dressler&#039;s syndrome]], which is a post myocardial infarction syndrome. It is a form of fibrinous pericarditis that occurs in the setting of injury to the heart (myocardial infarction). Typically, it occurs 2 to 10 weeks following a myocardial infarction. This differentiates Dressler&#039;s syndrome from the much more common post myocardial infarction pericarditis that occurs in 17 to 25% of cases of acute myocardial infarction between days 2 and 4 after the myocardial infarction. Dressler&#039;s syndrome also needs to be differentiated from pulmonary embolism, another identifiable cause of pleuritic (and non-pleuritic) chest pain in people who have been hospitalized and/or undergone surgical procedures within the preceding weeks.&lt;br /&gt;
It is believed to result from an autoimmune inflammatory reaction to myocardial neo-antigens.&lt;br /&gt;
&lt;br /&gt;
The treatment of choice is high dose enteric coated [[Aspirin]]. Acetaminophen may be added for pain management.&lt;br /&gt;
|AnswerA=Corticosteroids&lt;br /&gt;
|AnswerAExp=Corticosteroids are not the treatment of choice in Dressler&#039;s syndrome.  Glucocorticoids and nonsteroidal antiinflammatory drugs are potentially harmful for treatment of pericarditis after STEMI.&lt;br /&gt;
|AnswerB=Aspirin&lt;br /&gt;
|AnswerBExp=Is the treatment of choice to treat Dressler&#039;s syndrome.&lt;br /&gt;
|AnswerC=Morphine&lt;br /&gt;
|AnswerCExp=Administration of acetaminophen, colchicine, or narcotic analgesics may be reasonable if aspirin, even in higher doses, is not effective.&lt;br /&gt;
|AnswerD=Colchicine&lt;br /&gt;
|AnswerDExp=Administration of acetaminophen, colchicine, or narcotic analgesics may be reasonable if aspirin, even in higher doses, is not effective.&lt;br /&gt;
|AnswerE=Rest&lt;br /&gt;
|AnswerEExp=Rest alone will not treat Dressler&#039;s syndrome.  Pharmacological therapy with aspirin is the recommended drug of choice. &lt;br /&gt;
|EducationalObjectives=Dressler&#039;s syndrome is a form of pericarditis that presents 2 to 10 weeks following a myocardial infarction.&lt;br /&gt;
The treatment of choice is high dose enteric coded aspirin.&lt;br /&gt;
|References=O&#039;Gara PT, Kushner FG, Ascheim DD, et al. (December 2012). &amp;quot;2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive Summary: A Report of the American College of Cardiology &lt;br /&gt;
|RightAnswer=B&lt;br /&gt;
|WBRKeyword=MI, Pericarditis, Aspirin, NSAIDs, Dressler&#039;s syndrome&lt;br /&gt;
|Approved=Yes&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Gonzalo Romero</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=WBR0017&amp;diff=956588</id>
		<title>WBR0017</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=WBR0017&amp;diff=956588"/>
		<updated>2014-03-15T19:37:23Z</updated>

		<summary type="html">&lt;p&gt;Gonzalo Romero: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{WBRQuestion&lt;br /&gt;
|QuestionAuthor=Raviteja Reddy Guddeti MBBS, Aarti Narayan MBBS (Reviewed by Gonzalo Romero)&lt;br /&gt;
|ExamType=USMLE Step 2 CK&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|Prompt=A-65-year old male presents to the ER due to a crushing retrosternal chest pain, which started 20 minutes ago.  Additionally, he has nausea and diaphoresis. Following 2 hours of ER arrival, percutaneous coronary intervention is performed; he recovers over the next 5 days. 6 weeks following discharge, he returns to the office due to a mild retrosternal chest pain, which is aggravated when lying flat, and relieved when sitting up.  Concomitantly, he has a mild cough and runny nose consistent with a recent upper respiratory tract infection.  Complete blood count is within normal limits.  What is the most likely diagnosis?&lt;br /&gt;
|Explanation=This patient is returning to the office due to [[Dressler syndrome]], which is a post myocardial infarction syndrome.  It is a form of fibrinous pericarditis that occurs in the setting of injury to the heart (myocardial infarction). Typically, it occurs 2 to 10 weeks following a myocardial infarction.  It is usually treated with aspirin.  &lt;br /&gt;
* [[Acute pericarditis]] presents between 6 weeks to 6 months of the disease onset.  Acute pericarditis is more common than chronic pericarditis, and often occurs as a complication of viral infections, immunologic conditions, or as a result of a heart attack (myocardial infarction). &lt;br /&gt;
* Subacute pericarditis presents within 6 weeks to 6 months of the disease onset&lt;br /&gt;
* Chronic pericarditis manifests after 6 months of the disease onset. Chronic pericarditis is less common. It may manifest as scarring of the pericardium, which is a condition known as constrictive pericarditis.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;table&amp;gt;&lt;br /&gt;
&amp;lt;tr class=&amp;quot;Diagnosis&amp;quot;&amp;gt;&amp;lt;td&amp;gt; &amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;&#039;&#039;&#039;Typical Presentation&#039;&#039;&#039;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;&#039;&#039;&#039;Diagnostic Tests&#039;&#039;&#039; &amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&#039;&#039;&#039;Pericarditis&#039;&#039;&#039;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Pain aggravated supine and inspiration,  alleviated when sitting, friction rub&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;EKG with diffuse ST elevation and PR depressions followed by T-wave inversions &amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&#039;&#039;&#039;Costochondritis&#039;&#039;&#039;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Localized chest tenderness to palpation, localized&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Physical examination&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&#039;&#039;&#039;Aortic dissection&#039;&#039;&#039;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Acute onset, tearing pain radiated to the back, asymmetric pulses and BP between upper extremities, chronic hypertension&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;CXR with mediastinal widening, chest CT angiogram, MRI or TEE&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&#039;&#039;&#039;Pulmonary embolus&#039;&#039;&#039;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Sudden onset dyspnea, tachycardia and tachypnea&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Spiral CT, V/Q scan&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&#039;&#039;&#039;Pneumothorax&#039;&#039;&#039;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Pleuritic pain, shortness of breath, deviated trachea, trauma&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;CXR&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&#039;&#039;&#039;Pneumonia&#039;&#039;&#039;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Productive cough, hemoptysis, fever&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;CXR&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&#039;&#039;&#039;GERD&#039;&#039;&#039;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Acidic taste, chronic cough, hoarsenss&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Response to PPIs and antiacids&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&#039;&#039;&#039;PUD&#039;&#039;&#039;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Burning pain, change with eating&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Upper endoscopy&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;/table&amp;gt;&lt;br /&gt;
|AnswerA=Viral pericarditis&lt;br /&gt;
|AnswerAExp=Viral pericarditis is commonly caused by different virus such as:  Coxsackie B, Echovirus, HIV or Adenovirus.  It typically presents as an acute pericarditis with unspecific symptoms&lt;br /&gt;
It is important to consider the timeline of the chest pain occurring after the MI, which is 6 weeks in this case.  The history of this patient is consistent with Dressler&#039;s syndrome.&lt;br /&gt;
|AnswerB=Tuberculous pericarditis&lt;br /&gt;
|AnswerBExp=[[Tuberculous pericarditis]] usually presents with night sweats, weight loss and fever.  Pericardial fluid with an interferon-γ level greater than 50 pg/mL is highly specific for tuberculous pericarditis.  There is nothing else in the patient history to suggest a past medical history of [[tuberculosis]].&lt;br /&gt;
|AnswerC=Post-cardiac injury pericarditis&lt;br /&gt;
|AnswerCExp=Post-cardiac injury pericarditis, also known as post-myocardial infarction pericarditis has similar clinical presentation, but it occurs 2-4 days following an MI.  The pathophysiology is thought to be of autoimmune origin due to a reaction to the myocardial neo-antigens.&lt;br /&gt;
|AnswerD=Dressler’s syndrome&lt;br /&gt;
|AnswerDExp=This patient is returning to the office due to [[Dressler syndrome]], which is a post myocardial infarction syndrome.  It is a form of pericarditis that occurs in the setting of injury to the heart (myocardial infarction). Typically, it occurs 2 to 10 weeks following a myocardial infarction.&lt;br /&gt;
|AnswerE=Aortic dissection&lt;br /&gt;
|AnswerEExp=The history of MI suggests that [[myocardial infarction]] is the inciting factor for the pericarditis.&lt;br /&gt;
|EducationalObjectives=#[[Dressler syndrome]] is a form of pericarditis that presents 2 to 10 weeks following a myocardial infarction.  &lt;br /&gt;
# The symptoms of pericarditis include:  retrosternal chest pain aggravated when lying down and alleviated by sitting up.  The EKG may show diffuse ST segment elevations and PR interval depression.&lt;br /&gt;
Remember the causes of pericarditis using this mnemonic &#039;&#039;&#039;CARDIAC RIND&#039;&#039;&#039;, which stands for:  &lt;br /&gt;
* Collagen vascular disease&lt;br /&gt;
* Aortic dissection&lt;br /&gt;
* Radiation&lt;br /&gt;
* Drugs&lt;br /&gt;
* Infections&lt;br /&gt;
* Acute renal failure&lt;br /&gt;
* Cardiac (MI)&lt;br /&gt;
* Rheumatic fever&lt;br /&gt;
* Injury&lt;br /&gt;
* Neoplasms&lt;br /&gt;
* Dressler&#039;s syndrome&lt;br /&gt;
|References=Master the Boards for Step 2CK 2013 edition, page 54&lt;br /&gt;
&amp;lt;br&amp;gt; Read more here:  http://www.ncbi.nlm.nih.gov/pubmed/20194155&lt;br /&gt;
|RightAnswer=D&lt;br /&gt;
|WBRKeyword=MI, Pericarditis, Chest pain, Dressler syndrome&lt;br /&gt;
|Approved=Yes&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Gonzalo Romero</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=WBR0017&amp;diff=956586</id>
		<title>WBR0017</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=WBR0017&amp;diff=956586"/>
		<updated>2014-03-15T19:36:35Z</updated>

		<summary type="html">&lt;p&gt;Gonzalo Romero: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{WBRQuestion&lt;br /&gt;
|QuestionAuthor=Raviteja Reddy Guddeti MBBS, Aarti Narayan MBBS (Reviewed by Gonzalo Romero)&lt;br /&gt;
|ExamType=USMLE Step 2 CK&lt;br /&gt;
|Prompt=A-65-year old male presents to the ER due to a crushing retrosternal chest pain, which started 20 minutes ago.  Additionally, he has nausea and diaphoresis. Following 2 hours of ER arrival, percutaneous coronary intervention is performed; he recovers over the next 5 days. 6 weeks following discharge, he returns to the office due to a mild retrosternal chest pain, which is aggravated when lying flat, and relieved when sitting up.  Concomitantly, he has a mild cough and runny nose consistent with a recent upper respiratory tract infection.  Complete blood count is within normal limits.  What is the most likely diagnosis?&lt;br /&gt;
|Explanation=This patient is returning to the office due to [[Dressler syndrome]], which is a post myocardial infarction syndrome.  It is a form of fibrinous pericarditis that occurs in the setting of injury to the heart (myocardial infarction). Typically, it occurs 2 to 10 weeks following a myocardial infarction.  It is usually treated with aspirin.  &lt;br /&gt;
* [[Acute pericarditis]] presents between 6 weeks to 6 months of the disease onset.  Acute pericarditis is more common than chronic pericarditis, and often occurs as a complication of viral infections, immunologic conditions, or as a result of a heart attack (myocardial infarction). &lt;br /&gt;
* Subacute pericarditis presents within 6 weeks to 6 months of the disease onset&lt;br /&gt;
* Chronic pericarditis manifests after 6 months of the disease onset. Chronic pericarditis is less common. It may manifest as scarring of the pericardium, which is a condition known as constrictive pericarditis.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;table&amp;gt;&lt;br /&gt;
&amp;lt;tr class=&amp;quot;Diagnosis&amp;quot;&amp;gt;&amp;lt;td&amp;gt; &amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;&#039;&#039;&#039;Typical Presentation&#039;&#039;&#039;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;&#039;&#039;&#039;Diagnostic Tests&#039;&#039;&#039; &amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&#039;&#039;&#039;Pericarditis&#039;&#039;&#039;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Pain aggravated supine and inspiration,  alleviated when sitting, friction rub&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;EKG with diffuse ST elevation and PR depressions followed by T-wave inversions &amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&#039;&#039;&#039;Costochondritis&#039;&#039;&#039;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Localized chest tenderness to palpation, localized&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Physical examination&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&#039;&#039;&#039;Aortic dissection&#039;&#039;&#039;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Acute onset, tearing pain radiated to the back, asymmetric pulses and BP between upper extremities, chronic hypertension&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;CXR with mediastinal widening, chest CT angiogram, MRI or TEE&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&#039;&#039;&#039;Pulmonary embolus&#039;&#039;&#039;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Sudden onset dyspnea, tachycardia and tachypnea&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Spiral CT, V/Q scan&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&#039;&#039;&#039;Pneumothorax&#039;&#039;&#039;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Pleuritic pain, shortness of breath, deviated trachea, trauma&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;CXR&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&#039;&#039;&#039;Pneumonia&#039;&#039;&#039;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Productive cough, hemoptysis, fever&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;CXR&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&#039;&#039;&#039;GERD&#039;&#039;&#039;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Acidic taste, chronic cough, hoarsenss&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Response to PPIs and antiacids&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&#039;&#039;&#039;PUD&#039;&#039;&#039;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Burning pain, change with eating&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Upper endoscopy&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;/table&amp;gt;&lt;br /&gt;
|AnswerA=Viral pericarditis&lt;br /&gt;
|AnswerAExp=Viral pericarditis is commonly caused by different virus such as:  Coxsackie B, Echovirus, HIV or Adenovirus.  It typically presents as an acute pericarditis with unspecific symptoms&lt;br /&gt;
It is important to consider the timeline of the chest pain occurring after the MI, which is 6 weeks in this case.  The history of this patient is consistent with Dressler&#039;s syndrome.&lt;br /&gt;
|AnswerB=Tuberculous pericarditis&lt;br /&gt;
|AnswerBExp=[[Tuberculous pericarditis]] usually presents with night sweats, weight loss and fever.  Pericardial fluid with an interferon-γ level greater than 50 pg/mL is highly specific for tuberculous pericarditis.  There is nothing else in the patient history to suggest a past medical history of [[tuberculosis]].&lt;br /&gt;
|AnswerC=Post-cardiac injury pericarditis&lt;br /&gt;
|AnswerCExp=Post-cardiac injury pericarditis, also known as post-myocardial infarction pericarditis has similar clinical presentation, but it occurs 2-4 days following an MI.  The pathophysiology is thought to be of autoimmune origin due to a reaction to the myocardial neo-antigens.&lt;br /&gt;
|AnswerD=Dressler’s syndrome&lt;br /&gt;
|AnswerDExp=This patient is returning to the office due to [[Dressler syndrome]], which is a post myocardial infarction syndrome.  It is a form of pericarditis that occurs in the setting of injury to the heart (myocardial infarction). Typically, it occurs 2 to 10 weeks following a myocardial infarction.&lt;br /&gt;
|AnswerE=Aortic dissection&lt;br /&gt;
|AnswerEExp=The history of MI suggests that [[myocardial infarction]] is the inciting factor for the pericarditis.&lt;br /&gt;
|EducationalObjectives=#[[Dressler syndrome]] is a form of pericarditis that presents 2 to 10 weeks following a myocardial infarction.  &lt;br /&gt;
# The symptoms of pericarditis include:  retrosternal chest pain aggravated when lying down and alleviated by sitting up.  The EKG may show diffuse ST segment elevations and PR interval depression.&lt;br /&gt;
Remember the causes of pericarditis using this mnemonic &#039;&#039;&#039;CARDIAC RIND&#039;&#039;&#039;, which stands for:  &lt;br /&gt;
* Collagen vascular disease&lt;br /&gt;
* Aortic dissection&lt;br /&gt;
* Radiation&lt;br /&gt;
* Drugs&lt;br /&gt;
* Infections&lt;br /&gt;
* Acute renal failure&lt;br /&gt;
* Cardiac (MI)&lt;br /&gt;
* Rheumatic fever&lt;br /&gt;
* Injury&lt;br /&gt;
* Neoplasms&lt;br /&gt;
* Dressler&#039;s syndrome&lt;br /&gt;
|References=Master the Boards for Step 2CK 2013 edition, page 54&lt;br /&gt;
&amp;lt;br&amp;gt; Read more here:  http://www.ncbi.nlm.nih.gov/pubmed/20194155&lt;br /&gt;
|RightAnswer=D&lt;br /&gt;
|WBRKeyword=MI, Pericarditis, Chest pain&lt;br /&gt;
|Approved=Yes&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Gonzalo Romero</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=WBR0017&amp;diff=956582</id>
		<title>WBR0017</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=WBR0017&amp;diff=956582"/>
		<updated>2014-03-15T19:33:54Z</updated>

		<summary type="html">&lt;p&gt;Gonzalo Romero: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{WBRQuestion&lt;br /&gt;
|QuestionAuthor=Raviteja Reddy Guddeti MBBS, Aarti Narayan MBBS (Reviewed by Gonzalo Romero)&lt;br /&gt;
|ExamType=USMLE Step 2 CK&lt;br /&gt;
|Prompt=A-65-year old male presents to the ER due to a crushing retrosternal chest pain, which started 20 minutes ago.  Additionally, he has nausea and diaphoresis. Following 2 hours of ER arrival, percutaneous coronary intervention is performed; he recovers over the next 5 days. 6 weeks following discharge, he returns to the office due to a mild retrosternal chest pain, which is aggravated when lying flat, and relieved when sitting up.  Concomitantly, he has a mild cough and runny nose consistent with a recent upper respiratory tract infection.  Complete blood count is within normal limits.  What is the most likely diagnosis?&lt;br /&gt;
|Explanation=This patient is returning to the office due to [[Dressler syndrome]], which is a post myocardial infarction syndrome.  It is a form of fibrinous pericarditis that occurs in the setting of injury to the heart (myocardial infarction). Typically, it occurs 2 to 10 weeks following a myocardial infarction.  It is usually treated with aspirin.  &lt;br /&gt;
* [[Acute pericarditis]] presents between 6 weeks to 6 months of the disease onset.  Acute pericarditis is more common than chronic pericarditis, and often occurs as a complication of viral infections, immunologic conditions, or as a result of a heart attack (myocardial infarction). &lt;br /&gt;
* Subacute pericarditis presents within 6 weeks to 6 months of the disease onset&lt;br /&gt;
* Chronic pericarditis manifests after 6 months of the disease onset. Chronic pericarditis is less common. It may manifest as scarring of the pericardium, which is a condition known as constrictive pericarditis.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;table&amp;gt;&lt;br /&gt;
&amp;lt;tr class=&amp;quot;Diagnosis&amp;quot;&amp;gt;&amp;lt;td&amp;gt; &amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;&#039;&#039;&#039;Typical Presentation&#039;&#039;&#039;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;&#039;&#039;&#039;Diagnostic Tests&#039;&#039;&#039; &amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&#039;&#039;&#039;Pericarditis&#039;&#039;&#039;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Pain aggravated by lying and alleviated when sitting, friction rub&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;EKG with diffuse ST elevation and PR depressions followed by T-wave inversions &amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&#039;&#039;&#039;Costochondritis&#039;&#039;&#039;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Localized chest tenderness to palpation, localized&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Physical examination&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&#039;&#039;&#039;Aortic dissection&#039;&#039;&#039;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Acute onset, tearing pain radiated to the back, asymmetric pulses and BP between upper extremities, chronic hypertension&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;CXR with mediastinal widening, chest CT angiogram, MRI or TEE&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&#039;&#039;&#039;Pulmonary embolus&#039;&#039;&#039;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Sudden onset dyspnea, tachycardia and tachypnea&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Spiral CT, V/Q scan&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&#039;&#039;&#039;Pneumothorax&#039;&#039;&#039;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Pleuritic pain, shortness of breath, deviated trachea, trauma&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;CXR&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&#039;&#039;&#039;Pneumonia&#039;&#039;&#039;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Productive cough, hemoptysis, fever&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;CXR&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&#039;&#039;&#039;GERD&#039;&#039;&#039;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Acidic taste, chronic cough, hoarsenss&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Response to PPIs and antiacids&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&#039;&#039;&#039;PUD&#039;&#039;&#039;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Burning pain, change with eating&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Upper endoscopy&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;/table&amp;gt;&lt;br /&gt;
|AnswerA=Viral pericarditis&lt;br /&gt;
|AnswerAExp=Viral pericarditis is commonly caused by different virus such as:  Coxsackie B, Echovirus, HIV or Adenovirus.  It typically presents as an acute pericarditis with unspecific symptoms&lt;br /&gt;
It is important to consider the timeline of the chest pain occurring after the MI, which is 6 weeks in this case.  The history of this patient is consistent with Dressler&#039;s syndrome.&lt;br /&gt;
|AnswerB=Tuberculous pericarditis&lt;br /&gt;
|AnswerBExp=[[Tuberculous pericarditis]] usually presents with night sweats, weight loss and fever.  Pericardial fluid with an interferon-γ level greater than 50 pg/mL is highly specific for tuberculous pericarditis.  There is nothing else in the patient history to suggest a past medical history of [[tuberculosis]].  &lt;br /&gt;
|AnswerC=Post-cardiac injury pericarditis&lt;br /&gt;
|AnswerCExp=Post-cardiac injury pericarditis, also known as post-myocardial infarction pericarditis has similar clinical presentation, but it occurs 2-4 days following an MI.  The pathophysiology is thought to be of autoimmune origin due to a reaction to the myocardial neo-antigens.&lt;br /&gt;
|AnswerD=Dressler’s syndrome&lt;br /&gt;
|AnswerDExp=This patient is returning to the office due to [[Dressler syndrome]], which is a post myocardial infarction syndrome.  It is a form of pericarditis that occurs in the setting of injury to the heart (myocardial infarction). Typically, it occurs 2 to 10 weeks following a myocardial infarction.&lt;br /&gt;
|AnswerE=Aortic dissection&lt;br /&gt;
|AnswerEExp=The history of MI suggests that [[myocardial infarction]] is the inciting factor for the pericarditis.&lt;br /&gt;
|EducationalObjectives=#[[Dressler syndrome]] is a form of pericarditis that presents 2 to 10 weeks following a myocardial infarction.  &lt;br /&gt;
# The symptoms of pericarditis include:  retrosternal chest pain aggravated when lying down and alleviated by sitting up.  The EKG may show diffuse ST segment elevations and PR interval depression.&lt;br /&gt;
Remember the causes of pericarditis using this mnemonic &#039;&#039;&#039;CARDIAC RIND&#039;&#039;&#039;, which stands for:  &lt;br /&gt;
* Collagen vascular disease&lt;br /&gt;
* Aortic dissection&lt;br /&gt;
* Radiation&lt;br /&gt;
* Drugs&lt;br /&gt;
* Infections&lt;br /&gt;
* Acute renal failure&lt;br /&gt;
* Cardiac (MI)&lt;br /&gt;
* Rheumatic fever&lt;br /&gt;
* Injury&lt;br /&gt;
* Neoplasms&lt;br /&gt;
* Dressler&#039;s syndrome&lt;br /&gt;
|References=Master the Boards for Step 2CK 2013 edition, page 54&lt;br /&gt;
&amp;lt;br&amp;gt; Read more here:  http://www.ncbi.nlm.nih.gov/pubmed/20194155&lt;br /&gt;
|RightAnswer=D&lt;br /&gt;
|WBRKeyword=MI, Pericarditis, Chest pain&lt;br /&gt;
|Approved=Yes&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Gonzalo Romero</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=WBR0017&amp;diff=956572</id>
		<title>WBR0017</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=WBR0017&amp;diff=956572"/>
		<updated>2014-03-15T19:22:33Z</updated>

		<summary type="html">&lt;p&gt;Gonzalo Romero: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{WBRQuestion&lt;br /&gt;
|QuestionAuthor=Raviteja Reddy Guddeti MBBS, Aarti Narayan MBBS (Reviewed by Gonzalo Romero)&lt;br /&gt;
|ExamType=USMLE Step 2 CK&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|Prompt=A-65-year old male presents to the ER due to a crushing retrosternal chest pain, which started 20 minutes ago.  Additionally, he has nausea and diaphoresis. Following 2 hours of ER arrival, percutaneous coronary intervention is performed; he recovers over the next 5 days. 6 weeks following discharge, he returns to the office due to a mild retrosternal chest pain, which is aggravated when lying flat, and relieved when sitting up.  Concomitantly, he has a mild cough and runny nose consistent with a recent upper respiratory tract infection.  Complete blood count is within normal limits.  What is the most likely diagnosis?&lt;br /&gt;
|Explanation=This patient is returning to the office due to [[Dressler syndrome]], which is a post myocardial infarction syndrome.  It is a form of pericarditis that occurs in the setting of injury to the heart (myocardial infarction). Typically, it occurs 2 to 10 weeks following a myocardial infarction.&lt;br /&gt;
* [[Acute pericarditis]] presents between 6 weeks to 6 months of the disease onset.  Acute pericarditis is more common than chronic pericarditis, and often occurs as a complication of viral infections, immunologic conditions, or as a result of a heart attack (myocardial infarction). &lt;br /&gt;
* Subacute pericarditis presents within 6 weeks to 6 months of the disease onset&lt;br /&gt;
* Chronic pericarditis manifests after 6 months of the disease onset. Chronic pericarditis is less common. It may manifest as scarring of the pericardium, which is a condition known as constrictive pericarditis.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;table&amp;gt;&lt;br /&gt;
&amp;lt;tr class=&amp;quot;Diagnosis&amp;quot;&amp;gt;&amp;lt;td&amp;gt; &amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;&#039;&#039;&#039;Typical Presentation&#039;&#039;&#039;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;&#039;&#039;&#039;Diagnostic Tests&#039;&#039;&#039; &amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&#039;&#039;&#039;Pericarditis&#039;&#039;&#039;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Pain aggravated by lying and alleviated when sitting, friction rub&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;EKG with diffuse ST elevation and PR depressions followed by T-wave inversions &amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&#039;&#039;&#039;Costochondritis&#039;&#039;&#039;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Localized chest tenderness to palpation, localized&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Physical examination&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&#039;&#039;&#039;Aortic dissection&#039;&#039;&#039;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Acute onset, tearing pain radiated to the back, asymmetric pulses and BP between upper extremities, chronic hypertension&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;CXR with mediastinal widening, chest CT angiogram, MRI or TEE&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&#039;&#039;&#039;Pulmonary embolus&#039;&#039;&#039;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Sudden onset dyspnea, tachycardia and tachypnea&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Spiral CT, V/Q scan&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&#039;&#039;&#039;Pneumothorax&#039;&#039;&#039;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Pleuritic pain, shortness of breath, deviated trachea, trauma&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;CXR&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&#039;&#039;&#039;Pneumonia&#039;&#039;&#039;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Productive cough, hemoptysis, fever&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;CXR&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&#039;&#039;&#039;GERD&#039;&#039;&#039;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Acidic taste, chronic cough, hoarsenss&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Response to PPIs and antiacids&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&#039;&#039;&#039;PUD&#039;&#039;&#039;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Burning pain, change with eating&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Upper endoscopy&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;/table&amp;gt;&lt;br /&gt;
|AnswerA=Viral pericarditis&lt;br /&gt;
|AnswerAExp=Viral pericarditis caused by different virus, commonly Coxsackie B virus, Echovirus, HIV or Adenovirus.  It typically presents as an acute pericarditis. &lt;br /&gt;
It is important to consider the timeline of the chest pain occurring after the MI, which is 6 weeks in this case.  The history of this patient is consistent with Dressler&#039;s syndrome.&lt;br /&gt;
|AnswerB=Tuberculous pericarditis&lt;br /&gt;
|AnswerBExp=There is nothing else in the patient history to suggest a different form of pericarditis, and no past medical history of [[tuberculosis]].&lt;br /&gt;
|AnswerC=Post-cardiac injury pericarditis&lt;br /&gt;
|AnswerCExp=Post-cardiac injury pericarditis, also known as post-myocardial infarction pericarditis has similar clinical presentation, but it occurs 2-4 days following an MI.  The pathophysiology is thought to be of autoimmune origin due to a reaction to the myocardial neo-antigens.&lt;br /&gt;
|AnswerD=Dressler’s syndrome&lt;br /&gt;
|AnswerDExp=This patient is returning to the office due to [[Dressler syndrome]], which is a post myocardial infarction syndrome.  It is a form of pericarditis that occurs in the setting of injury to the heart (myocardial infarction). Typically, it occurs 2 to 10 weeks following a myocardial infarction.&lt;br /&gt;
|AnswerE=Aortic dissection&lt;br /&gt;
|AnswerEExp=The history of MI suggests that [[myocardial infarction]] is the inciting factor for the pericarditis.&lt;br /&gt;
|EducationalObjectives=#[[Dressler syndrome]] is a form of pericarditis that presents 2 to 10 weeks following a myocardial infarction.  &lt;br /&gt;
# The symptoms of pericarditis include:  retrosternal chest pain aggravated when lying down and alleviated by sitting up.  The EKG may show diffuse ST segment elevations and PR interval depression.&lt;br /&gt;
Remember the causes of pericarditis using this mnemonic &#039;&#039;&#039;CARDIAC RIND&#039;&#039;&#039;, which stands for:  &lt;br /&gt;
* Collagen vascular disease&lt;br /&gt;
* Aortic dissection&lt;br /&gt;
* Radiation&lt;br /&gt;
* Drugs&lt;br /&gt;
* Infections&lt;br /&gt;
* Acute renal failure&lt;br /&gt;
* Cardiac (MI)&lt;br /&gt;
* Rheumatic fever&lt;br /&gt;
* Injury&lt;br /&gt;
* Neoplasms&lt;br /&gt;
* Dressler&#039;s syndrome&lt;br /&gt;
|References=Master the Boards for Step 2CK 2013 edition, page 54&lt;br /&gt;
&amp;lt;br&amp;gt; Read more here:  http://www.ncbi.nlm.nih.gov/pubmed/20194155&lt;br /&gt;
|RightAnswer=D&lt;br /&gt;
|WBRKeyword=MI, Pericarditis, Chest pain&lt;br /&gt;
|Approved=Yes&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Gonzalo Romero</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=WBR0017&amp;diff=956559</id>
		<title>WBR0017</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=WBR0017&amp;diff=956559"/>
		<updated>2014-03-15T18:55:05Z</updated>

		<summary type="html">&lt;p&gt;Gonzalo Romero: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{WBRQuestion&lt;br /&gt;
|QuestionAuthor=Raviteja Reddy Guddeti MBBS, Aarti Narayan MBBS (Reviewed by Gonzalo Romero)&lt;br /&gt;
|ExamType=USMLE Step 2 CK&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|Prompt=A-65-year old male presents to the ER due to a crushing retrosternal chest pain, which started 20 minutes ago.  Additionally, he has nausea and diaphoresis. Following 2 hours of ER arrival, percutaneous coronary intervention is performed; he recovers over the next 5 days. 6 weeks following discharge, he returns to the office due to a mild retrosternal chest pain, which is aggravated when lying flat, and relieved when sitting up.  Concomitantly, he has a mild cough and runny nose consistent with a recent upper respiratory tract infection.  Complete blood count is within normal limits.  What is the most likely diagnosis?&lt;br /&gt;
|Explanation=This patient is returning to the office due to [[Dressler syndrome]], which is a post myocardial infarction syndrome.  It is a form of pericarditis that occurs in the setting of injury to the heart (myocardial infarction). Typically, it occurs 2 to 10 weeks following a myocardial infarction.&lt;br /&gt;
* [[Acute pericarditis]] presents between 6 weeks to 6 months of the disease onset.  Acute pericarditis is more common than chronic pericarditis, and often occurs as a complication of viral infections, immunologic conditions, or as a result of a heart attack (myocardial infarction). &lt;br /&gt;
* Subacute pericarditis presents within 6 weeks to 6 months of the disease onset&lt;br /&gt;
* Chronic pericarditis manifests after 6 months of the disease onset. Chronic pericarditis is less common. It may manifest as scarring of the pericardium, which is a condition known as constrictive pericarditis.&lt;br /&gt;
|AnswerA=Viral pericarditis&lt;br /&gt;
|AnswerAExp=Viral pericarditis caused by different virus, commonly Coxsackie B virus, Echovirus, HIV or Adenovirus.  It typically presents as an acute pericarditis. &lt;br /&gt;
It is important to consider the timeline of the chest pain occurring after the MI, which is 6 weeks in this case.  The history of this patient is consistent with Dressler&#039;s syndrome.&lt;br /&gt;
|AnswerB=Tuberculous pericarditis&lt;br /&gt;
|AnswerBExp=There is nothing else in the patient history to suggest a different form of pericarditis, and no past medical history of [[tuberculosis]].&lt;br /&gt;
|AnswerC=Post-cardiac injury pericarditis&lt;br /&gt;
|AnswerCExp=Post-cardiac injury pericarditis, also known as post-myocardial infarction pericarditis has similar clinical presentation, but it occurs 2-4 days following an MI.  The pathophysiology is thought to be of autoimmune origin due to a reaction to the myocardial neo-antigens.&lt;br /&gt;
|AnswerD=Dressler’s syndrome&lt;br /&gt;
|AnswerDExp=This patient is returning to the office due to [[Dressler syndrome]], which is a post myocardial infarction syndrome.  It is a form of pericarditis that occurs in the setting of injury to the heart (myocardial infarction). Typically, it occurs 2 to 10 weeks following a myocardial infarction.&lt;br /&gt;
|AnswerE=Aortic dissection&lt;br /&gt;
|AnswerEExp=The history of MI suggests that [[myocardial infarction]] is the inciting factor for the pericarditis.&lt;br /&gt;
|EducationalObjectives=# [[Dressler syndrome]] is a form of pericarditis that presents 2 to 10 weeks following a myocardial infarction.  &lt;br /&gt;
# The symptoms of pericarditis include:  retrosternal chest pain aggravated when lying down and alleviated by sitting up.  The EKG may show diffuse ST segment elevations and PR interval depression.&lt;br /&gt;
|References=Master the Boards for Step 2CK 2013 edition, page 54&lt;br /&gt;
&amp;lt;br&amp;gt; Read more here:  http://www.ncbi.nlm.nih.gov/pubmed/20194155&lt;br /&gt;
|RightAnswer=D&lt;br /&gt;
|WBRKeyword=MI, Pericarditis, Chest pain&lt;br /&gt;
|Approved=Yes&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Gonzalo Romero</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=WBR0017&amp;diff=956556</id>
		<title>WBR0017</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=WBR0017&amp;diff=956556"/>
		<updated>2014-03-15T18:53:34Z</updated>

		<summary type="html">&lt;p&gt;Gonzalo Romero: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{WBRQuestion&lt;br /&gt;
|QuestionAuthor=Raviteja Reddy Guddeti MBBS, Aarti Narayan MBBS (Reviewed by Gonzalo Romero)&lt;br /&gt;
|ExamType=USMLE Step 2 CK&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|Prompt=A-65-year old male presents to the ER due to a crushing retrosternal chest pain, which started 20 minutes ago.  Additionally, he has nausea and diaphoresis. Following 2 hours of ER arrival, percutaneous coronary intervention is performed; he recovers over the next 5 days. 6 weeks following discharge, he returns to the office due to a mild retrosternal chest pain, which is aggravated when lying flat, and relieved when sitting up.  Concomitantly, he has a mild cough and runny nose consistent with a recent upper respiratory tract infection.  Complete blood count is within normal limits.  What is the most likely diagnosis?&lt;br /&gt;
|Explanation=This patient is returning to the office due to [[Dressler syndrome]], which is a post myocardial infarction syndrome.  It is a form of pericarditis that occurs in the setting of injury to the heart (myocardial infarction). Typically, it occurs 2 to 10 weeks following a myocardial infarction.&lt;br /&gt;
* [[Acute pericarditis]] presents between 6 weeks to 6 months of the disease onset.  Acute pericarditis is more common than chronic pericarditis, and often occurs as a complication of viral infections, immunologic conditions, or as a result of a heart attack (myocardial infarction). &lt;br /&gt;
* Subacute pericarditis presents within 6 weeks to 6 months of the disease onset&lt;br /&gt;
* Chronic pericarditis manifests after 6 months of the disease onset. Chronic pericarditis is less common. It may manifest as scarring of the pericardium, which is a condition known as constrictive pericarditis.&lt;br /&gt;
&lt;br /&gt;
|AnswerA=Viral pericarditis&lt;br /&gt;
|AnswerAExp=Viral pericarditis caused by different virus, commonly Coxsackie B virus, Echovirus, HIV or Adenovirus.  It typically presents as an acute pericarditis. &lt;br /&gt;
It is important to consider the timeline of the chest pain occurring after the MI, which is 6 weeks in this case.  The history of this patient is consistent with Dressler&#039;s syndrome. &lt;br /&gt;
|AnswerB=Tuberculous pericarditis&lt;br /&gt;
|AnswerBExp=There is nothing else in the patient history to suggest a different form of pericarditis, and no past medical history of [[tuberculosis]].&lt;br /&gt;
|AnswerC=Post-cardiac injury pericarditis&lt;br /&gt;
|AnswerCExp=Post-cardiac injury pericarditis, also known as post-myocardial infarction pericarditis has similar clinical presentation, but it occurs 2-4 days following an MI.  The pathophysiology is thought to be of autoimmune origin due to a reaction to the myocardial neo-antigens.&lt;br /&gt;
|AnswerD=Dressler’s syndrome&lt;br /&gt;
|AnswerDExp=This patient is returning to the office due to [[Dressler syndrome]], which is a post myocardial infarction syndrome.  It is a form of pericarditis that occurs in the setting of injury to the heart (myocardial infarction). Typically, it occurs 2 to 10 weeks following a myocardial infarction.&lt;br /&gt;
|AnswerE=Aortic dissection&lt;br /&gt;
|AnswerEExp=The history of MI suggests that [[myocardial infarction]] is the inciting factor for the pericarditis.&lt;br /&gt;
|EducationalObjectives=[[Dressler syndrome]] is a form of pericarditis that presents 2 to 10 weeks following a myocardial infarction.  &lt;br /&gt;
The symptoms of pericarditis include:  retrosternal chest pain aggravated when lying down and alleviated by sitting up.  The EKG may show diffuse ST segment elevations and PR interval depression.&lt;br /&gt;
|References=Master the Boards for Step 2CK page 54&lt;br /&gt;
Read more here:  http://www.ncbi.nlm.nih.gov/pubmed/20194155&lt;br /&gt;
|RightAnswer=D&lt;br /&gt;
|WBRKeyword=MI, Pericarditis, Chest pain&lt;br /&gt;
|Approved=Yes&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Gonzalo Romero</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=Sepsis_resident_survival_guide&amp;diff=947806</id>
		<title>Sepsis resident survival guide</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=Sepsis_resident_survival_guide&amp;diff=947806"/>
		<updated>2014-02-26T01:44:47Z</updated>

		<summary type="html">&lt;p&gt;Gonzalo Romero: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Sepsis}}&lt;br /&gt;
{{CMG}}; {{AE}} {{AZ}}&lt;br /&gt;
&lt;br /&gt;
==Definition==&lt;br /&gt;
:*&#039;&#039;&#039;Sepsis = Infection + SIRS&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
:*The presence of systemic inflammatory syndrome (SIRS) is due to many factors. The presence of infection increases the chances of sepsis and increase the SIRS criteria .&lt;br /&gt;
&lt;br /&gt;
:*The endothelial dysfunction is the main trigger transforming the localized infection into systemic organ dysfunction&lt;br /&gt;
&lt;br /&gt;
:* There is no definitive biomarkers have been associated with the endothelial dysfunction of sepsis.&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;SIRS&#039;&#039;&#039; is diagnosed by &#039;&#039;&#039;2&#039;&#039;&#039; or more of the following:&lt;br /&gt;
::*[[Tachycardia]] &amp;gt; 90 bpm&lt;br /&gt;
::*[[Tachypnea]] &amp;gt; 20 breaths per minute or on [[blood gas]], a P&amp;lt;sub&amp;gt;a&amp;lt;/sub&amp;gt;CO&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt; &amp;lt; 32 mm Hg&lt;br /&gt;
::*[[Temperature]] &amp;lt; 36 (96.8 °F) or &amp;gt; 38 °C (100.4 °F)&lt;br /&gt;
::*[[White blood cell]] count &amp;lt; 4000 cells/mm³ ( &amp;lt; 4 x 10&amp;lt;sup&amp;gt;9&amp;lt;/sup&amp;gt;cells/[[litre|L]] ) or &amp;gt; 12000 cells/mm³ ( &amp;gt; 12 x 10&amp;lt;sup&amp;gt;9&amp;lt;/sup&amp;gt; cells/[[litre|L]])  or &amp;gt; 10% bandemia ( immature WBCs ).&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;[[Sepsis]]&#039;&#039;&#039; is diagnosed by at least &#039;&#039;&#039;1&#039;&#039;&#039; of the following signs of organ failure: [&#039;&#039;&#039;HOME&#039;&#039;&#039;]&lt;br /&gt;
::*&#039;&#039;&#039;H&#039;&#039;&#039;ypoxemia (arterial oxygen tension [PaO2] &amp;lt; 72 mm Hg at fraction of inspired oxygen [FiO2] 0.21; overt pulmonary disease not the direct cause of hypoxemia)&lt;br /&gt;
::*&#039;&#039;&#039;O&#039;&#039;&#039;iguria (urine output &amp;lt; 30 mL or 0.5 mL/kg for at least 1 h)&lt;br /&gt;
::*&#039;&#039;&#039;M&#039;&#039;&#039;ental status alteration&lt;br /&gt;
::*&#039;&#039;&#039;E&#039;&#039;&#039;levated plasma lactate level &amp;gt; 4 mmol/L &lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Severe sepsis&#039;&#039;&#039;&lt;br /&gt;
::*[[Sepsis]] + organ dysfunction&lt;br /&gt;
::*Organ damage can present as decreased urine output, acute kidney injury, and elevated liver function tests.&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Septic shock&#039;&#039;&#039;&lt;br /&gt;
::*Severe sepsis + persistent [[hypotension]] after adequate fluid challenge.&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Multiple organ dysfunction syndrome&#039;&#039;&#039; (&#039;&#039;&#039;MODS&#039;&#039;&#039;) is the presence of altered organ function in a acutely ill patient whom homeostasis cannot be maintained without intervention.&lt;br /&gt;
&lt;br /&gt;
===Diagnostic Criteria For Sepsis (Documented/Suspected Infection &#039;&#039;&#039;Plus&#039;&#039;&#039; Inflammatory variables&#039;&#039;&#039;Plus&#039;&#039;&#039; One of The Organ Dysfunction)===&lt;br /&gt;
----&lt;br /&gt;
:&#039;&#039;&#039;General variables&#039;&#039;&#039;&lt;br /&gt;
:*Fever &amp;gt; 38.3°C&lt;br /&gt;
:*Hypothermia ( core temperature &amp;lt; 36°C )&lt;br /&gt;
:*Heart rate &amp;gt; 90/min–1 or &amp;gt; 2 SD above the normal value for age&lt;br /&gt;
:*Tachypnea&lt;br /&gt;
:*Altered mental status&lt;br /&gt;
:*Edema&lt;br /&gt;
:*Positive fluid balance ( &amp;gt; 20 mL/kg over 24 hr)&lt;br /&gt;
:*Hyperglycemia ( plasma glucose &amp;gt; 140 mg/dL or 7.7 mmol/L ) in the absence of diabetes&lt;br /&gt;
&lt;br /&gt;
:&#039;&#039;&#039;Inflammatory variables&#039;&#039;&#039;&lt;br /&gt;
:*Leukocytosis ( WBC count &amp;gt; 12,000 µL–1 )&lt;br /&gt;
:*Leukopenia ( WBC count &amp;lt; 4000 µL–1 )&lt;br /&gt;
:*Immature WBCs forms are &amp;gt; 10% with normal count&lt;br /&gt;
:*Plasma C-reactive protein &amp;gt; 2 SD above the normal value&lt;br /&gt;
:*Plasma procalcitonin &amp;gt; 2 SD above the normal value&lt;br /&gt;
:*Hemodynamic variables&lt;br /&gt;
:*Arterial hypotension after 30 ml/kg fluid bolus  ( SBP &amp;lt; 90 mm Hg, MAP &amp;lt; 70 mm Hg, or an SBP decrease &amp;gt; 40 mm Hg in adults or &amp;lt; 2 SD below normal for age )&lt;br /&gt;
&lt;br /&gt;
:&#039;&#039;&#039;Organ dysfunction variables&#039;&#039;&#039;&lt;br /&gt;
:*Arterial hypoxemia ( Pao2/Fio2 &amp;lt; 300 )&lt;br /&gt;
:*Acute oliguria ( urine output &amp;lt; 0.5 mL/kg/hr for at least 2 hrs despite adequate fluid resuscitation )&lt;br /&gt;
:*Creatinine increase &amp;gt; 0.5 mg/dL or 44.2 µmol/L&lt;br /&gt;
:*Coagulation abnormalities ( INR &amp;gt; 1.5 or aPTT &amp;gt; 60 Sec )&lt;br /&gt;
:*Ileus ( absent bowel sounds )&lt;br /&gt;
:*Thrombocytopenia ( platelet count &amp;lt; 100,000 µL–1 )&lt;br /&gt;
:*Hyperbilirubinemia ( plasma total bilirubin &amp;gt; 4 mg/dL or 70 µmol/L )&lt;br /&gt;
:*Tissue perfusion variables&lt;br /&gt;
:*Hyperlactatemia &amp;gt; 1 mmol/L&lt;br /&gt;
:*Decreased capillary refill or mottling&lt;br /&gt;
:*Evidence of acute lung injury (&#039;&#039;&#039;ALI&#039;&#039;&#039;):&amp;lt;ref name=&amp;quot;Bernard-1994&amp;quot;&amp;gt;{{Cite journal  | last1 = Bernard | first1 = GR. | last2 = Artigas | first2 = A. | last3 = Brigham |first3 = KL. | last4 = Carlet | first4 = J. | last5 = Falke | first5 = K. | last6 = Hudson | first6 = L. | last7 = Lamy | first7 = M. | last8 = Legall |first8 = JR. |last9 = Morris | first9 = A. | title = The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. | journal = Am J Respir Crit Care Med | volume = 149 | issue = 3 Pt 1 | pages = 818-24 | month = Mar | year = 1994 |doi = 10.1164/ajrccm.149.3.7509706 | PMID = 7509706 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
::# Oxygenation abnormality with a PaO2/FiO2 ratio &amp;lt; 300&lt;br /&gt;
::# Chest Xray with bilateral opacities compatible with pulmonary edema&lt;br /&gt;
::# PA &amp;lt; 18 mm Hg or no clinical evidence of left atrial hypertension if PaO2 is not available&lt;br /&gt;
:*Acute respiratory distress syndrome (&#039;&#039;&#039;ARDS&#039;&#039;&#039;) is a more severe form of ALI and is defined similarly but a characteristic PaO2/FiO2 ratio is &amp;lt; 200&lt;br /&gt;
&lt;br /&gt;
==Causes==&lt;br /&gt;
&lt;br /&gt;
===Life Threatening Causes===&lt;br /&gt;
&lt;br /&gt;
:*Bacteremia: 95% of positive blood cultures were associated with sepsis, severe sepsis, or septic shock.&amp;lt;ref name=&amp;quot;Jones-1996&amp;quot;&amp;gt;{{Cite journal  | last1 = Jones | first1 = GR. | last2 = Lowes | first2 = JA. | title = The systemic inflammatory response syndrome as a predictor of bacteraemia and outcome from sepsis. | journal = QJM | volume = 89 | issue = 7 | pages = 515-22 | month = Jul | year = 1996 | doi =  | PMID = 8759492 }}&amp;lt;/ref&amp;gt;. However septic shock can occur without bacteremia &amp;quot;viable bacteria in the blood&amp;quot;. In fact, septic shock is associated with culture-positive bacteremia in only 30-50% of cases.&amp;lt;ref name=&amp;quot;Brun-Buisson-1995&amp;quot;&amp;gt;{{Cite journal  | last1 = Brun-Buisson | first1 = C. | last2 = Doyon | first2 = F. | last3 = Carlet | first3 = J. | last4 = Dellamonica | first4 = P. | last5 = Gouin | first5 = F. | last6 = Lepoutre | first6 = A. | last7 = Mercier | first7 = JC. | last8 = Offenstadt | first8 = G. |last9 = Régnier | first9 = B. | title = Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis. | journal = JAMA | volume = 274 | issue = 12 | pages = 968-74 | month = Sep | year = 1995 | doi =  |PMID = 7674528 }}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;Sands-1997&amp;quot;&amp;gt;{{Cite journal  | last1 = Sands | first1 = KE. | last2 = Bates | first2 = DW. | last3 = Lanken | first3 = PN. |last4 = Graman | first4 = PS. | last5 = Hibberd | first5 = PL. | last6 = Kahn | first6 = KL. | last7 = Parsonnet | first7 = J. | last8 = Panzer | first8 = R.| last9 = Orav | first9 = EJ. | title = Epidemiology of sepsis syndrome in 8 academic medical centers. | journal = JAMA | volume = 278 | issue = 3 | pages = 234-40 | month = Jul | year = 1997 | doi =  | PMID = 9218672 }}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;Kumar-2006&amp;quot;&amp;gt;{{Cite journal  | last1 = Kumar | first1 = A. | last2 = Roberts |first2 = D. | last3 = Wood | first3 = KE. | last4 = Light | first4 = B. | last5 = Parrillo | first5 = JE. | last6 = Sharma | first6 = S. | last7 = Suppes |first7 = R. | last8 = Feinstein | first8 = D. | last9 = Zanotti | first9 = S. | title = Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. | journal = Crit Care Med | volume = 34 | issue = 6 | pages = 1589-96 | month = Jun |year = 2006 | doi = 10.1097/01.CCM.0000217961.75225.E9 | PMID = 16625125 }}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;Bernard-2001&amp;quot;&amp;gt;{{Cite journal  | last1 = Bernard | first1 = GR. |last2 = Vincent | first2 = JL. | last3 = Laterre | first3 = PF. | last4 = LaRosa | first4 = SP. | last5 = Dhainaut | first5 = JF. | last6 = Lopez-Rodriguez |first6 = A. | last7 = Steingrub | first7 = JS. | last8 = Garber | first8 = GE. | last9 = Helterbrand | first9 = JD. | title = Efficacy and safety of recombinant human activated protein C for severe sepsis. | journal = N Engl J Med | volume = 344 | issue = 10 | pages = 699-709 | month = Mar | year = 2001 |doi = 10.1056/NEJM200103083441001 | PMID = 11236773 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Common Causes===&lt;br /&gt;
&lt;br /&gt;
:*Community acquired pneumonia: 48% develop severe sepsis.&amp;lt;ref name=&amp;quot;Dremsizov-2006&amp;quot;&amp;gt;{{Cite journal  | last1 = Dremsizov | first1 = T. | last2 = Clermont |first2 = G. | last3 = Kellum | first3 = JA. | last4 = Kalassian | first4 = KG. | last5 = Fine | first5 = MJ. | last6 = Angus | first6 = DC. | title = Severe sepsis in community-acquired pneumonia: when does it happen, and do systemic inflammatory response syndrome criteria help predict course? | journal = Chest |volume = 129 | issue = 4 | pages = 968-78 | month = Apr | year = 2006 | doi = 10.1378/chest.129.4.968 | PMID = 16608946 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
:*Diabetes and renal disease may explain the higher rates of infection related septic shock.&lt;br /&gt;
:*Immunosuppression&lt;br /&gt;
&lt;br /&gt;
===Prognosis===&lt;br /&gt;
&lt;br /&gt;
:*Advanced age &amp;gt; 65 year old: a strong correlation exists between the incidence of septic shock in patients older than 50 years.&lt;br /&gt;
:*Organ dysfunction is more related to bad prognosis than meeting SIRS criteria. A study found that just meeting SIRS criteria without evidence of organ dysfunction did not predict increased mortality. This concludes the importance of identification of organs dysfunction over the presence of SIRS criteria.&amp;lt;ref name=&amp;quot;Shapiro-2006&amp;quot;&amp;gt;{{Cite journal  | last1 = Shapiro | first1 = N. | last2 = Howell | first2 = MD. | last3 = Bates | first3 = DW. | last4 = Angus | first4 = DC. | last5 = Ngo | first5 = L. | last6 = Talmor | first6 = D. | title = The association of sepsis syndrome and organ dysfunction with mortality in emergency department patients with suspected infection. | journal = Ann Emerg Med | volume = 48 | issue = 5 | pages = 583-90, 590.e1 | month = Nov | year = 2006 | doi = 10.1016/j.annemergmed.2006.07.007 | PMID = 17052559 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Management==&lt;br /&gt;
&lt;br /&gt;
Goals during the first six hours of fluid resuscitation, as suggested by the Surviving Sepsis Campaign guidelines, include the following:&amp;lt;ref name=&amp;quot;Dellinger-2013&amp;quot;&amp;gt;{{Cite journal  | last1 = Dellinger | first1 = RP. | last2 = Levy | first2 = MM. | last3 = Rhodes | first3 = A. | last4 = Annane | first4 = D. | last5 = Gerlach | first5 = H. | last6 = Opal | first6 = SM. | last7 = Sevransky | first7 = JE. | last8 = Sprung | first8 = CL. | last9 = Douglas | first9 = IS. | title = Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. | journal = Intensive Care Med | volume = 39 | issue = 2 | pages = 165-228 | month = Feb | year = 2013 | doi = 10.1007/s00134-012-2769-8 | PMID = 23361625 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*&#039;&#039;&#039;CVP&#039;&#039;&#039; 8-12 mmHg&lt;br /&gt;
*&#039;&#039;&#039;SCVo2&#039;&#039;&#039; (superior vena cava) 70% or &#039;&#039;&#039;SVo2&#039;&#039;&#039; 65%&lt;br /&gt;
*&#039;&#039;&#039;MAP&#039;&#039;&#039; ≥ 65 mmHg&lt;br /&gt;
*&#039;&#039;&#039;Urine output&#039;&#039;&#039; ≥ 0.5 mL/kg/hour&lt;br /&gt;
&lt;br /&gt;
{{Family tree/start}}&lt;br /&gt;
{{Family tree | | | | | | A01 | | | | | | | |A01= &#039;&#039;&#039;Sepsis screening&#039;&#039;&#039; &amp;lt;br&amp;gt; Patient identification}}&lt;br /&gt;
{{Family tree | | | | | | |!| | | | | }}&lt;br /&gt;
{{Family tree | | | | | | B01 | | | |B01= &#039;&#039;&#039;History of infection&#039;&#039;&#039;}}&lt;br /&gt;
{{Family tree | | | |,|-|-|^|-|-|-|-|.| | }}&lt;br /&gt;
{{Family tree | | |C01 | | | | | |C02 |boxstyle_C01=BACKGROUND:SALMON|C01=Yes, &#039;&#039;&#039;history of infection&#039;&#039;&#039;|boxstyle_C02=BACKGROUND:MEDIUMAQUAMARINE|C02=No History}}&lt;br /&gt;
{{Family tree | | | |!| | | | | | | |!| }}&lt;br /&gt;
{{Family tree | | |E01 | | | | | |E02 |boxstyle_E01=BACKGROUND:SALMON|E01=Yes,&#039;&#039;&#039;Clinical  symptoms&#039;&#039;&#039;|boxstyle_E02=BACKGROUND:MEDIUMAQUAMARINE|E02=No clinical symptoms}}&lt;br /&gt;
{{Family tree | | | |!| | | | | | | |!| | }}&lt;br /&gt;
{{Family tree | | |G01 | | | | | |G02 |boxstyle_G01=BACKGROUND:SALMON|G01= &#039;&#039;&#039;Activate Sepsis Protocol&#039;&#039;&#039; &amp;lt;br&amp;gt;Blood culture 2X, &amp;lt;br&amp;gt; then early antibiotics within 1 hr &amp;lt;br&amp;gt; &#039;&#039;&#039;Check lactate elevation, evidence of organ dysfunction&#039;&#039;&#039;|boxstyle_G02=BACKGROUND:MEDIUMAQUAMARINE|G02=No lactate &amp;lt;br&amp;gt; No evidence of organ dysfunction &amp;lt;br&amp;gt; &#039;&#039;&#039;Normal tissue perfusion&#039;&#039;&#039;}}&lt;br /&gt;
{{Family tree | | | |!| | | | | | | | | | }}&lt;br /&gt;
{{Family tree | | | H01 | |H01=&#039;&#039;&#039;Tissue hypoperfusion&#039;&#039;&#039;}}&lt;br /&gt;
{{Family tree | |,|-|^|-|.|}}&lt;br /&gt;
{{Family tree | |!| | | |!| |}}&lt;br /&gt;
{{Family tree |I01 | |I02 | | | |boxstyle_I01=BACKGROUND:SALMON|I01= Yes, &#039;&#039;&#039;Tissue hypoperfusion&#039;&#039;&#039;|I02= No tissue hypoperfusion}}&lt;br /&gt;
{{Family tree | |!| | | |!| |}}&lt;br /&gt;
{{Family tree | J01 | | |!| |J01= SBO ≤ 90mm Hg &amp;lt;br&amp;gt; MAP ≤ 65 mm Hg &amp;lt;br&amp;gt; Lactate ≥ 4mmol/L }}&lt;br /&gt;
{{Family tree | |!| | | |!| | }}&lt;br /&gt;
{{Family tree | K01 | | K02 | |K01= &#039;&#039;&#039;Protocol A&#039;&#039;&#039; and &#039;&#039;&#039;B&#039;&#039;&#039;|K02= &#039;&#039;&#039;Protocol B&#039;&#039;&#039; }}&lt;br /&gt;
{{Family tree/end}}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
----&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{{Family tree/start}}&lt;br /&gt;
{{Family tree | | | | | B01 | | |B01= &#039;&#039;&#039;PROTOCOL A&#039;&#039;&#039; &amp;lt;br&amp;gt; Sepsis-induced Hypoperfusion &amp;lt;br&amp;gt; Clinical picture &#039;&#039;&#039;plus&#039;&#039;&#039; &amp;lt;br&amp;gt; &amp;lt; 65mm Hg &amp;lt;br&amp;gt; Lactate &amp;gt; 4mmol/L}}&lt;br /&gt;
{{Family tree | | | | | |!| | | | | }}&lt;br /&gt;
{{Family tree | | | | | C01 | | | |C01=Supplemental O2 (Targeted by O2) &amp;lt;br&amp;gt; Fluid resuscitation at least crystalloid bolus or &amp;lt;br&amp;gt; colloid equivalent 20ml/kg}}&lt;br /&gt;
{{Family tree | | | | | |!| | | | | }}&lt;br /&gt;
{{Family tree | | | | |D01 | | | |boxstyle_D01=BACKGROUND:SALMON|D01=&#039;&#039;&#039;CVP measurement&#039;&#039;&#039;}}&lt;br /&gt;
{{Family tree | | |,|-|-|^|-|-|.| }}&lt;br /&gt;
{{Family tree | | E01 | | | | |!| | E01= CVP &amp;lt; 8mm Hg}}}} &lt;br /&gt;
{{Family tree | | |!| | | | | |!| |}}&lt;br /&gt;
{{Family tree | | F01 |-|-|-| E02 |F01= Crystalloid bolus or colloid equivalent till CVP &amp;gt; 8 mm Hg|E02= CVP &amp;gt; 8mm Hg}}&lt;br /&gt;
{{Family tree | | | | | | | | |!| |}}&lt;br /&gt;
{{Family tree | | | | | | | |F03 |boxstyle_F03=BACKGROUND:SALMON|F03=&#039;&#039;&#039;MAP&#039;&#039;&#039; }}&lt;br /&gt;
{{Family tree | | | | | |,|-|-|^|-|-|.| | }}&lt;br /&gt;
{{Family tree | | | | | G01 | | | | |!| |G01=&#039;&#039;&#039;MAP&#039;&#039;&#039; &amp;lt; 65 mmHg}}&lt;br /&gt;
{{Family tree | | | | | |!| | | | | |!| | }}&lt;br /&gt;
{{Family tree | | | | | H01 |-|-|-| H02 | |H01= &#039;&#039;&#039;Vasopressors&#039;&#039;&#039; &amp;lt;br&amp;gt; ( 1st line &#039;&#039;&#039;Norepinephrine&#039;&#039;&#039; 0.05 mcg/kg/min ) &amp;lt;br&amp;gt; ( 2nd line &#039;&#039;&#039;Dopamine&#039;&#039;&#039; / &#039;&#039;&#039;Vasopressin&#039;&#039;&#039; ) &amp;lt;br&amp;gt; (3rd-4th line &#039;&#039;&#039;Phenylephrine&#039;&#039;&#039; ) till &#039;&#039;&#039;MAP&#039;&#039;&#039; &amp;gt; 65 mmHg|H02=&#039;&#039;&#039;MAP&#039;&#039;&#039; &amp;gt; 65 mmHg}}&lt;br /&gt;
{{Family tree | | | | | | | | | | | |!| | }}&lt;br /&gt;
{{Family tree | | | | | | | | | | |I01 | |boxstyle_I01=BACKGROUND:SALMON|I01= &#039;&#039;&#039;SeVO2&#039;&#039;&#039;}}&lt;br /&gt;
{{Family tree | | | | | | | | |,|-|-|^|-|-|.| | }}&lt;br /&gt;
{{Family tree | | | | | | | | J01 | | | | J02 |J01= &#039;&#039;&#039;SeVO2&#039;&#039;&#039; &amp;lt; 70% |J02= &#039;&#039;&#039;SeVO2&#039;&#039;&#039; &amp;gt; 70% }}&lt;br /&gt;
{{Family tree | | | | | | | | |!| | | | | |!| | }}&lt;br /&gt;
{{Family tree | | | | | | | | K01 | | | | |!| |K01= Transfuse &#039;&#039;&#039;PRBCs&#039;&#039;&#039;, &amp;lt;br&amp;gt; if HCT ≤ 30 &amp;lt;br&amp;gt; &#039;&#039;&#039;Dobutamine&#039;&#039;&#039; &amp;lt;br&amp;gt; if HCT &amp;gt; 30 }}&lt;br /&gt;
{{Family tree | | | | | | | | |!| | | | | |!| | |}}&lt;br /&gt;
{{Family tree | | | | | | | | L01 |-|v|-| L02 | | |L01= Goals achieved|L02= Goals achieved }}&lt;br /&gt;
{{Family tree | | | | | | | | | | | |!| | }}&lt;br /&gt;
{{Family tree | | | | | | | | | M01 |^| M02 | |M01= Resuscitation completed &amp;lt;br&amp;gt; Reevaluate |M02= Vasopressors still required &amp;lt;br&amp;gt; Stress Dose Steroids }}&lt;br /&gt;
{{Family tree/end}}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
----&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{{Family tree/start}}&lt;br /&gt;
{{Family tree | | | | | | | | B01 | | |B01=&#039;&#039;&#039;PROTOCOL B&#039;&#039;&#039; &amp;lt;br&amp;gt; Sepsis shock with &#039;&#039;&#039;NO&#039;&#039;&#039; tissue hypoperfusion &amp;lt;br&amp;gt; &#039;&#039;&#039;Normal Perfusion&#039;&#039;&#039;}}&lt;br /&gt;
{{Family tree | | | | |,|-|-|-|+|-|-|-|-|.| }}&lt;br /&gt;
{{Family tree | | | | C01 | | C03 | | | C02 | |C01= Assess requirement for &#039;&#039;&#039;Mechanical ventilation&#039;&#039;&#039; (Targeted by O2) |C02= &#039;&#039;&#039;Plasma glucose level&#039;&#039;&#039;|C03= Infection source identification &amp;lt;br&amp;gt; Empirical antibiotics after 2 blood cultures}}&lt;br /&gt;
{{Family tree | | | | |!| | | | | | | | |!| | }}&lt;br /&gt;
{{Family tree | | D01 |^| D02 | | | D03 |^| D04 |D01= Mechanical ventilation required |D02= No mechanical ventilation required |D03= &amp;lt; 180 mg/dl &amp;lt;br&amp;gt; maintain &amp;lt; 150 mg/dl |D04= &amp;gt; 180 mg/dl}}&lt;br /&gt;
{{Family tree | | |!| | | | | | | | | | | | |!| }}&lt;br /&gt;
{{Family tree | | E01 | | | | | | | | | | | E02 |E01= Semi Recumbent position &amp;lt;br&amp;gt; Lung-protective ventilation for ALI/ARDS &amp;lt;br&amp;gt; Maintain intermittent positive pressure (IPPP) &amp;lt; 30 cm H2o |E02= Start insulin to keep glucose &amp;lt; 150 }}&lt;br /&gt;
{{Family tree/end}}&lt;br /&gt;
&lt;br /&gt;
==Do&#039;s==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Do within 3 Hours&#039;&#039;&#039;&lt;br /&gt;
:#Measure lactate level.&lt;br /&gt;
:#Obtain at least 2 sets of blood cultures and cultures of other relevant sites, provided it does not cause a delay exceeding 45 minutes in starting antimicrobial therapy.&lt;br /&gt;
:#Administer broad spectrum antibiotics at least 1 drug with activity against all likely pathogens ( bacterial, fungal, or viral )&lt;br /&gt;
:#Administer adequate fluid challenge (40-60 mL/kg) crystalloid for hypotension or lactate 4 mmol/L.&lt;br /&gt;
:#Maintian CVP 8-12 cm H2o in non-intubated patients, and CVP 12-15 cm H2o for intubated patients.&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Do within 6 Hours&#039;&#039;&#039;&lt;br /&gt;
:#Apply vasopressors in hypotension refractory to initial fluid resuscitation.&lt;br /&gt;
:#Maintain a mean arterial pressure (MAP) ≥ 65 mm Hg.&lt;br /&gt;
:#In persistent arterial hypotension despite volume resuscitation or initial lactate 4 mmol/L ( 36 mg/dL ): check &#039;&#039;&#039;CVP&#039;&#039;&#039;and &#039;&#039;&#039;ScvO2&#039;&#039;&#039;.&lt;br /&gt;
:#Re-measure lactate if initial lactate was elevated. &lt;br /&gt;
:#Initiating broad-spectrum coverage until the specific organism is cultured and antibiotic sensitivities are determined is important.&lt;br /&gt;
&lt;br /&gt;
==Don&#039;ts==&lt;br /&gt;
:*Routine use of hemodynamic drugs to raise [[cardiac output]] to supranormal levels is not recommended.&lt;br /&gt;
:*Increasing the [[cardiac index]] in order to enhance the oxygen delivery has no improvement on outcome but it has worsened morbidity and mortality.&lt;br /&gt;
:*Administration of bicarbonate in order to correct the acidosis may worsen the intracellular acidosis. Correction of acidemia with sodium bicarbonate has not been proved to improve hemodynamics in a critically ill patient with increased blood lactate levels.&lt;br /&gt;
:*Immunosuppressive agents that could suppress the overwhelming inflammatory mediators responsible for MODs, as high-dose corticosteroids, have not shown any benefit in humans. However the encouraging data from animal studies.&lt;br /&gt;
:*Unfractionated heparin in patients with sepsis did not have any beneficial effect on length of hospital stay, MODs, and mortality compared to placebo.&amp;lt;ref name=&amp;quot;Jaimes-2009&amp;quot;&amp;gt;{{Cite journal  | last1 = Jaimes | first1 = F. | last2 = De La Rosa | first2 = G. | last3 = Morales | first3 = C. | last4 = Fortich | first4 = F. | last5 = Arango | first5 = C. | last6 = Aguirre | first6 = D. | last7 = Muñoz | first7 = A. | title = Unfractioned heparin for treatment of sepsis: A randomized clinical trial (The HETRASE Study). | journal = Crit Care Med | volume = 37 | issue = 4 | pages = 1185-96 | month = Apr | year = 2009 | doi = 10.1097/CCM.0b013e31819c06bc | PMID = 19242322 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|2}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Medicine]]&lt;br /&gt;
[[Category:Resident survival guide]]&lt;br /&gt;
&lt;br /&gt;
{{WH}}&lt;br /&gt;
{{WS}}&lt;/div&gt;</summary>
		<author><name>Gonzalo Romero</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=WBR0017&amp;diff=946849</id>
		<title>WBR0017</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=WBR0017&amp;diff=946849"/>
		<updated>2014-02-24T06:59:20Z</updated>

		<summary type="html">&lt;p&gt;Gonzalo Romero: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{WBRQuestion&lt;br /&gt;
|QuestionAuthor=Raviteja Reddy Guddeti MBBS, Aarti Narayan MBBS&lt;br /&gt;
|ExamType=USMLE Step 2 CK&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|Prompt=A-65-year old male presents to the ER due to a crushing retrosternal chest pain, which started 20 minutes ago.  Additionally, he has nausea and diaphoresis. Following 2 hours of ER arrival, percutaneous coronary intervention is performed; he recovers over the next days. 6 weeks following discharge, he returns to the office due to a mild retrosternal chest pain, aggravated when lying flat, and relieved when sitting up.  He also has a mild cough and runny nose consistent with a recent upper respiratory tract infection. Complete blood count is within normal limits. What is the most likely diagnosis?&lt;br /&gt;
|Explanation=This patient is returning to the office due to [[Dressler syndrome]], which is a post myocardial infarction syndrome.  It is a form of pericarditis that occurs in the setting of injury to the heart (myocardial infarction). Typically occurs 2 to 10 weeks after the myocardial infarction.&lt;br /&gt;
* [[Acute pericarditis]] presents between 6 weeks to 6 months of the disease onset.  Acute pericarditis is more common than chronic pericarditis, and often occurs as a complication of viral infections, immunologic conditions, or as a result of a heart attack(myocardial infarction). &lt;br /&gt;
* Subacute pericarditis presents within 6 weeks to 6 months of the disease onset&lt;br /&gt;
* Chronic pericarditis manifests after 6 months of the disease onset. Chronic pericarditis is less common. It may manifest as scarring of the pericardium, which is a condition known as constrictive pericarditis.&lt;br /&gt;
&#039;&#039;&#039;Educational Objective:&#039;&#039;&#039;  &lt;br /&gt;
&amp;lt;br&amp;gt;References: Master the Boards for Step 2CK, Step Up to CK 2014&lt;br /&gt;
&amp;lt;br&amp;gt; Read more here:  http://www.ncbi.nlm.nih.gov/pubmed/20194155&lt;br /&gt;
|AnswerA=Viral pericarditis&lt;br /&gt;
|AnswerAExp=The history of this patient is more consistent with Dressler&#039;s syndrome. It is important to consider the timeline of the chest pain occurring after the MI, which is 6 weeks in this case.  Viral pericarditis caused by different virus, commonly Coxsackie B virus, Echovirus, HIV or Adenovirus.&lt;br /&gt;
Influenza|AnswerB=Tuberculous pericarditis&lt;br /&gt;
|AnswerBExp=The history of this patient is more consistent with Dressler&#039;s syndrome. There is nothing else in the patient history to suggest a different form of pericarditis, and no past medical history of [[tuberculosis]].&lt;br /&gt;
|AnswerC=Post-cardiac injury pericarditis&lt;br /&gt;
|AnswerCExp=Post-cardiac injury pericarditis, also known as post-myocardial infarction pericarditis has similar clinical presentation, but it occurs 2-4 days following an MI. The pathophysiology is thought to be of autoimmune origin due to a reaction to the myocardial neo-antigens.&lt;br /&gt;
|AnswerD=Dressler’s syndrome&lt;br /&gt;
|AnswerDExp=Dressler&#039;s syndrome is the correct answer.&lt;br /&gt;
|AnswerE=Idiopathic&lt;br /&gt;
|AnswerEExp=The history of MI suggests that [[myocardial infarction]] is the inciting factor for the pericarditis, and it is not idiopathic.&lt;br /&gt;
|RightAnswer=D&lt;br /&gt;
|Approved=Yes&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Gonzalo Romero</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=WBR0017&amp;diff=946848</id>
		<title>WBR0017</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=WBR0017&amp;diff=946848"/>
		<updated>2014-02-24T06:57:59Z</updated>

		<summary type="html">&lt;p&gt;Gonzalo Romero: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{WBRQuestion&lt;br /&gt;
|QuestionAuthor=Raviteja Reddy Guddeti MBBS, Aarti Narayan MBBS&lt;br /&gt;
|ExamType=USMLE Step 2 CK&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|Prompt=A-65-year old male presents to the ER due to a crushing retrosternal chest pain, which started 20 minutes ago.  Additionally, he has nausea and diaphoresis. Following 2 hours of ER arrival, percutaneous coronary intervention is performed; he recovers over the next days. 6 weeks following discharge, he returns to the office due to a mild retrosternal chest pain, aggravated when lying flat, and relieved when sitting up.  He also has a mild cough and runny nose consistent with a recent upper respiratory tract infection. Complete blood count is within normal limits. What is the most likely diagnosis?&lt;br /&gt;
|Explanation=This patient is returning to the office due to [[Dressler syndrome]], which is a post myocardial infarction syndrome.  It is a form of pericarditis that occurs in the setting of injury to the heart (myocardial infarction). Typically occurs 2 to 10 weeks after the myocardial infarction.&lt;br /&gt;
* [[Acute pericarditis]] presents between 6 weeks to 6 months of the disease onset.  Acute pericarditis is more common than chronic pericarditis, and often occurs as a complication of viral infections, immunologic conditions, or as a result of a heart attack(myocardial infarction). &lt;br /&gt;
* Subacute pericarditis presents within 6 weeks to 6 months of the disease onset&lt;br /&gt;
* Chronic pericarditis manifests after 6 months of the disease onset. Chronic pericarditis is less common. It may manifest as scarring of the pericardium, which is a condition known as constrictive pericarditis.&lt;br /&gt;
&#039;&#039;&#039;Educational Objective:&#039;&#039;&#039;  &lt;br /&gt;
&amp;lt;br&amp;gt;References: Master the Boards for Step 2CK, Step Up to CK 2014&lt;br /&gt;
&amp;lt;br&amp;gt; Read more here:  http://www.ncbi.nlm.nih.gov/pubmed/20194155&lt;br /&gt;
|AnswerA=Viral pericarditis&lt;br /&gt;
|AnswerAExp=The history of this patient is more consistent with Dressler&#039;s syndrome. It is important to consider the timeline of the chest pain occurring after the MI, which is 6 weeks in this case.  Viral pericarditis caused by different virus, commonlyCoxsackie B virus, Echovirus, HIV and Adenovirus.&lt;br /&gt;
Influenza|AnswerB=Tuberculous pericarditis&lt;br /&gt;
|AnswerBExp=The history of this patient is more consistent with Dressler&#039;s syndrome. There is nothing else in the patient history to suggest a different form of pericarditis, and no past medical history of [[tuberculosis]].&lt;br /&gt;
|AnswerC=Post-cardiac injury pericarditis&lt;br /&gt;
|AnswerCExp=Post-cardiac injury pericarditis, also known as post-myocardial infarction pericarditis has similar clinical presentation, but it occurs 2-4 days following an MI. The pathophysiology is thought to be of autoimmune origin due to a reaction to the myocardial neo-antigens.&lt;br /&gt;
|AnswerD=Dressler’s syndrome&lt;br /&gt;
|AnswerDExp=Dressler&#039;s syndrome is the correct answer.&lt;br /&gt;
|AnswerE=Idiopathic&lt;br /&gt;
|AnswerEExp=The history of MI suggests that [[myocardial infarction]] is the inciting factor for the pericarditis, and it is not idiopathic.&lt;br /&gt;
|RightAnswer=D&lt;br /&gt;
|Approved=Yes&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Gonzalo Romero</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=WBR0017&amp;diff=946847</id>
		<title>WBR0017</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=WBR0017&amp;diff=946847"/>
		<updated>2014-02-24T06:48:01Z</updated>

		<summary type="html">&lt;p&gt;Gonzalo Romero: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{WBRQuestion&lt;br /&gt;
|QuestionAuthor=Raviteja Reddy Guddeti MBBS, Aarti Narayan MBBS&lt;br /&gt;
|ExamType=USMLE Step 2 CK&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|Prompt=A-65-year old male presents to the ER due to a crushing retrosternal chest pain, which started 20 minutes ago.  Additionally, he has nausea and diaphoresis. Following 2 hours of ER arrival, percutaneous coronary intervention is performed; he recovers over the next days. 6 weeks following discharge, he returns to the office due to a mild retrosternal chest pain, aggravated when lying flat, and relieved when sitting up.  He also has a mild cough and runny nose consistent with a recent upper respiratory tract infection. Complete blood count is within normal limits. What is the most likely diagnosis?&lt;br /&gt;
|Explanation=This patient is returning to the office due to [[Dressler syndrome]], which is a post myocardial infarction syndrome.  It is a form of pericarditis that occurs in the setting of injury to the heart (myocardial infarction). Typically occurs 2 to 10 weeks after the myocardial infarction.&lt;br /&gt;
* [[Acute pericarditis]] presents between 6 weeks to 6 months of the disease onset.  Acute pericarditis is more common than chronic pericarditis, and often occurs as a complication of viral infections, immunologic conditions, or as a result of a heart attack(myocardial infarction). &lt;br /&gt;
* Subacute pericarditis presents within 6 weeks to 6 months of the disease onset&lt;br /&gt;
* Chronic pericarditis manifests after 6 months of the disease onset. Chronic pericarditis is less common. It may manifest as scarring of the pericardium, which is a condition known as constrictive pericarditis.&lt;br /&gt;
&#039;&#039;&#039;Educational Objective:&#039;&#039;&#039;  &lt;br /&gt;
&amp;lt;br&amp;gt;References: Master the Boards for Step 2CK, Step Up to CK 2014&lt;br /&gt;
|AnswerA=Viral pericarditis&lt;br /&gt;
|AnswerAExp=The history of this patient is more consistent with Dressler&#039;s syndrome. It is important to consider the timeline of the chest pain occurring after the MI, which is 6 weeks in this case.  Viral pericarditis caused by different virus, commonlyCoxsackie B virus, Echovirus, HIV and Adenovirus.&lt;br /&gt;
Influenza|AnswerB=Tuberculous pericarditis&lt;br /&gt;
|AnswerBExp=The history of this patient is more consistent with Dressler&#039;s syndrome. There is nothing else in the patient history to suggest a different form of pericarditis, and no past medical history of [[tuberculosis]].&lt;br /&gt;
|AnswerC=Post-cardiac injury pericarditis&lt;br /&gt;
|AnswerCExp=Post-cardiac injury pericarditis, also known as post-myocardial infarction pericarditis has similar clinical presentation, but it occurs 2-4 days following an MI. The pathophysiology is thought to be of autoimmune origin due to a reaction to the myocardial neo-antigens.&lt;br /&gt;
|AnswerD=Dressler’s syndrome&lt;br /&gt;
|AnswerDExp=Dressler&#039;s syndrome is the correct answer.&lt;br /&gt;
|AnswerE=Idiopathic&lt;br /&gt;
|AnswerEExp=The history of MI suggests that [[myocardial infarction]] is the inciting factor for the pericarditis, and it is not idiopathic.&lt;br /&gt;
|RightAnswer=D&lt;br /&gt;
|Approved=Yes&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Gonzalo Romero</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=WBR0017&amp;diff=946845</id>
		<title>WBR0017</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=WBR0017&amp;diff=946845"/>
		<updated>2014-02-24T06:41:47Z</updated>

		<summary type="html">&lt;p&gt;Gonzalo Romero: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{WBRQuestion&lt;br /&gt;
|QuestionAuthor=Raviteja Reddy Guddeti MBBS, Aarti Narayan MBBS&lt;br /&gt;
|ExamType=USMLE Step 2 CK&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|Prompt=A-65-year old male presents to the ER due to a crushing retrosternal chest pain, which started 20 minutes ago.  Additionally, he has nausea and diaphoresis. Following 2 hours of ER arrival, percutaneous coronary intervention is performed; he recovers over the next days. 6 weeks following discharge, he returns to the office due to a mild retrosternal chest pain, aggravated by supine position, and relieved by leaning forward.  He also has a mild cough and runny nose consistent with a recent upper respiratory tract infection. Complete blood count is within normal limits. What is the most likely diagnosis?&lt;br /&gt;
|Explanation=This patient is returning to the office due to [[Dressler syndrome]], which is a post myocardial infarction syndrome.  It is a form of pericarditis that occurs in the setting of injury to the heart (myocardial infarction). Typically occurs 2 to 10 weeks after the myocardial infarction.&lt;br /&gt;
* [[Acute pericarditis]] presents between 6 weeks to 6 months of the disease onset.  Acute pericarditis is more common than chronic pericarditis, and often occurs as a complication of viral infections, immunologic conditions, or as a result of a heart attack(myocardial infarction). &lt;br /&gt;
* Subacute pericarditis presents within 6 weeks to 6 months of the disease onset&lt;br /&gt;
* Chronic pericarditis manifests after 6 months of the disease onset. Chronic pericarditis is less common. It may manifest as scarring of the pericardium, which is a condition known as constrictive pericarditis.&lt;br /&gt;
&#039;&#039;&#039;Educational Objective:&#039;&#039;&#039;  &lt;br /&gt;
&amp;lt;br&amp;gt;References: Master the Boards for Step 2CK, Step Up to CK 2014&lt;br /&gt;
|AnswerA=Viral pericarditis&lt;br /&gt;
|AnswerAExp=The history of this patient is more consistent with Dressler&#039;s syndrome. It is important to consider the timeline of the chest pain occurring after the MI, which is 6 weeks in this case.  Viral pericarditis caused by different virus, commonlyCoxsackie B virus, Echovirus, HIV and Adenovirus.&lt;br /&gt;
Influenza|AnswerB=Tuberculous pericarditis&lt;br /&gt;
|AnswerBExp=The history of this patient is more consistent with Dressler&#039;s syndrome. There is nothing else in the patient history to suggest a different form of pericarditis, and no past medical history of [[tuberculosis]].&lt;br /&gt;
|AnswerC=Post-cardiac injury pericarditis&lt;br /&gt;
|AnswerCExp=Post-cardiac injury pericarditis, also known as post-myocardial infarction pericarditis has similar clinical presentation, but it occurs 2-4 days following an MI. The pathophysiology is thought to be of autoimmune origin due to a reaction to the myocardial neo-antigens.&lt;br /&gt;
|AnswerD=Dressler’s syndrome&lt;br /&gt;
|AnswerDExp=Dressler&#039;s syndrome is the correct answer.&lt;br /&gt;
|AnswerE=Idiopathic&lt;br /&gt;
|AnswerEExp=The history of MI suggests that [[myocardial infarction]] is the inciting factor for the pericarditis, and it is not idiopathic.&lt;br /&gt;
|RightAnswer=D&lt;br /&gt;
|Approved=Yes&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Gonzalo Romero</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=WBR0017&amp;diff=946841</id>
		<title>WBR0017</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=WBR0017&amp;diff=946841"/>
		<updated>2014-02-24T06:00:11Z</updated>

		<summary type="html">&lt;p&gt;Gonzalo Romero: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{WBRQuestion&lt;br /&gt;
|QuestionAuthor=Raviteja Reddy Guddeti MBBS, Aarti Narayan MBBS&lt;br /&gt;
|ExamType=USMLE Step 2 CK&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|MainCategory=Internal medicine&lt;br /&gt;
|SubCategory=Cardiovascular&lt;br /&gt;
|Prompt=A-65-year old male presents to the ER due to a crushing retrosternal chest pain, which started 20 minutes ago.  Additionally, he has nausea and diaphoresis. Following 2 hours of ER arrival, percutaneous coronary intervention is performed; he recovers over the next days. 6 weeks following discharge, he returns to the office due to a mild retrosternal chest pain, aggravated by supine position, and relieved by leaning forward.  He also has a mild cough and runny nose consistent with a recent upper respiratory tract infection. Complete blood count is within normal limits. What is the most likely diagnosis?&lt;br /&gt;
|Explanation=This patient is returning to the office due to [[Dressler syndrome]], which is a post myocardial infarction syndrome.  It is a form of pericarditis that occurs in the setting of injury to the heart (myocardial infarction). Typically occurs 2 to 10 weeks after the myocardial infarction.&lt;br /&gt;
* [[Acute pericarditis]] presents between 6 weeks to 6 months of the disease onset.  Acute pericarditis is more common than chronic pericarditis, and often occurs as a complication of viral infections, immunologic conditions, or as a result of a heart attack(myocardial infarction). &lt;br /&gt;
* Subacute pericarditis presents within 6 weeks to 6 months of the disease onset&lt;br /&gt;
* Chronic pericarditis manifests after 6 months of the disease onset. Chronic pericarditis is less common. It may manifest as scarring of the pericardium, which is a condition known as constrictive pericarditis.&lt;br /&gt;
&#039;&#039;&#039;Educational Objective:&#039;&#039;&#039;  &lt;br /&gt;
&amp;lt;br&amp;gt;References: Master the Boards for Step 2CK&lt;br /&gt;
|AnswerA=Viral pericarditis&lt;br /&gt;
|AnswerAExp=The history of this patient is more consistent with Dressler&#039;s syndrome. It is important to consider the timeline of the chest pain occurring after the MI, which is 6 weeks in this case.  Viral pericarditis caused by different virus, commonlyCoxsackie B virus, Echovirus, HIV and Adenovirus.&lt;br /&gt;
Influenza|AnswerB=Tuberculous pericarditis&lt;br /&gt;
|AnswerBExp=The history of this patient is more consistent with Dressler&#039;s syndrome. There is nothing else in the patient history to suggest a different form of pericarditis, and no past medical history of [[tuberculosis]].&lt;br /&gt;
|AnswerC=Post-cardiac injury pericarditis&lt;br /&gt;
|AnswerCExp=Post-cardiac injury pericarditis, also known as post-myocardial infarction pericarditis has similar clinical presentation, but it occurs 2-4 days following an MI. The pathophysiology is thought to be of autoimmune origin due to a reaction to the myocardial neo-antigens.&lt;br /&gt;
|AnswerD=Dressler’s syndrome&lt;br /&gt;
|AnswerDExp=Dressler&#039;s syndrome is the correct answer.&lt;br /&gt;
|AnswerE=Idiopathic&lt;br /&gt;
|AnswerEExp=The history of MI suggests that [[myocardial infarction]] is the inciting factor for the pericarditis, and it is not idiopathic.&lt;br /&gt;
|RightAnswer=D&lt;br /&gt;
|Approved=Yes&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Gonzalo Romero</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=Fungus&amp;diff=943286</id>
		<title>Fungus</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=Fungus&amp;diff=943286"/>
		<updated>2014-02-13T19:17:23Z</updated>

		<summary type="html">&lt;p&gt;Gonzalo Romero: /* With plants */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Taxobox&lt;br /&gt;
| color = lightblue&lt;br /&gt;
| name = Fungi&lt;br /&gt;
| fossil_range = Early [[Devonian]] - Recent (but see text)&lt;br /&gt;
| image = Fungi_collage.jpg&lt;br /&gt;
| image_width = 280px&lt;br /&gt;
| image_caption = Clockwise from top left: &#039;&#039;[[Amanita muscaria]]&#039;&#039;, a basidiomycete; &#039;&#039;[[Sarcoscypha coccinea]]&#039;&#039;, an ascomycete; [[black bread mold]], a zygomycete; a chytrid; a &#039;&#039;[[Penicillium]]&#039;&#039; [[conidiophore]].&lt;br /&gt;
| domain=[[Eukarya]]&lt;br /&gt;
| unranked_regnum = [[Opisthokont]]a&lt;br /&gt;
| regnum = &#039;&#039;&#039;Fungi&#039;&#039;&#039;&lt;br /&gt;
| regnum_authority = ([[Carolus Linnaeus|L.]], 1753) R.T. Moore, 1980&amp;lt;ref&amp;gt;{{cite journal | title=Taxonomic proposals for the classification of marine yeasts and other yeast-like fungi including the smuts | year=1980 | journal=Bot. Mar. | volume=23 | pages=371}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
| subdivision_ranks = Subkingdoms/Phyla&lt;br /&gt;
| subdivision =&lt;br /&gt;
:[[Chytridiomycota]]&lt;br /&gt;
:[[Blastocladiomycota]]&lt;br /&gt;
:[[Neocallimastigomycota]]&lt;br /&gt;
:[[Glomeromycota]]&lt;br /&gt;
:[[Zygomycota]]&lt;br /&gt;
[[Dikarya]] (inc. [[Deuteromycota]])&amp;lt;br/&amp;gt;&lt;br /&gt;
:[[Ascomycota]]&lt;br /&gt;
:[[Basidiomycota]]&lt;br /&gt;
}}&lt;br /&gt;
{{CMG}}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
A &#039;&#039;&#039;fungus&#039;&#039;&#039; ({{pronEng|ˈfʌŋgəs}}) is a [[Eukaryote|eukaryotic]] [[organism]] that is a member of the [[Kingdom (biology)|kingdom]] &#039;&#039;&#039;Fungi&#039;&#039;&#039; ({{pronEng|ˈfʌndʒaɪ}}).&amp;lt;ref&amp;gt;These are the pronunciations listed first in most dictionaries. See, for example, the [http://www.m-w.com/dictionary/fungus  Merriam-Webster Online entry] Alternative pronunciations for &#039;&#039;fungi&#039;&#039; include /ˈfʌŋgaɪ/, /ˈfʌndʒi/, and /ˈfʌŋgi/. &#039;&#039;Funguses&#039;&#039; (/ˈfʌŋgəsəz/) is an alternative plural form.&amp;lt;/ref&amp;gt; The fungi are [[heterotrophic]] organisms possessing a [[chitin]]ous [[cell wall]]. The majority of species grow as [[Multicellular organism|multicellular]] filaments called [[hyphae]] forming a [[mycelium]]; some fungal species also grow as single [[cell (biology)|cell]]s. Sexual and asexual reproduction of the fungi is commonly via [[spore]]s, often produced on specialized structures or in [[fruiting bodies]]. Some species have lost the ability to form specialized reproductive structures, and propagate solely by [[Vegetative reproduction|vegetative]] growth. [[Yeasts]], [[molds]], and [[mushrooms]] are examples of fungi. The fungi are a [[monophyletic]] group that is [[phylogeny|phylogenetically]] clearly distinct from the morphologically similar [[slime mold]]s ([[myxomycetes]]) and [[water mold]]s ([[oomycetes]]). The fungi are more closely related to [[animal]]s than [[plant]]s, yet the discipline of [[biology]] devoted to the study of fungi, known as [[mycology]], often falls under a branch of [[botany]].&lt;br /&gt;
&lt;br /&gt;
Occurring worldwide, most fungi are largely invisible to the naked eye, living for the most part in soil, dead matter, and as [[symbiont]]s of plants, animals, or other fungi. They perform an essential role in all ecosystems in decomposing [[Organic material|organic matter]] and are indispensable in [[Biogeochemical cycle|nutrient cycling]] and exchange. Some fungi become noticeable when fruiting, either as mushrooms or molds. Many fungal species have long been used as a direct source of food, such as mushrooms and [[Tuber (genus)|truffle]]s and in [[fermentation]] of various food products, such as [[wine]], [[beer]], and [[soy sauce]]. More recently, fungi are being used as sources for [[antibiotic]]s used in medicine and various [[enzyme]]s, such as [[cellulase]]s, [[pectinase]]s, and [[protease]]s, important for industrial use or as active ingredients of [[detergent]]s. Many fungi produce [[bioactive]] compounds called [[mycotoxin]]s, such as [[alkaloid]]s and [[polyketide]]s that are toxic to animals including humans. Some fungi are used [[Recreational drug use|recreationally]] or in traditional ceremonies as a source of [[psychotropic]] compounds. Several species of the fungi are significant [[pathogen]]s of humans and other animals, and losses due to [[disease]]s of [[crop]]s (e.g., [[rice blast disease]]) or food [[spoilage]] caused by fungi can have a large impact on human [[Food security|food supply]] and local economies.&lt;br /&gt;
&lt;br /&gt;
==Etymology and definition==&lt;br /&gt;
The [[English language|English]] word &#039;&#039;fungus&#039;&#039; is directly adopted from the [[Latin]] &#039;&#039;fungus&#039;&#039;, meaning &amp;quot;mushroom&amp;quot;, used in [[Horace]] and [[Pliny the Elder|Pliny]].&amp;lt;ref&amp;gt;{{cite book|last=Simpson|first=D.P.|title= Cassell&#039;s Latin Dictionary|publisher=Cassell Ltd.|date=1979 |edition=5|location=London|pages= 883|id = ISBN 0-304-52257-0}}&amp;lt;/ref&amp;gt; This in turn is derived from the [[Ancient Greek|Greek]] word &#039;&#039;sphongos&#039;&#039;/σφογγος (&amp;quot;sponge&amp;quot;), referring to the [[macroscopic]] structures and morphology of some mushrooms and molds and also used in other languages (e.g., the [[German language|German]] &#039;&#039;Schwamm&#039;&#039; (&amp;quot;sponge&amp;quot;) or &#039;&#039;Schwammerl&#039;&#039; for some types of mushroom).&lt;br /&gt;
&lt;br /&gt;
==Diversity==&lt;br /&gt;
Fungi have a worldwide distribution, and grow in a wide range of habitats, including [[desert fungi|deserts]]. Most fungi grow in terrestrial environments, but several species occur only in aquatic habitats. Fungi along with [[bacteria]] are the primary [[decomposers]] of organic matter in most if not all terrestrial [[ecosystem]]s worldwide. Based on observations of the ratio of the number of fungal species to the number of plant species in some environments, the fungal kingdom has been estimated to contain about 1.5 million species. &amp;lt;ref name=&amp;quot;Hawksworth&amp;quot;&amp;gt;{{cite journal|author=Hawksworth DL|year= 2006|title=The fungal dimension of biodiversity: magnitude, significance, and conservation|journal=Mycol. Res.|volume=95|pages=641–655}}&amp;lt;/ref&amp;gt; Around 70,000 fungal species have been formally described by taxonomists, but the true dimension of fungal diversity is still unknown. &amp;lt;ref name=&amp;quot;Mueller&amp;amp;Schmit&amp;quot;&amp;gt;{{cite journal|author=Mueller GM, Schmit JP|year= 2006|title=Fungal biodiversity: what do we know? What can we predict?|journal=Biodivers Conserv|volume=16|pages=1–5}}&amp;lt;/ref&amp;gt; Most fungi grow as thread-like filaments called [[hypha]]e, which form a [[mycelium]], while others grow as single cells. &amp;lt;ref name=&amp;quot;Alexopoulos&amp;quot;&amp;gt;{{cite book|author=Alexopoulos CJ, Mims CW, Blackwell M| title=Introductory Mycology | year=1996 | publisher=John Wiley and Sons | isbn=0471522295}}&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;{{cite web| url = http://tolweb.org/Fungi| title =  Eumycota: mushrooms, sac fungi, yeast, molds, rusts, smuts, etc.&lt;br /&gt;
| accessdate = 2007-04-06| author = Meredith Blackwell| coauthors = Rytas Vilgalys, and John W. Taylor| date = [[2005-02-14]]|language = English}}&amp;lt;/ref&amp;gt; Until recently many fungal species were described based mainly on morphological characteristics, such as the size and shape of spores or fruiting structures, and [[biological species concept]]s; the application of [[Molecular biology|molecular]] tools, such as [[DNA sequencing]], to study fungal diversity has greatly enhanced the resolution and added robustness to estimates of diversity within various taxonomic groups.&amp;lt;ref name=&amp;quot;Hibbett&amp;quot;&amp;gt;{{cite journal | author=Hibbett, D.S., &#039;&#039;et al.&#039;&#039; | year=2007 | title=A higher level phylogenetic classification of the &#039;&#039;Fungi&#039;&#039;| journal=Mycol. Res. | volume=111|issue=5 | pages=509-547 | doi=doi:10.1016/j.mycres.2007.03.004}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Importance for human use==&lt;br /&gt;
[[Image:S cerevisiae under DIC microscopy.jpg|thumb|upright|right|Sacharomyces cerevisiae cells in DIC microscopy.]]&lt;br /&gt;
Human use of fungi for food preparation or preservation and other purposes is extensive and has a long history: [[yeast]]s are required for [[fermentation (food)|fermentation]] of [[beer]], [[wine]] &amp;lt;ref&amp;gt; [http://winemaking.jackkeller.net/strains.asp Strains of wine yeast] &amp;lt;/ref&amp;gt; and [[bread]], some other fungal species are used in the production of [[soy sauce]] and [[tempeh]].  [[Mushroom farming]] and [[mushroom gathering]] are large industries in many countries. Many fungi are producers of [[antibiotics]], including [[β-lactam antibiotic]]s such as [[penicillin]] and [[cephalosporin]].&amp;lt;ref name=&amp;quot;Demain&amp;quot;&amp;gt;{{cite journal|author=Demain AL.|year= 1991|title=Production of beta-lactam antibiotics and its regulation.|journal=Proc Natl Sci Counc Repub China B.|volume=15|pages=251-265|id=PMID 1815263}}&amp;lt;/ref&amp;gt; Widespread use of these antibiotics for the treatment of bacterial diseases, such as [[tuberculosis]], [[syphilis]], [[leprosy]], and many others began in the early 20th century and continues to play a major part in anti-bacterial [[chemotherapy]]. The study of the historical uses and sociological impact of fungi is known as [[ethnomycology]]. &lt;br /&gt;
&lt;br /&gt;
====Cultured foods====&lt;br /&gt;
[[Baker&#039;s yeast]] or &#039;&#039;[[Saccharomyces cerevisiae]]&#039;&#039;, a single-cell fungus, is used in the baking of [[bread]] and other wheat-based products, such as [[pizza]] and [[dumpling]]s.&amp;lt;ref&amp;gt;{{cite book |title=Handbook of Cereal Science and Technology |last=Kulp |first=Karel |year=2000 |publisher=CRC Press |isbn=0824782941 }}&amp;lt;/ref&amp;gt; Several yeast species of the genus [[Saccharomyces]] are also used in the production of [[alcoholic beverage]]s through [[Fermentation (food)|fermentation]].&amp;lt;ref name=&amp;quot;Piskur&amp;quot;&amp;gt;{{cite journal|author=Piskur J, Rozpedowska E, Polakova S, Merico A, Compagno C.|year= 2006|title=How did Saccharomyces evolve to become a good brewer?|journal=Trends Genet.|volume=22|pages=183-186|id=PMID 16499989}}&amp;lt;/ref&amp;gt; Mycelial fungi, such as the [[shoyu koji mold]] (&#039;&#039;[[Aspergillus oryzae]]&#039;&#039;), are used in the brewing of [[Shoyu]] ([[soy sauce]]) and preparation of [[tempeh]].&amp;lt;ref name=&amp;quot;Kitamoto&amp;quot;&amp;gt;{{cite journal|author=Kitamoto N, Yoshino S, Ohmiya K, Tsukagoshi N.|year= 1999|title=Sequence analysis, overexpression, and antisense inhibition of a beta-xylosidase gene, xylA, from Aspergillus oryzae KBN616.|journal=Appl. Env. Microbiol.|volume=65|pages=20-24|id=PMID 9872754}}&amp;lt;/ref&amp;gt; [[Quorn]] is a high-protein product made from the mold, &#039;&#039;[[Fusarium venenatum]]&#039;&#039;, and is used in [[vegetarian]] cooking.&lt;br /&gt;
&lt;br /&gt;
====Other human uses====&lt;br /&gt;
Fungi are also used extensively to produce industrial chemicals like [[lactic acid]], [[antibiotics]] and even to make stonewashed [[jeans]].&amp;lt;ref&amp;gt;{{cite web|url=http://www.nysaes.cornell.edu/ent/biocontrol/pathogens/trichoderma.html|title=Trichoderma spp., including T. harzianum, T. viride, T. koningii, T. hamatum and other spp. Deuteromycetes, Moniliales (asexual classification system)|accessdate=2007-07-10|work=Biological Control: A Guide to Natural Enemies in North America}}&amp;lt;/ref&amp;gt; Several fungal species are ingested for their [[psychedelic drug|psychedelic]] properties, both [[recreational drug|recreationally]] and religiously (see main article, &#039;&#039;[[Psilocybin mushrooms]]&#039;&#039;).&lt;br /&gt;
&lt;br /&gt;
==== Mycotoxins ====&lt;br /&gt;
{{main|Mycotoxins}}&lt;br /&gt;
Many fungi produce compounds with [[biological activity]]. Several of these compounds are [[toxin|toxic]] and are therefore called [[mycotoxins]], referring to their fungal origin and toxic activity. Of particular relevance to humans are those mycotoxins that are produced by moulds causing food spoilage and poisonous mushrooms (see below). Particularly infamous are the [[aflatoxin]]s, which are insidious [[liver]] toxins and highly [[carcinogenic]] metabolites produced by &#039;&#039;[[Aspergillus]]&#039;&#039; species often growing in or on grains and nuts consumed by humans, and the lethal [[amatoxin]]s produced by mushrooms of the genus &#039;&#039;[[Amanita]]&#039;&#039;. Other notable mycotoxins include [[ochratoxin]]s, [[patulin]], [[ergotamine|ergot alkaloid]]s, and [[trichothecene]]s and fumonisins, all of which have significant impact on human food supplies or animal [[livestock]]. &amp;lt;ref name=&amp;quot;van Egmond&amp;quot;&amp;gt;{{cite journal|author=van Egmond HP, Schothorst RC, Jonker MA|year= 2007|title=Regulations relating to mycotoxins in food: perspectives in a global and European context|journal=Anal Bioanal Chem.|volume=389|pages=147-157|id=PMID 17508207}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Mycotoxins belong to the group of [[secondary metabolite]]s (or [[natural product]]s). Originally, this group of compounds had been thought to be mere byproducts of [[primary metabolism]], hence the name &amp;quot;secondary&amp;quot; metabolites. However, recent research has shown the existence of [[biochemical pathways]] solely for the purpose of producing mycotoxins and other natural products in fungi. &amp;lt;ref name=&amp;quot;Keller, Turner, &amp;amp; Bennett&amp;quot;&amp;gt;{{cite journal|author=Keller NP, Turner G, Bennett JW|year= 2005|title=Fungal secondary metabolism - from biochemistry to genomics|journal=Nat Rev Microbiol.|volume=3|pages=937-497|id=PMID 16322742}}&amp;lt;/ref&amp;gt; Mycotoxins provide a number of [[Fitness (biology)|fitness]] benefits to the fungi that produce them in terms of physiological adaptation, competition with other microbes and fungi, and protection from [[fungivory]]. &amp;lt;ref name=&amp;quot;Demain and Fang&amp;quot;&amp;gt;{{cite journal|author=Demain AL, Fang A|year= 2000|title=The natural functions of secondary metabolites|journal=Adv Biochem Eng Biotechnol.|volume=69|pages=1-39|id=PMID 11036689}}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;Rohlfs et al&amp;quot;&amp;gt;{{cite journal|author=Rohlfs M, Albert M, Keller NP, Kempken F|year= 2007|title=Secondary chemicals protect mould from fungivory|journal=Biol Lett.|volume=3|pages=523-525|id=PMID 17686752}}&amp;lt;/ref&amp;gt; These fitness benefits and the existence of dedicated biosynthetic pathways for mycotoxin production suggest that the mycotoxins are important for fungal persistence and survival.&lt;br /&gt;
&lt;br /&gt;
====Edible and poisonous fungi====&lt;br /&gt;
[[Image:Asian mushrooms.jpg|left|thumb|Asian mushrooms, clockwise from left, [[enokitake]], buna-shimeji, bunapi-shimeji, [[king oyster mushroom]] and [[shiitake]].]]&lt;br /&gt;
[[Image:Truffe coupée.jpg|thumb|right|Black Périgord Truffle (&#039;&#039;[[Tuber melanosporum]]&#039;&#039;), cut in half.]]&lt;br /&gt;
[[Image:Blue Stilton Quarter Front.jpg|thumb|right|[[Stilton cheese]] veined with &#039;&#039;[[Penicillium roqueforti]]&#039;&#039;.]]&lt;br /&gt;
Some of the best known types of fungi are the [[Edible mushroom|edible]] and the [[Mushroom poisoning|poisonous]] mushrooms. Many species are commercially raised, but others must be harvested from the wild. &#039;&#039;[[Agaricus bisporus]]&#039;&#039;, sold as button mushrooms when small or Portobello mushrooms when larger, are the most commonly eaten species, used in salads, soups, and many other dishes. Many Asian fungi are commercially grown and have gained in popularity in the West. They are often available fresh in grocery stores and markets, including [[straw mushroom]]s (&#039;&#039;[[Volvariella volvacea]]&#039;&#039;), [[oyster mushroom]]s (&#039;&#039;[[Pleurotus ostreatus]]&#039;&#039;), [[shiitake]]s (&#039;&#039;[[Lentinula edodes]]&#039;&#039;), and [[enokitake]] (&#039;&#039;[[Flammulina]]&#039;&#039; spp.).&lt;br /&gt;
&lt;br /&gt;
There are many more mushroom species that are [[Mushroom hunting|harvested from the wild]] for personal consumption or commercial sale. [[Lactarius deliciosus|Milk mushrooms]], [[morel]]s, [[chanterelle]]s, [[Tuber (genus)|truffles]], [[Craterellus|black trumpets]], and &#039;&#039;porcini&#039;&#039; mushrooms (&#039;&#039;[[Boletus edulis]]&#039;&#039;) (also known as king boletes) all demand a high price on the market. They are often used in gourmet dishes.&lt;br /&gt;
&lt;br /&gt;
For certain types of [[cheese]]s, it is also a common practice to inoculate milk curds with fungal spores to foment the growth of specific species of [[mold]] that impart a unique flavor and texture to the cheese. This accounts for the [[blue cheese|blue]] colour in cheeses such as [[Stilton cheese|Stilton]] or [[Roquefort]] which is created using &#039;&#039;[[Penicillium roqueforti]]&#039;&#039; spores.&amp;lt;ref&amp;gt;[http://whatscookingamerica.net/Q-A/CheeseMold.htm Questions &amp;amp; Answers - Mold on Cheese] whatscookingamerica.net. Retrieved [[2007-04-06]].&amp;lt;/ref&amp;gt; Molds used in cheese production are usually non-toxic and are thus safe for human consumption; however, mycotoxins (e.g., aflatoxins, [[roquefortine C]], patulin, or others) may accumulate due to fungal spoilage during cheese ripening or storage.&amp;lt;ref name=&amp;quot;Erdogan&amp;quot;&amp;gt;{{cite journal|author=Erdogan A, Gurses M, Sert S.|year= 2004|title=Isolation of moulds capable of producing mycotoxins from blue mouldy Tulum cheeses produced in Turkey.|journal=Int J Food Microbiol.|volume=85|pages=83-85|id=PMID 12810273}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Many mushroom species are toxic to humans, with toxicities ranging from slight digestive problems or [[allergy|allergic]] reactions as well as [[hallucination]]s to severe organ failures and death. Some of the most deadly mushrooms belong to the genera &#039;&#039;[[Inocybe]]&#039;&#039;, &#039;&#039;[[Cortinarius]]&#039;&#039;, and most infamously, &#039;&#039;[[Amanita]]&#039;&#039;. The latter genus includes the destroying angel &#039;&#039;([[Amanita virosa|A. virosa]])&#039;&#039;  and the death cap &#039;&#039;([[Amanita phalloides|A. phalloides]])&#039;&#039;, the most common cause of deadly mushroom poisoning. &amp;lt;ref&amp;gt;[http://www.npr.org/templates/story/story.php?storyId=7251327 On the Trail of the Death Cap Mushroom] Richard Harris,  www.npr.org, [[2007-02-08]]. Retrieved [[2007-04-06]].&amp;lt;/ref&amp;gt; The false morel (&#039;&#039;[[Gyromitra esculenta]]&#039;&#039;) is considered a delicacy by some when cooked, yet can be highly toxic when eaten raw. &amp;lt;ref name=&amp;quot;Leathem and Dorran&amp;quot;&amp;gt;{{cite journal|author=Leathem AM, Dorran TJ|year=2007|title=Poisoning due to raw Gyromitra esculenta (false morels) west of the Rockies|journal=CJEM|volume=9|pages=127-130|id=PMID 17391587}}&amp;lt;/ref&amp;gt;  &#039;&#039;[[Tricholoma equestre]]&#039;&#039; was considered edible until being implicated in some serious poisonings causing [[rhabdomyolysis]]. &amp;lt;ref name=&amp;quot;Karlson-Stiber and Persson&amp;quot;&amp;gt;{{cite journal|author=Karlson-Stiber C, Persson H|year=2003|title=Cytotoxic fungi--an overview|journal=Toxicon.|volume=42|pages=339-349|id=PMID 14505933}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Amanita muscaria|Fly agaric]] mushrooms (&#039;&#039;A. muscaria&#039;&#039;) also cause occasional poisonings, mostly as a result of ingestion for use as a [[recreational drug use|recreational]] drug for its [[Psychedelics, dissociatives and deliriants|hallucinogenic]] properties. Historically Fly agaric was used by [[Celt]]ic [[Druids]] in Northern Europe and the [[Koryaks|Koryak people]] of north-eastern [[Siberia]] for religious or shamanic purposes.&amp;lt;ref&amp;gt;[http://www.treesforlife.org.uk/forest/mythfolk/flyagaric.html Mythology and Folklore of Fly Agaric] Paul Kendall, Trees for Life. Retrieved [[2007-04-06]].&amp;lt;/ref&amp;gt; It is difficult to identify a safe mushroom without proper training and knowledge, thus it is often advised to assume that a mushroom in the wild is poisonous and not to consume it.&lt;br /&gt;
&lt;br /&gt;
====Fungi in the biological control of pests====&lt;br /&gt;
In agricultural settings, fungi that actively compete for nutrients and space with, and eventually prevail over, [[pathogen]]ic microorganisms, such as bacteria or other fungi, via the [[competitive exclusion principle]],&amp;lt;ref name=&amp;quot;López-Gómez and Molina-Meyer&amp;quot;&amp;gt;{{cite journal|author=López-Gómez J, Molina-Meyer M|year= 2006|title=The competitive exclusion principle versus biodiversity through competitive segregation and further adaptation to spatial heterogeneities|journal=Theor Popul Biol.|volume=69|pages=94-109|id=PMID 16223517}}&amp;lt;/ref&amp;gt; or are [[parasitism|parasites]] of these pathogens, may be beneficial agents for human use. For example, some fungi may be used to suppress growth or eliminate harmful plant pathogens, such as insects, [[mites]], [[weed]]s, [[nematodes]] and other fungi that cause diseases of important [[crop]] plants.&amp;lt;ref&amp;gt;[http://www.ars.usda.gov/is/AR/archive/jul98/fung0798.htm  Setting the Stage To Screen Biocontrol Fungi] Hank Becker, July 1998. Retrieved [[2007-04-06]].&amp;lt;/ref&amp;gt; This has generated strong interest in the use and practical application of these fungi for the [[biological control]] of these agricultural pests. [[Entomopathogenic fungi]] can be used as [[biopesticides]], as they actively kill insects.&amp;lt;ref&amp;gt;[http://www.uvminnovations.com/graphics/microfactory.pdf WHEY-BASED FUNGAL MICROFACTORY TECHNOLOGY FOR ENHANCED BIOLOGICAL PEST MANAGEMENT USING FUNGI] Todd. S. Keiller, Technology Transfer, University of Vermont. Retrieved [[2007-04-06]].&amp;lt;/ref&amp;gt; Examples of fungi that have been used as [[biological insecticide]]s are &#039;&#039;[[Beauveria bassiana]]&#039;&#039;, &#039;&#039;[[Metarhizium anisopliae]]&#039;&#039;, &#039;&#039;[[Hirsutella]]&#039;&#039; spp, &#039;&#039;[[Paecilomyces]]&#039;&#039; spp, and &#039;&#039;[[Verticillium lecanii]]&#039;&#039;.&amp;lt;ref name=&amp;quot;Deshpande&amp;quot;&amp;gt;{{cite journal|author=Deshpande MV.|year= 1999|title=Mycopesticide production by fermentation: potential and challenges.|journal=Crit Rev Microbiol. |volume=25|pages=229-243|id=PMID 10524330}}&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;Thomas&amp;quot;&amp;gt;{{cite journal|author=Thomas MB, Read AF.|year=2007|title=Can fungal biopesticides control malaria?|journal=Nat Rev Microbiol.|volume=5|pages=377-383|id=PMID 17426726 | doi = 10.1038/nrmicro1638 &amp;lt;!--Retrieved from Yahoo! by DOI bot--&amp;gt;}}&amp;lt;/ref&amp;gt; Endophytic fungi of grasses of the genus &#039;&#039;[[Neotyphodium]]&#039;&#039;, such as &#039;&#039;[[Neotyphodium coenophialum|N. coenophialum]]&#039;&#039; produce [[alkaloids]] that are toxic to a range of invertebrate and vertebrate  [[herbivores]]. These alkaloids protect the infected grass plants from herbivory, but some endophyte alkaloids can cause poisoning of grazing animals, such as cattle and sheep. &amp;lt;ref name=&amp;quot;Bush&amp;quot;&amp;gt;{{cite journal|author=Bush LP, Wilkinson HH, Schardl CL.|year=1997|title=Bioprotective Alkaloids of Grass-Fungal Endophyte Symbioses|journal=Plant Physiol.|volume=114|pages=1-7|id=PMID 12223685}}&amp;lt;/ref&amp;gt; Infection of grass cultivars of [[turf grass|turf]] or [[forage plant|forage]] grasses with isolates of the grass endophytes that produce only specific alkaloids to improve grass hardiness and  resistance to herbivores such as insects, while being non-toxic to livestock, is being used in [[plant breeding|grass breeding]] programs.&amp;lt;ref name=&amp;quot;Bouton&amp;quot;&amp;gt;{{cite journal|author=Bouton JH, Latch GCM, Hill NS, Hoveland CS, McCannc MA, Watson RH, Parish JA, Hawkins LL, Thompson FN|year=2002|title=Use of nonergot alkaloid-producing endophytes for alleviating tall fescue toxicosis in sheep.|journal=Agron. J.|volume=94|pages=567-574|id=http://agron.scijournals.org/cgi/content/full/94/3/567}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Bioremediation===&lt;br /&gt;
{{Main|Mycoremediation}}&lt;br /&gt;
Certain fungi, in particular &#039;white rot&#039; fungi, can degrade insecticides, herbicides, pentachlorophenol, creosote, coal tars, and heavy fuels and turn them into carbon dioxide, water, and basic elements.&amp;lt;ref&amp;gt;Douglas, M.S. (1995). [http://stinet.dtic.mil/oai/oai?verb=getRecord&amp;amp;metadataPrefix=html&amp;amp;identifier=ADA307994 Bioremediation of Contaminated Soils Using the White Rot Fungus Phanerochaete Chrysosporium]. DTIC.&amp;lt;/ref&amp;gt; Research has recently discovered that fungi can be used to lock uranium into mineral form.&amp;lt;ref&amp;gt;BBC. (2008). [http://news.bbc.co.uk/2/hi/uk_news/scotland/tayside_and_central/7384500.stm Fungi to fight &#039;toxic war zones&#039;]&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Ecology==&lt;br /&gt;
[[Image:fungi in Borneo.jpg|right|thumb|upright|[[Polypores]] growing on a tree in Borneo]]&lt;br /&gt;
Although often inconspicuous, fungi occur in every environment on [[Earth]] and play very important roles in most [[ecosystems]]. Along with bacteria, fungi are the major [[decomposers]] in most terrestrial (and some aquatic) ecosystems, and therefore play a critical role in [[biogeochemical cycles]] and in many [[food webs]]. As decomposers, they play an indispensable role in [[nutrient cycling]], especially as [[saprotroph]]s and [[symbiont]]s, degrading organic matter to inorganic molecules, which can then re-enter anabolic metabolic pathways in plants or other organisms.&amp;lt;ref name=&amp;quot;Lindahl&amp;quot;&amp;gt;{{cite journal|author=Lindahl BD, Ihrmark K, Boberg J, Trumbore SE, Högberg P, Stenlid J, Finlay RD|year= 2007|title=Spatial separation of litter decomposition and mycorrhizal nitrogen uptake in a boreal forest|journal=New Phytol.|volume=173|pages=611-620|id=PMID 17244056}}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;Barea&amp;quot;&amp;gt;{{cite journal|author=Barea JM, Pozo MJ, Azcón R, Azcón-Aguilar C|year= 2005|title=Microbial co-operation in the rhizosphere|journal=J. Exp. Bot.|volume=56|pages=1761-1778|id=PMID 15911555}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Symbiosis===&lt;br /&gt;
Many fungi have important [[symbiotic]] relationships with organisms from most if not all [[Kingdom (biology)|Kingdom]]s.&amp;lt;ref name=&amp;quot;Aanen&amp;quot;&amp;gt;{{cite journal|author=Aanen DK.|year= 2006|title=As you reap, so shall you sow: coupling of harvesting and inoculating stabilizes the mutualism between termites and fungi.|journal=Biol Lett.|volume=2|pages=209-212|id=PMID 17148364}}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;Nikoh and Fukatsu&amp;quot;&amp;gt;{{cite journal|author=Nikoh N, Fukatsu T.|year= 2000|title=Interkingdom host jumping underground: phylogenetic analysis of entomoparasitic fungi of the genus Cordyceps.|journal=Mol Biol Evol.|volume=17|pages=2629-2638|id=PMID 10742053}}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;Perotto and Bonfante&amp;quot;&amp;gt;{{cite journal|author=Perotto S, Bonfante P.|year=1997|title=Bacterial associations with mycorrhizal fungi: close and distant friends in the rhizosphere.|journal=Trends Microbiol.|volume=5|pages=496-501|id=PMID 9447662}}&amp;lt;/ref&amp;gt; These interactions can be mutualistic or antagonistic in nature, or in case of commensal fungi are of no apparent benefit or detriment to the host. &amp;lt;ref name=&amp;quot;Arnold&amp;quot;&amp;gt;{{cite journal|author=Arnold AE, Mejía LC, Kyllo D, Rojas EI, Maynard Z, Robbins N, Herre EA.|year=2003|title=Fungal endophytes limit pathogen damage in a tropical tree.|journal=Proc. Natl. Acad. Sci. USA|volume=100|pages=15649-15654|id=PMID 14671327}}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;Paszkowski&amp;quot;&amp;gt;{{cite journal|author=Paszkowski U.|year=2006|title=Mutualism and parasitism: the yin and yang of plant symbioses.|journal=Curr Opin Plant Biol.|volume=9|pages=364-370|id=PMID 16713732}}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;Hube&amp;quot;&amp;gt;{{cite journal|author=Hube B.|year=2004|title=From commensal to pathogen: stage- and tissue-specific gene expression of Candida albicans.|journal=Curr Opin Microbiol.|volume=7|pages=336-341|id=PMID 15288621}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====With plants====&lt;br /&gt;
&lt;br /&gt;
[[Mycorrhiza]]l symbiosis between [[plants]] and fungi is one of the most well-known plant-fungus associations and is of significant importance for plant growth and persistence in many ecosystems; over 90% of all plant species engage in some kind of mycorrhizal relationship with fungi and are dependent upon this relationship for survival.&amp;lt;ref&amp;gt;{{cite web  | last = Volk  | first = Tom  | title = Tom Volk&#039;s Fungi FAQ|url=http://botit.botany.wisc.edu/toms_fungi/faq.html  | accessdate = 2006-09-21}}&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;{{cite web  | last = Wong  | first = George  | title = Symbiosis: Mycorrhizae and Lichens  | url=http://www.botany.hawaii.edu/faculty/wong/BOT135/Lect26.htm  | accessdate = 2006-09-21}} &amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;[http://southwestfarmpress.com/news/6-10-05-nitrogen-transfer-beneficial-fungi/ Knowledge of nitrogen transfer between plants and beneficial fungi expands] southwestfarmpress.com. [[2005-06-10]] Retrieved [[2007-04-06]].&amp;lt;/ref&amp;gt; The mycorrhizal symbiosis is ancient, dating to at least 400 million years ago.&amp;lt;ref name=&amp;quot;Remy et al.&amp;quot;&amp;gt;{{cite journal|author=Remy W, Taylor TN, Hass H, Kerp H |year=1994|title= 4-hundred million year old vesicular-arbuscular mycorrhizae.|journal= Proc. Natl. Acad. Sci|volume=91|pages=11841-11843|id=PMID 11607500}}&amp;lt;/ref&amp;gt; It often increases the plant&#039;s uptake of inorganic compounds, such as [[nitrate]] and [[phosphate]] from soils having low concentrations of these key plant nutrients.  In some mycorrhizal associations, the fungal partners may mediate plant-to-plant transfer of carbohydrates and other nutrients. Such mycorrhizal communities are called &amp;quot;common mycorrhizal networks&amp;quot;. &amp;lt;ref name=&amp;quot;Selosse&amp;quot;&amp;gt;{{cite journal|author=Selosse MA, Richard F, He X, Simard SW|year= 2006|title=Mycorrhizal networks: des liaisons dangereuses?|journal=Trends Ecol Evol.|volume=21|pages=621-628|id=PMID 16843567}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Lichens are formed by a symbiotic relationship between [[algae]] or [[cyanobacteria]] (referred to in lichens as &amp;quot;photobionts&amp;quot;) and fungi (mostly various species of ascomycetes and a few basidiomycetes), in which individual photobiont cells are embedded in a tissue formed by the fungus.&amp;lt;ref name=&amp;quot;lichens&amp;quot;&amp;gt;{{cite book |title=Lichens of North America |last=Brodo |first=Irwin M. |coauthors=Sylvia Duran Sharnoff |year=2001 |publisher=Yale University Press |isbn=0300082495 }}&amp;lt;/ref&amp;gt; As in [[mycorrhizas]], the photobiont provides sugars and other carbohydrates, while the fungus provides minerals and water. The functions of both symbiotic organisms are so closely intertwined that they function almost as a single organism.&lt;br /&gt;
&lt;br /&gt;
====With insects====&lt;br /&gt;
&lt;br /&gt;
Many insects also engage in [[Ant-fungus mutualism|mutualistic relationships]] with various types of fungi. Several groups of ants cultivate fungi in the order [[Agaricales]] as their primary food source, while [[ambrosia beetles]] cultivate various species of fungi in the bark of trees that they infest.&amp;lt;ref&amp;gt;[http://www.botany.hawaii.edu/faculty/wong/BOT135/Lect24.htm Fungi and Insect Symbiosis] www.botany.hawaii.edu. Retrieved [[2007-04-06]].&amp;lt;/ref&amp;gt;  Termites on the African Savannah are also known to cultivate fungi.&amp;lt;ref&amp;gt;Pascal Jouquet, Virginie Tavernier, Luc Abbadie and Michel Lepage. &#039;&#039;Nests of subterranean fungus-growing termites (Isoptera, Macrotermitinae) as nutrient patches for grasses in savannah ecosystems&#039;&#039;. African Journal of Ecology. 2005. Vol 43, 191–196&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====As pathogens and parasites====&lt;br /&gt;
&lt;br /&gt;
However, many fungi are parasites on plants, animals (including [[humans]]), and other fungi. Serious fungal pathogens of many cultivated plants causing extensive damage and losses to agriculture and forestry include the [[rice blast]] fungus &#039;&#039;[[Magnaporthe oryzae]]&#039;&#039;,&amp;lt;ref name=&amp;quot;Talbot&amp;quot;&amp;gt;{{cite journal|author=Talbot NJ|year=2003|title=On the trail of a cereal killer: Exploring the biology of Magnaporthe grisea.|journal=Annu Rev Microbiol.|volume=57|pages=177-202|id=PMID 14527276}}&amp;lt;/ref&amp;gt; tree pathogens such as &#039;&#039;[[Ophiostoma ulmi]]&#039;&#039; and &#039;&#039;[[Ophiostoma novo-ulmi]]&#039;&#039; causing [[Dutch elm disease]],&amp;lt;ref name=&amp;quot;Paoletti &amp;quot;&amp;gt;{{cite journal|author=Paoletti M, Buck KW, Brasier CM.|year=2006|title=Selective acquisition of novel mating type and vegetative incompatibility genes via interspecies gene transfer in the globally invading eukaryote Ophiostoma novo-ulmi.|journal=Mol Ecol.|volume=15|pages=249-262|id=PMID 16367844}}&amp;lt;/ref&amp;gt; and &#039;&#039;[[Cryphonectria parasitica]]&#039;&#039; responsible for [[chestnut blight]], &amp;lt;ref name=&amp;quot;Gryzenhout&amp;quot;&amp;gt;{{cite journal|author=Gryzenhout M, Wingfield BD, Wingfield MJ.|year=2006|title=New taxonomic concepts for the important forest pathogen Cryphonectria parasitica and related fungi.|journal=FEMS Microbiol Lett.|volume=258|pages=161-172|id=PMID 16640568}}&amp;lt;/ref&amp;gt; and plant-pathogenic fungi in the genera &#039;&#039;[[Fusarium]]&#039;&#039;, &#039;&#039;[[Ustilago]]&#039;&#039;, &#039;&#039;[[Alternaria]]&#039;&#039;, and &#039;&#039;[[Cochliobolus]]&#039;&#039;; &amp;lt;ref name=&amp;quot;Paszkowski&amp;quot;/&amp;gt; fungi with the potential to cause serious human diseases, especially in persons with [[Immune system|immuno-deficiencies]], are in the genera &#039;&#039;[[Aspergillus]]&#039;&#039;, &#039;&#039;[[Candida (genus)|Candida]]&#039;&#039;, &#039;&#039;[[Cryptococcus neoformans|Cryptoccocus]]&#039;&#039;,&amp;lt;ref name=&amp;quot;Nielsen and Heitman&amp;quot;&amp;gt;{{cite journal|author=Nielsen K, Heitman J.|year=2007|title=Sex and virulence of human pathogenic fungi.|journal=Adv Genet.|volume=57|pages=143-173|id=PMID 17352904}}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;Hube&amp;quot;/&amp;gt;&amp;lt;ref name=&amp;quot;Brakhage&amp;quot;&amp;gt;{{cite journal|author=Brakhage AA|year=2005|title=Systemic fungal infections caused by Aspergillus species: epidemiology, infection process and virulence determinants.|journal=Curr. Drug Targets|volume=6|pages=875-886|id=PMID 16375671 | doi = 10.2174/138945005774912717 &amp;lt;!--Retrieved from Yahoo! by DOI bot--&amp;gt;}}&amp;lt;/ref&amp;gt; &#039;&#039;[[Histoplasma]]&#039;&#039;,&amp;lt;ref name=&amp;quot;Kauffman&amp;quot;&amp;gt;{{cite journal|author=Kauffman CA.|year=2007|title=Histoplasmosis: a clinical and laboratory update|journal=Clin Microbiol Rev.|volume=20|pages=115-132|id=PMID 17223625}}&amp;lt;/ref&amp;gt; and &#039;&#039;[[Pneumocystis]]&#039;&#039;. &amp;lt;ref name=&amp;quot;Cushion&amp;quot;&amp;gt;{{cite journal|author=Cushion MT, Smulian AG, Slaven BE, Sesterhenn T, Arnold J, Staben C, Porollo A, Adamczak R, Meller J.|year=2007|title=Transcriptome of Pneumocystis carinii during Fulminate Infection: Carbohydrate Metabolism and the Concept of a Compatible Parasite.|journal=PLoS ONE|volume=2|pages=e423|id=PMID 17487271 | doi = 10.1371/journal.pone.0000423 &amp;lt;!--Retrieved from Yahoo! by DOI bot--&amp;gt;}}&amp;lt;/ref&amp;gt; Several pathogenic fungi are also responsible for relatively minor human [[disease]]s, such as [[athlete’s foot]] and [[ringworm]]. Some fungi are [[predators]] of [[nematodes]], which they capture using an array of specialized structures, such as constricting rings or adhesive nets.&amp;lt;ref&amp;gt;[http://www.uoguelph.ca/~gbarron/MISC2003/illustra.htm ILLUSTRATIONS for Predatory Fungi, wood Decay and the Carbon Cycle] www.uoguelph.ca. Retrieved [[2007-04-06]].&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Nutrition and possible autotrophy===&lt;br /&gt;
&lt;br /&gt;
Growth of fungi as [[hypha]]e on or in solid substrates or single cells in aquatic environments is adapted to efficient extraction of nutrients from these environments, because these growth forms have high [[surface area to volume ratio]]s. These adaptations in [[morphology (biology)|morphology]] are complemented by [[cellulase|hydrolytic enzymes]] secreted into the environment for digestion of large organic molecules, such as [[polysaccharide]]s, [[protein]]s, [[lipid]]s, and other organic substrates into smaller molecules. &amp;lt;ref name=&amp;quot;Pereira&amp;quot;&amp;gt;{{cite journal|author=Pereira JL, Noronha EF, Miller RN, Franco OL.|year= 2007|title=Novel insights in the use of hydrolytic enzymes secreted by fungi with biotechnological potential.|journal=Lett Appl Microbiol.|volume=44|pages=573-581|id=PMID 17576216}}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;Schaller&amp;quot;&amp;gt;{{cite journal|author=Schaller M, Borelli C, Korting HC, Hube B.|year= 2007|title=Hydrolytic enzymes as virulence factors of Candida albicans.|journal=Mycoses|volume=48|pages=365-377|id=PMID 16262871}}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;Farrar&amp;quot;&amp;gt;{{cite journal|author=Farrar JF|year=1985|title=Carbohydrate metabolism in biotrophic plant pathogens.|journal=Microbiol Sci.|volume=2|pages=314-317|id=PMID 3939987}}&amp;lt;/ref&amp;gt; These molecules are then absorbed as nutrients into the fungal [[cell (biology)|cell]]s.&lt;br /&gt;
&lt;br /&gt;
Traditionally, the fungi are considered [[heterotroph]]s, organisms that rely solely on carbon fixed by other organisms for [[metabolism]]. Fungi have [[evolution|evolved]] a remarkable metabolic versatility that allows many of them to use a large variety of organic substrates for growth, including simple compounds as [[nitrate]], [[ammonia]], [[acetate]], or [[ethanol]].&amp;lt;ref name=&amp;quot;Marzluf&amp;quot;&amp;gt;{{cite journal|author=Marzluf GA|year=1981|title=Regulation of nitrogen metabolism and gene expression in fungi|journal=Microbiol Rev.|volume=45|pages=437-461|id=PMID 6117784}}&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;Heynes&amp;quot;&amp;gt;{{cite journal|author=Heynes MJ|year=1994|title=Regulatory circuits of the amdS gene of Aspergillus nidulans|journal=Antonie Van Leeuwenhoek.|volume=65|pages=179-782|id=PMID 7847883}}&amp;lt;/ref&amp;gt; Recent research raises the possibility that some fungi utilize the pigment [[melanin]] to extract energy from [[ionizing radiation]], such as [[gamma rays|gamma radiation]] for [[radiotrophic fungus|&amp;quot;radiotrophic&amp;quot;]] growth. &amp;lt;ref name=&amp;quot;Dadachova&amp;quot;&amp;gt;{{cite journal|author=Dadachova E, Bryan RA, Huang X, Moadel T, Schweitzer AD, Aisen P, Nosanchuk JD, Casadevall A.|year= 2007|title=Ionizing radiation changes the electronic properties of&lt;br /&gt;
melanin and enhances the growth of melanized fungi|journal=PLoS ONE|volume=2|pages=e457|id=PMID 17520016}}&amp;lt;/ref&amp;gt; It has been proposed that this process might bear some similarity to photosynthesis in plants, &amp;lt;ref name=&amp;quot;Dadachova&amp;quot;/&amp;gt; but detailed biochemical data supporting the existence of this hypothetical pathway are presently lacking.&lt;br /&gt;
&lt;br /&gt;
==Morphology==&lt;br /&gt;
===Microscopic structures===&lt;br /&gt;
[[Image:DecayingPeachSmall.gif|frame|left|Mold covering a decaying peach over a period of six days. The frames were taken approximately 12 hours apart.]]&lt;br /&gt;
Though fungi are part of the [[opisthokont]] clade, all phyla except for the [[chytrids]] have lost their posterior flagella.&amp;lt;ref&amp;gt;[http://mbe.oxfordjournals.org/cgi/content/full/23/1/93 The Protistan Origins of Animals and Fungi] Emma T. Steenkamp, Jane Wright and Sandra L. Baldauf. Molecular Biology and Evolution 2006 23(1):93-106; doi:10.1093/molbev/msj011. Retrieved [[2007-04-06]].&amp;lt;/ref&amp;gt; Fungi are unusual among the eukaryotes in having a cell wall that, besides [[glucan]]s (e.g., β-1,3-glucan) and other typical components, contains the [[biopolymer]] [[chitin]].&amp;lt;ref name=&amp;quot;Stevens&amp;quot;&amp;gt;{{cite journal|author=Stevens DA, Ichinomiya M, Koshi Y, Horiuchi H.|year= 2006|title=Escape of Candida from caspofungin inhibition at concentrations above the MIC (paradoxical effect) accomplished by increased cell wall chitin; evidence for beta-1,6-glucan synthesis inhibition by caspofungin.|journal=Antimicrob Agents Chemother.|volume=50|pages=3160-3161.|id=PMID 16940118}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Many fungi grow as thread-like filamentous microscopic structures called [[hypha]]e, and an assemblage of intertwined and interconnected hyphae is called a [[mycelium]]. &amp;lt;ref name=&amp;quot;Alexopoulos&amp;quot;&amp;gt;{{cite book|author=Alexopoulos CJ, Mims CW, Blackwell M| title=Introductory Mycology | year=1996 | publisher=John Wiley and Sons | isbn=0471522295}}&amp;lt;/ref&amp;gt; Hyphae can be septate, i.e., divided into hyphal compartments separated by a &#039;&#039;[[septum]]&#039;&#039;, each compartment containing one or more [[cell nucleus|nuclei]] or can be [[coenocytic]], i.e., lacking hyphal compartmentalization. However, septa have pores, such as the [[doliporus]] in the basidiomycetes that allow cytoplasm, organelles, and sometimes nuclei to pass through.&amp;lt;ref name=&amp;quot;Alexopoulos&amp;quot;/&amp;gt; Coenocytic hyphae are essentially [[multinucleate]] supercells.&amp;lt;ref&amp;gt;{{cite book |title=Mushrooms: Cultivation, Nutritional Value, Medicinal Effect and Environmental Impact |last=Chang |first=Shu-ting |coauthors=Philip G. Miles |year=2004 |publisher=CRC Press |isbn=0849310431 }}&amp;lt;/ref&amp;gt; In some cases, fungi have developed specialized structures for nutrient uptake from living hosts; examples include [[haustoria]] in plant-parasitic fungi of nearly all divisions, and [[arbuscules]] of several [[mycorrhiza]]l fungi,&amp;lt;ref&amp;gt;[http://bugs.bio.usyd.edu.au/Mycology/StructureFunction/haustoria.shtml “Fungal Biology” at The University of Sydney] Retrieved on 26 June 2007 &amp;lt;/ref&amp;gt; which penetrate into the host cells for nutrient uptake by the fungus.&lt;br /&gt;
&lt;br /&gt;
===Macroscopic structures===&lt;br /&gt;
&lt;br /&gt;
Fungal mycelia can become visible macroscopically, for example, as concentric rings on various surfaces, such as damp walls, and on other substrates, such as spoilt food (see figure), and are commonly and generically called &#039;&#039;[[mould]]&#039;&#039; ([[American spelling]], &#039;&#039;mold&#039;&#039;); fungal mycelia grown on solid [[agar]] media in laboratory [[petri dish]]es are usually referred to as colonies, with many species exhibiting characteristic macroscopic growth morphologies and colours, due to spores or [[pigment]]ation.&lt;br /&gt;
&lt;br /&gt;
Specialized fungal structures important in [[sexual reproduction]] are the [[apothecia]], [[perithecia]], and [[cleistothecia]] in the ascomycetes, and the [[fruiting bodies]] of the basidiomycetes, and a few ascomycetes. These reproductive structures can sometimes grow very large, and are well known as [[mushrooms]].&lt;br /&gt;
&lt;br /&gt;
===Morphological and physiological features for substrate penetration===&lt;br /&gt;
Fungal hyphae are specifically adapted to growth on solid surfaces and within substrates, and can exert astoundingly large penetrative mechanical forces. The [[plant pathogen]], &#039;&#039;[[Magnaporthe grisea]]&#039;&#039;, forms a structure called an [[appressorium]] specifically designed for penetration of plant tissues, and the pressure generated by the appressorium, which is directed against the plant [[Epidermis (botany)|epidermis]] can exceed 8 [[Pascal (unit)|MPa]] (80 [[Bar (unit)|bar]]s). &amp;lt;ref name=&amp;quot;Howard et al&amp;quot;&amp;gt;{{cite journal|author=Howard RJ, Ferrari MA, Roach DH, Money NP|year=1991|title=Penetration of hard substrates by a fungus employing enormous turgor pressures|journal=Proc Natl Acad Sci U S A.|volume=88|pages=11281-11284|id=PMID 1837147}}&amp;lt;/ref&amp;gt; The generation of these mechanical pressures is the result of an interplay between physiological processes to increase intracellular [[turgor]] by production of [[osmolyte]]s such as [[glycerol]], and the morphology of the appressorium. &amp;lt;ref name=&amp;quot;Wang et al&amp;quot;&amp;gt;{{cite journal|author=Wang ZY, Jenkinson JM, Holcombe LJ, Soanes DM, Veneault-Fourrey C, Bhambra GK, Talbot NJ|year=2005|title=The molecular biology of appressorium turgor generation by the rice blast fungus Magnaporthe grisea|journal=Biochem Soc Trans.|volume=33|pages=384-388|id=PMID 15787612}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Reproduction==&lt;br /&gt;
[[Image:DirkvdM barbed fungus.jpg|thumb|left|Fungi on a fence post near [[Orosí]], Costa Rica.]]&lt;br /&gt;
&lt;br /&gt;
Reproduction of fungi is complex, reflecting the heterogeneity in lifestyles and genetic make up within this group of organisms. &amp;lt;ref name=&amp;quot;Alexopoulos&amp;quot;/&amp;gt; Many fungi reproduce either sexually or asexually, depending on conditions in the environment. These conditions trigger genetically determined developmental programs leading to the expression of specialized structures for sexual or asexual reproduction. These structures aid both reproduction and efficient dissemination of spores or spore-containing propagules.&lt;br /&gt;
&lt;br /&gt;
===Asexual reproduction===&lt;br /&gt;
&lt;br /&gt;
[[Asexual reproduction]] via vegetative [[spore]]s or through mycelial fragmentation is common in many fungal species and allows more rapid dispersal than sexual reproduction. In the case of the &amp;quot;Fungi imperfecti&amp;quot; or [[Deuteromycota]], which lack a sexual cycle, it is the only means of propagation. Asexual spores, upon [[germination]], may found a population that is [[clone (genetics)|clonal]] to the population from which the spore originated, and thus colonize new environments.&lt;br /&gt;
&lt;br /&gt;
===Sexual reproduction===&lt;br /&gt;
Sexual reproduction with [[meiosis]] exists in all fungal phyla, except the [[Deuteromycota]]. It differs in many aspects from sexual reproduction in animals or plants. Many differences also exist between fungal groups and have been used to discriminate fungal clades and species based on morphological differences in sexual structures and reproductive strategies. Experimental crosses between fungal isolates can also be used to identify species based on [[biological species concept]]s. The major fungal clades have initially been delineated based on the morphology of their sexual structures and spores; for example, the spore-containing structures, [[ascus|asci]] and [[basidium|basidia]], can be used in the identification of ascomycetes and basidiomycetes, respectively. Many fungal species have elaborate [[vegetative incompatibility]] systems that allow [[mating]] only between individuals of opposite [[mating type]], while others can mate and sexually reproduce with any other individual or itself. Species of the former mating system are called [[heterothallic]], and of the latter [[homothallic]]. &amp;lt;ref name=&amp;quot;Metzenberg&amp;quot;&amp;gt;{{cite journal|author=Metzenberg RL, Glass NL.|year= 1990|title=Mating type and mating strategies in Neurospora.|journal=Bioessays|volume=12|pages=53-59|id=PMID 2140508 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Most fungi have both a [[haploid]] and [[diploid]] stage in their life cycles. In all sexually reproducing fungi, compatible individuals combine by cell fusion of vegetative hyphae by [[anastomosis]], required for the initiation of the sexual cycle. Ascomycetes and basidiomycetes go through a [[dikaryotic]] stage, in which the [[cell nucleus|nuclei]] inherited from the two parents do not fuse immediately after cell fusion, but remain separate in the hyphal cells (see [[heterokaryosis]]). &lt;br /&gt;
&lt;br /&gt;
In ascomycetes, dikaryotic hyphae of the [[hymenium]] form a characteristic &#039;&#039;hook&#039;&#039; at the hyphal septum. During [[cell division]] formation of the hook ensures proper distribution of the newly divided nuclei into the apical and basal hyphal compartments. An  [[ascus]] (plural &#039;&#039;&#039;asci&#039;&#039;&#039;) is then formed, in which [[karyogamy]] (nuclear fusion) occurs. These asci are embedded in an [[ascocarp]], or fruiting body, of the fungus. Karyogamy in the asci is followed immediately by meiosis and the production of ascospores. The ascospores are disseminated and germinate and may form a new haploid mycelium.&amp;lt;ref name=&amp;quot;Strasburger&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Sexual reproduction in basidiomycetes is similar to that of the ascomycetes. Compatible haploid hyphae fuse to produce a dikaryotic mycelium. However, the dikaryotic phase is more extensive in the basidiomycetes, in many cases also present in the vegetatively growing mycelium. A specialized anatomical structure, called a &#039;&#039;[[clamp connection]]&#039;&#039;, is formed at each hyphal septum. As with the structurally similar hook in the ascomycetes, formation of the clamp connection in the basidiomycetes is required for controlled transfer of nuclei during cell division, to maintain the dikaryotic stage with two genetically different nuclei in each hyphal compartment. &amp;lt;ref name=&amp;quot;Strasburger&amp;quot;/&amp;gt;  A [[basidiocarp]] is formed in which club-like structures known as [[basidia]] generate haploid [[basidiospores]] after karyogamy and meiosis.&amp;lt;ref&amp;gt;[http://www.microbiologybytes.com/introduction/myc2.html Reproduction of fungi] MicrobiologyBytes, [[2007-01-18]]. Retrieved [[2007-04-06]].&amp;lt;/ref&amp;gt; The most commonly known basidiocarps are mushrooms, but they may also take many other forms (see Morphology section).&lt;br /&gt;
&lt;br /&gt;
In zygomycetes, haploid hyphae of two individuals fuse, forming a [[zygote]], which develops into a [[zygospore]]. When the zygospore germinates, it quickly undergoes [[meiosis]], generating new haploid hyphae, which in turn may form asexual [[sporangiospore]]s. These sporangiospores are means of rapid dispersal of the fungus and germinate into new genetically identical haploid fungal colonies, able to mate and undergo another sexual cycle followed by the generation of new zygospores, thus completing the lifecycle.&lt;br /&gt;
&lt;br /&gt;
===Spore dispersal===&lt;br /&gt;
&lt;br /&gt;
Both asexual and sexual spores or sporangiospores of many fungal species are actively dispersed by forcible ejection from their reproductive structures. This ejection ensures exit of the spores from the reproductive structures as well as travelling through the air over long distances. Many fungi thereby possess specialized mechanical and physiological mechanisms as well as spore-surface structures, such as [[hydrophobin]]s, for spore ejection. These mechanisms include, for example, forcible discharge of ascospores enabled by the structure of the ascus and accumulation of [[osmolyte]]s in the fluids of the ascus that lead to explosive discharge of the ascospores into the air. &amp;lt;ref name=&amp;quot;Trail&amp;quot;&amp;gt;{{cite journal|author=Trail F.|year= 2007|title=Fungal cannons: explosive spore discharge in the Ascomycota|journal=FEMS Microbiol Lett.|volume=276|pages=12-18|id=PMID 17784861}}&amp;lt;/ref&amp;gt; The forcible discharge of single spores termed &#039;&#039;ballistospores&#039;&#039; involves formation of a small drop of water ([[Buller&#039;s drop]]), which upon contact with the spore leads to its projectile release with an initial acceleration of more than 10,000 [[G-force|g]]. &amp;lt;ref name=&amp;quot;Pringle et al&amp;quot;&amp;gt;{{cite journal|author=Pringle A, Patek SN, Fischer M, Stolze J, Money NP.|year= 2005|title=The captured launch of a ballistospore|journal=Mycologia|volume=97|pages=866-871|id=PMID 16457355}}&amp;lt;/ref&amp;gt; Other fungi rely on alternative mechanisms for spore release, such as external mechanical forces, exemplified by [[puffballs]]. Attracting insects, such as flies, to fruiting structures, by virtue of their having lively colours and a putrid odour, for dispersal of fungal spores is yet another strategy, most prominently used by the [[stinkhorns]].&lt;br /&gt;
&lt;br /&gt;
===Other sexual processes===&lt;br /&gt;
&lt;br /&gt;
Besides regular sexual reproduction with meiosis, some fungal species may exchange genetic material via [[parasexuality|parasexual]] processes, initiated by anastomosis between hyphae and [[plasmogamy]] of fungal cells. The frequency and relative importance of parasexual events is unclear and may be lower than other sexual processes. However, it is known to play a role in intraspecific hybridization &amp;lt;ref name=&amp;quot;Furlaneto&amp;quot;&amp;gt;{{cite journal|author=Furlaneto MC, Pizzirani-Kleiner AA.|year= 1992|title=Intraspecific hybridisation of Trichoderma pseudokoningii by anastomosis and by protoplast fusion.|journal= FEMS Microbiol Lett.|volume=69|pages=191-195|id=PMID 1537549}}&amp;lt;/ref&amp;gt; and is also likely required for hybridization between fungal species, which has been associated with major events in fungal evolution. &amp;lt;ref name=&amp;quot;Schardl&amp;quot;&amp;gt;{{cite journal|author=Schardl CL, Craven KD.|year= 2003|title=Interspecific hybridization in plant-associated fungi and oomycetes: a review.|journal= Mol. Ecol.|volume=12|pages=2861-2873|id=PMID 14629368}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Phylogeny and classification==&lt;br /&gt;
[[Image:Oudemansiella nocturnum.JPG|thumb|right|The mushroom &#039;&#039;[[Oudemansiella nocturnum]]&#039;&#039; eats wood]]&lt;br /&gt;
For a long time [[taxonomy|taxonomists]] considered fungi to be members of the [[Plant| Plant Kingdom]]. This early classification was based mainly on similarities in lifestyle: both fungi and plant are mainly [[sessile]], have similarities in general [[morphology (biology)|morphology]] and growth habitat (like plants, fungi often grow in soil, in the case of [[mushrooms]] forming conspicuous [[fruiting bodies]], which sometimes bear resemblance to plants such as [[mosses]]). Moreover, both groups possess a [[cell wall]], which is absent in the [[Animal|Animal Kingdom]]. However, the fungi are now considered a separate kingdom, distinct from both plants and animals, from which they appear to have diverged approximately one billion years ago.&amp;lt;ref name=&amp;quot;Bruns&amp;quot;&amp;gt;{{cite journal|author=Bruns T.|year= 2006|title=Evolutionary biology: a kingdom revised.|journal=Nature|volume=443|pages=758-761|id=PMID 17051197 | doi = 10.1038/443758a%3Ca | doilabel = 10.1038/443758a&amp;lt;a &amp;lt;!--Retrieved from Yahoo! by DOI bot--&amp;gt;}}&amp;lt;/ref&amp;gt; Many studies have identified several distinct morphological, biochemical, and genetic features in the Fungi, clearly delineating this group from the other kingdoms. For these reasons, the fungi are placed in their own kingdom.&lt;br /&gt;
&lt;br /&gt;
===Physiological and morphological traits===&lt;br /&gt;
&lt;br /&gt;
Similar to animals and unlike most plants, fungi lack the capacity to synthesize organic carbon by chlorophyll-based [[photosynthesis]]; whereas plants store the reduced carbon as [[starch]], fungi, like animals and some bacteria, use [[glycogen]] &amp;lt;ref name=&amp;quot;Lomako&amp;gt;{{cite journal|author=Lomako J, Lomako WM, Whelan WJ.|year= 2004|title=Glycogenin: the primer for mammalian and yeast glycogen synthesis|journal=Biochim Biophys Acta.|volume=1673|pages=45-55|id=PMID 15238248}}&amp;lt;/ref&amp;gt; for storage of [[carbohydrates]]. A major component of the cell wall in many fungal species is the nitrogen-containing [[carbohydrate]], [[chitin]],&amp;lt;ref name=&amp;quot;Bowman and Free&amp;quot;&amp;gt;{{cite journal|author=Bowman SM, Free SJ.|year= 2006|title=The structure and synthesis of the fungal cell wall|journal=Bioessays|volume=28|pages=799-808|id=PMID 16927300}}&amp;lt;/ref&amp;gt; also present in some animals, such as the [[insect]]s and [[crustacea]]ns, while the plant cell wall consists chiefly of the carbohydrate [[cellulose]]. The defining and unique characteristics of fungal cells include growth as [[hypha]]e, which are microscopic filaments of between 2-10 microns in diameter and up to several centimetres in length, and which combined form the fungal [[mycelium]]. Some fungi, such as yeasts, grow as single ovoid cells, similar to unicellular [[algae]] and the [[protist]]s.&lt;br /&gt;
&lt;br /&gt;
Unlike many plants, most fungi lack an efficient [[vascular tissue|vascular]] system, such as [[xylem]] or [[phloem]] for long-distance transport of water and nutrients; as an example for [[convergent evolution]], some fungi, such as &#039;&#039;[[Armillaria]]&#039;&#039;, form rhizomorphs or [[mycelial cord]]s,&amp;lt;ref name=&amp;quot;Mikhail&amp;quot;&amp;gt;{{cite journal|author= 	&lt;br /&gt;
Mihail JD, Bruhn JN.|year= 2005|title=Foraging behaviour of Armillaria rhizomorph systems|journal=Mycol. Res.|volume=109|pages=1195-1207|id=PMID 16279413}}&amp;lt;/ref&amp;gt; resembling and functionally related to, but morphologically distinct from, [[plant root]]s.&lt;br /&gt;
&lt;br /&gt;
Some characteristics shared between plants and fungi include the presence of [[vacuole]]s in the cell,&amp;lt;ref name=&amp;quot;Shoji &amp;quot;&amp;gt;{{cite journal|author=Shoji JY, Arioka M, Kitamoto K|year= 2006|title=Possible involvement of pleiomorphic vacuolar networks in nutrient recycling in filamentous fungi|journal=Autophagy. |volume=2|pages=226-227|id=PMID 16874107}}&amp;lt;/ref&amp;gt; and a similar pathway in the biosynthesis of [[terpenes]] using [[mevalonic acid]] and [[pyrophosphate]] as [[Precursor (chemistry)|biochemical precursor]]s; plants however use an additional terpene biosynthesis pathway in the [[chloroplast]]s that is apparently absent in fungi.&amp;lt;ref name=&amp;quot;Wu&amp;quot;&amp;gt;{{cite journal|author=Wu S, Schalk M, Clark A, Miles RB, Coates R, Chappell J.|year= 2007|title=Redirection of cytosolic or plastidic isoprenoid precursors elevates terpene production in plants|journal=Nat Biotechnol.|volume=24|pages=1441-7|id=PMID 17057703}}&amp;lt;/ref&amp;gt; Ancestral traits shared among members of the fungi include [[chitinous]] cell walls and heterotrophy by absorption.&amp;lt;ref name=&amp;quot;Strasburger&amp;quot;/&amp;gt; A further characteristic of the fungi that is absent from other eukaryotes, and shared only with some bacteria, is the biosynthesis of the amino acid, L-[[lysine]], via the α-aminoadipate pathway. &amp;lt;ref name=&amp;quot;Xu&amp;quot;&amp;gt;{{cite journal|author=Xu H, Andi B, Qian J, West AH, Cook PF|year= 2006|title=The alpha-aminoadipate pathway for lysine biosynthesis in fungi|journal=Cell Biochem Biophys.|volume=46|pages=43-64|id=PMID 16943623}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Similar to plants, fungi produce a plethora of [[secondary metabolites]] functioning as defensive compounds or for [[niche adaptation]]; however, biochemical pathways for the synthesis of similar or even identical compounds often differ markedly between fungi and plants. &amp;lt;ref name=&amp;quot;Tudzynski&amp;quot;&amp;gt;{{cite journal|author=Tudzynski B.|year= 2005|title=Gibberellin biosynthesis in fungi: genes, enzymes, evolution, and impact on biotechnology|journal=Appl Microbiol Biotechnol.|volume=66|pages=597-611|id=PMID 15578178}}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;Siewers&amp;quot;&amp;gt;{{cite journal|author=Siewers V, Smedsgaard J, Tudzynski P.|year= 2004|title=The P450 monooxygenase BcABA1 is essential for abscisic acid biosynthesis in Botrytis cinerea.|journal=Appl Environ. Microbiol.|volume=70|pages=3868-3876|id=PMID 15240257 | doi = 10.1128/AEM.70.7.3868-3876.2004 &amp;lt;!--Retrieved from Yahoo! by DOI bot--&amp;gt;}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Evolutionary history===&lt;br /&gt;
{{Main|Evolution of fungi}}&lt;br /&gt;
The first organisms having features typical of fungi date to 1200, the Proterozoic.&amp;lt;ref name=Butterfield2005&amp;gt;{{cite journal&lt;br /&gt;
 | author = Butterfield, N.J.&lt;br /&gt;
 | year = 2005&lt;br /&gt;
 | title = Probable Proterozoic fungi&lt;br /&gt;
 | journal = Paleobiology&lt;br /&gt;
 | volume = 31&lt;br /&gt;
 | issue = 1&lt;br /&gt;
 | pages = 165-182&lt;br /&gt;
 | doi = ...&lt;br /&gt;
 | doilabel=10.1666/0094-8373(2005)031%3C0165:PPF%3E2.0.CO;2 &lt;br /&gt;
 | accessdate = 2008-05-05&lt;br /&gt;
}}&amp;lt;/ref&amp;gt;  However, fungal fossils do not become common and uncontroversial until the early Devonian, when they are abundant in the Rhynie chert.&amp;lt;ref name=Brundrett2002/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Even though traditionally included in many botany curricula and textbooks, fungi are now thought to be more closely related to [[animal]]s than to plants and are placed with the animals in the [[monophyletic]] group of [[opisthokont]]s.&amp;lt;ref name=&amp;quot;Strasburger&amp;quot;&amp;gt;{{cite book|author= P. Sitte, H. Ziegler, F. Ehrendorfer|title=Strasburger Lehrbuch der Botanik (Textbook of Botany)|year=1991|edition=33 ed|publisher=Urban &amp;amp; Fischer| isbn=3437204475}}&amp;lt;/ref&amp;gt; For much of the [[Paleozoic]] Era, the fungi appear to have been aquatic, and consisted of organisms similar to the [[Extant taxon|extant]] Chytrids in having flagellum-bearing spores.&amp;lt;ref name=&amp;quot;James&amp;quot;&amp;gt;{{cite journal|author=James TY et al|year= 2006|title=Reconstructing the early evolution of Fungi using a six-gene phylogeny.|journal=Nature|volume=443|pages=818-822|id=PMID 17051209 | doi = 10.1038/nature05110}}&amp;lt;/ref&amp;gt; The early fossil record of the fungi is fragmentary, to say the least.  The fungi probably colonized the land during the [[Cambrian]], long before land plants.&amp;lt;ref name=Brundrett2002&amp;gt;{{cite journal&lt;br /&gt;
 | author = Brundrett, M.C.&lt;br /&gt;
 | year = 2002&lt;br /&gt;
 | title = Coevolution of roots and mycorrhizas of land plants&lt;br /&gt;
 | journal = New Phytologist&lt;br /&gt;
 | volume = 154&lt;br /&gt;
 | issue = 2&lt;br /&gt;
 | pages = 275-304&lt;br /&gt;
 | doi = 10.1046/j.1469-8137.2002.00397.x}}&amp;lt;/ref&amp;gt; For some time after the [[Permian-Triassic extinction event]], a fungal spike, originally thought to be an extraordinary abundance of fungal spores in [[sediment]]s formed shortly after this event, suggested that they were the dominant life form during this period—nearly 100% of the [[fossil record]] available from this period.&amp;lt;ref name=&amp;quot;eshet&amp;quot;&amp;gt;Eshet, Y. et al. (1995) Fungal event and palynological record of ecological crisis and recovery across the Permian-Triassic boundary. &#039;&#039;Geology&#039;&#039;, 23, 967-970.&amp;lt;/ref&amp;gt;  However, the relative proportion of fungal spores relative to spores formed by algal species is difficult to assess, &amp;lt;ref name=&amp;quot;FosterEtAl2002RevisionOfReduviasporonites&amp;quot;&amp;gt;{{cite journal | author = Foster, C.B. | coauthors = Stephenson, M.H.; Marshall, C.; Logan, G.A.; Greenwood, P.F. | year = 2002 | title = A Revision Of Reduviasporonites Wilson 1962: Description, Illustration, Comparison And Biological Affinities | journal = Palynology | volume = 26 | issue = 1 | pages = 35-58 | doi = 10.2113/0260035 | url=http://palynology.geoscienceworld.org/cgi/content/abstract/26/1/35}}&amp;lt;/ref&amp;gt; the spike did not appear world-wide, &amp;lt;ref&amp;gt;{{ cite journal | authors=López-Gómez, J. and Taylor, E.L. | title=Permian-Triassic Transition in Spain: A multidisciplinary approach | journal=Palaeogeography, Palaeoclimatology, Palaeoecology | &lt;br /&gt;
volume=229 | issue=1-2 | date=2005 | pages=1-2 | &lt;br /&gt;
doi=10.1016/j.palaeo.2005.06.028 | url=http://www.sciencedirect.com/science?_ob=ArticleURL&amp;amp;_udi=B6V6R-4GR8RWF-5&amp;amp;_user=1495569&amp;amp;_rdoc=1&amp;amp;_fmt=&amp;amp;_orig=search&amp;amp;_sort=d&amp;amp;view=c&amp;amp;_acct=C000053194&amp;amp;_version=1&amp;amp;_urlVersion=0&amp;amp;_userid=1495569&amp;amp;md5=537a1a5b0a8e04cca2221ecb12afb1e9 }}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;LooyEtAl2005EndPermianDeadZone&amp;quot;&amp;gt;{{cite journal | author = Looy, C.V. | coauthors = Twitchett, R.J.; Dilcher, D.L.; Van Konijnenburg-van Cittert, J.H.A.; Visscher, H. | year = 2005 | title = Life in the end-Permian dead zone | journal = Proceedings of the National Academy of Sciences | volume = 162 | issue = 4 | pages = 653-659 | doi = 10.1073/pnas.131218098 | quote = See image 2&lt;br /&gt;
}}&amp;lt;/ref&amp;gt; and in many places it did not fall on the Permian-Triassic boundary.&amp;lt;ref name=&amp;quot;wardetal&amp;quot;&amp;gt;&lt;br /&gt;
{{&lt;br /&gt;
cite journal|author=Ward PD, Botha J, Buick R, De Kock MO, Erwin DH, Garrison GH, Kirschvink JL &amp;amp; Smith R|date=2005|title=Abrupt and Gradual Extinction Among Late Permian Land Vertebrates in the Karoo Basin, South Africa|journal=Science|volume=307|issue=5710|pages=709–714|doi=10.1126/science.1107068&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Analyses using [[molecular phylogenetics]] support a [[monophyletic group|monophyletic]] origin of the Fungi.&amp;lt;ref name=&amp;quot;Hibbett&amp;quot;/&amp;gt; The [[taxonomy]] of the Fungi is in a state of constant flux, especially due to recent research based on DNA comparisons. These current phylogenetic analyses often overturn classifications based on older and sometimes less discriminative methods based on morphological features and [[biological species concept]]s obtained from experimental [[mating]]s.&amp;lt;ref&amp;gt;See [http://www.palaeos.com/Fungi/default.htm Palaeos: Fungi] for an  introduction to fungal taxonomy, including recent controversies.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;[http://www.clarku.edu/faculty/dhibbett/AFTOL/documents/AFTOL%20class%20mss%2023,%2024/AFTOL%20CLASS%20MS%20resub.pdf “A Higher-Level Phylogenetic Classification of the Fungi” by David S. Hibbett,] (.pdf file) Retrieved on 8 March 2007 &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
There is no unique generally accepted system at the higher taxonomic levels and there are constant name changes at every level, from species upwards. However, efforts among fungal researchers are now underway to establish and encourage usage of a unified and more consistent [[Botanical nomenclature|nomenclature]].&amp;lt;ref name=&amp;quot;Hibbett&amp;quot;/&amp;gt; Fungal species can also have multiple scientific names depending on its life cycle and mode (sexual or asexual) of reproduction. Web sites such as [[Index Fungorum]] and [[Integrated Taxonomic Information System|ITIS]] define preferred up-to-date names (with cross-references to older synonyms), but do not always agree with each other.&lt;br /&gt;
&lt;br /&gt;
====Cladogram====&lt;br /&gt;
&amp;lt;center&amp;gt;&lt;br /&gt;
{{Clade &lt;br /&gt;
| style= font-size:100%; line-height:100%&lt;br /&gt;
|    label1=&#039;&#039;[[Unikonta]]&#039;&#039;&amp;amp;nbsp;&amp;amp;nbsp;&lt;br /&gt;
|    1={{clade&lt;br /&gt;
|        1=&#039;&#039;[[Amoebozoa]]&#039;&#039;&lt;br /&gt;
|        label2=&amp;amp;nbsp;&amp;amp;nbsp;&#039;&#039;[[Opisthokonta]]&#039;&#039;&amp;amp;nbsp;&amp;amp;nbsp;&lt;br /&gt;
|        2={{clade&lt;br /&gt;
|        label1 =&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&lt;br /&gt;
|           1={{clade|label1=&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;|1=&#039;&#039;[[Animalia]]&#039;&#039;|2=&#039;&#039;[[Choanozoa]]&#039;&#039;}}&lt;br /&gt;
|           label3=&amp;amp;nbsp;&amp;amp;nbsp;&#039;&#039;&#039;&#039;&#039;Fungi&#039;&#039;&#039;&#039;&#039;&amp;amp;nbsp;&amp;amp;nbsp;&lt;br /&gt;
|           3={{clade&lt;br /&gt;
|              1=&#039;&#039;[[Chytridiomycota]]&#039;&#039;&lt;br /&gt;
|              2=&#039;&#039;[[Blastocladiomycota]]&#039;&#039;&lt;br /&gt;
|              3=&#039;&#039;[[Neocallimastigomycota]]&#039;&#039;&lt;br /&gt;
|              4=&#039;&#039;[[Zygomycota]]&#039;&#039;&lt;br /&gt;
|              5=&#039;&#039;[[Glomeromycota]]&#039;&#039;&lt;br /&gt;
|              label6=&amp;amp;nbsp;&amp;amp;nbsp;&#039;&#039;[[Dikarya]]&#039;&#039;&amp;amp;nbsp;&amp;amp;nbsp;&lt;br /&gt;
|              6={{clade&lt;br /&gt;
|                1=&#039;&#039;[[Ascomycota]]&#039;&#039;&lt;br /&gt;
|                2=&#039;&#039;[[Basidiomycota]]&#039;&#039;&lt;br /&gt;
               }}&lt;br /&gt;
              }}  &lt;br /&gt;
}}&lt;br /&gt;
}}  }}&lt;br /&gt;
&amp;lt;/center&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===The taxonomic groups of fungi===&lt;br /&gt;
The major divisions ([[phylum|phyla]]) of fungi have been classified based mainly on their sexual [[reproduction|reproductive]] structures. Currently, seven fungal divisions are proposed:&amp;lt;ref name=&amp;quot;Hibbett&amp;quot;/&amp;gt;&lt;br /&gt;
[[Image:Wn8-05-2.JPG|thumb|&#039;&#039;[[Arbuscular mycorrhiza]]&#039;&#039; seen under microscope. [[Flax]] root cortical cells containing paired arbuscules.]]&lt;br /&gt;
[[Image:Aspergillus.jpg|thumb|right|[[Conidiophore]]s of molds of the genus &lt;br /&gt;
&#039;&#039;[[Aspergillus]]&#039;&#039;, an ascomycete, seen under microscope.]]&lt;br /&gt;
* The [[Chytridiomycota]] are commonly known as chytrids. These fungi are ubiquitous with a worldwide distribution; chytrids produce [[zoospore]]s that are capable of active movement through aqueous phases with a single [[flagellum]]. Consequently, some [[taxonomist]]s had earlier classified them as [[protist]]s on the basis of the flagellum. Molecular phylogenies, inferred from the rRNA-operon sequences representing the 18S, 28S, and 5.8S ribosomal subunits, suggest that the Chytrids are a basal fungal group divergent from the other fungal divisions, consisting of four major clades with some evidence for paraphyly or possibly polyphyly. &amp;lt;ref name=&amp;quot;James&amp;quot;&amp;gt;{{cite journal|author=James TY, Letcher PM, Longcore JE, Mozley-Standridge SE, Porter D, Powell MJ, Griffith GW, Vilgalys R.|year=2006|title=A molecular phylogeny of the flagellated fungi (Chytridiomycota) and description of a new phylum (Blastocladiomycota).|journal=Mycologia|volume=98|pages=860-871|id=PMID 17486963}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
* The [[Blastocladiomycota]] were previously considered a taxonomic clade within the Chytridiomycota. Recent molecular data and ultrastructural characteristics, however, place the Blastocladiomycota as a sister clade to the Zygomycota, Glomeromycota, and Dikarya (Ascomycota and Basiomycota). The blastocladiomycetes are fungi that are saprotrophs and parasites of all eukaryotic groups and undergo sporic meiosis unlike their close relatives, the chytrids, which mostly exhibit zygotic meiosis. &amp;lt;ref name=&amp;quot;James&amp;quot;/&amp;gt;&lt;br /&gt;
*The [[Neocallimastigomycota]] were earlier placed in the phylum Chytridomycota. Members of this small phylum are anaerobic organisms, living in the digestive system of larger herbivorous mammals and possibly in other terrestrial and aquatic environments. They lack [[mitochondria]] but contain [[hydrogenosome]]s of mitochondrial origin. As the related chrytrids, neocallimastigomycetes form zoospores that are posteriorly uniflagellate or polyflagellate.&amp;lt;ref name=&amp;quot;Hibbett&amp;quot;/&amp;gt;&lt;br /&gt;
* The [[Zygomycota]] contain the [[taxa]], Zygomycetes and Trichomycetes, and reproduce sexually with [[meiospore]]s called zygospores and asexually with [[sporangiospore]]s. [[Black bread mold]] (&#039;&#039;[[Rhizopus stolonifer]]&#039;&#039;) is a common species that belongs to this group; another is &#039;&#039;[[Pilobolus]]&#039;&#039;, which is capable of ejecting [[spore]]s several meters through the air.  Medically relevant genera include &#039;&#039;[[Mucor]]&#039;&#039;, &#039;&#039;[[Rhizomucor]]&#039;&#039;, and &#039;&#039;[[Rhizopus]]&#039;&#039;. [[Molecular phylogenetic]] investigation has shown the Zygomycota to be a [[polyphyletic]] phylum with evidence of [[paraphyly]] within this taxonomic group. &amp;lt;ref name=&amp;quot;White et al&amp;quot;&amp;gt;{{cite journal|author=White MM, James TY, O&#039;Donnell K, Cafaro MJ, Tanabe Y, Sugiyama J.|year=2006|title=Phylogeny of the Zygomycota based on nuclear ribosomal sequence data.|journal=Mycologia|volume=98|pages=872-884|id=PMID 17486964}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
* Members of the [[Glomeromycota]] are fungi forming [[arbuscular mycorrhizae]] with higher plants. Only one species has been observed forming zygospores; all other species solely reproduce asexually. The symbiotic association between the Glomeromycota and plants is ancient, with evidence dating to 400 million years ago.&amp;lt;ref name=&amp;quot;Remy et al.&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Image:Ascocarp2.png|thumb|right|Diagram of an apothecium (the typical cup-like reproductive structure of Ascomycetes) showing sterile tissues as well as developing and mature asci.]]&lt;br /&gt;
* The [[Ascomycota]], commonly known as sac fungi or ascomycetes, constitute the largest taxonomic group within the Eumycota. These fungi form meiotic spores called [[ascospore]]s, which are enclosed in a special sac-like structure called an [[ascus]]. This division includes [[morel]]s, a few [[mushroom]]s and [[Tuber (genus)|truffle]]s, single-celled [[yeast]]s (e.g., of the genera &#039;&#039;[[Saccharomyces]]&#039;&#039;, &#039;&#039;[[Kluyveromyces]]&#039;&#039;, &#039;&#039;[[Pichia]]&#039;&#039;, and &#039;&#039;[[Candida (genus)|Candida]]&#039;&#039;), and many filamentous fungi living as saprotrophs, parasites, and mutualistic symbionts. Prominent and important genera of filamentous ascomycetes include &#039;&#039;[[Aspergillus]]&#039;&#039;, &#039;&#039;[[Penicillium]]&#039;&#039;, &#039;&#039;[[Fusarium]]&#039;&#039;, and &#039;&#039;[[Claviceps]]&#039;&#039;. Many ascomycetes species have only been observed undergoing asexual reproduction (called [[anamorph]]ic species), but molecular data has often been able to identify their closest [[teleomorph]]s in the Ascomycota. Because the products of meiosis are retained within the sac-like ascus, several ascomyctes have been used for elucidating principles of genetics and heredity (e.g. &#039;&#039;[[Neurospora crassa]]&#039;&#039;).&lt;br /&gt;
* Members of the [[Basidiomycota]], commonly known as the club fungi or basidiomycetes, produce meiospores called [[basidiospore]]s on club-like stalks called [[basidium|basidia]]. Most common [[mushroom]]s belong to this group, as well as [[rust (fungus)]] and [[smut (fungus)|smut fungi]], which are major pathogens of grains. Other important Basidiomyces include the [[maize]] pathogen,&#039;&#039;[[Ustilago maydis]]&#039;&#039;, human commensal species of the genus &#039;&#039;[[Malassezia]]&#039;&#039;, and the opportunistic human pathogen, &#039;&#039;[[Cryptococcus neoformans]]&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
===Phylogenetic relationships with other fungus-like organisms===&lt;br /&gt;
&lt;br /&gt;
Because of some similarities in morphology and lifestyle, the slime molds (myxomycetes) and water molds (oomycetes) were formerly classified in the kingdom Fungi. Unlike true fungi, however, the cell walls of these organisms contain cellulose and lack chitin. Slime molds are [[unikont]]s like fungi, but are grouped in the [[Amoebozoa]]. Water molds are diploid [[bikont]]s, grouped in the [[Chromalveolate]] kingdom. Neither water molds nor slime molds are closely related to the true fungi, and, therefore, [[taxonomist]]s no longer group them in the kingdom Fungi. Nonetheless, studies of the oomycetes and myxomycetes are still often included in [[mycology]] textbooks and primary research literature.&lt;br /&gt;
&lt;br /&gt;
It has been suggested that the [[nucleariid]]s, currently grouped in the [[Choanozoa]], may be a sister group to the oomycete clade, and as such could be included in an expanded fungal kingdom.&amp;lt;ref&amp;gt;{{cite book |title=The Mycota: A Comprehensive Treatise on Fungi as Experimental Systems for Basic and Applied Research |last=Esser |first=Karl |coauthors=Paul A. Lemke |year=1994 |publisher=Springer |isbn=3540580085 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
*[[Bioaerosol]]&lt;br /&gt;
*[[Carnivorous fungus]]&lt;br /&gt;
*[[Entomopathogenic fungi]]&lt;br /&gt;
*[[Fusicoccin]]&lt;br /&gt;
*[[List of fungal orders]]&lt;br /&gt;
*[[MycoBank]]&lt;br /&gt;
*[[Plant pathology]] &lt;br /&gt;
*[[Wood-decay fungus]]&lt;br /&gt;
*[[Pathogenic fungi]]&lt;br /&gt;
&lt;br /&gt;
==Notes and references==&lt;br /&gt;
{{reflist|2}}&lt;br /&gt;
&lt;br /&gt;
==Further reading==&lt;br /&gt;
*Alexopoulos, C.J.,  Charles W. Mims, M. Blackwell  et al., &#039;&#039;Introductory Mycology, 4&amp;lt;sup&amp;gt;th&amp;lt;/sup&amp;gt; ed.&#039;&#039; (John Wiley and Sons, Hoboken NJ, 2004)  ISBN 0-471-52229-5&lt;br /&gt;
*Arora, David. (1986). &amp;quot;Mushrooms Demystified: A Comprehensive Guide to the Fleshy Fungi&amp;quot;. 2nd ed. Ten Speed Press. ISBN 0898151694&lt;br /&gt;
* Deacon JW. (2005). &amp;quot;Fungal Biology&amp;quot; (4th ed). Malden, MA: Blackwell Publishers. ISBN 1-4051-3066-0.&lt;br /&gt;
* Kaminstein D. (2002). [http://www.healthatoz.com/healthatoz/Atoz/ency/mushroom_poisoning.jsp Mushroom poisoning].&lt;br /&gt;
&lt;br /&gt;
==External links==&lt;br /&gt;
*[http://mycology.cornell.edu/ The WWW Virtual Library: Mycology]&lt;br /&gt;
*[http://www.mykoweb.com/ MykoWeb]&lt;br /&gt;
*[http://www.ilmyco.gen.chicago.il.us/Terms/TermsFrame.html Illinois Mycological Association Mycological Glossary]&lt;br /&gt;
*[http://tolweb.org/fungi Tree of Life web project: Fungi]&lt;br /&gt;
*[http://bugs.bio.usyd.edu.au/Mycology/contents.shtml &#039;&#039;Fungal Biology&#039;&#039;], &#039;&#039;[[University of Sydney]], School of Biological Sciences&#039;&#039;, June, 2004. – Online textbook&lt;br /&gt;
*[http://www.mycolog.com/fifthtoc.html &#039;&#039;The Fifth Kingdom&#039;&#039;] – Online textbook&lt;br /&gt;
*[http://www.speciesfungorum.org/ CABI Bioscience Databases] - Includes &#039;&#039;Index Fungorum&#039;&#039; genus and species names and top-down hierarchy&lt;br /&gt;
*[http://img.jgi.doe.gov/cgi-bin/pub/main.cgi?section=TaxonList&amp;amp;page=lineageMicrobes&amp;amp;phylum=Fungi Comparative Analysis of Fungal Genomes] (at [[United States Department of Energy|DOE&#039;s]] [[Integrated Microbial Genomes System|IMG system]])&lt;br /&gt;
*[http://www.iq.usp.br/wwwdocentes/stevani/ Fungi Bioluminescence Laboratory] - Chemistry Institute, University of São Paulo, Brazil&lt;br /&gt;
&lt;br /&gt;
[[Category:Fungi| ]]&lt;br /&gt;
&lt;br /&gt;
{{Link FA|lt}}&lt;br /&gt;
[[ar:فطر]]&lt;br /&gt;
[[ast:Fungi]]&lt;br /&gt;
[[bn:ছত্রাক]]&lt;br /&gt;
[[zh-min-nan:Ko͘]]&lt;br /&gt;
[[bg:Гъби]]&lt;br /&gt;
[[ca:Fong]]&lt;br /&gt;
[[cv:Кăмпа]]&lt;br /&gt;
[[cs:Houby]]&lt;br /&gt;
[[cy:Ffwng]]&lt;br /&gt;
[[da:Svampe]]&lt;br /&gt;
[[de:Pilze]]&lt;br /&gt;
[[et:Seened]]&lt;br /&gt;
[[el:Μύκητας]]&lt;br /&gt;
[[es:Fungi]]&lt;br /&gt;
[[eo:Fungoj]]&lt;br /&gt;
[[fr:Mycota]]&lt;br /&gt;
[[ga:Fungas]]&lt;br /&gt;
[[ko:균계]]&lt;br /&gt;
[[hi:कवक]]&lt;br /&gt;
[[hsb:Hriby]]&lt;br /&gt;
[[hr:Gljive]]&lt;br /&gt;
[[id:Fungi]]&lt;br /&gt;
[[is:Sveppur]]&lt;br /&gt;
[[it:Funghi]]&lt;br /&gt;
[[he:פטריות]]&lt;br /&gt;
[[la:Fungi]]&lt;br /&gt;
[[lv:Sēnes]]&lt;br /&gt;
[[lb:Pilzeräich]]&lt;br /&gt;
[[lt:Grybai]]&lt;br /&gt;
[[hu:Gombák]]&lt;br /&gt;
[[mk:Габа]]&lt;br /&gt;
[[ms:Kulat]]&lt;br /&gt;
[[nah:Nanacatl]]&lt;br /&gt;
[[nl:Schimmels]]&lt;br /&gt;
[[ja:菌類]]&lt;br /&gt;
[[no:Sopper]]&lt;br /&gt;
[[nn:Sopp]]&lt;br /&gt;
[[oc:Mycota]]&lt;br /&gt;
[[nds:Poggenstöhl]]&lt;br /&gt;
[[pl:Grzyby]]&lt;br /&gt;
[[pt:Fungi]]&lt;br /&gt;
[[ro:Regn Fungi]]&lt;br /&gt;
[[qu:K&#039;allampa]]&lt;br /&gt;
[[ru:Грибы]]&lt;br /&gt;
[[scn:Funci]]&lt;br /&gt;
[[simple:Fungus]]&lt;br /&gt;
[[sk:Huby]]&lt;br /&gt;
[[sl:Glive]]&lt;br /&gt;
[[sr:Гљиве]]&lt;br /&gt;
[[fi:Sienet]]&lt;br /&gt;
[[sv:Svampar]]&lt;br /&gt;
[[ta:பூஞ்சைகள்]]&lt;br /&gt;
[[th:เห็ดรา]]&lt;br /&gt;
[[vi:Nấm]]&lt;br /&gt;
[[tr:Mantar]]&lt;br /&gt;
[[uk:Гриб]]&lt;br /&gt;
[[wa:Tchampion]]&lt;br /&gt;
[[yi:פאנגוס]]&lt;br /&gt;
[[bat-smg:Kremblē]]&lt;br /&gt;
[[zh:真菌]]&lt;br /&gt;
&lt;br /&gt;
{{WikiDoc Help Menu}}&lt;br /&gt;
{{WikiDoc Sources}}&lt;br /&gt;
{{jb1}}&lt;br /&gt;
{{jb2}}&lt;/div&gt;</summary>
		<author><name>Gonzalo Romero</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=COPD_exacerbation_resident_survival_guide&amp;diff=942664</id>
		<title>COPD exacerbation resident survival guide</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=COPD_exacerbation_resident_survival_guide&amp;diff=942664"/>
		<updated>2014-02-12T15:48:15Z</updated>

		<summary type="html">&lt;p&gt;Gonzalo Romero: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{CMG}} {{AE}} {{AK}}&lt;br /&gt;
&lt;br /&gt;
==Definition==&lt;br /&gt;
* Exacerbation of COPD is an acute event characterized by a worsening of the patient’s respiratory symptoms that is beyond normal day-to-day variations and leads to a change in medication.&amp;lt;ref name=&amp;quot;Burge-2003&amp;quot;&amp;gt;{{Cite journal  | last1 = Burge | first1 = S. | last2 = Wedzicha | first2 = JA. | title = COPD exacerbations: definitions and classifications. |journal = Eur Respir J Suppl | volume = 41 | issue =  | pages = 46s-53s | month = Jun | year = 2003 | doi =  | PMID = 12795331 }}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;Celli-2007&amp;quot;&amp;gt;{{Cite journal  | last1 = Celli | first1 = BR. | last2 = Barnes | first2 = PJ. | title = Exacerbations of chronic obstructive pulmonary disease. | journal = Eur Respir J | volume = 29 | issue = 6 | pages = 1224-38 | month = Jun | year = 2007 | doi = 10.1183/09031936.00109906 | PMID = 17540785 }}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;Rodriguez-Roisin-2000&amp;quot;&amp;gt;{{Cite journal  | last1 = Rodriguez-Roisin | first1 = R. | title = Toward a consensus definition for COPD exacerbations. | journal = Chest | volume = 117 | issue = 5 Suppl 2 | pages = 398S-401S | month = May | year = 2000 | doi =  |PMID = 10843984 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
* The diagnosis of an exacerbation relies exclusively on the clinical presentation of the patient complaining of an acute change of symptoms (&#039;&#039;&#039;baseline dyspnea, cough, and/or sputum production&#039;&#039;&#039;) that is beyond normal day-to-day variation.&amp;lt;ref name=&amp;quot;Vestbo-2013&amp;quot;&amp;gt;{{Cite journal  | last1 = Vestbo | first1 = J. | last2 = Hurd | first2 = SS. | last3 = Agustí | first3 = AG. | last4 = Jones | first4 = PW. | last5 = Vogelmeier | first5 = C. | last6 = Anzueto | first6 = A. | last7 = Barnes | first7 = PJ. | last8 = Fabbri | first8 = LM. | last9 = Martinez | first9 = FJ. | title = Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. |journal = Am J Respir Crit Care Med | volume = 187 | issue = 4 | pages = 347-65 | month = Feb | year = 2013 | doi = 10.1164/rccm.201204-0596PP | PMID = 22878278 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Causes==&lt;br /&gt;
===Life-Threatening Causes===&lt;br /&gt;
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.&amp;lt;br&amp;gt;&lt;br /&gt;
* [[Arrhythmia]]&lt;br /&gt;
* [[Congestive heart failure]]&lt;br /&gt;
* [[Pleural effusion]]&lt;br /&gt;
* [[Pneumonia]]&lt;br /&gt;
* [[Pneumothorax]]&lt;br /&gt;
* [[Pulmonary embolism]]&lt;br /&gt;
&lt;br /&gt;
===Common Causes===&lt;br /&gt;
* [[Respiratory tract infections]] (~½)&lt;br /&gt;
* Unknown (~⅓)&lt;br /&gt;
* Air pollutants&lt;br /&gt;
&lt;br /&gt;
==Management==&lt;br /&gt;
{{familytree/start}}&lt;br /&gt;
{{familytree  | | | | | | | | | | | | | | | | | A01 | | | | | | | | | | | | | | |A01=&amp;lt;div style=&amp;quot;float: left; text-align: left; line-height: 150%; &amp;quot;&amp;gt;&#039;&#039;&#039;Characterize the symptoms:&#039;&#039;&#039;&lt;br /&gt;
----&lt;br /&gt;
❑ Increased [[cough]]  &amp;lt;br&amp;gt; ❑ Increased [[dyspnea]]  &amp;lt;br&amp;gt; ❑ Increased [[sputum]] production &amp;lt;/div&amp;gt;}}&lt;br /&gt;
{{familytree  | | | | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | |}}&lt;br /&gt;
{{familytree  | | | | | | | | | | | | | | | | | B01 | | | | | | | | | | | | | | |B01=&amp;lt;div style=&amp;quot;float: left; text-align: left; line-height: 150% &amp;quot;&amp;gt;&#039;&#039;&#039;Examine the patient:&#039;&#039;&#039;&lt;br /&gt;
----&lt;br /&gt;
❑ [[Pulse oximetry]] &amp;lt;br&amp;gt;  ❑ [[Arterial blood gas]] &amp;lt;/div&amp;gt; }}&lt;br /&gt;
{{familytree  | | | | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | |}}&lt;br /&gt;
{{familytree  | | | | | | | | | | | | | | | | | C01 | | | | | | | | | | | | | | |C01=&amp;lt;div style=&amp;quot;float: left; text-align: left; line-height: 150%; &amp;quot;&amp;gt;&#039;&#039;&#039;Consider alternative dagnosis:&#039;&#039;&#039;&lt;br /&gt;
----&lt;br /&gt;
 ❑ [[Pulmonary embolism]] &amp;lt;br&amp;gt; ❑ [[Heart failure]] &amp;lt;br&amp;gt; ❑ [[Asthma]] exacerbation &amp;lt;br&amp;gt; ❑ [[Bronchiectasis]] &amp;lt;br&amp;gt; ❑ Broncholitis obliterans &amp;lt;/div&amp;gt;}}&lt;br /&gt;
{{familytree  | | | | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | |}}&lt;br /&gt;
{{familytree  | | | | | | | | | | | | | | | | | D01 | | | | | | | | | | | | | | |D01=&amp;lt;div style=&amp;quot;float: left; text-align: left; line-height: 150%; &amp;quot;&amp;gt;&#039;&#039;&#039;Supplement Oxygen: (Urgent)&#039;&#039;&#039; &amp;lt;br&amp;gt; ❑ Maintain SaO&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt; ≥ 88-92% )&amp;lt;ref name=&amp;quot;Austin-2010&amp;quot;&amp;gt;{{Cite journal  | last1 = Austin | first1 = MA. | last2 = Wills | first2 = KE. | last3 = Blizzard | first3 = L. | last4 = Walters | first4 = EH. | last5 = Wood-Baker | first5 = R. | title = Effect of high flow oxygen on mortality in chronic obstructive pulmonary disease patients in prehospital setting: randomised controlled trial. | journal = BMJ | volume = 341 | issue =  | pages = c5462 | month =  | year = 2010 | doi =  | PMID = 20959284 }}&amp;lt;/ref&amp;gt; &amp;lt;/div&amp;gt;}}&lt;br /&gt;
{{familytree  | | | | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | |}}&lt;br /&gt;
{{familytree  | | | | | | | | | | | | | | | | | E01 | | | | | | | | | | | | | | |E01=&amp;lt;div style=&amp;quot;float: left; text-align: left; line-height: 150%; &amp;quot;&amp;gt;&#039;&#039;&#039;Need for ICU admission?&#039;&#039;&#039; &amp;lt;BR&amp;gt; ❑ Hemodynamic instability AND/OR &amp;lt;BR&amp;gt; ❑ Changes in mental status (confusion, lethargy, coma) AND/OR &amp;lt;BR&amp;gt; ❑ Severe dyspnea that responds inadequately to initial emergency therapy AND/OR &amp;lt;BR&amp;gt; ❑ Worsening hypoxemia (Pa&amp;lt;sub&amp;gt;O&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;&amp;lt;/sub&amp;gt; &amp;lt;40 mm Hg) and/or respiratory acidosis (pH &amp;lt;7.25) &amp;lt;/div&amp;gt; }}&lt;br /&gt;
{{familytree  | | | | | | | | | |,|-|-|-|-|-|-|-|^|-|-|-|-|-|-|-|-|.| | | | | | | | | |}}&lt;br /&gt;
{{familytree  | | | | | | | | | F01 | | | | | | | | | | | | | | | F02 | | | | | | | | |F01=No |F02=Yes}}&lt;br /&gt;
{{familytree  | | | | | |,|-|-|-|^|-|-|-|.| | | | | | | | | | | | |!| | | | | | | | | |}}&lt;br /&gt;
{{familytree  | | | | | G01 | | | | | | G02 | | | | | | | | | | | G03 | | | | | | | | |G01=&amp;lt;div style=&amp;quot;float: left; text-align: left; line-height: 150% &amp;quot;&amp;gt;&#039;&#039;&#039;Indications for Hospitalization:&#039;&#039;&#039; &amp;lt;div class=&amp;quot;mw-collapsible-content&amp;quot;&amp;gt;&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible mw-collapsed&amp;quot;&amp;gt;&amp;lt;BR&amp;gt; ❑ Marked increase in intensity of symptoms (eg, sudden development of resting dyspnea) &amp;lt;BR&amp;gt; ❑ Presence of serious comorbidities (eg, heart failure or newly occurring arrhythmias) &amp;lt;BR&amp;gt; ❑ Failure of an exacerbation to respond to initial medical management &amp;lt;BR&amp;gt; ❑ Onset of new physical signs (eg, cyanosis, peripheral edema) &amp;lt;BR&amp;gt; ❑ Severe underlying COPD (GOLD 3—4 categories) &amp;lt;BR&amp;gt; ❑ Frequent exacerbations (≥2 events per year) &amp;lt;BR&amp;gt; ❑ Insufficient home support &amp;lt;BR&amp;gt; ❑ Older age (&amp;gt;65 years) &amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt; |G02=&amp;lt;div style=&amp;quot;float: left; text-align: left; line-height: 150% &amp;quot;&amp;gt;&#039;&#039;&#039;Assessment of Exacerbation:&#039;&#039;&#039; &amp;lt;div class=&amp;quot;mw-collapsible-content&amp;quot;&amp;gt;&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible mw-collapsed&amp;quot;&amp;gt;&amp;lt;BR&amp;gt; ❑ Cardinal symptoms (↑ dyspnea, ↑ sputum volume, and ↑ sputum purulence) &amp;lt;BR&amp;gt; ❑ ECG (identify coexisting cardiac problems) &amp;lt;BR&amp;gt; ❑ Chest radiograph (exclude alternative diagnoses)&amp;lt;BR&amp;gt; ❑ Whole-blood count (identify polycythemia, anemia, or leukocytosis) &amp;lt;BR&amp;gt; ❑ Electrolytes and glucose (identify electrolyte disturbances or hyperglycemia)&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt; |G03=&amp;lt;div style=&amp;quot;float: left; text-align: left; line-height: 150% &amp;quot;&amp;gt; ❑ Admit patient to ICU &amp;lt;br&amp;gt; ❑ Classify as Life-threatening COPD exacerbation &amp;lt;br&amp;gt; ❑ Assess patients need for mechanical ventilation &amp;lt;/div&amp;gt; }}&lt;br /&gt;
{{familytree  | | | | | | | | | | | | | |!| | | | | | | | | | |,|-|-|^|-|-|.| | | | | | |}}&lt;br /&gt;
{{familytree  | | | | | | | | | | | | | |!| | | | | | | | | | H01 | | | | H02 | | | | | |H01=&amp;lt;div style=&amp;quot;float: left; text-align: left; line-height: 150% &amp;quot;&amp;gt;&#039;&#039;&#039;Indications for Noninvasive Mechanical Ventilation&#039;&#039;&#039; &amp;lt;div class=&amp;quot;mw-collapsible-content&amp;quot;&amp;gt;&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible mw-collapsed&amp;quot;&amp;gt; &amp;lt;BR&amp;gt; ❑ Respiratory acidosis (arterial pH &amp;lt; 7.35 or Pa&amp;lt;sub&amp;gt;CO&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;&amp;lt;/sub&amp;gt; &amp;gt;45 mm Hg) &amp;lt;BR&amp;gt; ❑ Severe dyspnea with signs of respiratory muscle fatigue &amp;lt;BR&amp;gt; ❑ Increased work of breathing &amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;&lt;br /&gt;
|H02=&amp;lt;div style=&amp;quot;float: left; text-align: left; line-height: 150% &amp;quot;&amp;gt;&#039;&#039;&#039;Indications for Invasive Mechanical Ventilation&#039;&#039;&#039; &amp;lt;div class=&amp;quot;mw-collapsible-content&amp;quot;&amp;gt;&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible mw-collapsed&amp;quot;&amp;gt;&amp;lt;BR&amp;gt; ❑ Diminished consciousness, psychomotor agitation inadequately controlled by sedation &amp;lt;BR&amp;gt; ❑ Severe hemodynamic instability without response to fluids and vasoactive drugs &amp;lt;BR&amp;gt; ❑ Respiratory pauses with loss of consciousness or gasping for air &amp;lt;BR&amp;gt; ❑ Life-threatening hypoxemia in patients unable to tolerate NIV &amp;lt;BR&amp;gt; ❑ Persistent inability to remove respiratory secretions &amp;lt;BR&amp;gt; ❑ Heart rate &amp;lt;50/min with loss of alertness &amp;lt;BR&amp;gt;❑ Severe ventricular arrhythmias &amp;lt;BR&amp;gt; ❑ Respiratory or cardiac arrest &amp;lt;BR&amp;gt; ❑ Failure of initial trial of NIV &amp;lt;BR&amp;gt; ❑ Massive aspiration&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;}}&lt;br /&gt;
{{familytree  | | | | | | | | | | | | | |!| | | | | | | | | | |`|-|-|v|-|-|&#039;| | | | | | |}}&lt;br /&gt;
{{familytree  | | | | | | | | | | | | | |!| | | | | | | | | | | | | |!| | | |}}&lt;br /&gt;
{{familytree  | | | | | | | | |,|-|-|-|-|+|-|-|-|-|.| | | | | | | | |!| | | |}}&lt;br /&gt;
{{familytree  | | | | | | | | I01 | | | I02 | | | I03 |-|-|-|-|-|-|-|&#039;| | | | I01=&amp;lt;div style=&amp;quot;float: left; text-align: left; line-height: 150% &amp;quot;&amp;gt;&#039;&#039;&#039;Mild Exacerbation&#039;&#039;&#039; (⊕ 1 cardinal symptom) &amp;lt;BR&amp;gt; ❑ Consider outpatient management &amp;lt;BR&amp;gt; ❑ Require change of inhaled treatment by the patient&amp;lt;/div&amp;gt; |I02=&amp;lt;div style=&amp;quot;float: left; text-align: left; line-height: 150% &amp;quot;&amp;gt;&#039;&#039;&#039;Moderate Exacerbation&#039;&#039;&#039; (⊕ 2 cardinal symptoms) &amp;lt;BR&amp;gt; ❑ Consider outpatient management &amp;lt;BR&amp;gt; ❑ Require a short course of antibiotics and/or oral corticosteroids &amp;lt;/div&amp;gt;|I03=&amp;lt;div style=&amp;quot;float: left; text-align: left; line-height: 150% &amp;quot;&amp;gt;&#039;&#039;&#039;Severe Exacerbation&#039;&#039;&#039; (⊕ 3 cardinal symptoms)&amp;lt;div class=&amp;quot;mw-collapsible-content&amp;quot;&amp;gt;&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible mw-collapsed&amp;quot;&amp;gt; &amp;lt;BR&amp;gt; ❑ Consider inpatient management &amp;lt;BR&amp;gt; ❑ Assess symptoms, ABG, and CXR &amp;lt;BR&amp;gt; ❑ Monitor fluid balance and nutrition&amp;lt;BR&amp;gt; ❑ Identify and treat associated conditions &amp;lt;BR&amp;gt; ❑ Consider subcutaneous heparin or LMWH &amp;lt;BR&amp;gt; ❑ Controlled oxygen therapy (consider NIV if indicated) &amp;lt;BR&amp;gt;❑ Antibiotics (if ↑ sputum purulence or ⊕ bacterial infection) &amp;lt;BR&amp;gt; ❑ Corticosteroids &amp;lt;BR&amp;gt; ❑ Bronchodilators &amp;lt;BR&amp;gt; ▸ Increase doses/frequency of short-acting bronchodilators &amp;lt;BR&amp;gt; ▸ Combine short-acting β2-agonists and anticholinergics &amp;lt;BR&amp;gt; ▸ Use spacers or air-driven nebulizers &amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;}}&lt;br /&gt;
{{familytree/end}}&lt;br /&gt;
&lt;br /&gt;
==Pharmacologic Treatment==&lt;br /&gt;
{{Family tree/start}}&lt;br /&gt;
{{Family tree |border=2|boxstyle=background: WhiteSmoke;|A1|A1=&amp;lt;div style=&amp;quot;float: left; text-align: left; height: 17em; width: 45em; padding:1em;&amp;quot;&amp;gt;&#039;&#039;&#039;&#039;&#039;β2-adrenergic agonists&#039;&#039;&#039;&#039;&#039; &amp;lt;BR&amp;gt; ▸ &#039;&#039;&#039;&#039;&#039;[[Albuterol]] MDI 4—8 puffs IH q1—2h OR Nebulizer 2.5—5 mg IH q1—2h&#039;&#039;&#039;&#039;&#039;&lt;br /&gt;
----&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;&#039;&#039;Anticholinergics&#039;&#039;&#039;&#039;&#039; &amp;lt;BR&amp;gt; ▸ &#039;&#039;&#039;&#039;&#039;[[Ipratropium]] MDI 4—8 puffs IH q1—2h OR Nebulizer 0.5 mg IH q1—2h&#039;&#039;&#039;&#039;&#039;&lt;br /&gt;
----&lt;br /&gt;
&#039;&#039;&#039;&#039;&#039;Methylxanthines&#039;&#039;&#039;&#039;&#039; &amp;lt;BR&amp;gt; ▸ &#039;&#039;&#039;&#039;&#039;[[Aminophylline]] 0.9 mg/kg/hr IV&#039;&#039;&#039;&#039;&#039; &amp;lt;BR&amp;gt; ▸ &#039;&#039;&#039;&#039;&#039;[[Theophylline]] 150—450 mg PO bid&#039;&#039;&#039;&#039;&#039;&lt;br /&gt;
----&lt;br /&gt;
&#039;&#039;&#039;Treatment Notes&#039;&#039;&#039;&amp;lt;ref name=&amp;quot;Stoller-2002&amp;quot;&amp;gt;{{Cite journal  | last1 = Stoller | first1 = JK. | title = Clinical practice. Acute exacerbations of chronic obstructive pulmonary disease. | journal = N Engl J Med | volume = 346 | issue = 13 | pages = 988-94 | month = Mar | year = 2002 | doi = 10.1056/NEJMcp012477 | PMID = 11919309 }}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;Celli-2004&amp;quot;&amp;gt;{{Cite journal  | last1 = Celli | first1 = BR. | last2 = MacNee | first2 = W. | title = Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. | journal = Eur Respir J | volume = 23 | issue = 6 | pages = 932-46 | month = Jun | year = 2004 | doi =  | PMID = 15219010 }}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;Barberá-1992&amp;quot;&amp;gt;{{Cite journal  | last1 = Barberá | first1 = JA. | last2 = Reyes | first2 = A. | last3 = Roca | first3 = J. | last4 = Montserrat | first4 = JM. | last5 = Wagner | first5 = PD. | last6 = Rodríguez-Roisin | first6 = R. | title = Effect of intravenously administered aminophylline on ventilation/perfusion inequality during recovery from exacerbations of chronic obstructive pulmonary disease. | journal = Am Rev Respir Dis | volume = 145 | issue = 6 | pages = 1328-33 | month = Jun | year = 1992 |doi = 10.1164/ajrccm/145.6.1328 | PMID = 1595998 }}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;Emerman-1990&amp;quot;&amp;gt;{{Cite journal  | last1 = Emerman | first1 = CL. | last2 = Connors | first2 = AF. | last3 = Lukens| first3 = TW. | last4 = May | first4 = ME. | last5 = Effron | first5 = D. | title = Theophylline concentrations in patients with acute exacerbation of COPD. | journal = Am J Emerg Med |volume = 8 | issue = 4 | pages = 289-92 | month = Jul | year = 1990 | doi =  | PMID = 2363749 }}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;Lloberes-1988&amp;quot;&amp;gt;{{Cite journal  | last1 = Lloberes | first1 = P. |last2 = Ramis | first2 = L. | last3 = Montserrat | first3 = JM. | last4 = Serra | first4 = J. | last5 = Campistol | first5 = J. | last6 = Picado | first6 = C. | last7 = Agusti-Vidal |first7 = A. | title = Effect of three different bronchodilators during an exacerbation of chronic obstructive pulmonary disease. | journal = Eur Respir J | volume = 1 |issue = 6 |pages = 536-9 | month = Jun | year = 1988 | doi =  | PMID = 2971565 }}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;Mahon-1999&amp;quot;&amp;gt;{{Cite journal  | last1 = Mahon | first1 = JL. | last2 = Laupacis |first2 = A. |last3 = Hodder | first3 = RV. | last4 = McKim | first4 = DA. | last5 = Paterson | first5 = NA. | last6 = Wood | first6 = TE. | last7 = Donner | first7 = A. | title = Theophylline for irreversible chronic airflow limitation: a randomized study comparing n of 1 trials to standard practice. | journal = Chest | volume = 115 | issue = 1 | pages = 38-48 | month = Jan |year = 1999 | doi =  | PMID = 9925061 }}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;Murciano-1984&amp;quot;&amp;gt;{{Cite journal  | last1 = Murciano | first1 = D. | last2 = Aubier | first2 = M. | last3 = Lecocguic | first3 = Y. | last4 = Pariente | first4 = R. | title = Effects of theophylline on diaphragmatic strength and fatigue in patients with chronic obstructive pulmonary disease. | journal = N Engl J Med | volume = 311 | issue = 6 | pages = 349-53 | month = Aug | year = 1984 | doi = 10.1056/NEJM198408093110601 | PMID = 6738652 }}&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;{{Cite web  | last =  | first =  |title = http://www.nice.org.uk/nicemedia/live/13029/49397/49397.pdf | url = http://www.nice.org.uk/nicemedia/live/13029/49397/49397.pdf | publisher =  | date =  | accessdate = 18 December 2013 }}&amp;lt;/ref&amp;gt; &amp;lt;BR&amp;gt; ❑ Short-acting β2-agonists with or without short-acting anticholinergics are generally preferred &amp;lt;BR&amp;gt; ❑ Consider methylxanthine as an adjunct if inadequate response to bronchodilators&amp;lt;/div&amp;gt;}}&lt;br /&gt;
{{Family tree/end}}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{{Family tree/start}}&lt;br /&gt;
{{Family tree |border=2|boxstyle=background: WhiteSmoke;|A1|A1=&amp;lt;div style=&amp;quot;float: left; text-align: left; height: 9em; width: 45em; padding:1em;&amp;quot;&amp;gt;&#039;&#039;&#039;&#039;&#039;Corticosteroids&#039;&#039;&#039;&#039;&#039; &amp;lt;BR&amp;gt; ▸ &#039;&#039;&#039;&#039;&#039;[[Prednisolone]] 30—40 mg PO q24h for 10—14 days&#039;&#039;&#039;&#039;&#039; (for mild/moderate exacerbation) &amp;lt;BR&amp;gt; ▸ &#039;&#039;&#039;&#039;&#039;[[Methylprednisolone]] 125 mg IV q6h for 3 days&#039;&#039;&#039;&#039;&#039; (for severe exacerbation)&lt;br /&gt;
----&lt;br /&gt;
&#039;&#039;&#039;Treatment Notes&#039;&#039;&#039;&amp;lt;ref name=&amp;quot;Vestbo-2013&amp;quot;&amp;gt;{{Cite journal  | last1 = Vestbo | first1 = J. | last2 = Hurd | first2 = SS. | last3 = Agustí | first3 = AG. | last4 = Jones | first4 = PW. | last5 = Vogelmeier | first5 = C. | last6 = Anzueto | first6 = A. | last7 = Barnes | first7 = PJ. | last8 = Fabbri | first8 = LM. | last9 = Martinez | first9 = FJ. | title = Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. | journal = Am J Respir Crit Care Med | volume = 187| issue = 4 | pages = 347-65 | month = Feb | year = 2013 | doi = 10.1164/rccm.201204-0596PP | PMID = 22878278 }}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;Maltais-2002&amp;quot;&amp;gt;{{Cite journal  | last1 = Maltais |first1 = F. | last2 = Ostinelli | first2 = J. | last3 = Bourbeau | first3 = J. | last4 = Tonnel | first4 = AB. | last5 = Jacquemet | first5 = N. | last6 = Haddon | first6 = J. |last7 = Rouleau | first7 = M. | last8 = Boukhana | first8 = M. | last9 = Martinot | first9 = JB. | title = Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial. | journal = Am J Respir Crit Care Med | volume = 165 | issue = 5 |pages = 698-703 | month = Mar | year = 2002 | doi = 10.1164/ajrccm.165.5.2109093 | PMID = 11874817 }}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;Gunen-2007&amp;quot;&amp;gt;{{Cite journal  | last1 = Gunen | first1 = H. |last2 = Hacievliyagil | first2 = SS. | last3 = Yetkin | first3 = O. | last4 = Gulbas | first4 = G. | last5 = Mutlu | first5 = LC. | last6 = In | first6 = E. | title = The role of nebulised budesonide in the treatment of exacerbations of COPD. | journal = Eur Respir J | volume = 29 | issue = 4 | pages = 660-7 | month = Apr | year = 2007 | doi = 10.1183/09031936.00073506 | PMID = 17251232 }}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;Ställberg-2009&amp;quot;&amp;gt;{{Cite journal  | last1 = Ställberg | first1 = B. | last2 = Selroos | first2 = O. | last3 = Vogelmeier| first3 = C. | last4 = Andersson | first4 = E. | last5 = Ekström | first5 = T. | last6 = Larsson | first6 = K. | title = Budesonide/formoterol as effective as prednisolone plus formoterol in acute exacerbations of COPD. A double-blind, randomised, non-inferiority, parallel-group, multicentre study. |journal = Respir Res | volume = 10 | issue =  | pages = 11 | month =  | year = 2009 | doi = 10.1186/1465-9921-10-11 | PMID = 19228428 }}&amp;lt;/ref&amp;gt; &amp;lt;BR&amp;gt; ❑ &#039;&#039;&#039;&#039;&#039;[[Budesonide]] 400 mcg IH bid&#039;&#039;&#039;&#039;&#039; may be an alternative to oral corticosteroids&amp;lt;BR&amp;gt; ❑ Corticosteroids should be tapered over 2 weeks&amp;lt;/div&amp;gt;}}&lt;br /&gt;
{{Family tree/end}}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{{Family tree/start}}&lt;br /&gt;
{{Family tree |border=2|boxstyle=background: WhiteSmoke;|A1|A1=&amp;lt;div style=&amp;quot;float: left; text-align: left; height: 43em; width: 45em; padding: 1em;&amp;quot;&amp;gt;&#039;&#039;&#039;Indications for Antibiotics&#039;&#039;&#039;&amp;lt;BR&amp;gt; ❑ Mechanical ventilation required &amp;lt;BR&amp;gt; ❑ Severe exacerbation (⊕ 3 cardinal symptoms) &amp;lt;BR&amp;gt; ❑ Moderate exacerbation with ↑ sputum purulence &lt;br /&gt;
----&lt;br /&gt;
&#039;&#039;&#039;&#039;&#039;Complicated COPD&#039;&#039;&#039;&#039;&#039; (⊕ Risk Factors) &amp;lt;BR&amp;gt; ❑ Age ≥65 years &amp;lt;BR&amp;gt; ❑ FEV&amp;lt;sub&amp;gt;1&amp;lt;/sub&amp;gt; ≤50% predicted &amp;lt;BR&amp;gt; ❑ ≥3 exacerbations per year &amp;lt;BR&amp;gt; ❑ Cardiac disease &amp;lt;BR&amp;gt; ▸ &#039;&#039;&#039;&#039;&#039;[[Moxifloxacin]] 400 mg PO q24h&#039;&#039;&#039;&#039;&#039; &amp;lt;BR&amp;gt; ▸ &#039;&#039;&#039;&#039;&#039;[[Gemifloxacin]] 320 mg PO q24h&#039;&#039;&#039;&#039;&#039; &amp;lt;BR&amp;gt; ▸ &#039;&#039;&#039;&#039;&#039;[[Levofloxacin]] 500 mg PO q24h&#039;&#039;&#039;&#039;&#039; &amp;lt;BR&amp;gt; ▸ &#039;&#039;&#039;&#039;&#039;[[Amoxicillin/Clavulanate|Amoxicillin-Clavulanate]] 875/125 mg PO bid or 2000/125 mg PO bid or 500/125 mg PO q8h&#039;&#039;&#039;&#039;&#039; &amp;lt;BR&amp;gt; ▸ &#039;&#039;&#039;&#039;&#039;[[Ciprofloxacin]] 750 mg PO q12h with sputum culture&#039;&#039;&#039;&#039;&#039; (if at risk for &#039;&#039;Pseudomonas&#039;&#039;)&lt;br /&gt;
----&lt;br /&gt;
&#039;&#039;&#039;&#039;&#039;Uncomplicated COPD&#039;&#039;&#039;&#039;&#039; (⌀ Risk Factors) &amp;lt;BR&amp;gt; ▸ &#039;&#039;&#039;&#039;&#039;[[Azithromycin]] 500 mg PO q24h or 500 mg PO x1 dose followed by 250 mg PO q24h&#039;&#039;&#039;&#039;&#039; &amp;lt;BR&amp;gt; ▸ &#039;&#039;&#039;&#039;&#039;[[Clarithromycin]]extended-release 1000 mg PO q24h&#039;&#039;&#039;&#039;&#039;&amp;lt;BR&amp;gt; ▸ &#039;&#039;&#039;&#039;&#039;[[Cefuroxime axetil]] 250 or 500 mg PO q12h&#039;&#039;&#039;&#039;&#039; &amp;lt;BR&amp;gt; ▸ &#039;&#039;&#039;&#039;&#039;[[Cefpodoxime]] 200 mg PO q12h&#039;&#039;&#039;&#039;&#039; &amp;lt;BR&amp;gt; ▸ &#039;&#039;&#039;&#039;&#039;[[Cefdinir]] 300 mg PO q12h or 600 mg PO q24h&#039;&#039;&#039;&#039;&#039; &amp;lt;BR&amp;gt; ▸ &#039;&#039;&#039;&#039;&#039;[[Doxycycline]] 100 mg PO bid&#039;&#039;&#039;&#039;&#039; &amp;lt;BR&amp;gt; ▸ &#039;&#039;&#039;&#039;&#039;[[Trimethoprim-Sulfamethoxazole]] 160/800 mg PO bid&#039;&#039;&#039;&#039;&#039;&lt;br /&gt;
----&lt;br /&gt;
&#039;&#039;&#039;Treatment Notes&#039;&#039;&#039;&amp;lt;ref name=&amp;quot;Sethi-2008&amp;quot;&amp;gt;{{Cite journal  | last1 = Sethi | first1 = S. | last2 = Murphy | first2 = TF. | title = Infection in the pathogenesis and course of chronic obstructive pulmonary disease. | journal = N Engl J Med | volume = 359 | issue = 22 | pages = 2355-65 | month = Nov | year = 2008 | doi = 10.1056/NEJMra0800353 | PMID = 19038881 }}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;isbn1-9308-0874-7&amp;quot;&amp;gt;{{cite book | author = | authorlink = | editor = |others = | title = The Sanford Guide to Antimicrobial Therapy | edition = | language = |publisher = | location = | year = |origyear = | pages = |quote = | isbn = 1-9308-0874-7 | oclc = |doi = |url = | accessdate = }}&amp;lt;/ref&amp;gt; &amp;lt;BR&amp;gt; ❑ Antibiotic choice should reflect local resistance pattern &amp;lt;BR&amp;gt; ❑ Use alternative class if antibiotic exposure within 3 months &amp;lt;BR&amp;gt; ❑ Re-evaluate and consider sputum culture if failed to respond in 72 hours &amp;lt;BR&amp;gt; ❑ The recommended length of antibiotic therapy is usually 5—10 days &amp;lt;/div&amp;gt;}}&lt;br /&gt;
{{Family tree/end}}&lt;br /&gt;
&lt;br /&gt;
==Checklist at Time of Discharge From Hospital==&lt;br /&gt;
{{Family tree/start}}&lt;br /&gt;
{{Family tree |border=2|boxstyle=background: WhiteSmoke;|A1|A1=&amp;lt;div style=&amp;quot;float: left; text-align: left; height: 13em; width: 41em; padding: 1em;&amp;quot;&amp;gt;&#039;&#039;&#039;Action Items at Discharge&#039;&#039;&#039;&amp;lt;BR&amp;gt; ❑ Reinforce smoking cessation measures &amp;lt;BR&amp;gt; ❑ Assure effective home maintenance of pharmacotherapy regimen &amp;lt;BR&amp;gt; ❑ Reassess inhaler technique &amp;lt;BR&amp;gt; ❑ Educate about maintenance regimen &amp;lt;BR&amp;gt; ❑ Give instruction regarding completion of steroid therapy and antibiotics &amp;lt;BR&amp;gt; ❑ Assess need for long-term oxygen therapy &amp;lt;BR&amp;gt; ❑ Assure follow-up visit in 4—6 weeks&amp;lt;BR&amp;gt; ❑ Provide a management plan for comorbidities and their follow-up&amp;lt;/div&amp;gt;}}&lt;br /&gt;
{{Family tree/end}}&lt;br /&gt;
&lt;br /&gt;
==Checklist at Follow-Up Visit 4—6 Weeks After Discharge==&lt;br /&gt;
{{Family tree/start}}&lt;br /&gt;
{{Family tree |border=2|boxstyle=background: WhiteSmoke;|A1|A1=&amp;lt;div style=&amp;quot;float: left; text-align: left; height: 18em; width: 41em; padding: 1em;&amp;quot;&amp;gt;&#039;&#039;&#039;Action Items at Follow-Up Visit&#039;&#039;&#039; &amp;lt;BR&amp;gt; ❑ Smoking cessation measures &amp;lt;BR&amp;gt; ❑ Ability to cope in usual environment &amp;lt;BR&amp;gt; ❑ Reassess inhaler technique &amp;lt;BR&amp;gt; ❑ Measurement of FEV&amp;lt;sub&amp;gt;1&amp;lt;/sub&amp;gt; &amp;lt;BR&amp;gt; ❑ Inhaler technique &amp;lt;BR&amp;gt; ❑ Understanding of recommended treatment regimen &amp;lt;BR&amp;gt; ❑ Need for long-term oxygen therapy and/or home nebulizer &amp;lt;BR&amp;gt; ❑ Capacity to do physical activity and activities of daily living &amp;lt;BR&amp;gt; ❑ Chronic Obstructive Pulmonary Disease Assessment Test (CAT) &amp;lt;BR&amp;gt; ❑ Modified British Medical Research Council questionnaire on breathlessness (mMRC) &amp;lt;BR&amp;gt; ❑ Status of comorbidities&amp;lt;/div&amp;gt;}}&lt;br /&gt;
{{Family tree/end}}&lt;br /&gt;
&lt;br /&gt;
==Do&#039;s==&lt;br /&gt;
===Assessment===&lt;br /&gt;
* The presence of purulent [[sputum]] during an exacerbation can be sufficient indication for starting empirical antibiotic treatment.&amp;lt;ref name=&amp;quot;Stockley-2000&amp;quot;&amp;gt;{{Cite journal  |last1 = Stockley | first1 = RA. | last2 = O&#039;Brien | first2 = C. | last3 = Pye | first3 = A. | last4 = Hill | first4 = SL. | title = Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD. | journal = Chest | volume = 117 | issue = 6 | pages = 1638-45 | month = Jun | year = 2000 | doi =  | PMID = 10858396 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Treatment===&lt;br /&gt;
======Treatment Setting======&lt;br /&gt;
* When a patient comes to the [[ED]], the first actions are to provide controlled [[oxygen therapy]] and to determine whether the exacerbation is life-threatening. If so, the patient should be admitted to the [[ICU]] immediately.&amp;lt;ref name=&amp;quot;Vestbo-2013&amp;quot;&amp;gt;{{Cite journal  | last1 = Vestbo | first1 = J. | last2 = Hurd|first2 = SS. | last3 = Agustí |first3 = AG. | last4 = Jones | first4 = PW. | last5 = Vogelmeier | first5 = C. | last6 = Anzueto | first6 = A. | last7 = Barnes | first7 = PJ. | last8 = Fabbri | first8 = LM. | last9 = Martinez | first9 = FJ. | title = Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. | journal = Am J Respir Crit Care Med | volume = 187 | issue = 4 | pages = 347-65 | month = Feb | year = 2013 | doi = 10.1164/rccm.201204-0596PP | PMID = 22878278}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
======Short-Acting Bronchodilators======&lt;br /&gt;
* Short-acting inhaled [[Beta2-adrenergic receptor agonist|β2-agonists]] with or without short-acting [[anticholinergic]]s are usually the preferred [[bronchodilator]]s for treatment of an exacerbation.&amp;lt;ref name=&amp;quot;Celli-2004&amp;quot;&amp;gt;{{Cite journal  | last1 = Celli | first1 = BR. | last2 = MacNee | first2 = W. | title = Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. | journal = Eur Respir J | volume = 23 | issue = 6 | pages = 932-46 | month = Jun | year = 2004 | doi =  | PMID = 15219010 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
* A systematic review found no significant differences in [[FEV1|FEV&amp;lt;sub&amp;gt;1&amp;lt;/sub&amp;gt;]] between [[Metered-dose inhaler|MDI]] and [[Nebulizer|nebulizers]],&amp;lt;ref name=&amp;quot;Turner-&amp;quot;&amp;gt;{{Cite journal  | last1 = Turner | first1 = MO. | last2 = Patel | first2 = A. | last3 = Ginsburg | first3 = S. | last4 = FitzGerald | first4 = JM. | title = Bronchodilator delivery in acute airflow obstruction. A meta-analysis. | journal = Arch Intern Med | volume = 157 | issue = 15 | pages = 1736-44 | month =  | year =  | doi =  | PMID = 9250235 }}&amp;lt;/ref&amp;gt; although the latter can be more convenient for sicker or frail patients.&lt;br /&gt;
&lt;br /&gt;
* Intravenous [[methylxanthine]]s ([[theophylline]] or [[aminophylline]]) are only to be used in selected cases when there is insufficient response to [[SABA|short-acting bronchodilators]].&amp;lt;ref name=&amp;quot;Barberá-1992&amp;quot;&amp;gt;{{Cite journal  | last1 = Barberá | first1 = JA. | last2 = Reyes | first2 = A. | last3 = Roca | first3 = J. | last4 = Montserrat | first4 = JM. | last5 = Wagner | first5 = PD. | last6 = Rodríguez-Roisin | first6 = R. | title = Effect of intravenously administered aminophylline on ventilation/perfusion inequality during recovery from exacerbations of chronic obstructive pulmonary disease. | journal = Am Rev Respir Dis | volume = 145 | issue = 6 | pages = 1328-33 | month = Jun | year = 1992 |doi = 10.1164/ajrccm/145.6.1328 | PMID = 1595998 }}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;Emerman-1990&amp;quot;&amp;gt;{{Cite journal  | last1 = Emerman | first1 = CL. | last2 = Connors | first2 = AF. | last3 = Lukens| first3 = TW. | last4 = May | first4 = ME. | last5 = Effron | first5 = D. | title = Theophylline concentrations in patients with acute exacerbation of COPD. | journal = Am J Emerg Med | volume = 8 | issue = 4 | pages = 289-92 | month = Jul | year = 1990 | doi =  | PMID = 2363749 }}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;Lloberes-1988&amp;quot;&amp;gt;{{Cite journal  | last1 = Lloberes | first1 = P. | last2 = Ramis | first2 = L. | last3 = Montserrat | first3 = JM. | last4 = Serra | first4 = J. | last5 = Campistol | first5 = J. | last6 = Picado | first6 = C. | last7 = Agusti-Vidal | first7 = A. | title = Effect of three different bronchodilators during an exacerbation of chronic obstructive pulmonary disease. | journal = Eur Respir J | volume = 1 |issue = 6 | pages = 536-9 | month = Jun | year = 1988 | doi =  | PMID = 2971565 }}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;Mahon-1999&amp;quot;&amp;gt;{{Cite journal  | last1 = Mahon | first1 = JL. | last2 = Laupacis |first2 = A. | last3 = Hodder | first3 = RV. | last4 = McKim | first4 = DA. | last5 = Paterson | first5 = NA. | last6 = Wood | first6 = TE. | last7 = Donner | first7 = A. | title = Theophylline for irreversible chronic airflow limitation: a randomized study comparing n of 1 trials to standard practice. | journal = Chest | volume = 115 | issue = 1 | pages = 38-48 | month = Jan | year = 1999 | doi =  | PMID = 9925061 }}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;Murciano-1984&amp;quot;&amp;gt;{{Cite journal  | last1 = Murciano | first1 = D. | last2 = Aubier | first2 = M. | last3 = Lecocguic | first3 = Y. | last4 = Pariente | first4 = R. | title = Effects of theophylline on diaphragmatic strength and fatigue in patients with chronic obstructive pulmonary disease. | journal = N Engl J Med | volume = 311 | issue = 6 | pages = 349-53 | month = Aug | year = 1984 | doi = 10.1056/NEJM198408093110601 | PMID = 6738652 }}&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;{{Cite web  | last =  | first =  | title = http://www.nice.org.uk/nicemedia/live/13029/49397/49397.pdf | url = http://www.nice.org.uk/nicemedia/live/13029/49397/49397.pdf | publisher =  | date =  | accessdate = }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
======Corticosteroids======&lt;br /&gt;
* Systemic [[corticosteroids]] in COPD exacerbations shorten recovery time, improve [[FEV1|FEV&amp;lt;sub&amp;gt;1&amp;lt;/sub&amp;gt;]] and [[PaO2|Pa&amp;lt;sub&amp;gt;O&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;&amp;lt;/sub&amp;gt;]],&amp;lt;ref name=&amp;quot;Davies-1999&amp;quot;&amp;gt;{{Cite journal  | last1 = Davies | first1 = L. | last2 = Angus | first2 = RM. | last3 = Calverley | first3 = PM. | title = Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial. | journal = Lancet | volume = 354 | issue = 9177 | pages = 456-60 | month = Aug |year = 1999 | doi =  | PMID = 10465169 }}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;Maltais-2002&amp;quot;&amp;gt;{{Cite journal  | last1 = Maltais | first1 = F. | last2 = Ostinelli | first2 = J. | last3 = Bourbeau | first3 = J. | last4 = Tonnel | first4 = AB. | last5 = Jacquemet | first5 = N. | last6 = Haddon | first6 = J. | last7 = Rouleau | first7 = M. | last8 = Boukhana | first8 = M. | last9 = Martinot | first9 = JB. | title = Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial. | journal = Am J Respir Crit Care Med | volume = 165 | issue = 5 | pages = 698-703 | month = Mar | year = 2002 | doi = 10.1164/ajrccm.165.5.2109093 | PMID = 11874817 }}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;Niewoehner-1999&amp;quot;&amp;gt;{{Cite journal  | last1 = Niewoehner | first1 = DE. | last2 = Erbland | first2 = ML. | last3 = Deupree | first3 = RH. | last4 = Collins | first4 = D. |last5 = Gross | first5 = NJ. | last6 = Light | first6 = RW. | last7 = Anderson | first7 = P. | last8 = Morgan | first8 = NA.| title = Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group. | journal = N Engl J Med | volume = 340 | issue = 25 | pages = 1941-7| month = Jun | year = 1999 | doi = 10.1056/NEJM199906243402502 | PMID = 10379017 }}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;Thompson-1996&amp;quot;&amp;gt;{{Cite journal  |last1 = Thompson | first1 = WH. | last2 = Nielson | first2 = CP. | last3 = Carvalho | first3 = P. | last4 = Charan | first4 = NB. | last5 = Crowley | first5 = JJ. | title = Controlled trial of oral prednisone in outpatients with acute COPD exacerbation. | journal = Am J Respir Crit Care Med | volume = 154 | issue = 2 Pt 1 | pages = 407-12 | month = Aug| year = 1996 | doi = 10.1164/ajrccm.154.2.8756814 | PMID = 8756814 }}&amp;lt;/ref&amp;gt; and reduce the risk of early relapse, treatment failure, and length of hospital stay.&amp;lt;ref name=&amp;quot;Davies-1999&amp;quot;&amp;gt;{{Cite journal  | last1 = Davies | first1 = L. | last2 = Angus | first2 = RM. | last3 = Calverley | first3 = PM. | title = Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial. | journal = Lancet | volume = 354 | issue = 9177 | pages = 456-60 |month = Aug | year = 1999 | doi =  | PMID = 10465169 }}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;Niewoehner-1999&amp;quot;&amp;gt;{{Cite journal  | last1 = Niewoehner | first1 = DE. | last2 = Erbland | first2 = ML. | last3 = Deupree | first3 = RH. | last4 = Collins | first4 = D. | last5 = Gross | first5 = NJ. | last6 = Light | first6 = RW. | last7 = Anderson | first7 = P. | last8 = Morgan| first8 = NA. | title = Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group. |journal = N Engl J Med | volume = 340 | issue = 25 | pages = 1941-7 | month = Jun | year = 1999 | doi = 10.1056/NEJM199906243402502 | PMID = 10379017 }}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;Aaron-2003&amp;quot;&amp;gt;{{Cite journal  |last1 = Aaron | first1 = SD. | last2 = Vandemheen | first2 = KL. | last3 = Hebert | first3 = P. | last4 = Dales | first4 = R. | last5 = Stiell | first5 = IG. |last6 = Ahuja | first6 = J. | last7 = Dickinson | first7 = G. | last8 = Brison | first8 = R. | last9 = Rowe | first9 = BH. | title = Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease. | journal = N Engl J Med | volume = 348 | issue = 26 | pages = 2618-25 | month = Jun | year = 2003 | doi = 10.1056/NEJMoa023161 |PMID = 12826636 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
* Consensus on optimal [[corticosteroids]] dose and duration for COPD exacerbations has not been reached.&amp;lt;ref name=&amp;quot;Walters-2009&amp;quot;&amp;gt;{{Cite journal  | last1 = Walters | first1 = JA. |last2 = Gibson | first2 = PG. | last3 = Wood-Baker | first3 = R. | last4 = Hannay | first4 = M. | last5 = Walters | first5 = EH. | title = Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. | journal = Cochrane Database Syst Rev | volume =  | issue = 1 | pages = CD001288 | month =  | year = 2009 | doi = 10.1002/14651858.CD001288.pub3 | PMID = 19160195 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
======Antibiotics======&lt;br /&gt;
* &#039;&#039;[[Haemophilus influenzae]]&#039;&#039;, &#039;&#039;[[Streptococcus pneumoniae]]&#039;&#039;, and &#039;&#039;[[Moraxella catarrhalis]]&#039;&#039; are the most common bacterial pathogens involved in an exacerbation.&amp;lt;ref name=&amp;quot;Sethi-2008&amp;quot;&amp;gt;{{Cite journal  | last1 = Sethi | first1 = S. | last2 = Murphy | first2 = TF. | title = Infection in the pathogenesis and course of chronic obstructive pulmonary disease. | journal = N Engl J Med | volume = 359 | issue = 22 | pages = 2355-65 | month = Nov | year = 2008 | doi = 10.1056/NEJMra0800353 | PMID = 19038881 }}&amp;lt;/ref&amp;gt; However, the choice of the antibiotic should be based on the local bacterial resistance pattern.&lt;br /&gt;
&lt;br /&gt;
* Empirical coverage of &#039;&#039;[[Pseudomonas aeruginosa]]&#039;&#039; in GOLD 3 and GOLD 4 patients is important.&amp;lt;ref name=&amp;quot;Vestbo-2013&amp;quot;&amp;gt;{{Cite journal  | last1 = Vestbo | first1 = J. | last2 = Hurd |first2 = SS. | last3 = Agustí |first3 = AG. | last4 = Jones | first4 = PW. | last5 = Vogelmeier | first5 = C. | last6 = Anzueto | first6 = A. | last7 = Barnes | first7 = PJ. |last8 = Fabbri | first8 = LM. | last9 = Martinez | first9 = FJ. | title = Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. | journal = Am J Respir Crit Care Med | volume = 187 | issue = 4 | pages = 347-65 | month = Feb | year = 2013 | doi = 10.1164/rccm.201204-0596PP | PMID = 22878278}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
* [[Procalcitonin]] may be of value in the decision to use antibiotics.&amp;lt;ref name=&amp;quot;Christ-Crain-2004&amp;quot;&amp;gt;{{Cite journal  | last1 = Christ-Crain | first1 = M. | last2 = Jaccard-Stolz |first2 = D. | last3 = Bingisser | first3 = R. | last4 = Gencay | first4 = MM. | last5 = Huber | first5 = PR. | last6 = Tamm | first6 = M. | last7 = Müller | first7 = B. | title = Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. | journal = Lancet | volume = 363 | issue = 9409 | pages = 600-7 | month = Feb | year = 2004 | doi = 10.1016/S0140-6736(04)15591-8 | PMID = 14987884 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
======Adjunct Therapies======&lt;br /&gt;
* An appropriate fluid balance with special attention to the administration of [[diuretic]]s, [[anticoagulant]]s, treatment of [[comorbidities]], and nutritional aspects should be considered.&amp;lt;ref name=&amp;quot;Vestbo-2013&amp;quot;&amp;gt;{{Cite journal  | last1 = Vestbo | first1 = J. | last2 = Hurd | first2 = SS. | last3 = Agustí| first3 = AG. | last4 = Jones | first4 = PW. | last5 = Vogelmeier | first5 = C. | last6 = Anzueto | first6 = A. | last7 = Barnes | first7 = PJ. | last8 = Fabbri | first8 = LM. |last9 = Martinez | first9 = FJ. | title = Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. | journal = Am J Respir Crit Care Med | volume = 187 | issue = 4 |pages = 347-65 | month = Feb | year = 2013 | doi = 10.1164/rccm.201204-0596PP | PMID = 22878278 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
* Healthcare providers should strongly enforce stringent measures against active [[cigarette]] smoking.&amp;lt;ref name=&amp;quot;Vestbo-2013&amp;quot;&amp;gt;{{Cite journal  | last1 = Vestbo | first1 = J. | last2 = Hurd | first2 = SS. | last3 = Agustí| first3 = AG. | last4 = Jones | first4 = PW. | last5 = Vogelmeier | first5 = C. | last6 = Anzueto | first6 = A. | last7 = Barnes | first7 = PJ. | last8 = Fabbri | first8 = LM. |last9 = Martinez | first9 = FJ. | title = Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. | journal = Am J Respir Crit Care Med | volume = 187 | issue = 4 | pages = 347-65 | month = Feb | year = 2013 | doi = 10.1164/rccm.201204-0596PP |PMID = 22878278 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
======Respiratory Support======&lt;br /&gt;
* Once oxygen is started, [[arterial blood gases]] should be checked 30 to 60 minutes later to ensure satisfactory [[oxygenation]] without [[carbon dioxide]] retention or[[acidosis]].&amp;lt;ref name=&amp;quot;Vestbo-2013&amp;quot;&amp;gt;{{Cite journal  | last1 = Vestbo | first1 = J. | last2 = Hurd | first2 = SS. | last3 = Agustí| first3 = AG. | last4 = Jones | first4 = PW. |last5 = Vogelmeier | first5 = C. | last6 = Anzueto | first6 = A. | last7 = Barnes | first7 = PJ. | last8 = Fabbri | first8 = LM. |last9 = Martinez | first9 = FJ. | title = Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. | journal = Am J Respir Crit Care Med | volume = 187 | issue = 4 | pages = 347-65 | month = Feb | year = 2013 | doi = 10.1164/rccm.201204-0596PP |PMID = 22878278 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
* [[Venturi mask]]s offer more accurate and controlled delivery of [[oxygen]] than do [[Nasal cannula|nasal prongs]] but are less likely to be tolerated by the patient.&amp;lt;ref name=&amp;quot;Celli-2004&amp;quot;&amp;gt;{{Cite journal  | last1 = Celli | first1 = BR. | last2 = MacNee | first2 = W. | title = Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. | journal = Eur Respir J | volume = 23 | issue = 6 | pages = 932-46 | month = Jun | year = 2004 | doi =  | PMID = 15219010 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
* Noninvasive [[mechanical ventilation]] improves [[respiratory acidosis]] and decreases [[respiratory rate]], severity of breathlessness, complications such as [[ventilator-associated pneumonia]], length of hospital stay, [[mortality]], and [[intubation]] rates.&amp;lt;ref name=&amp;quot;Brochard-1995&amp;quot;&amp;gt;{{Cite journal  | last1 = Brochard | first1 = L. | last2 = Mancebo| first2 = J. | last3 = Wysocki | first3 = M. | last4 = Lofaso | first4 = F. | last5 = Conti | first5 = G. | last6 = Rauss | first6 = A. | last7 = Simonneau | first7 = G. | last8 = Benito | first8 = S. | last9 = Gasparetto | first9 = A. | title = Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. | journal = N Engl J Med| volume = 333 | issue = 13 | pages = 817-22 | month = Sep | year = 1995 | doi = 10.1056/NEJM199509283331301 | PMID = 7651472 }}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;Bott-1993&amp;quot;&amp;gt;{{Cite journal  | last1 = Bott | first1 = J. | last2 = Carroll | first2 = MP. | last3 = Conway | first3 = JH. | last4 = Keilty | first4 = SE. | last5 = Ward | first5 = EM. | last6 = Brown | first6 = AM. |last7 = Paul | first7 = EA. | last8 = Elliott | first8 = MW. | last9 = Godfrey | first9 = RC. | title = Randomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease. | journal = Lancet | volume = 341 | issue = 8860 | pages = 1555-7 | month = Jun | year = 1993 | doi =  | PMID = 8099639 }}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;Kramer-1995&amp;quot;&amp;gt;{{Cite journal  | last1 = Kramer | first1 = N. | last2 = Meyer | first2 = TJ. | last3 = Meharg | first3 = J. | last4 = Cece | first4 = RD. | last5 = Hill | first5 = NS. | title = Randomized, prospective trial of noninvasive positive pressure ventilation in acute respiratory failure. | journal = Am J Respir Crit Care Med | volume = 151 | issue = 6 | pages = 1799-806 | month = Jun | year = 1995 | doi = 10.1164/ajrccm.151.6.7767523 | PMID = 7767523 }}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;Plant-2000&amp;quot;&amp;gt;{{Cite journal  | last1 = Plant | first1 = PK. | last2 = Owen | first2 = JL. | last3 = Elliott | first3 = MW. | title = Early use of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: a multicentre randomised controlled trial. | journal = Lancet | volume = 355 | issue = 9219 | pages = 1931-5 | month = Jun | year = 2000 | doi =  |PMID = 10859037 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Hospital Discharge and Follow-up===&lt;br /&gt;
* In the hospital prior to discharge, patients should start [[LABA|long-acting bronchodilators]], either [[anticholinergics]] and/or [[Beta2-adrenergic receptor agonist|β2-agonists]] with or without inhaled [[corticosteroids]].&amp;lt;ref name=&amp;quot;Vestbo-2013&amp;quot;&amp;gt;{{Cite journal  | last1 = Vestbo | first1 = J. | last2 = Hurd|first2 = SS. | last3 = Agustí |first3 = AG. | last4 = Jones | first4 = PW. | last5 = Vogelmeier | first5 = C. | last6 = Anzueto | first6 = A. | last7 = Barnes | first7 = PJ. | last8 = Fabbri | first8 = LM. | last9 = Martinez | first9 = FJ. | title = Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. | journal = Am J Respir Crit Care Med | volume = 187 | issue = 4 | pages = 347-65 | month = Feb | year = 2013 | doi = 10.1164/rccm.201204-0596PP | PMID = 22878278}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
* For patients who are [[hypoxia|hypoxemic]] during an exacerbation, [[arterial blood gases]] and/or [[pulse oximetry]] should be evaluated prior to hospital discharge and in the following 3 months. If the patient remains hypoxemic, long-term supplemental [[oxygen therapy]] may be required.&amp;lt;ref name=&amp;quot;Vestbo-2013&amp;quot;&amp;gt;{{Cite journal  | last1 = Vestbo | first1 = J. | last2 = Hurd|first2 = SS. | last3 = Agustí |first3 = AG. | last4 = Jones | first4 = PW. | last5 = Vogelmeier | first5 = C. | last6 = Anzueto | first6 = A. | last7 = Barnes |first7 = PJ. | last8 = Fabbri | first8 = LM. | last9 = Martinez | first9 = FJ. | title = Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. | journal = Am J Respir Crit Care Med | volume = 187 | issue = 4 | pages = 347-65 | month = Feb | year = 2013 | doi = 10.1164/rccm.201204-0596PP | PMID = 22878278}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Prevention of COPD Exacerbations===&lt;br /&gt;
* [[Smoking cessation]], [[influenza vaccine|influenza]] and [[pneumococcal vaccine]]s, knowledge of current therapy including inhaler technique, and treatment with [[LABA|long-acting inhaled bronchodilators]], with or without inhaled [[corticosteroids]], and [[Phosphodiesterase inhibitors#PDE4-selective inhibitors|phosphodiesterase-4 inhibitors]] are all therapies that reduce the number of exacerbations and hospitalizations.&amp;lt;ref name=&amp;quot;Calverley-2007&amp;quot;&amp;gt;{{Cite journal  | last1 = Calverley | first1 = PM. | last2 = Anderson | first2 = JA. | last3 = Celli | first3 = B. | last4 = Ferguson | first4 = GT. | last5 = Jenkins | first5 = C. | last6 = Jones | first6 = PW. | last7 = Yates | first7 = JC. | last8 = Vestbo |first8 = J. | title = Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. | journal = N Engl J Med | volume = 356 | issue = 8 | pages = 775-89 | month = Feb | year = 2007 | doi = 10.1056/NEJMoa063070 | PMID = 17314337 }}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;Tashkin-2008&amp;quot;&amp;gt;{{Cite journal  | last1 = Tashkin | first1 = DP. | last2 = Celli |first2 = B. | last3 = Senn | first3 = S. | last4 = Burkhart | first4 = D. | last5 = Kesten | first5 = S. | last6 = Menjoge | first6 = S. | last7 = Decramer | first7 = M. | last8 = Schiavi | first8 = E. | last9 = Figueroa Casas | first9 = JC. | title = A 4-year trial of tiotropium in chronic obstructive pulmonary disease. | journal = N Engl J Med | volume = 359 | issue = 15 | pages = 1543-54 | month = Oct | year = 2008 | doi = 10.1056/NEJMoa0805800 | PMID = 18836213 }}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;Calverley-2009&amp;quot;&amp;gt;{{Cite journal  | last1 = Calverley| first1 = PM. | last2 = Rabe | first2 = KF. | last3 = Goehring | first3 = UM. | last4 = Kristiansen | first4 = S. | last5 = Fabbri | first5 = LM. | last6 = Martinez | first6 = FJ.| last7 = Abdool-Gaffar | first7 = MS. | last8 = Abdullah | first8 = IA. | last9 = Abdullah | first9 = I. | title = Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials. | journal = Lancet | volume = 374 | issue = 9691 | pages = 685-94 | month = Aug | year = 2009 | doi = 10.1016/S0140-6736(09)61255-1 | PMID = 19716960}}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;Fabbri-2009&amp;quot;&amp;gt;{{Cite journal  | last1 = Fabbri | first1 = LM. | last2 = Calverley | first2 = PM. | last3 = Izquierdo-Alonso | first3 = JL. | last4 = Bundschuh |first4 = DS. | last5 = Brose | first5 = M. | last6 = Martinez | first6 = FJ. | last7 = Rabe | first7 = KF. | last8 = Abdulla | first8 = R. | last9 = Abdullah | first9 = I. | title = Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials. | journal = Lancet | volume = 374 |issue = 9691 | pages = 695-703 | month = Aug | year = 2009 | doi = 10.1016/S0140-6736(09)61252-6 | PMID = 19716961 }}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;Decramer-2009&amp;quot;&amp;gt;{{Cite journal  | last1 = Decramer | first1 = M. | last2 = Celli | first2 = B. | last3 = Kesten | first3 = S. | last4 = Lystig | first4 = T. | last5 = Mehra | first5 = S. | last6 = Tashkin | first6 = DP. |last7 = Schiavi | first7 = E. | last8 = Casas | first8 = JC. | last9 = Rhodius | first9 = E. | title = Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial. | journal = Lancet | volume = 374 | issue = 9696 | pages = 1171-8 | month = Oct | year = 2009 | doi = 10.1016/S0140-6736(09)61298-8 | PMID = 19716598 }}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;Jenkins-2009&amp;quot;&amp;gt;{{Cite journal  | last1 = Jenkins | first1 = CR. | last2 = Jones | first2 = PW. |last3 = Calverley | first3 = PM. | last4 = Celli | first4 = B. | last5 = Anderson | first5 = JA. | last6 = Ferguson | first6 = GT. | last7 = Yates | first7 = JC. | last8 = Willits |first8 = LR. | last9 = Vestbo | first9 = J. | title = Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study. | journal = Respir Res | volume = 10 | issue =  | pages = 59 | month =  | year = 2009 | doi = 10.1186/1465-9921-10-59 | PMID = 19566934}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
* Early outpatient [[pulmonary rehabilitation]] after hospitalization for an exacerbation is safe and results in clinically significant improvements in exercise capacity and health status at 3 months.&amp;lt;ref name=&amp;quot;Man-2004&amp;quot;&amp;gt;{{Cite journal  | last1 = Man | first1 = WD. | last2 = Polkey | first2 = MI. | last3 = Donaldson | first3 = N. | last4 = Gray | first4 = BJ.| last5 = Moxham | first5 = J. | title = Community pulmonary rehabilitation after hospitalisation for acute exacerbations of chronic obstructive pulmonary disease: randomised controlled study. | journal = BMJ | volume = 329 | issue = 7476 | pages = 1209 | month = Nov | year = 2004 | doi = 10.1136/bmj.38258.662720.3A | PMID = 15504763 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Don&#039;ts==&lt;br /&gt;
===Assessment===&lt;br /&gt;
* [[Spirometry]] is &#039;&#039;&#039;not&#039;&#039;&#039; recommended during an exacerbation because it can be difficult to perform and measurements are not accurate enough.&amp;lt;ref name=&amp;quot;Vestbo-2013&amp;quot;&amp;gt;{{Cite journal  | last1 = Vestbo | first1 = J. | last2 = Hurd|first2 = SS. | last3 = Agustí |first3 = AG. | last4 = Jones | first4 = PW. | last5 = Vogelmeier | first5 = C. | last6 = Anzueto | first6 = A. | last7 = Barnes | first7 = PJ. | last8 = Fabbri | first8 = LM. | last9 = Martinez | first9 = FJ. | title = Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. | journal = Am J Respir Crit Care Med | volume = 187 | issue = 4 | pages = 347-65 | month = Feb | year = 2013 | doi = 10.1164/rccm.201204-0596PP | PMID = 22878278}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Treatment===&lt;br /&gt;
======Adjunct Therapies======&lt;br /&gt;
* The use of [[Mucolytic agent|mucolytics]] is &#039;&#039;&#039;not&#039;&#039;&#039; well-supported by evidence.&amp;lt;ref name=&amp;quot;McCrory-2001&amp;quot;&amp;gt;{{Cite journal  | last1 = McCrory | first1 = DC. | last2 = Brown |first2 = C. | last3 = Gelfand | first3 = SE. | last4 = Bach | first4 = PB. | title = Management of acute exacerbations of COPD: a summary and appraisal of published evidence. |journal = Chest | volume = 119 | issue = 4 | pages = 1190-209 | month = Apr | year = 2001 | doi =  | PMID = 11296189 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
======Respiratory Support======&lt;br /&gt;
* NIPPV is &#039;&#039;&#039;not&#039;&#039;&#039; considered in the following conditions:&lt;br /&gt;
&lt;br /&gt;
{{Family tree/start}}&lt;br /&gt;
{{Family tree |border=2|boxstyle=background: WhiteSmoke;|A1|A1=&amp;lt;div style=&amp;quot;float: left; text-align: left; height: 16em; width: 27em; padding: 1em;&amp;quot;&amp;gt;&#039;&#039;&#039;Contraindications for NIPPV&#039;&#039;&#039;&amp;lt;ref name=&amp;quot;-2001&amp;quot;&amp;gt;{{Cite journal  | title = International Consensus Conferences in Intensive Care Medicine: noninvasive positive pressure ventilation in acute Respiratory failure. | journal = Am J Respir Crit Care Med | volume = 163 | issue = 1 | pages = 283-91 | month = Jan | year = 2001 | doi = 10.1164/ajrccm.163.1.ats1000 | PMID = 11208659 }}&amp;lt;/ref&amp;gt; &amp;lt;BR&amp;gt; ❑ Inability to cooperate/protect the airway &amp;lt;BR&amp;gt; ❑ Inability to clear respiratory secretions &amp;lt;BR&amp;gt; ❑ Facial surgery, trauma, or deformity &amp;lt;BR&amp;gt; ❑ Upper airway obstruction &amp;lt;BR&amp;gt; ❑ High risk for aspiration &amp;lt;BR&amp;gt; ❑ Cardiac or respiratory arrest &amp;lt;BR&amp;gt; ❑ Nonrespiratory organ failure &amp;lt;BR&amp;gt; ▸ Severe encephalopathy (e.g., GCS &amp;lt;10) &amp;lt;BR&amp;gt; ▸ Severe upper gastrointestinal bleeding &amp;lt;BR&amp;gt; ▸ Hemodynamic instability or unstable cardiac arrhythmia&amp;lt;/div&amp;gt;}}&lt;br /&gt;
{{Family tree/end}}&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|2}}&lt;/div&gt;</summary>
		<author><name>Gonzalo Romero</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=Hepatotoxicity_causes&amp;diff=941433</id>
		<title>Hepatotoxicity causes</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=Hepatotoxicity_causes&amp;diff=941433"/>
		<updated>2014-02-10T16:09:12Z</updated>

		<summary type="html">&lt;p&gt;Gonzalo Romero: /* Causes in Alphabetical Order */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
Please help WikiDoc by adding more content here. It&#039;s easy! Click [[help:How to Edit a Page|here]] to learn about editing. &lt;br /&gt;
{{Hepatotoxicity}}&lt;br /&gt;
{{CMG}}&lt;br /&gt;
&lt;br /&gt;
==Overview==&lt;br /&gt;
More than 900 drugs have been implicated in causing liver injury&amp;lt;ref name=&amp;quot;isbn0-8385-1551-7&amp;quot;&amp;gt;{{cite book |author=Friedman, Scott E.; Grendell, James H.; McQuaid, Kenneth R. |title=Current diagnosis &amp;amp; treatment in gastroenterology |publisher=Lang Medical Books/McGraw-Hill |location=New York |year=2003 |pages=p664-679 |isbn=0-8385-1551-7 |oclc= |doi=}}&amp;lt;/ref&amp;gt; and it is the most common reason for a drug to be withdrawn from the market. Chemicals often cause [[subclinical]] injury to liver which manifests only as abnormal [[Liver function tests|liver enzyme tests]]. Drug induced liver injury is responsible for 5% of all hospital admissions and 50% of all [[acute liver failure]]s.&amp;lt;ref name=&amp;quot;isbn1-56053-618-7&amp;quot;&amp;gt;{{cite book |author=McNally, Peter F. |title=GI/Liver Secrets: with STUDENT CONSULT Access |publisher=C.V. Mosby |location=Saint Louis |year= |pages= |isbn=1-56053-618-7 |oclc= |doi=}}&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;{{cite journal |author=Ostapowicz G, Fontana RJ, Schiødt FV, &#039;&#039;et al&#039;&#039; |title=Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States |journal=Ann. Intern. Med. |volume=137 |issue=12 |pages=947–54 |year=2002 |pmid=12484709 |doi=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Causes==&lt;br /&gt;
===Causes in Alphabetical Order===&lt;br /&gt;
: List the causes of the disease in alphabetical order. You may need to list across the page, as seen [[Jaundice causes#Causes in Alphabetical Order|here]]&lt;br /&gt;
{{col-begin|width=80%}}&lt;br /&gt;
{{col-break|width=33%}}&lt;br /&gt;
*[[5-fluorocytosine]]&lt;br /&gt;
*[[Abacavir]]&lt;br /&gt;
*[[Acetaminophen]] (paracetamol)&lt;br /&gt;
*[[Alcohol]]&lt;br /&gt;
*[[Allopurinol]]&lt;br /&gt;
*[[Amatoxins]]&lt;br /&gt;
*[[Amiodarone]]&lt;br /&gt;
*[[Amoxicillin]]&lt;br /&gt;
*[[Amoxicillin–clavulanate]]&lt;br /&gt;
*[[Amphotericin]]&lt;br /&gt;
*[[Anabolic c-17]]&lt;br /&gt;
*[[Anesthetic agent]]&lt;br /&gt;
*[[Antianginal agents]]&lt;br /&gt;
*[[Antiarrhythmics]]&lt;br /&gt;
*[[Antibiotics]]&lt;br /&gt;
*[[Anticoagulants]]&lt;br /&gt;
*[[Anticonvulsives]]&lt;br /&gt;
*[[Antifungals]]&lt;br /&gt;
*[[Antihyperlipidemic agents]]&lt;br /&gt;
*[[Antihypertensives]]&lt;br /&gt;
*[[Antineoplastic agents]]&lt;br /&gt;
*[[Antithyroid drugs]]&lt;br /&gt;
*[[Antituberculous agents]]&lt;br /&gt;
*[[Antiviral medication]]&lt;br /&gt;
*[[Aspirin]]&lt;br /&gt;
*[[Benzodiazepine]]&lt;br /&gt;
*[[British anti-lewisite penicillamine]]&lt;br /&gt;
*[[Bromfenac]]&lt;br /&gt;
*[[Bromfenacb]]&lt;br /&gt;
*[[Butyrophenone]]&lt;br /&gt;
*[[Captopril]]&lt;br /&gt;
*[[Carbamazepine]]&lt;br /&gt;
*[[Carbimazole]]&lt;br /&gt;
*[[Carbon tetrachloride]]&lt;br /&gt;
*[[Carboplatin]]&lt;br /&gt;
*[[Cephalosporin]]&lt;br /&gt;
*[[Chaparral]]&lt;br /&gt;
*[[Chlorambucil]]&lt;br /&gt;
*[[Chloramphenicol]]&lt;br /&gt;
*[[Chlormethiazole]]&lt;br /&gt;
*[[Chloroform]]&lt;br /&gt;
*[[Cimetidine]]&lt;br /&gt;
*[[Ciprofloxacin]]&lt;br /&gt;
*[[Clindamycin]]&lt;br /&gt;
*[[Cocaine]]&lt;br /&gt;
*[[Colchicine]]&lt;br /&gt;
*[[Comfrey]]&lt;br /&gt;
*[[Cotrimoxazole]]&lt;br /&gt;
*[[Cyclopropane]]&lt;br /&gt;
*[[Cycloserine]]&lt;br /&gt;
*[[Cyproterone acetate]]&lt;br /&gt;
*[[Cytarabine]]&lt;br /&gt;
*[[Dantrolene]]&lt;br /&gt;
*[[Dapsone]]&lt;br /&gt;
*[[Diclofenac]]&lt;br /&gt;
*[[Didanosine]]&lt;br /&gt;
*[[Dideoxyinosine]]&lt;br /&gt;
*[[Diflunisal]]&lt;br /&gt;
*[[Disulfiram]]&lt;br /&gt;
*[[Diuretic agents]]&lt;br /&gt;
*[[Doxycycline]]&lt;br /&gt;
*[[Ebrotidine]]&lt;br /&gt;
*[[Ecarazine]]&lt;br /&gt;
*[[Efavirenz]]&lt;br /&gt;
*[[Enalapril]]&lt;br /&gt;
*[[Endocrine agent]]&lt;br /&gt;
&lt;br /&gt;
{{col-break|width=33%}}&lt;br /&gt;
&lt;br /&gt;
*[[Enflurane]]&lt;br /&gt;
&lt;br /&gt;
*[[Erlotinib]]&lt;br /&gt;
&lt;br /&gt;
*[[Erythromycin estolate]]&lt;br /&gt;
&lt;br /&gt;
*[[Erythromycin ethyl succinate]]&lt;br /&gt;
&lt;br /&gt;
*[[Ethanol]]&lt;br /&gt;
&lt;br /&gt;
*[[Ether]]&lt;br /&gt;
&lt;br /&gt;
*[[Ethionamide]]&lt;br /&gt;
&lt;br /&gt;
*[[Etodolac]]&lt;br /&gt;
&lt;br /&gt;
*[[Felbamate]]&lt;br /&gt;
&lt;br /&gt;
*[[Fenoprofen]]&lt;br /&gt;
&lt;br /&gt;
*[[Fialuridine]]&lt;br /&gt;
&lt;br /&gt;
*[[Flucloxacillin]]&lt;br /&gt;
&lt;br /&gt;
*[[Flutamide]]&lt;br /&gt;
&lt;br /&gt;
*[[Gemcitabine]]&lt;br /&gt;
&lt;br /&gt;
*[[Gemtuzumab]]&lt;br /&gt;
&lt;br /&gt;
*[[Germander]]&lt;br /&gt;
&lt;br /&gt;
*[[Glucocorticoids]]&lt;br /&gt;
&lt;br /&gt;
*[[Gold]]&lt;br /&gt;
&lt;br /&gt;
*[[Greater celandine]]&lt;br /&gt;
&lt;br /&gt;
*[[Griseofulvin]]&lt;br /&gt;
&lt;br /&gt;
*[[Gyromitrin]]&lt;br /&gt;
&lt;br /&gt;
*[[Halothane]]&lt;br /&gt;
&lt;br /&gt;
*[[He shon wu]]&lt;br /&gt;
&lt;br /&gt;
*[[Herbal slimming aids]]&lt;br /&gt;
&lt;br /&gt;
*[[Herbalife®]]&lt;br /&gt;
&lt;br /&gt;
*[[Highly active antiretroviral treatment]]&lt;br /&gt;
&lt;br /&gt;
*[[Hydrazine sulfate]]&lt;br /&gt;
&lt;br /&gt;
*[[Hydroxycut®]]&lt;br /&gt;
&lt;br /&gt;
*[[Ibuprofen]]&lt;br /&gt;
&lt;br /&gt;
*[[Ibuprofen ]]&lt;br /&gt;
&lt;br /&gt;
*[[Idoxuridine]]&lt;br /&gt;
&lt;br /&gt;
*[[Imatinib mesylate]]&lt;br /&gt;
&lt;br /&gt;
*[[Indomethacin]]&lt;br /&gt;
&lt;br /&gt;
*[[Interferon beta]]&lt;br /&gt;
&lt;br /&gt;
*[[Interferons]]&lt;br /&gt;
&lt;br /&gt;
*[[Iodide ion]]&lt;br /&gt;
&lt;br /&gt;
*[[Iron compounds]]&lt;br /&gt;
&lt;br /&gt;
*[[Isoflurane]]&lt;br /&gt;
&lt;br /&gt;
*[[Isoniazid]]&lt;br /&gt;
&lt;br /&gt;
*[[Itraconazole]]&lt;br /&gt;
&lt;br /&gt;
*[[Kava 3,4- methylenedioxymethamphetamine]]&lt;br /&gt;
&lt;br /&gt;
*[[Kava kava]]&lt;br /&gt;
&lt;br /&gt;
*[[Ketoconazole]]&lt;br /&gt;
&lt;br /&gt;
*[[Labetalol]]&lt;br /&gt;
&lt;br /&gt;
*[[Lamotrigine]]&lt;br /&gt;
&lt;br /&gt;
*[[Leflunomide]]&lt;br /&gt;
&lt;br /&gt;
*[[Leflunomide ]]&lt;br /&gt;
&lt;br /&gt;
*[[Lipokinetix®]]&lt;br /&gt;
&lt;br /&gt;
*[[Lisinopril]]&lt;br /&gt;
&lt;br /&gt;
*[[Ma huang]]&lt;br /&gt;
&lt;br /&gt;
*[[Mdma (ecstasy)]]&lt;br /&gt;
&lt;br /&gt;
*[[Mephenytoin]]&lt;br /&gt;
&lt;br /&gt;
*[[Methamphetamine]]&lt;br /&gt;
&lt;br /&gt;
*[[Methotrexate]]&lt;br /&gt;
&lt;br /&gt;
*[[Methoxyflurane]]&lt;br /&gt;
&lt;br /&gt;
*[[Methyldopa]]&lt;br /&gt;
&lt;br /&gt;
*[[Minocycline]]&lt;br /&gt;
*[[Monoamine oxidase inhibitors]]&lt;br /&gt;
*[[Mushroom poisoning]]&lt;br /&gt;
*[[Naproxen]]&lt;br /&gt;
*[[Nefazodone]]&lt;br /&gt;
{{col-break|width=33%}}&lt;br /&gt;
*[[Nevirapine]]&lt;br /&gt;
*[[Nicotinic acid]]&lt;br /&gt;
*[[Nimesulide ]]&lt;br /&gt;
*[[Nitisinone]]&lt;br /&gt;
*[[Nitrofuran]]&lt;br /&gt;
*[[Nitrofurantoin]]&lt;br /&gt;
*[[Nitrous oxide]]&lt;br /&gt;
*[[Nonsteroidal anti-inflammatory drugs]]&lt;br /&gt;
*[[Novobiocin]]&lt;br /&gt;
*[[Ofloxacin]]&lt;br /&gt;
*[[Omeprazole]]&lt;br /&gt;
*[[Oral hypoglycemics]]&lt;br /&gt;
*[[Oxaprozin ]]&lt;br /&gt;
*[[P-aminosalicylic acid]]&lt;br /&gt;
*[[Paracetamol]]&lt;br /&gt;
*[[Pazopanib]]&lt;br /&gt;
*[[Pemoline]]&lt;br /&gt;
*[[Penicillin]]&lt;br /&gt;
*[[Phenobarbital]]&lt;br /&gt;
*[[Phenothiazines]]&lt;br /&gt;
*[[Phenprocoumon]]&lt;br /&gt;
*[[Phenylbutazone]]&lt;br /&gt;
*[[Phenytoin]]&lt;br /&gt;
*[[Piroxicam ]]&lt;br /&gt;
*[[Poison mushrooms (amanita phalloides)]]&lt;br /&gt;
*[[Propylthiouracil]]&lt;br /&gt;
*[[Psychotropic agents]]&lt;br /&gt;
*[[Pyrazinamide]]&lt;br /&gt;
*[[Quinolone]]&lt;br /&gt;
*[[Ranitidine]]&lt;br /&gt;
*[[Regorafenib]]&lt;br /&gt;
*[[Rifampicin]]&lt;br /&gt;
*[[Rifampin]]&lt;br /&gt;
*[[Salicylate]]&lt;br /&gt;
*[[Saramycetin]]&lt;br /&gt;
*[[Senecio]]&lt;br /&gt;
*[[Spectinomycin]]&lt;br /&gt;
*[[Statins]]&lt;br /&gt;
*[[Steroids]]&lt;br /&gt;
*[[Sulfonamide]]&lt;br /&gt;
*[[Sulfonamides]]&lt;br /&gt;
*[[Sulfones]]&lt;br /&gt;
*[[Sulindac]]&lt;br /&gt;
*[[Suloctidil]]&lt;br /&gt;
*[[Tacrine]]&lt;br /&gt;
*[[Tamoxifen]]&lt;br /&gt;
*[[Telithromycin]]&lt;br /&gt;
*[[Terbinafine]]&lt;br /&gt;
*[[Tetrabamate]]&lt;br /&gt;
*[[Tetracycline]]&lt;br /&gt;
*[[Thioxanthene]]&lt;br /&gt;
*[[Thorotrast]]&lt;br /&gt;
*[[Tienilic acid]]&lt;br /&gt;
*[[Tolcapone]]&lt;br /&gt;
*[[Toluene]]&lt;br /&gt;
*[[Topiramate]]&lt;br /&gt;
*[[Tricyclic antidepressant]]&lt;br /&gt;
*[[Tricyclic antidepressants]]&lt;br /&gt;
*[[Troglitazone]]&lt;br /&gt;
*[[Trovofloxacin]]&lt;br /&gt;
*[[Valproic acid]]&lt;br /&gt;
*[[Vidarabine]]&lt;br /&gt;
*[[Vitamin a]]&lt;br /&gt;
*[[Xenylamine]]&lt;br /&gt;
*[[Zafirlukast]]&lt;br /&gt;
*[[Zalcitabine]]&lt;br /&gt;
*[[Zoxazolamine]]&lt;br /&gt;
{{col-end}}&lt;br /&gt;
&lt;br /&gt;
===Specific Drug or Toxin===&lt;br /&gt;
&lt;br /&gt;
*Acetaminophen: [[Acetaminophen]] (paracetamol, also known by the brand name Tylenol and Panadol) is usually well tolerated in prescribed dose but overdose is the most common cause of drug induced liver disease and [[acute liver failure]] worldwide,&amp;lt;ref name=&amp;quot;isbn0-443-06633-7&amp;quot;&amp;gt;{{cite book |author=Keeffe, Emmet B; Friedman, Lawrence M. |title=Handbook of liver diseases |publisher=Churchill Livingstone |location=Edinburgh |year=2004 |pages=104-123 |isbn=0-443-06633-7 |oclc= |doi= |accessdate=2007-09-07}}&amp;lt;/ref&amp;gt; which is one of the most painful experiences patients report.  Reports of death from accute hepatotoxicity have been reported to be as low as 2.5 grams over a 24 hour period. Damage to the liver is not due to the drug itself but to a toxic metabolite (&#039;&#039;N&#039;&#039;-acetyl-&#039;&#039;p&#039;&#039;-benzoquinone imine NAPQI, or NABQI) which is produced by cytochrome P450 enzymes in the liver.&amp;lt;ref name=&amp;quot;pmid15345657&amp;quot;&amp;gt;{{cite journal |author=Wallace JL |title=Acetaminophen hepatotoxicity: NO to the rescue |journal=Br. J. Pharmacol. |volume=143 |issue=1 |pages=1–2 |year=2004 |pmid=15345657 |doi=10.1038/sj.bjp.0705781}}&amp;lt;/ref&amp;gt; In normal circumstances this metabolite is detoxified by conjugating with [[glutathione]] in phase 2 reaction. In overdose large amount of NAPQI is generated which overwhelm the detoxification process and lead to damage to liver cells. [[Nitric oxide]] also plays role in inducing toxicity.&amp;lt;ref&amp;gt;{{cite journal |author=James LP, Mayeux PR, Hinson JA |title=Acetaminophen-induced hepatotoxicity |journal=Drug Metab. Dispos. |volume=31 |issue=12 |pages=1499–506 |year=2003 |pmid=14625346 |doi=10.1124/dmd.31.12.1499}}&amp;lt;/ref&amp;gt; The risk of liver injury is influenced by several factors including the dose ingested, concurrent alcohol or other drug intake, interval between ingestion and antidote etc. The dose toxic to liver is quite variable and is lower in chronic alcoholics. Measurement of blood level is important in assessing prognosis, higher level predicting worse prognosis. Administration of [[Acetylcysteine]], a precursor of glutathione, can limit the severity of the liver damage by capturing the toxic NAPQI. Those who develop [[acute liver failure]] can still recover spontaneously,  but may require transplantation if poor [[prognostic]] signs such as [[encephalopathy]] or [[coagulopathy]] is present (see [[King&#039;s College Criteria]]). [[Image:Paracetamol-rod-povray.png|thumb|center|Acetaminophen (3D structure) overdose is the most common cause of drug induced liver disease]]&lt;br /&gt;
&lt;br /&gt;
*Nonsteroidal anti-inflammatory drugs: Although individual analgesics rarely induce liver damage, due to their widespread use NSAIDs have emerged as a major group of drugs exhibiting hepatotoxicity. Both dose dependent and idiosyncratic reactions have been documented.&amp;lt;ref&amp;gt;{{cite journal |author=Manov I, Motanis H, Frumin I, Iancu TC |title=Hepatotoxicity of anti-inflammatory and analgesic drugs: ultrastructural aspects |journal=Acta Pharmacol. Sin. |volume=27 |issue=3 |pages=259–72 |year=2006 |pmid=16490160 |doi= |doi=10.1111/j.1745-7254.2006.00278.x}}&amp;lt;/ref&amp;gt; Aspirin and [[phenylbutazone]] are associated with intrinsic hepatotoxicity; idiosyncratic reaction has been associated with ibuprofen, sulindac,  phenylbutazone, piroxicam, diclofenac and indomethacin.&lt;br /&gt;
&lt;br /&gt;
*Glucocorticoids: Glucocorticoids are so named due to their effect on carbohydrate mechanism. they promote glycogen storage in liver. Enlarged liver is a rare side effect of long term steroid use in children.&amp;lt;ref name=&amp;quot;pmid3944744&amp;quot;&amp;gt;{{cite journal |author=Iancu TC, Shiloh H, Dembo L |title=Hepatomegaly following short-term high-dose steroid therapy |journal=J. Pediatr. Gastroenterol. Nutr. |volume=5 |issue=1 |pages=41–6 |year=1986 |pmid=3944744 |doi=}}&amp;lt;/ref&amp;gt; The classical effect of prolonged use both in adult and [[paediatric]] population is steatosis.&amp;lt;ref&amp;gt;&lt;br /&gt;
{{cite book&lt;br /&gt;
| last =Alpers DH | first = Sabesin SM| authorlink = | coauthors =Schiff L, Schiff ER, editors.  &lt;br /&gt;
| title =Diseases of the liver | publisher =JB Lippincott | date =1982 | location =Philadelphia | pages =813-45 | url = | doi = | id =  &lt;br /&gt;
| isbn = }}&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*Isoniazid: Isoniazide (INH) is one of the most commonly used drug for tuberculosis; it is associated with mild elevation of liver enzymes in up to 20% of patients and severe hepatotoxicity in 1-2% of patients.&amp;lt;ref name=&amp;quot;pmid10215642&amp;quot;&amp;gt;{{cite journal |author=Sarich TC, Adams SP, Petricca G, Wright JM |title=Inhibition of isoniazid-induced hepatotoxicity in rabbits by pretreatment with an amidase inhibitor |journal=J. Pharmacol. Exp. Ther. |volume=289 |issue=2 |pages=695–702 |year=1999 |pmid=10215642 |doi=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*Natural products like: Amanita mushroom, particularly the [[destroying angel]]s, aflatoxins&lt;br /&gt;
&lt;br /&gt;
*Industrial toxins like: Arsenic, carbon tetra chloride, vinyl chloride&lt;br /&gt;
&lt;br /&gt;
*Herbal and alternative remedies like: Ackee fruit, bajiaolian, camphor, copaltra, cycasin, kava, pyrrolizidine alkaloids, horse chestnut leaf, valerian, comfrey (often used in herbal tea)&amp;lt;ref name=&amp;quot;pmid15264453&amp;quot;&amp;gt;{{cite journal |author=Pak E, Esrason KT, Wu VH |title=Hepatotoxicity of herbal remedies: an emerging dilemma |journal=Progress in transplantation (Aliso Viejo, Calif.) |volume=14 |issue=2 |pages=91–6 |year=2004 |pmid=15264453 |doi=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*Chinese herbal remedies like: Jin Bu Huan, Ma-Huang, Sho-Wu-Pian&lt;br /&gt;
&lt;br /&gt;
&amp;lt;gallery&amp;gt;&lt;br /&gt;
Image:Amanita muscaria (fly agaric).JPG|Fly agaric (&#039;&#039;Amanita muscaria&#039;&#039;) is  one of the natural products toxic to the liver&lt;br /&gt;
Image:Horse chestnut leaf.jpg|Horse chestnut leaf&lt;br /&gt;
Image:Akee.jpg|Ackee fruit&lt;br /&gt;
Image:Saint johns wart flowers.jpg|Saint John&#039;s wort Induces Cytochrome P-450 enzyme&lt;br /&gt;
&amp;lt;/gallery&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|2}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Disease]]&lt;br /&gt;
[[Category:Hepatology]]&lt;br /&gt;
[[Category:Toxicology]]&lt;br /&gt;
[[Category:Gastroenterology]]&lt;br /&gt;
[[Category:Needs content]]&lt;br /&gt;
[[Category:Needs causes]]&lt;/div&gt;</summary>
		<author><name>Gonzalo Romero</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=How_to_create_a_board_review_question&amp;diff=937669</id>
		<title>How to create a board review question</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=How_to_create_a_board_review_question&amp;diff=937669"/>
		<updated>2014-02-03T20:24:24Z</updated>

		<summary type="html">&lt;p&gt;Gonzalo Romero: /* USMLE Step 3 Question Format */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Board review project}}&lt;br /&gt;
[[Image:Main_help_page_small.PNG|100px|link=Help]][[Image:Projects.PNG|100px|link=Projects]][[Image:Editor&#039;s_Tools.PNG|100px|link=Help Menu]]&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible mw-collapsed&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==How to Build a Question==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible-content&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
# Read and understand the tested material to grasp basic principles, diagnostic approach, management and therapeutics according to the BOARD level.&lt;br /&gt;
# Get familiar with the format, content and high Yield material. Take many exams using Q-banks, the NBME website [[http://www.nbme.org/]] and the actual exam, when ready!.  Respect Copy Rights sources from Q-banks.&lt;br /&gt;
# Select a specific content&lt;br /&gt;
# Use WikiDoc to obtain information, pictures, videos, and links on the explanations.&lt;br /&gt;
#  hallenge the test taker: do not give away the correct answer.  Avoid using proper or specific signs. Describe signs and symptoms in lay terms to give the hints. Example:  instead of “marfanoid appearance”, describe the patient with long extremities, skinny appearance and tall.&lt;br /&gt;
# Do not ask negatively i.e. &amp;quot;which of the following is incorrect, not correct or false?&amp;quot;.&lt;br /&gt;
# Long stems help recreate the challenge on test date. Short and moderate stems test specific facts.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible mw-collapsed&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Multi-step or Jump Question==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible-content&amp;quot;&amp;gt;&lt;br /&gt;
Include 2 or 3 Jump questions in order to test the medical thinking process, not just the content.  Follow these steps:&lt;br /&gt;
# Select one box with a specific topic (i.e. clinical presentation) from the diagram shown below.  Use facts such as:  the clinical presentation (symptoms and signs), the physical exam findings, specific test findings (i.e. labs, imaging, biopsy), the definitive diagnosis, the treatment of choice, its mechanism of action and the most common adverse effect associated with that medication.&lt;br /&gt;
# Describe the first box (i.e. typical clinical presentation) in the question stem.&lt;br /&gt;
# Ask a specific fact about another box (i.e. what is the mechanism of action of the treatment of choice?).  If possible, revert the order and add extra steps.&lt;br /&gt;
# &#039;&#039;&#039;You just created a jump question!&#039;&#039;&#039;&lt;br /&gt;
[[Image:WBRJumpQuestions.png|800px|center]]&lt;br /&gt;
===Example===&lt;br /&gt;
Microbiology questions require the reader to make the diagnosis, identify the treatment of choice and to know the mechanism of action (3 steps). &lt;br /&gt;
An equally difficult but less elegant question could ask what HLA-subtype is associated with a rheumatological disease.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible mw-collapsed&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Steps to Upload a Question==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible-content&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
# Go to the home page on WikiDoc, and click on the icon that says, &amp;quot;Board Review&amp;quot;, or click [[Board Review|here]].&lt;br /&gt;
# Click on the big green icon that says &amp;quot;add a board review question&amp;quot;.&lt;br /&gt;
# Type in your name in the Author Box.&lt;br /&gt;
# Select the Exam Type.&lt;br /&gt;
# Categories for the question will appear; check off ONE main category, and the appropriate subcategory.&lt;br /&gt;
# Introduce an Overall Explanation into the Box focusing on the correct answer choice.&lt;br /&gt;
# Use the remaining boxes to type in the answers to the questions and each answer choice explanation.&lt;br /&gt;
# You can add an image, if possible.&lt;br /&gt;
# Click save page if you&#039;re done, or show preview if you like to see how your question will look like.&lt;br /&gt;
# Make sure you click save page before you move on!&lt;br /&gt;
# Self quality check your work using the [[WBR quality checklist]]&lt;br /&gt;
# Contact via email the WBR Editors in Chief and WBR Team Members to review your question&lt;br /&gt;
# &#039;&#039;&#039;CONGRATULATIONS! You just created a high quality WBR Question!&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible mw-collapsed&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Question Design==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible-content&amp;quot;&amp;gt;&lt;br /&gt;
===Question Stem===&lt;br /&gt;
*The questions are preferred to be narrated as a clinical vignette, which is not an actual case. &lt;br /&gt;
*The information and illustrations should be the testing point&lt;br /&gt;
*Below are some of the key points that can be found in a question. They should be orderly included as follows:&lt;br /&gt;
**Age, Gender (e.g., a 70 year-old man)&lt;br /&gt;
**Site of Care (e.g., comes to the emergency department)&lt;br /&gt;
**Duration (e.g. that has started one week ago)&lt;br /&gt;
**Significant patient history&lt;br /&gt;
**Significant family history&lt;br /&gt;
**Significant diagnostic studies or the results of diagnostic studies &lt;br /&gt;
***Try as much as possible to include images whether still or motion&lt;br /&gt;
**Initial treatment and response&lt;br /&gt;
* The questions should not include negative phrasing, such as “except” or “not”&lt;br /&gt;
&lt;br /&gt;
===Answer Choices===&lt;br /&gt;
* Answers should include five choices,  with one correct answer and the remaining answers are distractors. &lt;br /&gt;
* Answers should not be &amp;quot;true&amp;quot; or &amp;quot;false&amp;quot;.&lt;br /&gt;
* All distractors should be homogeneous, as they should fall in the same category as the correct answer and should be similar in length. &lt;br /&gt;
* Long correct answers are discouraged.&lt;br /&gt;
* Illogical answers, absolute terms, word repeats (for example: a word or phrase in the correct answer choice, is the same as in the stem) are discouraged.&lt;br /&gt;
* “None of the above”, “All of the above” or some combination of response must not be used.&lt;br /&gt;
===Answer Explanations===&lt;br /&gt;
* These questions are intended to teach using sources such as:  graphics, references and guidelines if applicable.&lt;br /&gt;
====Overall Explanation====&lt;br /&gt;
* Only ONE answer is the best or the most appropriate one&lt;br /&gt;
* Justify why that choice is correct:  explain the pertinent positive findings, not just list the tested subject. (i.e.  the patient has this symptom which is a typical presentation of this disease). Explain also the pertinent negatives.&lt;br /&gt;
&lt;br /&gt;
* &#039;&#039;&#039;Educational Objectives:&#039;&#039;&#039;  include short high yield facts (1 or 2 take-home sentences/phrases).&lt;br /&gt;
====Answer Choice Explanation====&lt;br /&gt;
* Include why the correct answer is correct and why each of the distractors are incorrect.&lt;br /&gt;
* Include concise, yet thorough explanation providing a high yield information.&lt;br /&gt;
* Add additional information to the correct answer explanation, not explained on the overall explanation.&lt;br /&gt;
&lt;br /&gt;
===References===&lt;br /&gt;
References should be included, if possible, linking to new articles, review articles or guidelines that serve the initial teaching goal of the questions.&lt;br /&gt;
&lt;br /&gt;
==Resources==&lt;br /&gt;
===Internal Resources===&lt;br /&gt;
*Use WikiDoc content&lt;br /&gt;
*Promote WikiDoc use inserting internal links into the explanations&lt;br /&gt;
===External Resources===&lt;br /&gt;
Mention external sources used respecting Copy Rights.&lt;br /&gt;
*Books:&lt;br /&gt;
**First Aid for STEP 1 2014 (latest edition), by Tao Le and Vikas-Bhushan, updated yearly by students who aced the exam and by faculty physicians&lt;br /&gt;
**First Aid for Step 2 CK, eight edition, by Tao Le and Vikas-Bhushan. updated biyearly&lt;br /&gt;
**Med-Essentials For Step 1: High Yield Review, the fourth edition, by Kaplan Medical&lt;br /&gt;
**Master the Boards for Step 2 CK, the second edition, by Dr. Conrad Fischer&lt;br /&gt;
**Master the Boards for Step 3, the second edition, by Dr. Conrad Fischer&lt;br /&gt;
*Forums:&lt;br /&gt;
** [http://www.usmle-forums.com www.usmle-forums.com],  recent test takers give feedback about their experience and commonly tested facts, updated constantly&lt;br /&gt;
&lt;br /&gt;
===Matching Sets===&lt;br /&gt;
The format remains the same as above, but it tests two or three different concepts on separate questions having the same clinical vignette.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible mw-collapsed&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Step 1 Question Format==  &lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible-content&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
* Test the basic principles using calculations, clinical scenarios, and multimedia.&lt;br /&gt;
===Case Scenarios===&lt;br /&gt;
* Age&lt;br /&gt;
* Gender&lt;br /&gt;
* Past history and medications if remarkable&lt;br /&gt;
* Chief complaints and assoicated symptoms&lt;br /&gt;
* Vital signs and pertinent physical findings&lt;br /&gt;
* Laboratory results&lt;br /&gt;
* Heart or lung auscultation audios&lt;br /&gt;
* Electrocardiography if relevant&lt;br /&gt;
* Pathologic or radiographic images&lt;br /&gt;
===Commonly Asked Questions===&lt;br /&gt;
* A deficiency of which of the following enzyme activities is the most likely cause of the findings in this patient?&lt;br /&gt;
* A mutation in which of the following genes is the most likely cause of the findings in this patient?&lt;br /&gt;
* A mutation is most likely to be found in which of the following genes?&lt;br /&gt;
* Inheritance of mutant alleles most likely caused impairment of which of the following enzyme activities in this patient?&lt;br /&gt;
* Pathologic examination is most likely to disclose an abnormality involving which of the following?&lt;br /&gt;
* Synthesis of which of the following substances is most likely to be inhibited as a result of this therapy?&lt;br /&gt;
* The causal organism is most likely transmitted by which of the following routes?&lt;br /&gt;
* The most appropriate next step in management is administration of which of the following?&lt;br /&gt;
* The most likely cause of these findings is a deficiency of which of the following nutrients?&lt;br /&gt;
* The morphologic changes most likely indicate which of the following processes?&lt;br /&gt;
* This patient most likely has which of the following conditions?&lt;br /&gt;
* This patient is at increased risk for developing which of the following as a result of this therapy?&lt;br /&gt;
* This patient is most likely receiving treatment with which of the following drugs?&lt;br /&gt;
* This patient is most likely to develop which of the following adverse effects?&lt;br /&gt;
* This patient is most likely to have a deficit of which of the following?&lt;br /&gt;
* This patient most likely had a recent history of which of the following?&lt;br /&gt;
* This patient should be monitored for which of the following adverse effects?&lt;br /&gt;
* To prevent further damage, which of the following is the most appropriate recommendation?&lt;br /&gt;
* Which of the following abnormalities is the most likely cause of these findings?&lt;br /&gt;
* Which of the following best explains these findings?&lt;br /&gt;
* Which of the following defense mechanisms best explains this patient’s behavior?&lt;br /&gt;
* Which of the following best explains this behavior?&lt;br /&gt;
* Which of the following findings is most likely?&lt;br /&gt;
* Which of the following graphs shown best corresponds to these results?&lt;br /&gt;
* Which of the following is the most likely causal organism?&lt;br /&gt;
* Which of the following is the most likely cause of death in this patient?&lt;br /&gt;
* Which of the following is the most likely cause of this patient&#039;s condition?&lt;br /&gt;
* Which of the following is the most likely cause of this patient&#039;s current condition?&lt;br /&gt;
* Which of the following is the most likely diagnosis?&lt;br /&gt;
* Which of the following is the most likely mechanism of action causing these adverse effects?&lt;br /&gt;
* Which of the following is the most appropriate initial treatment for this patient?&lt;br /&gt;
* Which of the following is the most appropriate next step in management?&lt;br /&gt;
* Which of the following is the most appropriate pharmacotherapy?&lt;br /&gt;
* Which of the following is the most appropriate response by the physician?&lt;br /&gt;
* Which of the following labeled areas is most likely damaged?&lt;br /&gt;
* Which of the following mechanisms best explains this cytogenetic abnormality?&lt;br /&gt;
* Which of the following pathologic findings is most likely seen in a biopsy specimen in this patient?&lt;br /&gt;
* Which of the following processes best describes these findings?&lt;br /&gt;
* Which of the following processes is most likely to occur in this patient as a result of the disease?&lt;br /&gt;
* Which of the following sets of changes most likely occurred following the infusion of drug X?&lt;br /&gt;
* Which of the following sets of laboratory findings is most likely in this patient?&lt;br /&gt;
* Which of the following sets of physiologic changes is most likely following administration of the drug?&lt;br /&gt;
* Which of the following treatments is most appropriate at this time?&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible mw-collapsed&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Step 2 CK Question Format==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible-content&amp;quot;&amp;gt;&lt;br /&gt;
* Follow the most recent Algorithms/Guidelines from WikiDoc&lt;br /&gt;
* Useful resources are the books: Master the Boards and First Aid for Step 2 CK&lt;br /&gt;
* Include basic STEP 1 questions; 50-60% of the knowledge from Step 2CK comes from Step 1&lt;br /&gt;
* Include labs&lt;br /&gt;
* Make long stems&lt;br /&gt;
* Accommodate information within the vignette that will benefit the test taker to identify the proper answer choice&lt;br /&gt;
* Include extra information that is not necessary leading towards the correct answer (distractors)&lt;br /&gt;
* Audio and video questions would be ideal also&lt;br /&gt;
===Case Scenarios===&lt;br /&gt;
* Age of patient&lt;br /&gt;
* Sex&lt;br /&gt;
* Past history if remarkable&lt;br /&gt;
* Chief complaint&lt;br /&gt;
* Vitals&lt;br /&gt;
* Describe the chief complaint&lt;br /&gt;
* Physical examination findings&lt;br /&gt;
* Laboratory findings&lt;br /&gt;
* Image or video (if applicable)&lt;br /&gt;
===Commonly Asked Questions===&lt;br /&gt;
* What is the most likely diagnosis?&lt;br /&gt;
* What is the most likely cause for this condition?&lt;br /&gt;
* What is the next best step in management?&lt;br /&gt;
* What is the best initial treatment?&lt;br /&gt;
* What is the best treatment for this condition?&lt;br /&gt;
* What is the best/ most accurate laboratory test to confirm diagnosis?&lt;br /&gt;
* What is the drug of choice to treat this condition?&lt;br /&gt;
* What is the most likely physical exam finding? (eg. On auscultation, abdominal examination, etc.)&lt;br /&gt;
* Which of the following is the most likely underlying mechanism?&lt;br /&gt;
* What is the most common risk factor for this condition?&lt;br /&gt;
* What is the most common complication of this condition?&lt;br /&gt;
* What is the best drug/ drug of choice used to treat this condition?&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible mw-collapsed&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Step 3 Question Format==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible-content&amp;quot;&amp;gt;&lt;br /&gt;
Testing mainly on management of case, covering the following fields:&lt;br /&gt;
===Application of Concepts===&lt;br /&gt;
* What is the most likely cause for this condition?&lt;br /&gt;
* What is the most likely underlying mechanism?&lt;br /&gt;
* What is the cause of (sign/ physical exam finding)?&lt;br /&gt;
* Questions related to research studies&lt;br /&gt;
===History and Physical Examination===&lt;br /&gt;
* What is the most likely physical exam finding?&lt;br /&gt;
* What facts from the past history are important for diagnosis?&lt;br /&gt;
* What is the most common risk factor for this condition?&lt;br /&gt;
===Laboratory and Diagnostic Studies===&lt;br /&gt;
* What is the most appropriate/accurate laboratory test to evaluate this patient?&lt;br /&gt;
* What is the most appropriate laboratory test to evaluate the efficacy of current treatment?&lt;br /&gt;
* What is the best initial laboratory test to order?&lt;br /&gt;
* What is the most likely result of this laboratory test seen in this condition?&lt;br /&gt;
* What is the most likely laboratory finding seen in this condition?&lt;br /&gt;
===Diagnosis===&lt;br /&gt;
* What is the most likely diagnosis?&lt;br /&gt;
* Which condition is most commonly associated with ____?&lt;br /&gt;
===Prognosis===&lt;br /&gt;
* Which of the following factors influences prognosis (good or bad)?&lt;br /&gt;
* Which of the following is the best/ worst prognostic indicator?&lt;br /&gt;
* Which of the following laboratory finding indicates best/ worst prognosis?&lt;br /&gt;
* After follow-up, which of the following is the most common factor that indicates favorable prognosis?&lt;br /&gt;
* What is the most appropriate counseling advice?&lt;br /&gt;
* What is the most common complication of this condition?&lt;br /&gt;
* What is the most likely outcome of this condition?&lt;br /&gt;
===Management===&lt;br /&gt;
* What is the next best step in management of this patient?&lt;br /&gt;
* What is the most appropriate screening test?&lt;br /&gt;
* What is the most appropriate preventive measure for this condition?&lt;br /&gt;
* What is the best initial treatment?&lt;br /&gt;
* What is the most accurate treatment?What is the best drug/ drug of choice used to treat this condition?&lt;br /&gt;
* What is the most appropriate discharge plan?&lt;br /&gt;
* Which drug is contraindicated in the treatment of this condition?&lt;br /&gt;
* Which of the following is a contraindication for the use of this drug?&lt;br /&gt;
* What is the most likely adverse effect of this drug?&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Ethics and Principles===&lt;br /&gt;
Wikidoc has strict rules and regulations against plagiarism. Those rules must be followed. Participants for the board review questions project will have to follow the highest standards of ethics and conduct when writing a question.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible mw-collapsed&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Resources==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible-content&amp;quot;&amp;gt;&lt;br /&gt;
===WikiDoc Links===&lt;br /&gt;
* [[MCAT]]&lt;br /&gt;
* [[USMLE Step 1]]&lt;br /&gt;
* [[USMLE Step 2-CK]]&lt;br /&gt;
* [[USMLE Step 2 Clinical Skills]]&lt;br /&gt;
* [[Step 2 CS study guide]]&lt;br /&gt;
* [[USMLE Step 3]]&lt;br /&gt;
*  [[Copyleft sources]]&lt;br /&gt;
* [[How to upload USMLE II Images]]&lt;br /&gt;
* [[COMLEX-USA]]&lt;br /&gt;
&lt;br /&gt;
===External Resources===&lt;br /&gt;
* http://www.usmle.org/pdfs/step-1/2013content_step1.pdf&lt;br /&gt;
* http://www.usmle.org/pdfs/step-2-ck/2012--13_FINAL_S2_GSI.pdf&lt;br /&gt;
* http://www.usmle.org/pdfs/step-3/2013content_step3.pdf&lt;br /&gt;
* http://www.nbme.org/&lt;br /&gt;
* http://www.nbome.org/&lt;br /&gt;
* http://www.ecfmg.org/&lt;br /&gt;
* http://www.osteopathic.org/Pages/default.aspx&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Help]]&lt;br /&gt;
[[Category:Projects]]&lt;br /&gt;
&lt;br /&gt;
{{WH}}&lt;br /&gt;
{{WS}}&lt;/div&gt;</summary>
		<author><name>Gonzalo Romero</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=How_to_create_a_board_review_question&amp;diff=937668</id>
		<title>How to create a board review question</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=How_to_create_a_board_review_question&amp;diff=937668"/>
		<updated>2014-02-03T20:24:10Z</updated>

		<summary type="html">&lt;p&gt;Gonzalo Romero: /* USMLE Step 2 CK Question Format */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Board review project}}&lt;br /&gt;
[[Image:Main_help_page_small.PNG|100px|link=Help]][[Image:Projects.PNG|100px|link=Projects]][[Image:Editor&#039;s_Tools.PNG|100px|link=Help Menu]]&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible mw-collapsed&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==How to Build a Question==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible-content&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
# Read and understand the tested material to grasp basic principles, diagnostic approach, management and therapeutics according to the BOARD level.&lt;br /&gt;
# Get familiar with the format, content and high Yield material. Take many exams using Q-banks, the NBME website [[http://www.nbme.org/]] and the actual exam, when ready!.  Respect Copy Rights sources from Q-banks.&lt;br /&gt;
# Select a specific content&lt;br /&gt;
# Use WikiDoc to obtain information, pictures, videos, and links on the explanations.&lt;br /&gt;
#  hallenge the test taker: do not give away the correct answer.  Avoid using proper or specific signs. Describe signs and symptoms in lay terms to give the hints. Example:  instead of “marfanoid appearance”, describe the patient with long extremities, skinny appearance and tall.&lt;br /&gt;
# Do not ask negatively i.e. &amp;quot;which of the following is incorrect, not correct or false?&amp;quot;.&lt;br /&gt;
# Long stems help recreate the challenge on test date. Short and moderate stems test specific facts.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible mw-collapsed&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Multi-step or Jump Question==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible-content&amp;quot;&amp;gt;&lt;br /&gt;
Include 2 or 3 Jump questions in order to test the medical thinking process, not just the content.  Follow these steps:&lt;br /&gt;
# Select one box with a specific topic (i.e. clinical presentation) from the diagram shown below.  Use facts such as:  the clinical presentation (symptoms and signs), the physical exam findings, specific test findings (i.e. labs, imaging, biopsy), the definitive diagnosis, the treatment of choice, its mechanism of action and the most common adverse effect associated with that medication.&lt;br /&gt;
# Describe the first box (i.e. typical clinical presentation) in the question stem.&lt;br /&gt;
# Ask a specific fact about another box (i.e. what is the mechanism of action of the treatment of choice?).  If possible, revert the order and add extra steps.&lt;br /&gt;
# &#039;&#039;&#039;You just created a jump question!&#039;&#039;&#039;&lt;br /&gt;
[[Image:WBRJumpQuestions.png|800px|center]]&lt;br /&gt;
===Example===&lt;br /&gt;
Microbiology questions require the reader to make the diagnosis, identify the treatment of choice and to know the mechanism of action (3 steps). &lt;br /&gt;
An equally difficult but less elegant question could ask what HLA-subtype is associated with a rheumatological disease.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible mw-collapsed&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Steps to Upload a Question==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible-content&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
# Go to the home page on WikiDoc, and click on the icon that says, &amp;quot;Board Review&amp;quot;, or click [[Board Review|here]].&lt;br /&gt;
# Click on the big green icon that says &amp;quot;add a board review question&amp;quot;.&lt;br /&gt;
# Type in your name in the Author Box.&lt;br /&gt;
# Select the Exam Type.&lt;br /&gt;
# Categories for the question will appear; check off ONE main category, and the appropriate subcategory.&lt;br /&gt;
# Introduce an Overall Explanation into the Box focusing on the correct answer choice.&lt;br /&gt;
# Use the remaining boxes to type in the answers to the questions and each answer choice explanation.&lt;br /&gt;
# You can add an image, if possible.&lt;br /&gt;
# Click save page if you&#039;re done, or show preview if you like to see how your question will look like.&lt;br /&gt;
# Make sure you click save page before you move on!&lt;br /&gt;
# Self quality check your work using the [[WBR quality checklist]]&lt;br /&gt;
# Contact via email the WBR Editors in Chief and WBR Team Members to review your question&lt;br /&gt;
# &#039;&#039;&#039;CONGRATULATIONS! You just created a high quality WBR Question!&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible mw-collapsed&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Question Design==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible-content&amp;quot;&amp;gt;&lt;br /&gt;
===Question Stem===&lt;br /&gt;
*The questions are preferred to be narrated as a clinical vignette, which is not an actual case. &lt;br /&gt;
*The information and illustrations should be the testing point&lt;br /&gt;
*Below are some of the key points that can be found in a question. They should be orderly included as follows:&lt;br /&gt;
**Age, Gender (e.g., a 70 year-old man)&lt;br /&gt;
**Site of Care (e.g., comes to the emergency department)&lt;br /&gt;
**Duration (e.g. that has started one week ago)&lt;br /&gt;
**Significant patient history&lt;br /&gt;
**Significant family history&lt;br /&gt;
**Significant diagnostic studies or the results of diagnostic studies &lt;br /&gt;
***Try as much as possible to include images whether still or motion&lt;br /&gt;
**Initial treatment and response&lt;br /&gt;
* The questions should not include negative phrasing, such as “except” or “not”&lt;br /&gt;
&lt;br /&gt;
===Answer Choices===&lt;br /&gt;
* Answers should include five choices,  with one correct answer and the remaining answers are distractors. &lt;br /&gt;
* Answers should not be &amp;quot;true&amp;quot; or &amp;quot;false&amp;quot;.&lt;br /&gt;
* All distractors should be homogeneous, as they should fall in the same category as the correct answer and should be similar in length. &lt;br /&gt;
* Long correct answers are discouraged.&lt;br /&gt;
* Illogical answers, absolute terms, word repeats (for example: a word or phrase in the correct answer choice, is the same as in the stem) are discouraged.&lt;br /&gt;
* “None of the above”, “All of the above” or some combination of response must not be used.&lt;br /&gt;
===Answer Explanations===&lt;br /&gt;
* These questions are intended to teach using sources such as:  graphics, references and guidelines if applicable.&lt;br /&gt;
====Overall Explanation====&lt;br /&gt;
* Only ONE answer is the best or the most appropriate one&lt;br /&gt;
* Justify why that choice is correct:  explain the pertinent positive findings, not just list the tested subject. (i.e.  the patient has this symptom which is a typical presentation of this disease). Explain also the pertinent negatives.&lt;br /&gt;
&lt;br /&gt;
* &#039;&#039;&#039;Educational Objectives:&#039;&#039;&#039;  include short high yield facts (1 or 2 take-home sentences/phrases).&lt;br /&gt;
====Answer Choice Explanation====&lt;br /&gt;
* Include why the correct answer is correct and why each of the distractors are incorrect.&lt;br /&gt;
* Include concise, yet thorough explanation providing a high yield information.&lt;br /&gt;
* Add additional information to the correct answer explanation, not explained on the overall explanation.&lt;br /&gt;
&lt;br /&gt;
===References===&lt;br /&gt;
References should be included, if possible, linking to new articles, review articles or guidelines that serve the initial teaching goal of the questions.&lt;br /&gt;
&lt;br /&gt;
==Resources==&lt;br /&gt;
===Internal Resources===&lt;br /&gt;
*Use WikiDoc content&lt;br /&gt;
*Promote WikiDoc use inserting internal links into the explanations&lt;br /&gt;
===External Resources===&lt;br /&gt;
Mention external sources used respecting Copy Rights.&lt;br /&gt;
*Books:&lt;br /&gt;
**First Aid for STEP 1 2014 (latest edition), by Tao Le and Vikas-Bhushan, updated yearly by students who aced the exam and by faculty physicians&lt;br /&gt;
**First Aid for Step 2 CK, eight edition, by Tao Le and Vikas-Bhushan. updated biyearly&lt;br /&gt;
**Med-Essentials For Step 1: High Yield Review, the fourth edition, by Kaplan Medical&lt;br /&gt;
**Master the Boards for Step 2 CK, the second edition, by Dr. Conrad Fischer&lt;br /&gt;
**Master the Boards for Step 3, the second edition, by Dr. Conrad Fischer&lt;br /&gt;
*Forums:&lt;br /&gt;
** [http://www.usmle-forums.com www.usmle-forums.com],  recent test takers give feedback about their experience and commonly tested facts, updated constantly&lt;br /&gt;
&lt;br /&gt;
===Matching Sets===&lt;br /&gt;
The format remains the same as above, but it tests two or three different concepts on separate questions having the same clinical vignette.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible mw-collapsed&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Step 1 Question Format==  &lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible-content&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
* Test the basic principles using calculations, clinical scenarios, and multimedia.&lt;br /&gt;
===Case Scenarios===&lt;br /&gt;
* Age&lt;br /&gt;
* Gender&lt;br /&gt;
* Past history and medications if remarkable&lt;br /&gt;
* Chief complaints and assoicated symptoms&lt;br /&gt;
* Vital signs and pertinent physical findings&lt;br /&gt;
* Laboratory results&lt;br /&gt;
* Heart or lung auscultation audios&lt;br /&gt;
* Electrocardiography if relevant&lt;br /&gt;
* Pathologic or radiographic images&lt;br /&gt;
===Commonly Asked Questions===&lt;br /&gt;
* A deficiency of which of the following enzyme activities is the most likely cause of the findings in this patient?&lt;br /&gt;
* A mutation in which of the following genes is the most likely cause of the findings in this patient?&lt;br /&gt;
* A mutation is most likely to be found in which of the following genes?&lt;br /&gt;
* Inheritance of mutant alleles most likely caused impairment of which of the following enzyme activities in this patient?&lt;br /&gt;
* Pathologic examination is most likely to disclose an abnormality involving which of the following?&lt;br /&gt;
* Synthesis of which of the following substances is most likely to be inhibited as a result of this therapy?&lt;br /&gt;
* The causal organism is most likely transmitted by which of the following routes?&lt;br /&gt;
* The most appropriate next step in management is administration of which of the following?&lt;br /&gt;
* The most likely cause of these findings is a deficiency of which of the following nutrients?&lt;br /&gt;
* The morphologic changes most likely indicate which of the following processes?&lt;br /&gt;
* This patient most likely has which of the following conditions?&lt;br /&gt;
* This patient is at increased risk for developing which of the following as a result of this therapy?&lt;br /&gt;
* This patient is most likely receiving treatment with which of the following drugs?&lt;br /&gt;
* This patient is most likely to develop which of the following adverse effects?&lt;br /&gt;
* This patient is most likely to have a deficit of which of the following?&lt;br /&gt;
* This patient most likely had a recent history of which of the following?&lt;br /&gt;
* This patient should be monitored for which of the following adverse effects?&lt;br /&gt;
* To prevent further damage, which of the following is the most appropriate recommendation?&lt;br /&gt;
* Which of the following abnormalities is the most likely cause of these findings?&lt;br /&gt;
* Which of the following best explains these findings?&lt;br /&gt;
* Which of the following defense mechanisms best explains this patient’s behavior?&lt;br /&gt;
* Which of the following best explains this behavior?&lt;br /&gt;
* Which of the following findings is most likely?&lt;br /&gt;
* Which of the following graphs shown best corresponds to these results?&lt;br /&gt;
* Which of the following is the most likely causal organism?&lt;br /&gt;
* Which of the following is the most likely cause of death in this patient?&lt;br /&gt;
* Which of the following is the most likely cause of this patient&#039;s condition?&lt;br /&gt;
* Which of the following is the most likely cause of this patient&#039;s current condition?&lt;br /&gt;
* Which of the following is the most likely diagnosis?&lt;br /&gt;
* Which of the following is the most likely mechanism of action causing these adverse effects?&lt;br /&gt;
* Which of the following is the most appropriate initial treatment for this patient?&lt;br /&gt;
* Which of the following is the most appropriate next step in management?&lt;br /&gt;
* Which of the following is the most appropriate pharmacotherapy?&lt;br /&gt;
* Which of the following is the most appropriate response by the physician?&lt;br /&gt;
* Which of the following labeled areas is most likely damaged?&lt;br /&gt;
* Which of the following mechanisms best explains this cytogenetic abnormality?&lt;br /&gt;
* Which of the following pathologic findings is most likely seen in a biopsy specimen in this patient?&lt;br /&gt;
* Which of the following processes best describes these findings?&lt;br /&gt;
* Which of the following processes is most likely to occur in this patient as a result of the disease?&lt;br /&gt;
* Which of the following sets of changes most likely occurred following the infusion of drug X?&lt;br /&gt;
* Which of the following sets of laboratory findings is most likely in this patient?&lt;br /&gt;
* Which of the following sets of physiologic changes is most likely following administration of the drug?&lt;br /&gt;
* Which of the following treatments is most appropriate at this time?&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible mw-collapsed&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Step 2 CK Question Format==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible-content&amp;quot;&amp;gt;&lt;br /&gt;
* Follow the most recent Algorithms/Guidelines from WikiDoc&lt;br /&gt;
* Useful resources are the books: Master the Boards and First Aid for Step 2 CK&lt;br /&gt;
* Include basic STEP 1 questions; 50-60% of the knowledge from Step 2CK comes from Step 1&lt;br /&gt;
* Include labs&lt;br /&gt;
* Make long stems&lt;br /&gt;
* Accommodate information within the vignette that will benefit the test taker to identify the proper answer choice&lt;br /&gt;
* Include extra information that is not necessary leading towards the correct answer (distractors)&lt;br /&gt;
* Audio and video questions would be ideal also&lt;br /&gt;
===Case Scenarios===&lt;br /&gt;
* Age of patient&lt;br /&gt;
* Sex&lt;br /&gt;
* Past history if remarkable&lt;br /&gt;
* Chief complaint&lt;br /&gt;
* Vitals&lt;br /&gt;
* Describe the chief complaint&lt;br /&gt;
* Physical examination findings&lt;br /&gt;
* Laboratory findings&lt;br /&gt;
* Image or video (if applicable)&lt;br /&gt;
===Commonly Asked Questions===&lt;br /&gt;
* What is the most likely diagnosis?&lt;br /&gt;
* What is the most likely cause for this condition?&lt;br /&gt;
* What is the next best step in management?&lt;br /&gt;
* What is the best initial treatment?&lt;br /&gt;
* What is the best treatment for this condition?&lt;br /&gt;
* What is the best/ most accurate laboratory test to confirm diagnosis?&lt;br /&gt;
* What is the drug of choice to treat this condition?&lt;br /&gt;
* What is the most likely physical exam finding? (eg. On auscultation, abdominal examination, etc.)&lt;br /&gt;
* Which of the following is the most likely underlying mechanism?&lt;br /&gt;
* What is the most common risk factor for this condition?&lt;br /&gt;
* What is the most common complication of this condition?&lt;br /&gt;
* What is the best drug/ drug of choice used to treat this condition?&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible mw-collapsed&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==USMLE Step 3 Question Format==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible-content&amp;quot;&amp;gt;&lt;br /&gt;
Testing mainly on management of case, covering the following fields:&lt;br /&gt;
===Application of Concepts===&lt;br /&gt;
* What is the most likely cause for this condition?&lt;br /&gt;
* What is the most likely underlying mechanism?&lt;br /&gt;
* What is the cause of (sign/ physical exam finding)?&lt;br /&gt;
* Questions related to research studies&lt;br /&gt;
===History and Physical Examination===&lt;br /&gt;
* What is the most likely physical exam finding?&lt;br /&gt;
* What facts from the past history are important for diagnosis?&lt;br /&gt;
* What is the most common risk factor for this condition?&lt;br /&gt;
===Laboratory and Diagnostic Studies===&lt;br /&gt;
* What is the most appropriate/accurate laboratory test to evaluate this patient?&lt;br /&gt;
* What is the most appropriate laboratory test to evaluate the efficacy of current treatment?&lt;br /&gt;
* What is the best initial laboratory test to order?&lt;br /&gt;
* What is the most likely result of this laboratory test seen in this condition?&lt;br /&gt;
* What is the most likely laboratory finding seen in this condition?&lt;br /&gt;
===Diagnosis===&lt;br /&gt;
* What is the most likely diagnosis?&lt;br /&gt;
* Which condition is most commonly associated with ____?&lt;br /&gt;
===Prognosis===&lt;br /&gt;
* Which of the following factors influences prognosis (good or bad)?&lt;br /&gt;
* Which of the following is the best/ worst prognostic indicator?&lt;br /&gt;
* Which of the following laboratory finding indicates best/ worst prognosis?&lt;br /&gt;
* After follow-up, which of the following is the most common factor that indicates favorable prognosis?&lt;br /&gt;
* What is the most appropriate counseling advice?&lt;br /&gt;
* What is the most common complication of this condition?&lt;br /&gt;
* What is the most likely outcome of this condition?&lt;br /&gt;
===Management===&lt;br /&gt;
* What is the next best step in management of this patient?&lt;br /&gt;
* What is the most appropriate screening test?&lt;br /&gt;
* What is the most appropriate preventive measure for this condition?&lt;br /&gt;
* What is the best initial treatment?&lt;br /&gt;
* What is the most accurate treatment?What is the best drug/ drug of choice used to treat this condition?&lt;br /&gt;
* What is the most appropriate discharge plan?&lt;br /&gt;
* Which drug is contraindicated in the treatment of this condition?&lt;br /&gt;
* Which of the following is a contraindication for the use of this drug?&lt;br /&gt;
* What is the most likely adverse effect of this drug?&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Ethics and Principles===&lt;br /&gt;
Wikidoc has strict rules and regulations against plagiarism. Those rules must be followed. Participants for the board review questions project will have to follow the highest standards of ethics and conduct when writing a question.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible mw-collapsed&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Resources==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible-content&amp;quot;&amp;gt;&lt;br /&gt;
===WikiDoc Links===&lt;br /&gt;
* [[MCAT]]&lt;br /&gt;
* [[USMLE Step 1]]&lt;br /&gt;
* [[USMLE Step 2-CK]]&lt;br /&gt;
* [[USMLE Step 2 Clinical Skills]]&lt;br /&gt;
* [[Step 2 CS study guide]]&lt;br /&gt;
* [[USMLE Step 3]]&lt;br /&gt;
*  [[Copyleft sources]]&lt;br /&gt;
* [[How to upload USMLE II Images]]&lt;br /&gt;
* [[COMLEX-USA]]&lt;br /&gt;
&lt;br /&gt;
===External Resources===&lt;br /&gt;
* http://www.usmle.org/pdfs/step-1/2013content_step1.pdf&lt;br /&gt;
* http://www.usmle.org/pdfs/step-2-ck/2012--13_FINAL_S2_GSI.pdf&lt;br /&gt;
* http://www.usmle.org/pdfs/step-3/2013content_step3.pdf&lt;br /&gt;
* http://www.nbme.org/&lt;br /&gt;
* http://www.nbome.org/&lt;br /&gt;
* http://www.ecfmg.org/&lt;br /&gt;
* http://www.osteopathic.org/Pages/default.aspx&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Help]]&lt;br /&gt;
[[Category:Projects]]&lt;br /&gt;
&lt;br /&gt;
{{WH}}&lt;br /&gt;
{{WS}}&lt;/div&gt;</summary>
		<author><name>Gonzalo Romero</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=Template:Board_review_project&amp;diff=937667</id>
		<title>Template:Board review project</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=Template:Board_review_project&amp;diff=937667"/>
		<updated>2014-02-03T20:23:47Z</updated>

		<summary type="html">&lt;p&gt;Gonzalo Romero: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{| style=&amp;quot;margin: 0 0 1em 1em; border: 2px solid #696969; float: right; width:12em&amp;quot; cellpadding=&amp;quot;10&amp;quot; cellspacing=&amp;quot;20&amp;quot;;&lt;br /&gt;
! style=&amp;quot;padding: 1 7px; font-size: 100%; background:MidnightBlue&amp;quot; align=center | {{fontcolor|#FFFFFF|WikiDoc Board Review}}&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;font-size: 100%; padding: 0.5 10px; background: #DCDCDC&amp;quot; align=left | &#039;&#039;&#039;[[Board review project|The Project]]&#039;&#039;&#039;&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;font-size: 100%; padding: 0.5 10px; background: #DCDCDC&amp;quot; align=left | &#039;&#039;&#039;[[WBR team|The Team]]&#039;&#039;&#039;&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;font-size: 100%; padding: 0.5 10px; background: #DCDCDC&amp;quot; align=left | &#039;&#039;&#039;[[How to create a board review project|Guidelines]]&#039;&#039;&#039;&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;font-size: 100%; padding: 0.5 10px; background: #DCDCDC&amp;quot; align=left | &#039;&#039;&#039;[[WBR|Question List]]&#039;&#039;&#039;&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;font-size: 100%; padding: 0.5 10px; background: #DCDCDC&amp;quot; align=left | &#039;&#039;&#039;[[WBR quality checklist|Quality Checklist]]&#039;&#039;&#039;&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;font-size: 100%; padding: 0.5 10px; background: #DCDCDC&amp;quot; align=left | &#039;&#039;&#039;[[WBR medical illustrations|Medical Illustrations]]&#039;&#039;&#039;&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;font-size: 100%; padding: 0.5 10px; background: #DCDCDC&amp;quot; align=left | &#039;&#039;&#039;[[WBR template questions|Question Template]]&#039;&#039;&#039;&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;font-size: 100%; padding: 0.5 10px; background: #DCDCDC&amp;quot; align=left | &#039;&#039;&#039;[[WBR high yield|High Yield!]]&#039;&#039;&#039;&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;font-size: 100%; padding: 0.5 10px; background: #DCDCDC&amp;quot; align=left | &#039;&#039;&#039;[[WBR labs|Normal Labs]]&#039;&#039;&#039;&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;font-size: 100%; padding: 0.5 10px; background: #DCDCDC&amp;quot; align=left | &#039;&#039;&#039;[[WBR mnemonics|Mnemonics]]&#039;&#039;&#039;&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;font-size: 100%; padding: 0.5 10px; background: #DCDCDC&amp;quot; align=left | &#039;&#039;&#039;[[Test taking strategies|Test Taking Tips]]&#039;&#039;&#039;&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
[[Category:Projects]]&lt;/div&gt;</summary>
		<author><name>Gonzalo Romero</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=How_to_create_a_board_review_question&amp;diff=937656</id>
		<title>How to create a board review question</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=How_to_create_a_board_review_question&amp;diff=937656"/>
		<updated>2014-02-03T20:20:29Z</updated>

		<summary type="html">&lt;p&gt;Gonzalo Romero: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Board review project}}&lt;br /&gt;
[[Image:Main_help_page_small.PNG|100px|link=Help]][[Image:Projects.PNG|100px|link=Projects]][[Image:Editor&#039;s_Tools.PNG|100px|link=Help Menu]]&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible mw-collapsed&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==How to Build a Question==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible-content&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
# Read and understand the tested material to grasp basic principles, diagnostic approach, management and therapeutics according to the BOARD level.&lt;br /&gt;
# Get familiar with the format, content and high Yield material. Take many exams using Q-banks, the NBME website [[http://www.nbme.org/]] and the actual exam, when ready!.  Respect Copy Rights sources from Q-banks.&lt;br /&gt;
# Select a specific content&lt;br /&gt;
# Use WikiDoc to obtain information, pictures, videos, and links on the explanations.&lt;br /&gt;
#  hallenge the test taker: do not give away the correct answer.  Avoid using proper or specific signs. Describe signs and symptoms in lay terms to give the hints. Example:  instead of “marfanoid appearance”, describe the patient with long extremities, skinny appearance and tall.&lt;br /&gt;
# Do not ask negatively i.e. &amp;quot;which of the following is incorrect, not correct or false?&amp;quot;.&lt;br /&gt;
# Long stems help recreate the challenge on test date. Short and moderate stems test specific facts.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible mw-collapsed&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Multi-step or Jump Question==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible-content&amp;quot;&amp;gt;&lt;br /&gt;
Include 2 or 3 Jump questions in order to test the medical thinking process, not just the content.  Follow these steps:&lt;br /&gt;
# Select one box with a specific topic (i.e. clinical presentation) from the diagram shown below.  Use facts such as:  the clinical presentation (symptoms and signs), the physical exam findings, specific test findings (i.e. labs, imaging, biopsy), the definitive diagnosis, the treatment of choice, its mechanism of action and the most common adverse effect associated with that medication.&lt;br /&gt;
# Describe the first box (i.e. typical clinical presentation) in the question stem.&lt;br /&gt;
# Ask a specific fact about another box (i.e. what is the mechanism of action of the treatment of choice?).  If possible, revert the order and add extra steps.&lt;br /&gt;
# &#039;&#039;&#039;You just created a jump question!&#039;&#039;&#039;&lt;br /&gt;
[[Image:WBRJumpQuestions.png|800px|center]]&lt;br /&gt;
===Example===&lt;br /&gt;
Microbiology questions require the reader to make the diagnosis, identify the treatment of choice and to know the mechanism of action (3 steps). &lt;br /&gt;
An equally difficult but less elegant question could ask what HLA-subtype is associated with a rheumatological disease.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible mw-collapsed&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Steps to Upload a Question==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible-content&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
# Go to the home page on WikiDoc, and click on the icon that says, &amp;quot;Board Review&amp;quot;, or click [[Board Review|here]].&lt;br /&gt;
# Click on the big green icon that says &amp;quot;add a board review question&amp;quot;.&lt;br /&gt;
# Type in your name in the Author Box.&lt;br /&gt;
# Select the Exam Type.&lt;br /&gt;
# Categories for the question will appear; check off ONE main category, and the appropriate subcategory.&lt;br /&gt;
# Introduce an Overall Explanation into the Box focusing on the correct answer choice.&lt;br /&gt;
# Use the remaining boxes to type in the answers to the questions and each answer choice explanation.&lt;br /&gt;
# You can add an image, if possible.&lt;br /&gt;
# Click save page if you&#039;re done, or show preview if you like to see how your question will look like.&lt;br /&gt;
# Make sure you click save page before you move on!&lt;br /&gt;
# Self quality check your work using the [[WBR quality checklist]]&lt;br /&gt;
# Contact via email the WBR Editors in Chief and WBR Team Members to review your question&lt;br /&gt;
# &#039;&#039;&#039;CONGRATULATIONS! You just created a high quality WBR Question!&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible mw-collapsed&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Question Design==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible-content&amp;quot;&amp;gt;&lt;br /&gt;
===Question Stem===&lt;br /&gt;
*The questions are preferred to be narrated as a clinical vignette, which is not an actual case. &lt;br /&gt;
*The information and illustrations should be the testing point&lt;br /&gt;
*Below are some of the key points that can be found in a question. They should be orderly included as follows:&lt;br /&gt;
**Age, Gender (e.g., a 70 year-old man)&lt;br /&gt;
**Site of Care (e.g., comes to the emergency department)&lt;br /&gt;
**Duration (e.g. that has started one week ago)&lt;br /&gt;
**Significant patient history&lt;br /&gt;
**Significant family history&lt;br /&gt;
**Significant diagnostic studies or the results of diagnostic studies &lt;br /&gt;
***Try as much as possible to include images whether still or motion&lt;br /&gt;
**Initial treatment and response&lt;br /&gt;
* The questions should not include negative phrasing, such as “except” or “not”&lt;br /&gt;
&lt;br /&gt;
===Answer Choices===&lt;br /&gt;
* Answers should include five choices,  with one correct answer and the remaining answers are distractors. &lt;br /&gt;
* Answers should not be &amp;quot;true&amp;quot; or &amp;quot;false&amp;quot;.&lt;br /&gt;
* All distractors should be homogeneous, as they should fall in the same category as the correct answer and should be similar in length. &lt;br /&gt;
* Long correct answers are discouraged.&lt;br /&gt;
* Illogical answers, absolute terms, word repeats (for example: a word or phrase in the correct answer choice, is the same as in the stem) are discouraged.&lt;br /&gt;
* “None of the above”, “All of the above” or some combination of response must not be used.&lt;br /&gt;
===Answer Explanations===&lt;br /&gt;
* These questions are intended to teach using sources such as:  graphics, references and guidelines if applicable.&lt;br /&gt;
====Overall Explanation====&lt;br /&gt;
* Only ONE answer is the best or the most appropriate one&lt;br /&gt;
* Justify why that choice is correct:  explain the pertinent positive findings, not just list the tested subject. (i.e.  the patient has this symptom which is a typical presentation of this disease). Explain also the pertinent negatives.&lt;br /&gt;
&lt;br /&gt;
* &#039;&#039;&#039;Educational Objectives:&#039;&#039;&#039;  include short high yield facts (1 or 2 take-home sentences/phrases).&lt;br /&gt;
====Answer Choice Explanation====&lt;br /&gt;
* Include why the correct answer is correct and why each of the distractors are incorrect.&lt;br /&gt;
* Include concise, yet thorough explanation providing a high yield information.&lt;br /&gt;
* Add additional information to the correct answer explanation, not explained on the overall explanation.&lt;br /&gt;
&lt;br /&gt;
===References===&lt;br /&gt;
References should be included, if possible, linking to new articles, review articles or guidelines that serve the initial teaching goal of the questions.&lt;br /&gt;
&lt;br /&gt;
==Resources==&lt;br /&gt;
===Internal Resources===&lt;br /&gt;
*Use WikiDoc content&lt;br /&gt;
*Promote WikiDoc use inserting internal links into the explanations&lt;br /&gt;
===External Resources===&lt;br /&gt;
Mention external sources used respecting Copy Rights.&lt;br /&gt;
*Books:&lt;br /&gt;
**First Aid for STEP 1 2014 (latest edition), by Tao Le and Vikas-Bhushan, updated yearly by students who aced the exam and by faculty physicians&lt;br /&gt;
**First Aid for Step 2 CK, eight edition, by Tao Le and Vikas-Bhushan. updated biyearly&lt;br /&gt;
**Med-Essentials For Step 1: High Yield Review, the fourth edition, by Kaplan Medical&lt;br /&gt;
**Master the Boards for Step 2 CK, the second edition, by Dr. Conrad Fischer&lt;br /&gt;
**Master the Boards for Step 3, the second edition, by Dr. Conrad Fischer&lt;br /&gt;
*Forums:&lt;br /&gt;
** [http://www.usmle-forums.com www.usmle-forums.com],  recent test takers give feedback about their experience and commonly tested facts, updated constantly&lt;br /&gt;
&lt;br /&gt;
===Matching Sets===&lt;br /&gt;
The format remains the same as above, but it tests two or three different concepts on separate questions having the same clinical vignette.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible mw-collapsed&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Step 1 Question Format==  &lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible-content&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
* Test the basic principles using calculations, clinical scenarios, and multimedia.&lt;br /&gt;
===Case Scenarios===&lt;br /&gt;
* Age&lt;br /&gt;
* Gender&lt;br /&gt;
* Past history and medications if remarkable&lt;br /&gt;
* Chief complaints and assoicated symptoms&lt;br /&gt;
* Vital signs and pertinent physical findings&lt;br /&gt;
* Laboratory results&lt;br /&gt;
* Heart or lung auscultation audios&lt;br /&gt;
* Electrocardiography if relevant&lt;br /&gt;
* Pathologic or radiographic images&lt;br /&gt;
===Commonly Asked Questions===&lt;br /&gt;
* A deficiency of which of the following enzyme activities is the most likely cause of the findings in this patient?&lt;br /&gt;
* A mutation in which of the following genes is the most likely cause of the findings in this patient?&lt;br /&gt;
* A mutation is most likely to be found in which of the following genes?&lt;br /&gt;
* Inheritance of mutant alleles most likely caused impairment of which of the following enzyme activities in this patient?&lt;br /&gt;
* Pathologic examination is most likely to disclose an abnormality involving which of the following?&lt;br /&gt;
* Synthesis of which of the following substances is most likely to be inhibited as a result of this therapy?&lt;br /&gt;
* The causal organism is most likely transmitted by which of the following routes?&lt;br /&gt;
* The most appropriate next step in management is administration of which of the following?&lt;br /&gt;
* The most likely cause of these findings is a deficiency of which of the following nutrients?&lt;br /&gt;
* The morphologic changes most likely indicate which of the following processes?&lt;br /&gt;
* This patient most likely has which of the following conditions?&lt;br /&gt;
* This patient is at increased risk for developing which of the following as a result of this therapy?&lt;br /&gt;
* This patient is most likely receiving treatment with which of the following drugs?&lt;br /&gt;
* This patient is most likely to develop which of the following adverse effects?&lt;br /&gt;
* This patient is most likely to have a deficit of which of the following?&lt;br /&gt;
* This patient most likely had a recent history of which of the following?&lt;br /&gt;
* This patient should be monitored for which of the following adverse effects?&lt;br /&gt;
* To prevent further damage, which of the following is the most appropriate recommendation?&lt;br /&gt;
* Which of the following abnormalities is the most likely cause of these findings?&lt;br /&gt;
* Which of the following best explains these findings?&lt;br /&gt;
* Which of the following defense mechanisms best explains this patient’s behavior?&lt;br /&gt;
* Which of the following best explains this behavior?&lt;br /&gt;
* Which of the following findings is most likely?&lt;br /&gt;
* Which of the following graphs shown best corresponds to these results?&lt;br /&gt;
* Which of the following is the most likely causal organism?&lt;br /&gt;
* Which of the following is the most likely cause of death in this patient?&lt;br /&gt;
* Which of the following is the most likely cause of this patient&#039;s condition?&lt;br /&gt;
* Which of the following is the most likely cause of this patient&#039;s current condition?&lt;br /&gt;
* Which of the following is the most likely diagnosis?&lt;br /&gt;
* Which of the following is the most likely mechanism of action causing these adverse effects?&lt;br /&gt;
* Which of the following is the most appropriate initial treatment for this patient?&lt;br /&gt;
* Which of the following is the most appropriate next step in management?&lt;br /&gt;
* Which of the following is the most appropriate pharmacotherapy?&lt;br /&gt;
* Which of the following is the most appropriate response by the physician?&lt;br /&gt;
* Which of the following labeled areas is most likely damaged?&lt;br /&gt;
* Which of the following mechanisms best explains this cytogenetic abnormality?&lt;br /&gt;
* Which of the following pathologic findings is most likely seen in a biopsy specimen in this patient?&lt;br /&gt;
* Which of the following processes best describes these findings?&lt;br /&gt;
* Which of the following processes is most likely to occur in this patient as a result of the disease?&lt;br /&gt;
* Which of the following sets of changes most likely occurred following the infusion of drug X?&lt;br /&gt;
* Which of the following sets of laboratory findings is most likely in this patient?&lt;br /&gt;
* Which of the following sets of physiologic changes is most likely following administration of the drug?&lt;br /&gt;
* Which of the following treatments is most appropriate at this time?&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible mw-collapsed&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==USMLE Step 2 CK Question Format==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible-content&amp;quot;&amp;gt;&lt;br /&gt;
* Follow the most recent Algorithms/Guidelines from WikiDoc&lt;br /&gt;
* Useful resources are the books: Master the Boards and First Aid for Step 2 CK&lt;br /&gt;
* Include basic STEP 1 questions; 50-60% of the knowledge from Step 2CK comes from Step 1&lt;br /&gt;
* Include labs&lt;br /&gt;
* Make long stems&lt;br /&gt;
* Accommodate information within the vignette that will benefit the test taker to identify the proper answer choice&lt;br /&gt;
* Include extra information that is not necessary leading towards the correct answer (distractors)&lt;br /&gt;
* Audio and video questions would be ideal also&lt;br /&gt;
===Case Scenarios===&lt;br /&gt;
* Age of patient&lt;br /&gt;
* Sex&lt;br /&gt;
* Past history if remarkable&lt;br /&gt;
* Chief complaint&lt;br /&gt;
* Vitals&lt;br /&gt;
* Describe the chief complaint&lt;br /&gt;
* Physical examination findings&lt;br /&gt;
* Laboratory findings&lt;br /&gt;
* Image or video (if applicable)&lt;br /&gt;
===Commonly Asked Questions===&lt;br /&gt;
* What is the most likely diagnosis?&lt;br /&gt;
* What is the most likely cause for this condition?&lt;br /&gt;
* What is the next best step in management?&lt;br /&gt;
* What is the best initial treatment?&lt;br /&gt;
* What is the best treatment for this condition?&lt;br /&gt;
* What is the best/ most accurate laboratory test to confirm diagnosis?&lt;br /&gt;
* What is the drug of choice to treat this condition?&lt;br /&gt;
* What is the most likely physical exam finding? (eg. On auscultation, abdominal examination, etc.)&lt;br /&gt;
* Which of the following is the most likely underlying mechanism?&lt;br /&gt;
* What is the most common risk factor for this condition?&lt;br /&gt;
* What is the most common complication of this condition?&lt;br /&gt;
* What is the best drug/ drug of choice used to treat this condition?&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible mw-collapsed&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==USMLE Step 3 Question Format==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible-content&amp;quot;&amp;gt;&lt;br /&gt;
Testing mainly on management of case, covering the following fields:&lt;br /&gt;
===Application of Concepts===&lt;br /&gt;
* What is the most likely cause for this condition?&lt;br /&gt;
* What is the most likely underlying mechanism?&lt;br /&gt;
* What is the cause of (sign/ physical exam finding)?&lt;br /&gt;
* Questions related to research studies&lt;br /&gt;
===History and Physical Examination===&lt;br /&gt;
* What is the most likely physical exam finding?&lt;br /&gt;
* What facts from the past history are important for diagnosis?&lt;br /&gt;
* What is the most common risk factor for this condition?&lt;br /&gt;
===Laboratory and Diagnostic Studies===&lt;br /&gt;
* What is the most appropriate/accurate laboratory test to evaluate this patient?&lt;br /&gt;
* What is the most appropriate laboratory test to evaluate the efficacy of current treatment?&lt;br /&gt;
* What is the best initial laboratory test to order?&lt;br /&gt;
* What is the most likely result of this laboratory test seen in this condition?&lt;br /&gt;
* What is the most likely laboratory finding seen in this condition?&lt;br /&gt;
===Diagnosis===&lt;br /&gt;
* What is the most likely diagnosis?&lt;br /&gt;
* Which condition is most commonly associated with ____?&lt;br /&gt;
===Prognosis===&lt;br /&gt;
* Which of the following factors influences prognosis (good or bad)?&lt;br /&gt;
* Which of the following is the best/ worst prognostic indicator?&lt;br /&gt;
* Which of the following laboratory finding indicates best/ worst prognosis?&lt;br /&gt;
* After follow-up, which of the following is the most common factor that indicates favorable prognosis?&lt;br /&gt;
* What is the most appropriate counseling advice?&lt;br /&gt;
* What is the most common complication of this condition?&lt;br /&gt;
* What is the most likely outcome of this condition?&lt;br /&gt;
===Management===&lt;br /&gt;
* What is the next best step in management of this patient?&lt;br /&gt;
* What is the most appropriate screening test?&lt;br /&gt;
* What is the most appropriate preventive measure for this condition?&lt;br /&gt;
* What is the best initial treatment?&lt;br /&gt;
* What is the most accurate treatment?What is the best drug/ drug of choice used to treat this condition?&lt;br /&gt;
* What is the most appropriate discharge plan?&lt;br /&gt;
* Which drug is contraindicated in the treatment of this condition?&lt;br /&gt;
* Which of the following is a contraindication for the use of this drug?&lt;br /&gt;
* What is the most likely adverse effect of this drug?&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Ethics and Principles===&lt;br /&gt;
Wikidoc has strict rules and regulations against plagiarism. Those rules must be followed. Participants for the board review questions project will have to follow the highest standards of ethics and conduct when writing a question.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible mw-collapsed&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Resources==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible-content&amp;quot;&amp;gt;&lt;br /&gt;
===WikiDoc Links===&lt;br /&gt;
* [[MCAT]]&lt;br /&gt;
* [[USMLE Step 1]]&lt;br /&gt;
* [[USMLE Step 2-CK]]&lt;br /&gt;
* [[USMLE Step 2 Clinical Skills]]&lt;br /&gt;
* [[Step 2 CS study guide]]&lt;br /&gt;
* [[USMLE Step 3]]&lt;br /&gt;
*  [[Copyleft sources]]&lt;br /&gt;
* [[How to upload USMLE II Images]]&lt;br /&gt;
* [[COMLEX-USA]]&lt;br /&gt;
&lt;br /&gt;
===External Resources===&lt;br /&gt;
* http://www.usmle.org/pdfs/step-1/2013content_step1.pdf&lt;br /&gt;
* http://www.usmle.org/pdfs/step-2-ck/2012--13_FINAL_S2_GSI.pdf&lt;br /&gt;
* http://www.usmle.org/pdfs/step-3/2013content_step3.pdf&lt;br /&gt;
* http://www.nbme.org/&lt;br /&gt;
* http://www.nbome.org/&lt;br /&gt;
* http://www.ecfmg.org/&lt;br /&gt;
* http://www.osteopathic.org/Pages/default.aspx&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Help]]&lt;br /&gt;
[[Category:Projects]]&lt;br /&gt;
&lt;br /&gt;
{{WH}}&lt;br /&gt;
{{WS}}&lt;/div&gt;</summary>
		<author><name>Gonzalo Romero</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=How_to_create_a_board_review_question&amp;diff=937652</id>
		<title>How to create a board review question</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=How_to_create_a_board_review_question&amp;diff=937652"/>
		<updated>2014-02-03T20:19:36Z</updated>

		<summary type="html">&lt;p&gt;Gonzalo Romero: /* USMLE Step 1 Question Format */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Board review project}}&lt;br /&gt;
[[Image:Main_help_page_small.PNG|100px|link=Help]][[Image:Projects.PNG|100px|link=Projects]][[Image:Editor&#039;s_Tools.PNG|100px|link=Help Menu]]&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible mw-collapsed&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==How to Build a Question==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible-content&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
# Read and understand the tested material to grasp basic principles, diagnostic approach, management and therapeutics according to the BOARD level.&lt;br /&gt;
# Get familiar with the format, content and high Yield material. Take many exams using Q-banks, the NBME website [[http://www.nbme.org/]] and the actual exam, when ready!.  Respect Copy Rights sources from Q-banks.&lt;br /&gt;
# Select a specific content&lt;br /&gt;
# Use WikiDoc to obtain information, pictures, videos, and links on the explanations.&lt;br /&gt;
#  hallenge the test taker: do not give away the correct answer.  Avoid using proper or specific signs. Describe signs and symptoms in lay terms to give the hints. Example:  instead of “marfanoid appearance”, describe the patient with long extremities, skinny appearance and tall.&lt;br /&gt;
# Do not ask negatively i.e. &amp;quot;which of the following is incorrect, not correct or false?&amp;quot;.&lt;br /&gt;
# Long stems help recreate the challenge on test date. Short and moderate stems test specific facts.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible mw-collapsed&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Multi-step or Jump Question==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible-content&amp;quot;&amp;gt;&lt;br /&gt;
Include 2 or 3 Jump questions in order to test the medical thinking process, not just the content.  Follow these steps:&lt;br /&gt;
# Select one box with a specific topic (i.e. clinical presentation) from the diagram shown below.  Use facts such as:  the clinical presentation (symptoms and signs), the physical exam findings, specific test findings (i.e. labs, imaging, biopsy), the definitive diagnosis, the treatment of choice, its mechanism of action and the most common adverse effect associated with that medication.&lt;br /&gt;
# Describe the first box (i.e. typical clinical presentation) in the question stem.&lt;br /&gt;
# Ask a specific fact about another box (i.e. what is the mechanism of action of the treatment of choice?).  If possible, revert the order and add extra steps.&lt;br /&gt;
# &#039;&#039;&#039;You just created a jump question!&#039;&#039;&#039;&lt;br /&gt;
[[Image:WBRJumpQuestions.png|800px|center]]&lt;br /&gt;
===Example===&lt;br /&gt;
Microbiology questions require the reader to make the diagnosis, identify the treatment of choice and to know the mechanism of action (3 steps). &lt;br /&gt;
An equally difficult but less elegant question could ask what HLA-subtype is associated with a rheumatological disease.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible mw-collapsed&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Steps to Upload a Question==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible-content&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
# Go to the home page on WikiDoc, and click on the icon that says, &amp;quot;Board Review&amp;quot;, or click [[Board Review|here]].&lt;br /&gt;
# Click on the big green icon that says &amp;quot;add a board review question&amp;quot;.&lt;br /&gt;
# Type in your name in the Author Box.&lt;br /&gt;
# Select the Exam Type.&lt;br /&gt;
# Categories for the question will appear; check off ONE main category, and the appropriate subcategory.&lt;br /&gt;
# Introduce an Overall Explanation into the Box focusing on the correct answer choice.&lt;br /&gt;
# Use the remaining boxes to type in the answers to the questions and each answer choice explanation.&lt;br /&gt;
# You can add an image, if possible.&lt;br /&gt;
# Click save page if you&#039;re done, or show preview if you like to see how your question will look like.&lt;br /&gt;
# Make sure you click save page before you move on!&lt;br /&gt;
# Self quality check your work using the [[WBR quality checklist]]&lt;br /&gt;
# Contact via email the WBR Editors in Chief and WBR Team Members to review your question&lt;br /&gt;
# &#039;&#039;&#039;CONGRATULATIONS! You just created a high quality WBR Question!&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible mw-collapsed&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Question Design==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible-content&amp;quot;&amp;gt;&lt;br /&gt;
===Question Stem===&lt;br /&gt;
*The questions are preferred to be narrated as a clinical vignette, which is not an actual case. &lt;br /&gt;
*The information and illustrations should be the testing point&lt;br /&gt;
*Below are some of the key points that can be found in a question. They should be orderly included as follows:&lt;br /&gt;
**Age, Gender (e.g., a 70 year-old man)&lt;br /&gt;
**Site of Care (e.g., comes to the emergency department)&lt;br /&gt;
**Duration (e.g. that has started one week ago)&lt;br /&gt;
**Significant patient history&lt;br /&gt;
**Significant family history&lt;br /&gt;
**Significant diagnostic studies or the results of diagnostic studies &lt;br /&gt;
***Try as much as possible to include images whether still or motion&lt;br /&gt;
**Initial treatment and response&lt;br /&gt;
* The questions should not include negative phrasing, such as “except” or “not”&lt;br /&gt;
&lt;br /&gt;
===Answer Choices===&lt;br /&gt;
* Answers should include five choices,  with one correct answer and the remaining answers are distractors. &lt;br /&gt;
* Answers should not be &amp;quot;true&amp;quot; or &amp;quot;false&amp;quot;.&lt;br /&gt;
* All distractors should be homogeneous, as they should fall in the same category as the correct answer and should be similar in length. &lt;br /&gt;
* Long correct answers are discouraged.&lt;br /&gt;
* Illogical answers, absolute terms, word repeats (for example: a word or phrase in the correct answer choice, is the same as in the stem) are discouraged.&lt;br /&gt;
* “None of the above”, “All of the above” or some combination of response must not be used.&lt;br /&gt;
===Answer Explanations===&lt;br /&gt;
* These questions are intended to teach using sources such as:  graphics, references and guidelines if applicable.&lt;br /&gt;
====Overall Explanation====&lt;br /&gt;
* Only ONE answer is the best or the most appropriate one&lt;br /&gt;
* Justify why that choice is correct:  explain the pertinent positive findings, not just list the tested subject. (i.e.  the patient has this symptom which is a typical presentation of this disease). Explain also the pertinent negatives.&lt;br /&gt;
&lt;br /&gt;
* &#039;&#039;&#039;Educational Objectives:&#039;&#039;&#039;  include short high yield facts (1 or 2 take-home sentences/phrases).&lt;br /&gt;
====Answer Choice Explanation====&lt;br /&gt;
* Include why the correct answer is correct and why each of the distractors are incorrect.&lt;br /&gt;
* Include concise, yet thorough explanation providing a high yield information.&lt;br /&gt;
* Add additional information to the correct answer explanation, not explained on the overall explanation.&lt;br /&gt;
&lt;br /&gt;
===References===&lt;br /&gt;
References should be included, if possible, linking to new articles, review articles or guidelines that serve the initial teaching goal of the questions.&lt;br /&gt;
&lt;br /&gt;
==Resources==&lt;br /&gt;
===Internal Resources===&lt;br /&gt;
*Use WikiDoc content&lt;br /&gt;
*Promote WikiDoc use inserting internal links into the explanations&lt;br /&gt;
===External Resources===&lt;br /&gt;
Mention external sources used respecting Copy Rights.&lt;br /&gt;
*Books:&lt;br /&gt;
**First Aid for STEP 1 2014 (latest edition), by Tao Le and Vikas-Bhushan, updated yearly by students who aced the exam and by faculty physicians&lt;br /&gt;
**First Aid for Step 2 CK, eight edition, by Tao Le and Vikas-Bhushan. updated biyearly&lt;br /&gt;
**Med-Essentials For Step 1: High Yield Review, the fourth edition, by Kaplan Medical&lt;br /&gt;
**Master the Boards for Step 2 CK, the second edition, by Dr. Conrad Fischer&lt;br /&gt;
**Master the Boards for Step 3, the second edition, by Dr. Conrad Fischer&lt;br /&gt;
*Forums:&lt;br /&gt;
** [http://www.usmle-forums.com www.usmle-forums.com],  recent test takers give feedback about their experience and commonly tested facts, updated constantly&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Matching Sets===&lt;br /&gt;
The format remains the same as above, but it tests two or three different concepts on separate questions having the same clinical vignette.&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible mw-collapsed&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Step 1 Question Format==  &lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible-content&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
* Test the basic principles using calculations, clinical scenarios, and multimedia.&lt;br /&gt;
===Case Scenarios===&lt;br /&gt;
* Age&lt;br /&gt;
* Gender&lt;br /&gt;
* Past history and medications if remarkable&lt;br /&gt;
* Chief complaints and assoicated symptoms&lt;br /&gt;
* Vital signs and pertinent physical findings&lt;br /&gt;
* Laboratory results&lt;br /&gt;
* Heart or lung auscultation audios&lt;br /&gt;
* Electrocardiography if relevant&lt;br /&gt;
* Pathologic or radiographic images&lt;br /&gt;
===Commonly Asked Questions===&lt;br /&gt;
* A deficiency of which of the following enzyme activities is the most likely cause of the findings in this patient?&lt;br /&gt;
* A mutation in which of the following genes is the most likely cause of the findings in this patient?&lt;br /&gt;
* A mutation is most likely to be found in which of the following genes?&lt;br /&gt;
* Inheritance of mutant alleles most likely caused impairment of which of the following enzyme activities in this patient?&lt;br /&gt;
* Pathologic examination is most likely to disclose an abnormality involving which of the following?&lt;br /&gt;
* Synthesis of which of the following substances is most likely to be inhibited as a result of this therapy?&lt;br /&gt;
* The causal organism is most likely transmitted by which of the following routes?&lt;br /&gt;
* The most appropriate next step in management is administration of which of the following?&lt;br /&gt;
* The most likely cause of these findings is a deficiency of which of the following nutrients?&lt;br /&gt;
* The morphologic changes most likely indicate which of the following processes?&lt;br /&gt;
* This patient most likely has which of the following conditions?&lt;br /&gt;
* This patient is at increased risk for developing which of the following as a result of this therapy?&lt;br /&gt;
* This patient is most likely receiving treatment with which of the following drugs?&lt;br /&gt;
* This patient is most likely to develop which of the following adverse effects?&lt;br /&gt;
* This patient is most likely to have a deficit of which of the following?&lt;br /&gt;
* This patient most likely had a recent history of which of the following?&lt;br /&gt;
* This patient should be monitored for which of the following adverse effects?&lt;br /&gt;
* To prevent further damage, which of the following is the most appropriate recommendation?&lt;br /&gt;
* Which of the following abnormalities is the most likely cause of these findings?&lt;br /&gt;
* Which of the following best explains these findings?&lt;br /&gt;
* Which of the following defense mechanisms best explains this patient’s behavior?&lt;br /&gt;
* Which of the following best explains this behavior?&lt;br /&gt;
* Which of the following findings is most likely?&lt;br /&gt;
* Which of the following graphs shown best corresponds to these results?&lt;br /&gt;
* Which of the following is the most likely causal organism?&lt;br /&gt;
* Which of the following is the most likely cause of death in this patient?&lt;br /&gt;
* Which of the following is the most likely cause of this patient&#039;s condition?&lt;br /&gt;
* Which of the following is the most likely cause of this patient&#039;s current condition?&lt;br /&gt;
* Which of the following is the most likely diagnosis?&lt;br /&gt;
* Which of the following is the most likely mechanism of action causing these adverse effects?&lt;br /&gt;
* Which of the following is the most appropriate initial treatment for this patient?&lt;br /&gt;
* Which of the following is the most appropriate next step in management?&lt;br /&gt;
* Which of the following is the most appropriate pharmacotherapy?&lt;br /&gt;
* Which of the following is the most appropriate response by the physician?&lt;br /&gt;
* Which of the following labeled areas is most likely damaged?&lt;br /&gt;
* Which of the following mechanisms best explains this cytogenetic abnormality?&lt;br /&gt;
* Which of the following pathologic findings is most likely seen in a biopsy specimen in this patient?&lt;br /&gt;
* Which of the following processes best describes these findings?&lt;br /&gt;
* Which of the following processes is most likely to occur in this patient as a result of the disease?&lt;br /&gt;
* Which of the following sets of changes most likely occurred following the infusion of drug X?&lt;br /&gt;
* Which of the following sets of laboratory findings is most likely in this patient?&lt;br /&gt;
* Which of the following sets of physiologic changes is most likely following administration of the drug?&lt;br /&gt;
* Which of the following treatments is most appropriate at this time?&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible mw-collapsed&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==USMLE Step 2 CK Question Format==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible-content&amp;quot;&amp;gt;&lt;br /&gt;
* Follow the most recent Algorithms/Guidelines from WikiDoc&lt;br /&gt;
* Useful resources are the books: Master the Boards and First Aid for Step 2 CK&lt;br /&gt;
* Include basic STEP 1 questions; 50-60% of the knowledge from Step 2CK comes from Step 1&lt;br /&gt;
* Include labs&lt;br /&gt;
* Make long stems&lt;br /&gt;
* Accommodate information within the vignette that will benefit the test taker to identify the proper answer choice&lt;br /&gt;
* Include extra information that is not necessary leading towards the correct answer (distractors)&lt;br /&gt;
* Audio and video questions would be ideal also&lt;br /&gt;
===Case Scenarios===&lt;br /&gt;
* Age of patient&lt;br /&gt;
* Sex&lt;br /&gt;
* Past history if remarkable&lt;br /&gt;
* Chief complaint&lt;br /&gt;
* Vitals&lt;br /&gt;
* Describe the chief complaint&lt;br /&gt;
* Physical examination findings&lt;br /&gt;
* Laboratory findings&lt;br /&gt;
* Image or video (if applicable)&lt;br /&gt;
===Commonly Asked Questions===&lt;br /&gt;
* What is the most likely diagnosis?&lt;br /&gt;
* What is the most likely cause for this condition?&lt;br /&gt;
* What is the next best step in management?&lt;br /&gt;
* What is the best initial treatment?&lt;br /&gt;
* What is the best treatment for this condition?&lt;br /&gt;
* What is the best/ most accurate laboratory test to confirm diagnosis?&lt;br /&gt;
* What is the drug of choice to treat this condition?&lt;br /&gt;
* What is the most likely physical exam finding? (eg. On auscultation, abdominal examination, etc.)&lt;br /&gt;
* Which of the following is the most likely underlying mechanism?&lt;br /&gt;
* What is the most common risk factor for this condition?&lt;br /&gt;
* What is the most common complication of this condition?&lt;br /&gt;
* What is the best drug/ drug of choice used to treat this condition?&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible mw-collapsed&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==USMLE Step 3 Question Format==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible-content&amp;quot;&amp;gt;&lt;br /&gt;
Testing mainly on management of case, covering the following fields:&lt;br /&gt;
===Application of Concepts===&lt;br /&gt;
* What is the most likely cause for this condition?&lt;br /&gt;
* What is the most likely underlying mechanism?&lt;br /&gt;
* What is the cause of (sign/ physical exam finding)?&lt;br /&gt;
* Questions related to research studies&lt;br /&gt;
===History and Physical Examination===&lt;br /&gt;
* What is the most likely physical exam finding?&lt;br /&gt;
* What facts from the past history are important for diagnosis?&lt;br /&gt;
* What is the most common risk factor for this condition?&lt;br /&gt;
===Laboratory and Diagnostic Studies===&lt;br /&gt;
* What is the most appropriate/accurate laboratory test to evaluate this patient?&lt;br /&gt;
* What is the most appropriate laboratory test to evaluate the efficacy of current treatment?&lt;br /&gt;
* What is the best initial laboratory test to order?&lt;br /&gt;
* What is the most likely result of this laboratory test seen in this condition?&lt;br /&gt;
* What is the most likely laboratory finding seen in this condition?&lt;br /&gt;
===Diagnosis===&lt;br /&gt;
* What is the most likely diagnosis?&lt;br /&gt;
* Which condition is most commonly associated with ____?&lt;br /&gt;
===Prognosis===&lt;br /&gt;
* Which of the following factors influences prognosis (good or bad)?&lt;br /&gt;
* Which of the following is the best/ worst prognostic indicator?&lt;br /&gt;
* Which of the following laboratory finding indicates best/ worst prognosis?&lt;br /&gt;
* After follow-up, which of the following is the most common factor that indicates favorable prognosis?&lt;br /&gt;
* What is the most appropriate counseling advice?&lt;br /&gt;
* What is the most common complication of this condition?&lt;br /&gt;
* What is the most likely outcome of this condition?&lt;br /&gt;
===Management===&lt;br /&gt;
* What is the next best step in management of this patient?&lt;br /&gt;
* What is the most appropriate screening test?&lt;br /&gt;
* What is the most appropriate preventive measure for this condition?&lt;br /&gt;
* What is the best initial treatment?&lt;br /&gt;
* What is the most accurate treatment?What is the best drug/ drug of choice used to treat this condition?&lt;br /&gt;
* What is the most appropriate discharge plan?&lt;br /&gt;
* Which drug is contraindicated in the treatment of this condition?&lt;br /&gt;
* Which of the following is a contraindication for the use of this drug?&lt;br /&gt;
* What is the most likely adverse effect of this drug?&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Ethics and Principles===&lt;br /&gt;
Wikidoc has strict rules and regulations against plagiarism. Those rules must be followed. Participants for the board review questions project will have to follow the highest standards of ethics and conduct when writing a question.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible mw-collapsed&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Resources==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible-content&amp;quot;&amp;gt;&lt;br /&gt;
===WikiDoc Links===&lt;br /&gt;
* [[MCAT]]&lt;br /&gt;
* [[USMLE Step 1]]&lt;br /&gt;
* [[USMLE Step 2-CK]]&lt;br /&gt;
* [[USMLE Step 2 Clinical Skills]]&lt;br /&gt;
* [[Step 2 CS study guide]]&lt;br /&gt;
* [[USMLE Step 3]]&lt;br /&gt;
*  [[Copyleft sources]]&lt;br /&gt;
* [[How to upload USMLE II Images]]&lt;br /&gt;
* [[COMLEX-USA]]&lt;br /&gt;
&lt;br /&gt;
===External Resources===&lt;br /&gt;
* http://www.usmle.org/pdfs/step-1/2013content_step1.pdf&lt;br /&gt;
* http://www.usmle.org/pdfs/step-2-ck/2012--13_FINAL_S2_GSI.pdf&lt;br /&gt;
* http://www.usmle.org/pdfs/step-3/2013content_step3.pdf&lt;br /&gt;
* http://www.nbme.org/&lt;br /&gt;
* http://www.nbome.org/&lt;br /&gt;
* http://www.ecfmg.org/&lt;br /&gt;
* http://www.osteopathic.org/Pages/default.aspx&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Help]]&lt;br /&gt;
[[Category:Projects]]&lt;br /&gt;
&lt;br /&gt;
{{WH}}&lt;br /&gt;
{{WS}}&lt;/div&gt;</summary>
		<author><name>Gonzalo Romero</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=How_to_create_a_board_review_question&amp;diff=937651</id>
		<title>How to create a board review question</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=How_to_create_a_board_review_question&amp;diff=937651"/>
		<updated>2014-02-03T20:19:18Z</updated>

		<summary type="html">&lt;p&gt;Gonzalo Romero: /* Links */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Board review project}}&lt;br /&gt;
[[Image:Main_help_page_small.PNG|100px|link=Help]][[Image:Projects.PNG|100px|link=Projects]][[Image:Editor&#039;s_Tools.PNG|100px|link=Help Menu]]&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible mw-collapsed&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==How to Build a Question==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible-content&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
# Read and understand the tested material to grasp basic principles, diagnostic approach, management and therapeutics according to the BOARD level.&lt;br /&gt;
# Get familiar with the format, content and high Yield material. Take many exams using Q-banks, the NBME website [[http://www.nbme.org/]] and the actual exam, when ready!.  Respect Copy Rights sources from Q-banks.&lt;br /&gt;
# Select a specific content&lt;br /&gt;
# Use WikiDoc to obtain information, pictures, videos, and links on the explanations.&lt;br /&gt;
#  hallenge the test taker: do not give away the correct answer.  Avoid using proper or specific signs. Describe signs and symptoms in lay terms to give the hints. Example:  instead of “marfanoid appearance”, describe the patient with long extremities, skinny appearance and tall.&lt;br /&gt;
# Do not ask negatively i.e. &amp;quot;which of the following is incorrect, not correct or false?&amp;quot;.&lt;br /&gt;
# Long stems help recreate the challenge on test date. Short and moderate stems test specific facts.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible mw-collapsed&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Multi-step or Jump Question==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible-content&amp;quot;&amp;gt;&lt;br /&gt;
Include 2 or 3 Jump questions in order to test the medical thinking process, not just the content.  Follow these steps:&lt;br /&gt;
# Select one box with a specific topic (i.e. clinical presentation) from the diagram shown below.  Use facts such as:  the clinical presentation (symptoms and signs), the physical exam findings, specific test findings (i.e. labs, imaging, biopsy), the definitive diagnosis, the treatment of choice, its mechanism of action and the most common adverse effect associated with that medication.&lt;br /&gt;
# Describe the first box (i.e. typical clinical presentation) in the question stem.&lt;br /&gt;
# Ask a specific fact about another box (i.e. what is the mechanism of action of the treatment of choice?).  If possible, revert the order and add extra steps.&lt;br /&gt;
# &#039;&#039;&#039;You just created a jump question!&#039;&#039;&#039;&lt;br /&gt;
[[Image:WBRJumpQuestions.png|800px|center]]&lt;br /&gt;
===Example===&lt;br /&gt;
Microbiology questions require the reader to make the diagnosis, identify the treatment of choice and to know the mechanism of action (3 steps). &lt;br /&gt;
An equally difficult but less elegant question could ask what HLA-subtype is associated with a rheumatological disease.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible mw-collapsed&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Steps to Upload a Question==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible-content&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
# Go to the home page on WikiDoc, and click on the icon that says, &amp;quot;Board Review&amp;quot;, or click [[Board Review|here]].&lt;br /&gt;
# Click on the big green icon that says &amp;quot;add a board review question&amp;quot;.&lt;br /&gt;
# Type in your name in the Author Box.&lt;br /&gt;
# Select the Exam Type.&lt;br /&gt;
# Categories for the question will appear; check off ONE main category, and the appropriate subcategory.&lt;br /&gt;
# Introduce an Overall Explanation into the Box focusing on the correct answer choice.&lt;br /&gt;
# Use the remaining boxes to type in the answers to the questions and each answer choice explanation.&lt;br /&gt;
# You can add an image, if possible.&lt;br /&gt;
# Click save page if you&#039;re done, or show preview if you like to see how your question will look like.&lt;br /&gt;
# Make sure you click save page before you move on!&lt;br /&gt;
# Self quality check your work using the [[WBR quality checklist]]&lt;br /&gt;
# Contact via email the WBR Editors in Chief and WBR Team Members to review your question&lt;br /&gt;
# &#039;&#039;&#039;CONGRATULATIONS! You just created a high quality WBR Question!&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible mw-collapsed&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Question Design==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible-content&amp;quot;&amp;gt;&lt;br /&gt;
===Question Stem===&lt;br /&gt;
*The questions are preferred to be narrated as a clinical vignette, which is not an actual case. &lt;br /&gt;
*The information and illustrations should be the testing point&lt;br /&gt;
*Below are some of the key points that can be found in a question. They should be orderly included as follows:&lt;br /&gt;
**Age, Gender (e.g., a 70 year-old man)&lt;br /&gt;
**Site of Care (e.g., comes to the emergency department)&lt;br /&gt;
**Duration (e.g. that has started one week ago)&lt;br /&gt;
**Significant patient history&lt;br /&gt;
**Significant family history&lt;br /&gt;
**Significant diagnostic studies or the results of diagnostic studies &lt;br /&gt;
***Try as much as possible to include images whether still or motion&lt;br /&gt;
**Initial treatment and response&lt;br /&gt;
* The questions should not include negative phrasing, such as “except” or “not”&lt;br /&gt;
&lt;br /&gt;
===Answer Choices===&lt;br /&gt;
* Answers should include five choices,  with one correct answer and the remaining answers are distractors. &lt;br /&gt;
* Answers should not be &amp;quot;true&amp;quot; or &amp;quot;false&amp;quot;.&lt;br /&gt;
* All distractors should be homogeneous, as they should fall in the same category as the correct answer and should be similar in length. &lt;br /&gt;
* Long correct answers are discouraged.&lt;br /&gt;
* Illogical answers, absolute terms, word repeats (for example: a word or phrase in the correct answer choice, is the same as in the stem) are discouraged.&lt;br /&gt;
* “None of the above”, “All of the above” or some combination of response must not be used.&lt;br /&gt;
===Answer Explanations===&lt;br /&gt;
* These questions are intended to teach using sources such as:  graphics, references and guidelines if applicable.&lt;br /&gt;
====Overall Explanation====&lt;br /&gt;
* Only ONE answer is the best or the most appropriate one&lt;br /&gt;
* Justify why that choice is correct:  explain the pertinent positive findings, not just list the tested subject. (i.e.  the patient has this symptom which is a typical presentation of this disease). Explain also the pertinent negatives.&lt;br /&gt;
&lt;br /&gt;
* &#039;&#039;&#039;Educational Objectives:&#039;&#039;&#039;  include short high yield facts (1 or 2 take-home sentences/phrases).&lt;br /&gt;
====Answer Choice Explanation====&lt;br /&gt;
* Include why the correct answer is correct and why each of the distractors are incorrect.&lt;br /&gt;
* Include concise, yet thorough explanation providing a high yield information.&lt;br /&gt;
* Add additional information to the correct answer explanation, not explained on the overall explanation.&lt;br /&gt;
&lt;br /&gt;
===References===&lt;br /&gt;
References should be included, if possible, linking to new articles, review articles or guidelines that serve the initial teaching goal of the questions.&lt;br /&gt;
&lt;br /&gt;
==Resources==&lt;br /&gt;
===Internal Resources===&lt;br /&gt;
*Use WikiDoc content&lt;br /&gt;
*Promote WikiDoc use inserting internal links into the explanations&lt;br /&gt;
===External Resources===&lt;br /&gt;
Mention external sources used respecting Copy Rights.&lt;br /&gt;
*Books:&lt;br /&gt;
**First Aid for STEP 1 2014 (latest edition), by Tao Le and Vikas-Bhushan, updated yearly by students who aced the exam and by faculty physicians&lt;br /&gt;
**First Aid for Step 2 CK, eight edition, by Tao Le and Vikas-Bhushan. updated biyearly&lt;br /&gt;
**Med-Essentials For Step 1: High Yield Review, the fourth edition, by Kaplan Medical&lt;br /&gt;
**Master the Boards for Step 2 CK, the second edition, by Dr. Conrad Fischer&lt;br /&gt;
**Master the Boards for Step 3, the second edition, by Dr. Conrad Fischer&lt;br /&gt;
*Forums:&lt;br /&gt;
** [http://www.usmle-forums.com www.usmle-forums.com],  recent test takers give feedback about their experience and commonly tested facts, updated constantly&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Matching Sets===&lt;br /&gt;
The format remains the same as above, but it tests two or three different concepts on separate questions having the same clinical vignette.&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible mw-collapsed&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==USMLE Step 1 Question Format==  &lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible-content&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
* Test the basic principles using calculations, clinical scenarios, and multimedia.&lt;br /&gt;
===Case Scenarios===&lt;br /&gt;
* Age&lt;br /&gt;
* Gender&lt;br /&gt;
* Past history and medications if remarkable&lt;br /&gt;
* Chief complaints and assoicated symptoms&lt;br /&gt;
* Vital signs and pertinent physical findings&lt;br /&gt;
* Laboratory results&lt;br /&gt;
* Heart or lung auscultation audios&lt;br /&gt;
* Electrocardiography if relevant&lt;br /&gt;
* Pathologic or radiographic images&lt;br /&gt;
===Commonly Asked Questions===&lt;br /&gt;
* A deficiency of which of the following enzyme activities is the most likely cause of the findings in this patient?&lt;br /&gt;
* A mutation in which of the following genes is the most likely cause of the findings in this patient?&lt;br /&gt;
* A mutation is most likely to be found in which of the following genes?&lt;br /&gt;
* Inheritance of mutant alleles most likely caused impairment of which of the following enzyme activities in this patient?&lt;br /&gt;
* Pathologic examination is most likely to disclose an abnormality involving which of the following?&lt;br /&gt;
* Synthesis of which of the following substances is most likely to be inhibited as a result of this therapy?&lt;br /&gt;
* The causal organism is most likely transmitted by which of the following routes?&lt;br /&gt;
* The most appropriate next step in management is administration of which of the following?&lt;br /&gt;
* The most likely cause of these findings is a deficiency of which of the following nutrients?&lt;br /&gt;
* The morphologic changes most likely indicate which of the following processes?&lt;br /&gt;
* This patient most likely has which of the following conditions?&lt;br /&gt;
* This patient is at increased risk for developing which of the following as a result of this therapy?&lt;br /&gt;
* This patient is most likely receiving treatment with which of the following drugs?&lt;br /&gt;
* This patient is most likely to develop which of the following adverse effects?&lt;br /&gt;
* This patient is most likely to have a deficit of which of the following?&lt;br /&gt;
* This patient most likely had a recent history of which of the following?&lt;br /&gt;
* This patient should be monitored for which of the following adverse effects?&lt;br /&gt;
* To prevent further damage, which of the following is the most appropriate recommendation?&lt;br /&gt;
* Which of the following abnormalities is the most likely cause of these findings?&lt;br /&gt;
* Which of the following best explains these findings?&lt;br /&gt;
* Which of the following defense mechanisms best explains this patient’s behavior?&lt;br /&gt;
* Which of the following best explains this behavior?&lt;br /&gt;
* Which of the following findings is most likely?&lt;br /&gt;
* Which of the following graphs shown best corresponds to these results?&lt;br /&gt;
* Which of the following is the most likely causal organism?&lt;br /&gt;
* Which of the following is the most likely cause of death in this patient?&lt;br /&gt;
* Which of the following is the most likely cause of this patient&#039;s condition?&lt;br /&gt;
* Which of the following is the most likely cause of this patient&#039;s current condition?&lt;br /&gt;
* Which of the following is the most likely diagnosis?&lt;br /&gt;
* Which of the following is the most likely mechanism of action causing these adverse effects?&lt;br /&gt;
* Which of the following is the most appropriate initial treatment for this patient?&lt;br /&gt;
* Which of the following is the most appropriate next step in management?&lt;br /&gt;
* Which of the following is the most appropriate pharmacotherapy?&lt;br /&gt;
* Which of the following is the most appropriate response by the physician?&lt;br /&gt;
* Which of the following labeled areas is most likely damaged?&lt;br /&gt;
* Which of the following mechanisms best explains this cytogenetic abnormality?&lt;br /&gt;
* Which of the following pathologic findings is most likely seen in a biopsy specimen in this patient?&lt;br /&gt;
* Which of the following processes best describes these findings?&lt;br /&gt;
* Which of the following processes is most likely to occur in this patient as a result of the disease?&lt;br /&gt;
* Which of the following sets of changes most likely occurred following the infusion of drug X?&lt;br /&gt;
* Which of the following sets of laboratory findings is most likely in this patient?&lt;br /&gt;
* Which of the following sets of physiologic changes is most likely following administration of the drug?&lt;br /&gt;
* Which of the following treatments is most appropriate at this time?&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible mw-collapsed&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==USMLE Step 2 CK Question Format==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible-content&amp;quot;&amp;gt;&lt;br /&gt;
* Follow the most recent Algorithms/Guidelines from WikiDoc&lt;br /&gt;
* Useful resources are the books: Master the Boards and First Aid for Step 2 CK&lt;br /&gt;
* Include basic STEP 1 questions; 50-60% of the knowledge from Step 2CK comes from Step 1&lt;br /&gt;
* Include labs&lt;br /&gt;
* Make long stems&lt;br /&gt;
* Accommodate information within the vignette that will benefit the test taker to identify the proper answer choice&lt;br /&gt;
* Include extra information that is not necessary leading towards the correct answer (distractors)&lt;br /&gt;
* Audio and video questions would be ideal also&lt;br /&gt;
===Case Scenarios===&lt;br /&gt;
* Age of patient&lt;br /&gt;
* Sex&lt;br /&gt;
* Past history if remarkable&lt;br /&gt;
* Chief complaint&lt;br /&gt;
* Vitals&lt;br /&gt;
* Describe the chief complaint&lt;br /&gt;
* Physical examination findings&lt;br /&gt;
* Laboratory findings&lt;br /&gt;
* Image or video (if applicable)&lt;br /&gt;
===Commonly Asked Questions===&lt;br /&gt;
* What is the most likely diagnosis?&lt;br /&gt;
* What is the most likely cause for this condition?&lt;br /&gt;
* What is the next best step in management?&lt;br /&gt;
* What is the best initial treatment?&lt;br /&gt;
* What is the best treatment for this condition?&lt;br /&gt;
* What is the best/ most accurate laboratory test to confirm diagnosis?&lt;br /&gt;
* What is the drug of choice to treat this condition?&lt;br /&gt;
* What is the most likely physical exam finding? (eg. On auscultation, abdominal examination, etc.)&lt;br /&gt;
* Which of the following is the most likely underlying mechanism?&lt;br /&gt;
* What is the most common risk factor for this condition?&lt;br /&gt;
* What is the most common complication of this condition?&lt;br /&gt;
* What is the best drug/ drug of choice used to treat this condition?&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible mw-collapsed&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==USMLE Step 3 Question Format==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible-content&amp;quot;&amp;gt;&lt;br /&gt;
Testing mainly on management of case, covering the following fields:&lt;br /&gt;
===Application of Concepts===&lt;br /&gt;
* What is the most likely cause for this condition?&lt;br /&gt;
* What is the most likely underlying mechanism?&lt;br /&gt;
* What is the cause of (sign/ physical exam finding)?&lt;br /&gt;
* Questions related to research studies&lt;br /&gt;
===History and Physical Examination===&lt;br /&gt;
* What is the most likely physical exam finding?&lt;br /&gt;
* What facts from the past history are important for diagnosis?&lt;br /&gt;
* What is the most common risk factor for this condition?&lt;br /&gt;
===Laboratory and Diagnostic Studies===&lt;br /&gt;
* What is the most appropriate/accurate laboratory test to evaluate this patient?&lt;br /&gt;
* What is the most appropriate laboratory test to evaluate the efficacy of current treatment?&lt;br /&gt;
* What is the best initial laboratory test to order?&lt;br /&gt;
* What is the most likely result of this laboratory test seen in this condition?&lt;br /&gt;
* What is the most likely laboratory finding seen in this condition?&lt;br /&gt;
===Diagnosis===&lt;br /&gt;
* What is the most likely diagnosis?&lt;br /&gt;
* Which condition is most commonly associated with ____?&lt;br /&gt;
===Prognosis===&lt;br /&gt;
* Which of the following factors influences prognosis (good or bad)?&lt;br /&gt;
* Which of the following is the best/ worst prognostic indicator?&lt;br /&gt;
* Which of the following laboratory finding indicates best/ worst prognosis?&lt;br /&gt;
* After follow-up, which of the following is the most common factor that indicates favorable prognosis?&lt;br /&gt;
* What is the most appropriate counseling advice?&lt;br /&gt;
* What is the most common complication of this condition?&lt;br /&gt;
* What is the most likely outcome of this condition?&lt;br /&gt;
===Management===&lt;br /&gt;
* What is the next best step in management of this patient?&lt;br /&gt;
* What is the most appropriate screening test?&lt;br /&gt;
* What is the most appropriate preventive measure for this condition?&lt;br /&gt;
* What is the best initial treatment?&lt;br /&gt;
* What is the most accurate treatment?What is the best drug/ drug of choice used to treat this condition?&lt;br /&gt;
* What is the most appropriate discharge plan?&lt;br /&gt;
* Which drug is contraindicated in the treatment of this condition?&lt;br /&gt;
* Which of the following is a contraindication for the use of this drug?&lt;br /&gt;
* What is the most likely adverse effect of this drug?&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Ethics and Principles===&lt;br /&gt;
Wikidoc has strict rules and regulations against plagiarism. Those rules must be followed. Participants for the board review questions project will have to follow the highest standards of ethics and conduct when writing a question.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible mw-collapsed&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Resources==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible-content&amp;quot;&amp;gt;&lt;br /&gt;
===WikiDoc Links===&lt;br /&gt;
* [[MCAT]]&lt;br /&gt;
* [[USMLE Step 1]]&lt;br /&gt;
* [[USMLE Step 2-CK]]&lt;br /&gt;
* [[USMLE Step 2 Clinical Skills]]&lt;br /&gt;
* [[Step 2 CS study guide]]&lt;br /&gt;
* [[USMLE Step 3]]&lt;br /&gt;
*  [[Copyleft sources]]&lt;br /&gt;
* [[How to upload USMLE II Images]]&lt;br /&gt;
* [[COMLEX-USA]]&lt;br /&gt;
&lt;br /&gt;
===External Resources===&lt;br /&gt;
* http://www.usmle.org/pdfs/step-1/2013content_step1.pdf&lt;br /&gt;
* http://www.usmle.org/pdfs/step-2-ck/2012--13_FINAL_S2_GSI.pdf&lt;br /&gt;
* http://www.usmle.org/pdfs/step-3/2013content_step3.pdf&lt;br /&gt;
* http://www.nbme.org/&lt;br /&gt;
* http://www.nbome.org/&lt;br /&gt;
* http://www.ecfmg.org/&lt;br /&gt;
* http://www.osteopathic.org/Pages/default.aspx&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Help]]&lt;br /&gt;
[[Category:Projects]]&lt;br /&gt;
&lt;br /&gt;
{{WH}}&lt;br /&gt;
{{WS}}&lt;/div&gt;</summary>
		<author><name>Gonzalo Romero</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=WBR_high_yield&amp;diff=937582</id>
		<title>WBR high yield</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=WBR_high_yield&amp;diff=937582"/>
		<updated>2014-02-03T19:51:47Z</updated>

		<summary type="html">&lt;p&gt;Gonzalo Romero: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Board review project}}&lt;br /&gt;
[[Image:Main_help_page_small.PNG|100px|link=Help]][[Image:Projects.PNG|100px|link=Projects]][[Image:Editor&#039;s_Tools.PNG|100px|link=Help Menu]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Editor-In-Chief:&#039;&#039;&#039; [[User:William J Gibson|Will Gibson]];  {{AE}}  [[User:Gonzalo Romero|Gonzalo A. Romero, M.D.]][mailto:gromero@wikidoc.org];{{Rim}};[[User:Sergekorjian|Serge Korjian]]; [[User:YazanDaaboul|Yazan Daaboul]]; {{VR}}; {{M.P}}; {{AO}}; {{MS}};&lt;br /&gt;
&lt;br /&gt;
==WBR High Yield Facts==&lt;br /&gt;
The &#039;&#039;&#039;WikiBoard Review Team&#039;&#039;&#039; would like to share &amp;lt;u&amp;gt;high yield&amp;lt;/u&amp;gt; or commonly tested facts for the USMLE Board Examinations.  The aim of these notes is to provide a quick review prior to taking the test. We are here to provide support while you prepare for the boards. &lt;br /&gt;
&lt;br /&gt;
Should you have any suggestions on High Yield content, send us an email to &#039;&#039;&#039;[mailto:willjgibson@gmail.com willjgibson@gmail.com]&#039;&#039;&#039;; we would be happy to hear your feedback to include in our WBR High Yield List!&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible mw-collapsed&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Step 1==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible-content&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible mw-collapsed&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
* Clinical Cases&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible-content&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
:* Anatomy&lt;br /&gt;
:* Biochemistry&lt;br /&gt;
:* Physiology&lt;br /&gt;
:* Microbiology&lt;br /&gt;
:* Immunology&lt;br /&gt;
:* Pharmacology&lt;br /&gt;
:* Pathology&lt;br /&gt;
:* Behavioral science&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;&lt;br /&gt;
&lt;br /&gt;
* Tests Results&lt;br /&gt;
* Syndromes&lt;br /&gt;
* Formulas&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible mw-collapsed&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Step 2 CK==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible-content&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
* Internal medicine&lt;br /&gt;
* Pediatrics&lt;br /&gt;
* Obstetrics and gynecology&lt;br /&gt;
* Behavioral science&lt;br /&gt;
* Psychiatry&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible mw-collapsed&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Step 3==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible-content&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
* Internal medicine&lt;br /&gt;
* Pediatrics&lt;br /&gt;
* Obstetrics and gynecology&lt;br /&gt;
* Behavioral science&lt;br /&gt;
* Psychiatry&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;&lt;/div&gt;</summary>
		<author><name>Gonzalo Romero</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=WBR_high_yield&amp;diff=937573</id>
		<title>WBR high yield</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=WBR_high_yield&amp;diff=937573"/>
		<updated>2014-02-03T19:46:22Z</updated>

		<summary type="html">&lt;p&gt;Gonzalo Romero: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Board review project}}&lt;br /&gt;
[[Image:Main_help_page_small.PNG|100px|link=Help]][[Image:Projects.PNG|100px|link=Projects]][[Image:Editor&#039;s_Tools.PNG|100px|link=Help Menu]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Editor-In-Chief:&#039;&#039;&#039; [[User:William J Gibson|Will Gibson]];  {{AE}}  [[User:Gonzalo Romero|Gonzalo A. Romero, M.D.]][mailto:gromero@wikidoc.org];{{Rim}};[[User:Sergekorjian|Serge Korjian]]; [[User:YazanDaaboul|Yazan Daaboul]]; {{VR}}; {{M.P}}; {{AO}}; {{MS}};&lt;br /&gt;
&lt;br /&gt;
==WBR High Yield Facts==&lt;br /&gt;
The &#039;&#039;&#039;WikiBoard Review Team&#039;&#039;&#039; would like to share &amp;lt;u&amp;gt;high yield&amp;lt;/u&amp;gt; or commonly tested facts for the USMLE Board Examinations.  The aim of these notes is to provide a quick review prior to taking the test. We are here to provide support while you prepare for the boards. &lt;br /&gt;
&lt;br /&gt;
Should you have any suggestions on High Yield content, send us an email to &#039;&#039;&#039;[mailto:willjgibson@gmail.com willjgibson@gmail.com]&#039;&#039;&#039;; we would be happy to hear your feedback to include in our WBR High Yield List!&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible mw-collapsed&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Step 1==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible-content&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible mw-collapsed&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
* Clinical Cases&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible-content&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
:* A&lt;br /&gt;
:* B&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;&lt;br /&gt;
&lt;br /&gt;
* Tests Results&lt;br /&gt;
* Syndromes&lt;br /&gt;
* Formulas&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible mw-collapsed&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Step 2 CK==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible-content&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
* Divisions&lt;br /&gt;
* Sub-Divisions&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible mw-collapsed&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Step 3==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible-content&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
* Divisions&lt;br /&gt;
* Sub-Divisions&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;&lt;/div&gt;</summary>
		<author><name>Gonzalo Romero</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=WBR_high_yield&amp;diff=937570</id>
		<title>WBR high yield</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=WBR_high_yield&amp;diff=937570"/>
		<updated>2014-02-03T19:44:03Z</updated>

		<summary type="html">&lt;p&gt;Gonzalo Romero: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Board review project}}&lt;br /&gt;
[[Image:Main_help_page_small.PNG|100px|link=Help]][[Image:Projects.PNG|100px|link=Projects]][[Image:Editor&#039;s_Tools.PNG|100px|link=Help Menu]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Editor-In-Chief:&#039;&#039;&#039; [[User:William J Gibson|Will Gibson]];  {{AE}}  [[User:Gonzalo Romero|Gonzalo A. Romero, M.D.]][mailto:gromero@wikidoc.org];{{Rim}};[[User:Sergekorjian|Serge Korjian]]; [[User:YazanDaaboul|Yazan Daaboul]]; {{VR}}; {{M.P}}; {{AO}}; {{MS}};&lt;br /&gt;
&lt;br /&gt;
==WBR High Yield Facts==&lt;br /&gt;
The &#039;&#039;&#039;WikiBoard Review Team&#039;&#039;&#039; would like to share &amp;lt;u&amp;gt;high yield&amp;lt;/u&amp;gt; or commonly tested facts for the USMLE Board Examinations.  The aim of these notes is to provide a quick review prior to taking the test. We are here to provide support while you prepare for the boards. &lt;br /&gt;
&lt;br /&gt;
Should you have any suggestions on High Yield content, send us an email to &#039;&#039;&#039;[mailto:willjgibson@gmail.com willjgibson@gmail.com]&#039;&#039;&#039;; we would be happy to hear your feedback to include in our WBR High Yield List!&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible mw-collapsed&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Step 1==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible-content&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible mw-collapsed&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
* Clinical Cases&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible-content&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
:* A&lt;br /&gt;
:* B&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;&lt;br /&gt;
&lt;br /&gt;
* Tests Results&lt;br /&gt;
* Syndromes&lt;br /&gt;
* Formulas&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Step 2 CK==&lt;br /&gt;
* Divisions&lt;br /&gt;
* Sub-Divisions&lt;br /&gt;
&lt;br /&gt;
==Step 3==&lt;br /&gt;
* Divisions&lt;br /&gt;
* Sub-Divisions&lt;/div&gt;</summary>
		<author><name>Gonzalo Romero</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=WBR_high_yield&amp;diff=937562</id>
		<title>WBR high yield</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=WBR_high_yield&amp;diff=937562"/>
		<updated>2014-02-03T19:36:51Z</updated>

		<summary type="html">&lt;p&gt;Gonzalo Romero: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Board review project}}&lt;br /&gt;
[[Image:Main_help_page_small.PNG|100px|link=Help]][[Image:Projects.PNG|100px|link=Projects]][[Image:Editor&#039;s_Tools.PNG|100px|link=Help Menu]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Editor-In-Chief:&#039;&#039;&#039; [[User:William J Gibson|Will Gibson]];  {{AE}}  [[User:Gonzalo Romero|Gonzalo A. Romero, M.D.]][mailto:gromero@wikidoc.org];{{Rim}};[[User:Sergekorjian|Serge Korjian]]; [[User:YazanDaaboul|Yazan Daaboul]]; {{VR}}; {{M.P}}; {{AO}}; {{MS}};&lt;br /&gt;
&lt;br /&gt;
==WBR High Yield Facts==&lt;br /&gt;
The &#039;&#039;&#039;WikiBoard Review Team&#039;&#039;&#039; would like to share &amp;lt;u&amp;gt;high yield&amp;lt;/u&amp;gt; or commonly tested facts for the USMLE Board Examinations.  The aim of these notes is to provide a quick review prior to taking the test. We are here to provide support while you prepare for the boards. &lt;br /&gt;
&lt;br /&gt;
Should you have any suggestions on High Yield content, send us an email to &#039;&#039;&#039;[mailto:willjgibson@gmail.com willjgibson@gmail.com]&#039;&#039;&#039;; we would be happy to hear your feedback to include in our WBR High Yield List!&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible mw-collapsed&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Step 1==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible-content&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
* Clinical Cases&lt;br /&gt;
* Tests Results&lt;br /&gt;
* Syndromes&lt;br /&gt;
* Formulas&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Step 2 CK==&lt;br /&gt;
* Divisions&lt;br /&gt;
* Sub-Divisions&lt;br /&gt;
&lt;br /&gt;
==Step 3==&lt;br /&gt;
* Divisions&lt;br /&gt;
* Sub-Divisions&lt;/div&gt;</summary>
		<author><name>Gonzalo Romero</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=Medical_Mnemonics_for_Examinations&amp;diff=936897</id>
		<title>Medical Mnemonics for Examinations</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=Medical_Mnemonics_for_Examinations&amp;diff=936897"/>
		<updated>2014-02-01T00:18:21Z</updated>

		<summary type="html">&lt;p&gt;Gonzalo Romero: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font color=&amp;quot;Navy&amp;quot;&amp;gt;&#039;&#039;&#039;1. ANATOMY&#039;&#039;&#039;&amp;lt;/font&amp;gt;&lt;br /&gt;
==GI Anatomy==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;D&#039;&#039;&#039;ow &#039;&#039;&#039;J&#039;&#039;&#039;ones &#039;&#039;&#039;I&#039;&#039;&#039;ndustrial &#039;&#039;&#039;A&#039;&#039;&#039;verage &#039;&#039;&#039;C&#039;&#039;&#039;losing &#039;&#039;&#039;S&#039;&#039;&#039;tock &#039;&#039;&#039;R&#039;&#039;&#039;eport}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&#039;&#039;From proximal to distal:&#039;&#039;&lt;br /&gt;
# &#039;&#039;&#039;D&#039;&#039;&#039;uodenum&lt;br /&gt;
# &#039;&#039;&#039;J&#039;&#039;&#039;ejunum&lt;br /&gt;
# &#039;&#039;&#039;I&#039;&#039;&#039;leum&lt;br /&gt;
# &#039;&#039;&#039;A&#039;&#039;&#039;ppendix&lt;br /&gt;
# &#039;&#039;&#039;C&#039;&#039;&#039;olon&lt;br /&gt;
# &#039;&#039;&#039;S&#039;&#039;&#039;igmoid&lt;br /&gt;
# &#039;&#039;&#039;R&#039;&#039;&#039;ectum&lt;br /&gt;
&lt;br /&gt;
==Brachial Plexus Organization==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Radical Teachers Drink Cold Beers&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Randy Travis Drinks Cold Beers&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Robert Taylor Drinks Cold Beer&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Red Trucks Drive Cats Nuts&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
# Roots&lt;br /&gt;
# Trunks&lt;br /&gt;
# Divisions&lt;br /&gt;
# Cords&lt;br /&gt;
# Branches&lt;br /&gt;
&lt;br /&gt;
==Cranial Nerves==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;On Old Olympus Towering Tops, A Finn And German Viewed Some Hops&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Our Only Object To Touch And Feel Virgin Girls Vagina And Hymen&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
# I - olfactory&lt;br /&gt;
# II - optic&lt;br /&gt;
# III - oculomotor&lt;br /&gt;
# IV - trochlear&lt;br /&gt;
# V - trigeminal&lt;br /&gt;
# VI - abducens&lt;br /&gt;
# VII - facial&lt;br /&gt;
# VIII - acoustic (vestibulocochlear)&lt;br /&gt;
# IX - glossophrayngeal&lt;br /&gt;
# X - vagus&lt;br /&gt;
# XI - accessory&lt;br /&gt;
# XII - hypoglossal&lt;br /&gt;
&lt;br /&gt;
==Extraocular Muscles Innervation==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;LR6 SO4 3&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;LR 6&#039;&#039;&#039; - &#039;&#039;&#039;L&#039;&#039;&#039;ateral &#039;&#039;&#039;R&#039;&#039;&#039;ectus by the &#039;&#039;&#039;VI&#039;&#039;&#039;  cranial nerve (Abducens)&lt;br /&gt;
* &#039;&#039;&#039;SO 4&#039;&#039;&#039; - &#039;&#039;&#039;S&#039;&#039;&#039;uperior &#039;&#039;&#039;O&#039;&#039;&#039;blique by the &#039;&#039;&#039;IV&#039;&#039;&#039; cranial nerve (Trochlear)&lt;br /&gt;
* &#039;&#039;&#039;3&#039;&#039;&#039; - The remaining by the &#039;&#039;&#039;III&#039;&#039;&#039; cranial nerve (Occulomotor)&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;LAST&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039; - &#039;&#039;&#039;L&#039;&#039;&#039;ateral Rectus&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;bducens Nerve&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039; - &#039;&#039;&#039;S&#039;&#039;&#039;uperior Oblique&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039; - &#039;&#039;&#039;T&#039;&#039;&#039;rochlear Nerve&lt;br /&gt;
&lt;br /&gt;
==Facial Nerve Branches==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Two Zebras Bought My Car&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Two Zebras Bit My Cookie&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;To Zanzibar By Motor Car&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Ten Zulus Buggered My Cat&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
# Temporal&lt;br /&gt;
# Zygomatic&lt;br /&gt;
# Buccal&lt;br /&gt;
# Mandibular&lt;br /&gt;
# Cervical&lt;br /&gt;
&lt;br /&gt;
==Penis Innervation==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;P&#039;&#039;&#039;oint and &#039;&#039;&#039;S&#039;&#039;&#039;hoot}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039;arasympathetic causes erection&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039;ympathetic causes ejaculation&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;S2, 3, 4 keep the penis off the floor&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* Innervation of the penis by branches of the pudendal nerve, derived from spinal cord levels &#039;&#039;&#039;S 2-4&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
==Aorta Branches==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;ABC&#039;S&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;ortic arch gives off the:&lt;br /&gt;
# &#039;&#039;&#039;B&#039;&#039;&#039; - &#039;&#039;&#039;B&#039;&#039;&#039;racheiocephalic trunk&lt;br /&gt;
# &#039;&#039;&#039;C&#039;&#039;&#039; - Left &#039;&#039;&#039;C&#039;&#039;&#039;ommon &#039;&#039;&#039;C&#039;&#039;&#039;arotid&lt;br /&gt;
# &#039;&#039;&#039;S&#039;&#039;&#039; - Left &#039;&#039;&#039;S&#039;&#039;&#039;ubclavian artery&lt;br /&gt;
&lt;br /&gt;
==Femoral Triangle Structures in Order==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;N (AVEL)&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;N&#039;&#039;&#039;erve&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;rtery&lt;br /&gt;
* &#039;&#039;&#039;V&#039;&#039;&#039;ein&lt;br /&gt;
* &#039;&#039;&#039;E&#039;&#039;&#039;mpty space&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039;ymphatics&lt;br /&gt;
- Parenthesis includes things contained in the femoral sheath.&lt;br /&gt;
&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;navy&amp;quot;&amp;gt;&#039;&#039;&#039;2. CELL BIOLOGY&#039;&#039;&#039;&amp;lt;/font&amp;gt;&lt;br /&gt;
==Cell Division Phases==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;People Meet And Talk&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039; - &#039;&#039;&#039;P&#039;&#039;&#039;rophase&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039; - &#039;&#039;&#039;M&#039;&#039;&#039;etaphase&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;naphase&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039; - &#039;&#039;&#039;T&#039;&#039;&#039;elophase&lt;br /&gt;
&lt;br /&gt;
==Cell Cycle Stages==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Go Sally Go! Make Children!&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;G1&#039;&#039;&#039; phase - Growth phase 1&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039; phase - DNA synthesis&lt;br /&gt;
* &#039;&#039;&#039;G2&#039;&#039;&#039; phase - Growth phase 2&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039; phase - Mitosis&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039; phase - Cytokinesis&lt;br /&gt;
&lt;br /&gt;
==Golgi Complex Functions==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Golgi Distributes A SPAM&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;Distributes&#039;&#039;&#039; proteins and lipids from ER&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;dd mannose onto specific lysosome proteins&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039;ulfation of sugars and slected tyrosine&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039;roteoglycan assembly&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;dd O-oligosugars to serine and threnonine&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039;odify N-ologosugars on asparagine&lt;br /&gt;
&lt;br /&gt;
==Collagen==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;COLLAGEN&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039; - &#039;&#039;&#039;C&#039;&#039;&#039;-terminal propeptide (procollagen) / &#039;&#039;&#039;C&#039;&#039;&#039;ovalent &#039;&#039;&#039;C&#039;&#039;&#039;ross links/ &#039;&#039;&#039;C&#039;&#039;&#039; vitamin/ &#039;&#039;&#039;C&#039;&#039;&#039;onnective tissue/&#039;&#039;&#039;C&#039;&#039;&#039;artilage/&#039;&#039;&#039;C&#039;&#039;&#039;hondroblasts/&#039;&#039;&#039;C&#039;&#039;&#039;opper Cofactor (Covalent Cross linking)&lt;br /&gt;
* &#039;&#039;&#039;O&#039;&#039;&#039; - &#039;&#039;&#039;O&#039;&#039;&#039;utside the cell is where collagen normally functions/ &#039;&#039;&#039;O&#039;&#039;&#039;steoblasts/ &#039;&#039;&#039;O&#039;&#039;&#039;steogenesis imperfecta&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039; - &#039;&#039;&#039;L&#039;&#039;&#039;ysyl hydroxylase / &#039;&#039;&#039;L&#039;&#039;&#039;ysyl oxidase (oxidatively deaminates lysyl and hydroxylysyl residues to form collagen cross links, last biosynthesis step)&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039; - &#039;&#039;&#039;L&#039;&#039;&#039;ong triple helical fibers / &#039;&#039;&#039;L&#039;&#039;&#039;igaments&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;lpha chains / &#039;&#039;&#039;A&#039;&#039;&#039;ttached by H bonds form triple helix / &#039;&#039;&#039;A&#039;&#039;&#039;scorbate for hydroxylation of lysyl and prolyl residues of pro-Alpha chains&lt;br /&gt;
(postranslational modification)&lt;br /&gt;
* &#039;&#039;&#039;G&#039;&#039;&#039; - &#039;&#039;&#039;G&#039;&#039;&#039;ly in every third position / &#039;&#039;&#039;G&#039;&#039;&#039;lycosylation of hydroxyl group of hydroxylysine with &#039;&#039;&#039;G&#039;&#039;&#039;lucose and &#039;&#039;&#039;G&#039;&#039;&#039;alactose;&#039;&#039;&#039;GO&#039;&#039;&#039;lgi allows procollagen to &#039;&#039;&#039;GO&#039;&#039;&#039; outside of cell&lt;br /&gt;
* &#039;&#039;&#039;E&#039;&#039;&#039; - &#039;&#039;&#039;E&#039;&#039;&#039;xtracellular matrix / &#039;&#039;&#039;E&#039;&#039;&#039;ye (cornea, sclera) / &#039;&#039;&#039;E&#039;&#039;&#039;hlers-Danlos Syndrome&lt;br /&gt;
* &#039;&#039;&#039;N&#039;&#039;&#039; - &#039;&#039;&#039;N&#039;&#039;&#039;-terminal propeptide (procollagen) / &#039;&#039;&#039;N&#039;&#039;&#039;onhelical terminal extensions&lt;br /&gt;
&lt;br /&gt;
==Carbon Monoxide: Electron Transport Chain Target==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;CO blocks CO&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
Carbon monoxide &#039;&#039;&#039;(CO)&#039;&#039;&#039; blocks Cytochrome Oxidase &#039;&#039;&#039;(CO)&#039;&#039;&#039; &lt;br /&gt;
&lt;br /&gt;
==Hemoglobin Binding Curve: Right Shift Causes==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;CADET, face right!&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* C = Increase in carbon dioxide&lt;br /&gt;
* A = Acidosis (low ph)&lt;br /&gt;
* D = Increase in 2,3 DPG aka 2,3 BPG&lt;br /&gt;
* E = Exercise&lt;br /&gt;
* T = increase in temperature&lt;br /&gt;
&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;Navy&amp;quot;&amp;gt;&#039;&#039;&#039;3. RECEPTORS&#039;&#039;&#039;&amp;lt;/font&amp;gt;&lt;br /&gt;
==G-proteins Receptors== &lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;QISS &amp;amp; QIQ&amp;quot; (Kiss and Kick)&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
In alphabetical order&lt;br /&gt;
* Q: alpha 1&lt;br /&gt;
* I: alpha 2&lt;br /&gt;
* S: beta 1&lt;br /&gt;
* S: beta 2&lt;br /&gt;
* &amp;amp;&lt;br /&gt;
* Q: M1&lt;br /&gt;
* I: M2&lt;br /&gt;
* Q: M3 &lt;br /&gt;
&lt;br /&gt;
==Adrenaline Mechanism==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;ABC of Adrenaline&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* Adrenaline--&amp;gt; activates&lt;br /&gt;
* Beta receptors--&amp;gt; increases&lt;br /&gt;
* Cyclic AMP&lt;br /&gt;
&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;Navy&amp;quot;&amp;gt;&#039;&#039;&#039;4. BIOCHEMISTRY&#039;&#039;&#039;&amp;lt;/font&amp;gt;&lt;br /&gt;
==Enzymes Classification==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Over The HILL&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;O&#039;&#039;&#039; - &#039;&#039;&#039;O&#039;&#039;&#039;xidoreductases&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039; - &#039;&#039;&#039;T&#039;&#039;&#039;ransferases&lt;br /&gt;
* &#039;&#039;&#039;H&#039;&#039;&#039; - &#039;&#039;&#039;H&#039;&#039;&#039;ydrolases&lt;br /&gt;
* &#039;&#039;&#039;I&#039;&#039;&#039; - &#039;&#039;&#039;I&#039;&#039;&#039;somerases&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039; - &#039;&#039;&#039;L&#039;&#039;&#039;igases&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039; - &#039;&#039;&#039;L&#039;&#039;&#039;yases&lt;br /&gt;
&lt;br /&gt;
==Glycolysis Enzymes==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Hungry Peter Pan And The Growling Pink Panther Eat Pies&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* Hexokinase&lt;br /&gt;
* Phosphohexo isomerase&lt;br /&gt;
* Phosphofructokinase-1 (6-phosphofructo-1 kinase)&lt;br /&gt;
* Aldolase, Triose phosphate isomerase&lt;br /&gt;
* Glyceraldehyde 3-phosphate dehydrogenase&lt;br /&gt;
* Phosphoglycerate kinase&lt;br /&gt;
* Phosphoglycerate mutase&lt;br /&gt;
* Enolase&lt;br /&gt;
* Pyruvate kinase&lt;br /&gt;
&lt;br /&gt;
==Glycolysis Steps==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Goodness Gracious, Father Franklin Did Go By Picking Pumpkins (to) Prepare Pies&#039;&#039;&#039;}}&amp;lt;/font&amp;gt; &lt;br /&gt;
* Glucose&lt;br /&gt;
* Glucose-6-P&lt;br /&gt;
* Fructose-6-P&lt;br /&gt;
* Fructose-1,6-diP&lt;br /&gt;
* Dihydroxyacetone-P&lt;br /&gt;
* Glyceraldehyde-P&lt;br /&gt;
* 1,3-Biphosphoglycerate&lt;br /&gt;
* 3-Phosphoglycerate&lt;br /&gt;
* 2-Phosphoglycerate (to)&lt;br /&gt;
* Phosphoenolpyruvate [PEP] Pyruvate • &#039;Did&#039;, &#039;By&#039; and &#039;Pies&#039; tell you the first part of those three: di-, bi-, and py-. &lt;br /&gt;
• &#039;PrEPare&#039; tells location of PEP in the process. &lt;br /&gt;
&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;Navy&amp;quot;&amp;gt;&#039;&#039;&#039;5. METABOLISM&#039;&#039;&#039;&amp;lt;/font&amp;gt;&lt;br /&gt;
==Metabolism Sites==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Use both arms to HUG&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
# Heme synthesis&lt;br /&gt;
# Urea cycle&lt;br /&gt;
# Gluconeogenesis&lt;br /&gt;
These reactions occur in both cytoplasm and mitochondria&lt;br /&gt;
&lt;br /&gt;
==AcetylCoA and AcetacetylCoA==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;A Lighter Lease (A LyTr LeIs)&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
Amino acids forming them:&lt;br /&gt;
* A=AcetylCoA or Acetoacetyl CoA&lt;br /&gt;
* Ly=Lysine&lt;br /&gt;
* Tr=Tryptophan&lt;br /&gt;
* Le=Leucine&lt;br /&gt;
* Is=Isoleucine &lt;br /&gt;
&lt;br /&gt;
==Citric Acid Cycle Compounds==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Our City Is Kept Safe And Sound From Malice&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* Oxaloacetate&lt;br /&gt;
* Citrate&lt;br /&gt;
* Isocitrate&lt;br /&gt;
* alpha-Ketoglutarate&lt;br /&gt;
* Succinyl-CoA&lt;br /&gt;
* Succinate&lt;br /&gt;
* Fumarate&lt;br /&gt;
* Malate&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Can I Keep Selling Sex For Money, Officer?&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* Citrate&lt;br /&gt;
* Isocitrate&lt;br /&gt;
* alpha-Ketogluterate&lt;br /&gt;
* Succinyl CoA&lt;br /&gt;
* Succinate&lt;br /&gt;
* Fumerate&lt;br /&gt;
* Malate&lt;br /&gt;
* Oxaloacetate&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Oh! Can I Keep Some Succinate For Myself?&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Oh Citric Acid Is Of (course) A SiLly STupid Funny Molecule&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* Oxaloacetate&lt;br /&gt;
* Citrate&lt;br /&gt;
* Isocitrate, alpha-Ketoglutarate&lt;br /&gt;
* Succinyl CoA&lt;br /&gt;
* Succinate&lt;br /&gt;
* Fumarate&lt;br /&gt;
* Malate &lt;br /&gt;
&lt;br /&gt;
==Citric Acid Cycle Enzymes==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Corrupt Anti Intelligence Agent Spoke Slander For Money&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* Citrate synthatase&lt;br /&gt;
* Aconitase&lt;br /&gt;
* Isocitrate dehydrogenase&lt;br /&gt;
* Alpha ketogluturate dehydrogenase&lt;br /&gt;
* Succinyl CoA synthetase&lt;br /&gt;
* Succinate dehydrogenase&lt;br /&gt;
* Fumarase&lt;br /&gt;
* Malate Dehydrogenase&lt;br /&gt;
&lt;br /&gt;
==Essential Amino Acids==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;P&#039;&#039;&#039; ri &#039;&#039;&#039;V&#039;&#039;&#039; a &#039;&#039;&#039;T&#039;&#039;&#039; e   &#039;&#039;&#039;TIM   HALL&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;PVT. TIM HALL&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;&amp;quot;PVT. TIM HALL always argues, never tires&amp;quot;&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039; - &#039;&#039;&#039;P&#039;&#039;&#039;he&lt;br /&gt;
* &#039;&#039;&#039;V&#039;&#039;&#039; - &#039;&#039;&#039;V&#039;&#039;&#039;al&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039; - &#039;&#039;&#039;T&#039;&#039;&#039;hr&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039; - &#039;&#039;&#039;T&#039;&#039;&#039;rp&lt;br /&gt;
* &#039;&#039;&#039;I&#039;&#039;&#039; - &#039;&#039;&#039;I&#039;&#039;&#039;le&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039; - &#039;&#039;&#039;M&#039;&#039;&#039;et&lt;br /&gt;
* &#039;&#039;&#039;H&#039;&#039;&#039; - &#039;&#039;&#039;H&#039;&#039;&#039;is&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;rg&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039; - &#039;&#039;&#039;L&#039;&#039;&#039;eu&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039; - &#039;&#039;&#039;L&#039;&#039;&#039;ys&lt;br /&gt;
* Pvt. is short for Private in the military&lt;br /&gt;
* Arg and His are considered semi-essential&lt;br /&gt;
* Alternatively: &#039;&#039;&#039;MATT VIL PHLy&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
==Creatine Phosphate: Amino Acid Precursors==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Nice GAMs!&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;G&#039;&#039;&#039; - &#039;&#039;&#039;G&#039;&#039;&#039;lycine&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;rginine&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039; - &#039;&#039;&#039;M&#039;&#039;&#039;ethionine&lt;br /&gt;
&lt;br /&gt;
==Branched Chain Amino Acids Catabolism Steps==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Truck hit the Ox to Death&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039; - &#039;&#039;&#039;T&#039;&#039;&#039;ransamination&lt;br /&gt;
* &#039;&#039;&#039;O&#039;&#039;&#039; - &#039;&#039;&#039;O&#039;&#039;&#039;xidative decarboxylation&lt;br /&gt;
* &#039;&#039;&#039;D&#039;&#039;&#039; - &#039;&#039;&#039;D&#039;&#039;&#039;ehydrogenation&lt;br /&gt;
&lt;br /&gt;
==Branched-chain Amino Acids Used by Skeletal Muscle (Fasting State)==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Muscles LIVe fast&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* Leucine&lt;br /&gt;
* Isoleucine&lt;br /&gt;
* Valine&lt;br /&gt;
&lt;br /&gt;
==Urea Cycle==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;O&#039;&#039;&#039;rdinarily &#039;&#039;&#039;C&#039;&#039;&#039;areless &#039;&#039;&#039;C&#039;&#039;&#039;rappers &#039;&#039;&#039;A&#039;&#039;&#039;re &#039;&#039;&#039;A&#039;&#039;&#039;lso &#039;&#039;&#039;F&#039;&#039;&#039;rivolous &#039;&#039;&#039;A&#039;&#039;&#039;bout &#039;&#039;&#039;U&#039;&#039;&#039;rination!}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;O&#039;&#039;&#039; - &#039;&#039;&#039;O&#039;&#039;&#039;rnithine&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039; - &#039;&#039;&#039;C&#039;&#039;&#039;arbamoyl&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039; - &#039;&#039;&#039;C&#039;&#039;&#039;itrulline&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;spartate&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;rginosuccinate&lt;br /&gt;
* &#039;&#039;&#039;F&#039;&#039;&#039; - &#039;&#039;&#039;F&#039;&#039;&#039;umarate&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;rginine&lt;br /&gt;
* &#039;&#039;&#039;U&#039;&#039;&#039; - &#039;&#039;&#039;U&#039;&#039;&#039;rea&lt;br /&gt;
&lt;br /&gt;
==Pyrimidines Nucleotides==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;CUT the PY (pie)&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039;ytosine&lt;br /&gt;
* &#039;&#039;&#039;U&#039;&#039;&#039;racil&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039;hiamine &lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039;he&lt;br /&gt;
* &#039;&#039;&#039;PY&#039;&#039;&#039;rimidines &lt;br /&gt;
&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;Navy&amp;quot;&amp;gt;&#039;&#039;&#039;6. ENZYME DEFICIENCIES&#039;&#039;&#039;&amp;lt;/font&amp;gt;&lt;br /&gt;
==G6PD: Oxidant Drugs Inducing Hemolytic Anemia == &lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;AAA&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* Antibiotic (eg: sufamethoxazole)&lt;br /&gt;
* Antimalarial (eg: primaquine)&lt;br /&gt;
* Antipyretics (eg: acetanilid, but not aspirin or acetaminophen)&lt;br /&gt;
&lt;br /&gt;
==Pompe&#039;s Disease==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Type &amp;quot;Police: Po + lys&amp;quot;&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;PO&#039;&#039;&#039;mpe&#039;s disease is a &#039;&#039;&#039;LYS&#039;&#039;&#039;osomal storage disease (alpha 1,4 glucosidase)&lt;br /&gt;
&lt;br /&gt;
==Galactosemia==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;GALIPUT&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* Galactose 1 Phosphate Uridyl Transferase&lt;br /&gt;
* There is an assay called the Galiput test for this&lt;br /&gt;
&lt;br /&gt;
==Fabry&#039;s Disease==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;FABRY &#039; S&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;F&#039;&#039;&#039; - &#039;&#039;&#039;F&#039;&#039;&#039;oam cells found in glomeruli and tubules / &#039;&#039;&#039;F&#039;&#039;&#039;ebrile episodes&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;lpha galactosidase &#039;&#039;&#039;A&#039;&#039;&#039; deficiency / &#039;&#039;&#039;A&#039;&#039;&#039;ngiokeratomas&lt;br /&gt;
* &#039;&#039;&#039;B&#039;&#039;&#039; - &#039;&#039;&#039;B&#039;&#039;&#039;urning pain in extremities / &#039;&#039;&#039;B&#039;&#039;&#039;UN increased in serum / &#039;&#039;&#039;B&#039;&#039;&#039;oys&lt;br /&gt;
* &#039;&#039;&#039;R&#039;&#039;&#039; - &#039;&#039;&#039;R&#039;&#039;&#039;enal failure&lt;br /&gt;
* &#039;&#039;&#039;Y&#039;&#039;&#039; - &#039;&#039;&#039;Y&#039;&#039;&#039;X genotype (male, X linked recessive)&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039; - &#039;&#039;&#039;S&#039;&#039;&#039;phingolipidoses&lt;br /&gt;
&lt;br /&gt;
==Hurler Syndrome Features== &lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;HURLER&#039;S&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
*&#039;&#039;&#039;H&#039;&#039;&#039;eptosplenomegaly &lt;br /&gt;
*&#039;&#039;&#039;U&#039;&#039;&#039;gly facies &lt;br /&gt;
*&#039;&#039;&#039;R&#039;&#039;&#039;ecessive (AR inheritance) &lt;br /&gt;
*&#039;&#039;&#039;L&#039;&#039;&#039;-iduronidase deficiency (alpha) &lt;br /&gt;
*&#039;&#039;&#039;E&#039;&#039;&#039;yes clouded &lt;br /&gt;
*&#039;&#039;&#039;R&#039;&#039;&#039;etarded &lt;br /&gt;
*&#039;&#039;&#039;S&#039;&#039;&#039;tubby fingers/&#039;&#039;&#039;S&#039;&#039;&#039;hort &lt;br /&gt;
&lt;br /&gt;
==Acute Intermittent Porphyria== &lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;5  P&#039;s &#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039;ain in abdomen&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039;olyneuropathy&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039;sychologial abnormalities&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039;ink urine&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039;recipitated by drugs (eg barbiturates, oral contraceptives, sulpha drugs)&lt;br /&gt;
&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;Navy&amp;quot;&amp;gt;&#039;&#039;&#039;7. VITAMINS&#039;&#039;&#039;&amp;lt;/font&amp;gt;&lt;br /&gt;
==B Vitamins==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;The Rhythm Nearly Proved Contagious&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
In increasing order: &lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039; - &#039;&#039;&#039;T&#039;&#039;&#039;hiamine (B1)&lt;br /&gt;
* &#039;&#039;&#039;R&#039;&#039;&#039; - &#039;&#039;&#039;R&#039;&#039;&#039;iboflavin (B2)&lt;br /&gt;
* &#039;&#039;&#039;N&#039;&#039;&#039; - &#039;&#039;&#039;N&#039;&#039;&#039;iacin (B3)&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039; - &#039;&#039;&#039;P&#039;&#039;&#039;yridoxine (B6)&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039; - &#039;&#039;&#039;C&#039;&#039;&#039;obalamin (B12)&lt;br /&gt;
&lt;br /&gt;
==Niacin Deficiency==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;The famous 4 D&#039;s&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
# Diarrhea&lt;br /&gt;
# Dermatitis&lt;br /&gt;
# Dementia&lt;br /&gt;
# Death (if untreated) &lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;The 3D&#039;s of pellagra&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
Vitamin B3 (niacin, nicotinic acid) deficiency&lt;br /&gt;
# Dermatitis&lt;br /&gt;
# Diarrhea&lt;br /&gt;
# Dementia&lt;br /&gt;
&lt;br /&gt;
==Folate Deficiency Causes==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;A FOLIC DROP&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* Alcoholism&lt;br /&gt;
* Folic acid antagonists&lt;br /&gt;
* Oral contraceptives&lt;br /&gt;
* Low dietary intake&lt;br /&gt;
* Infection with Giardia&lt;br /&gt;
* Celiac sprue&lt;br /&gt;
* Dilatin&lt;br /&gt;
* Relative folate deficiency&lt;br /&gt;
* Old&lt;br /&gt;
* Pregnant &lt;br /&gt;
&lt;br /&gt;
==Fat Soluble Vitamins==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;The FAT cat is in the ADEK (attic)&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
Fat soluble vitamins are &#039;&#039;A,D,E,K.&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
==Hypervitaminosis A==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|Increased Vitamin A makes you &#039;&#039;&#039;HARD&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;H&#039;&#039;&#039; - &#039;&#039;&#039;H&#039;&#039;&#039;eadache / &#039;&#039;&#039;H&#039;&#039;&#039;epatomegaly&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;norexia / &#039;&#039;&#039;A&#039;&#039;&#039;lopecia&lt;br /&gt;
* &#039;&#039;&#039;R&#039;&#039;&#039; - &#039;&#039;&#039;R&#039;&#039;&#039;eally painful bones&lt;br /&gt;
* &#039;&#039;&#039;D&#039;&#039;&#039; - &#039;&#039;&#039;D&#039;&#039;&#039;ry skin / &#039;&#039;&#039;D&#039;&#039;&#039;rowsiness&lt;br /&gt;
&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;Navy&amp;quot;&amp;gt;&#039;&#039;&#039;8. HISTORY TAKING&#039;&#039;&#039;&amp;lt;/font&amp;gt;&lt;br /&gt;
==Alcoholism Screening==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;CAGE&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* Have you ever felt it necessary to &#039;&#039;&#039;C&#039;&#039;&#039;UT DOWN on your drinking?&lt;br /&gt;
* Have you ever been &#039;&#039;&#039;A&#039;&#039;&#039;NNOYED when people suggest you cut down on your drinking?&lt;br /&gt;
* Have you ever felt &#039;&#039;&#039;G&#039;&#039;&#039;UILTY about your drinking?&lt;br /&gt;
* Have you ever felt the need to have a drink in the morning for an &#039;&#039;&#039;E&#039;&#039;&#039;YE OPENER?&lt;br /&gt;
&lt;br /&gt;
==Chief Complaint==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;OPQRST&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;O&#039;&#039;&#039; - &#039;&#039;&#039;O&#039;&#039;&#039;nset of pain:  what was the patient doing when the pain started?&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039; - &#039;&#039;&#039;P&#039;&#039;&#039;alliative or &#039;&#039;&#039;P&#039;&#039;&#039;rovocative factors for the pain&lt;br /&gt;
* &#039;&#039;&#039;Q&#039;&#039;&#039; - &#039;&#039;&#039;Q&#039;&#039;&#039;uality of pain (burning, stabbing, aching, etc.)&lt;br /&gt;
* &#039;&#039;&#039;R&#039;&#039;&#039; - &#039;&#039;&#039;R&#039;&#039;&#039;adiation (up to jaw, down left arm, etc.)&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039; - &#039;&#039;&#039;S&#039;&#039;&#039;everity of pain (usually 1 - 10 scale)&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039; - &#039;&#039;&#039;T&#039;&#039;&#039;iming of pain (eg: after meals, in the morning, how long it lasts, etc.)&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;SOCRATES&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039; - &#039;&#039;&#039;S&#039;&#039;&#039;ite of pain&lt;br /&gt;
* &#039;&#039;&#039;O&#039;&#039;&#039; - &#039;&#039;&#039;O&#039;&#039;&#039;nset of pain&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039; - &#039;&#039;&#039;C&#039;&#039;&#039;haracter of pain: dull, sharp, aching, stabbing, tearing&lt;br /&gt;
* &#039;&#039;&#039;R&#039;&#039;&#039; - &#039;&#039;&#039;R&#039;&#039;&#039;adiation of pain: central abdominal pain radiating to Right Iliac Fossa&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;ssociated factors: eg. nausea/vomiting&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039; - &#039;&#039;&#039;T&#039;&#039;&#039;iming of pain/duration&lt;br /&gt;
* &#039;&#039;&#039;E&#039;&#039;&#039; - &#039;&#039;&#039;E&#039;&#039;&#039;xacerbating/alleviating factors&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039; - &#039;&#039;&#039;S&#039;&#039;&#039;everity of pain (1 - 10 scale)&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;ASCLAST&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;ggravatiing and &#039;&#039;&#039;A&#039;&#039;&#039;lleviating factors&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039; - &#039;&#039;&#039;S&#039;&#039;&#039;everity&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039; - &#039;&#039;&#039;C&#039;&#039;&#039;haracter, quality&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039; - &#039;&#039;&#039;L&#039;&#039;&#039;ocation&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;ssociated symptoms&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039; - &#039;&#039;&#039;S&#039;&#039;&#039;etting&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039; - &#039;&#039;&#039;T&#039;&#039;&#039;iming&lt;br /&gt;
&lt;br /&gt;
NOTE: ASCLAST means let the patient talk first, then ask him/her specific questions.&lt;br /&gt;
&lt;br /&gt;
==Hospital Admission Orders==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;DAVE WILMINGTON&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;D&#039;&#039;&#039;iet&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;ctivity&lt;br /&gt;
* &#039;&#039;&#039;V&#039;&#039;&#039;ital signs: how often to monitor&lt;br /&gt;
* &#039;&#039;&#039;E&#039;&#039;&#039;xcrement: test urine/stool&lt;br /&gt;
* &#039;&#039;&#039;W&#039;&#039;&#039;eight: how often to monitor&lt;br /&gt;
* &#039;&#039;&#039;I&#039;&#039;&#039; / O: monitor input/output&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039;abs: which/how often&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039;eds: which/route/interval&lt;br /&gt;
* &#039;&#039;&#039;I&#039;&#039;&#039; V fluids: what/at what rate&lt;br /&gt;
* &#039;&#039;&#039;N&#039;&#039;&#039;ursing care: e.g. position, wound care, up in chair, ostomy care&lt;br /&gt;
* &#039;&#039;&#039;G&#039;&#039;&#039;eneral care: e.g. physical/respiratory therapy&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039;ests: e.g. X-ray/EKG/EEG&lt;br /&gt;
* &#039;&#039;&#039;O&#039;&#039;&#039;bserve for: reaction/seizure/neuro exams&lt;br /&gt;
* &#039;&#039;&#039;N&#039;&#039;&#039;otify parameters: e.g. Temperature &amp;gt; 100 F / respiration changes&lt;br /&gt;
&lt;br /&gt;
After noting date and time of admission as well as diagnosis and condition (ADC), use the mnemonic to ensure all areas are addressed, but not all apply to every patient.&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;ADC VAAN DIML&#039;&#039;&#039;, pronounced ADC van dim(e)L}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;dmit: 23 hours, full admit, service of attending&lt;br /&gt;
* &#039;&#039;&#039;D&#039;&#039;&#039;iagnosis&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039;ondition: &amp;quot;Stable&amp;quot;/&amp;quot;Guarded&amp;quot;&lt;br /&gt;
* &#039;&#039;&#039;V&#039;&#039;&#039;itals: post-op, routine, q 1 hour&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;llergies&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;ctivities: strict bed rest/fall precautions/ad lib/bathroom privileges&lt;br /&gt;
* &#039;&#039;&#039;N&#039;&#039;&#039;ursing: strict I&amp;amp;O&#039;s/daily weights/call P.R.N.&lt;br /&gt;
* &#039;&#039;&#039;D&#039;&#039;&#039;iet: NPO/regular/clears/advance diet as tolerated/2000 cal ADA/renal&lt;br /&gt;
* &#039;&#039;&#039;I&#039;&#039;&#039;V fluids: D5, 1/2 NS, 20 KCL at 110 ml/hr, LR @ 100 ml/hr&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039;eds: scheduled and PRN&#039;s&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039;abs and X-ray: CBC in AM, PCXR in PACU&lt;br /&gt;
&lt;br /&gt;
Note that IV fluids follows Diet. If one writes NPO, then &#039;&#039;&#039;all&#039;&#039;&#039; such patients get maintenance fluids (use the 4-2-1 rule).&lt;br /&gt;
&lt;br /&gt;
==Post-Op Fever Causes==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Five W&#039;s&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;W&#039;&#039;&#039;ind: pneumonia, atelectasis&lt;br /&gt;
* &#039;&#039;&#039;W&#039;&#039;&#039;ound: wound infections&lt;br /&gt;
* &#039;&#039;&#039;W&#039;&#039;&#039;ater: urinary tract infection&lt;br /&gt;
* &#039;&#039;&#039;W&#039;&#039;&#039;alking: DVT/PE (walking can help reduce DVT/PE)&lt;br /&gt;
* &#039;&#039;&#039;W&#039;&#039;&#039;onderdrugs: especially anesthesia&lt;br /&gt;
&lt;br /&gt;
==Predisposing Conditions for Pulmonary Embolism==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;TOM SCH PREFER&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039; - &#039;&#039;&#039;T&#039;&#039;&#039;rauma&lt;br /&gt;
* &#039;&#039;&#039;O&#039;&#039;&#039; - &#039;&#039;&#039;O&#039;&#039;&#039;besity&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039; - &#039;&#039;&#039;M&#039;&#039;&#039;alignancy&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039; - &#039;&#039;&#039;S&#039;&#039;&#039;urgery&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039; - &#039;&#039;&#039;C&#039;&#039;&#039;ardiac disease&lt;br /&gt;
* &#039;&#039;&#039;H&#039;&#039;&#039; - &#039;&#039;&#039;H&#039;&#039;&#039;ospitalization&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039; - &#039;&#039;&#039;P&#039;&#039;&#039;ast history&lt;br /&gt;
* &#039;&#039;&#039;R&#039;&#039;&#039; - &#039;&#039;&#039;R&#039;&#039;&#039;est (bed-bound)&lt;br /&gt;
* &#039;&#039;&#039;E&#039;&#039;&#039; - &#039;&#039;&#039;E&#039;&#039;&#039;strogen, pregnancy, post-partum&lt;br /&gt;
* &#039;&#039;&#039;F&#039;&#039;&#039; - &#039;&#039;&#039;F&#039;&#039;&#039;racture&lt;br /&gt;
* &#039;&#039;&#039;E&#039;&#039;&#039; - &#039;&#039;&#039;E&#039;&#039;&#039;lderly&lt;br /&gt;
* &#039;&#039;&#039;R&#039;&#039;&#039; - &#039;&#039;&#039;R&#039;&#039;&#039;oad trip&lt;br /&gt;
&lt;br /&gt;
==Compartment Syndrome Signs (Arterial Occlusion)==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;6 P&#039;s&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
# Pain&lt;br /&gt;
# Pale (Pallor)&lt;br /&gt;
# Perishing with Cold (Poikilothermia)&lt;br /&gt;
# Pulseless&lt;br /&gt;
# Paresthesias&lt;br /&gt;
# Paralysis&lt;br /&gt;
&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;Navy&amp;quot;&amp;gt;&#039;&#039;&#039;9. PATHOLOGY&#039;&#039;&#039;&amp;lt;/font&amp;gt;&lt;br /&gt;
==Causes of Diseases==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;VITAMIN C&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
*&#039;&#039;&#039;V&#039;&#039;&#039;ascular&lt;br /&gt;
*&#039;&#039;&#039;I&#039;&#039;&#039;nfectious&lt;br /&gt;
*&#039;&#039;&#039;T&#039;&#039;&#039;rauma&lt;br /&gt;
*&#039;&#039;&#039;A&#039;&#039;&#039;uto-immune&lt;br /&gt;
*&#039;&#039;&#039;M&#039;&#039;&#039;etabolic&lt;br /&gt;
*&#039;&#039;&#039;I&#039;&#039;&#039;diopathic/Iatrogenic&lt;br /&gt;
*&#039;&#039;&#039;N&#039;&#039;&#039;eoplastic&lt;br /&gt;
*&#039;&#039;&#039;C&#039;&#039;&#039;ongenital&lt;br /&gt;
&lt;br /&gt;
==5 Signs of Inflammation==&lt;br /&gt;
# &#039;&#039;&#039;Rubor&#039;&#039;&#039;: redness/erythema&lt;br /&gt;
# &#039;&#039;&#039;Calor&#039;&#039;&#039;: raised temperature&lt;br /&gt;
# &#039;&#039;&#039;Tumor&#039;&#039;&#039;: swelling&lt;br /&gt;
# &#039;&#039;&#039;Dolor&#039;&#039;&#039;: pain&lt;br /&gt;
# &#039;&#039;&#039;Functio Laesa&#039;&#039;&#039;: loss of function&lt;br /&gt;
- Described by Celsus&lt;br /&gt;
&lt;br /&gt;
==Hypersentivity Reactions (Gell &amp;amp; Goombs Classification)==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;ACID&#039;&#039;&#039;}}&amp;lt;/font&amp;gt; &amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;A&#039;&#039;&#039;nna &#039;&#039;&#039;C&#039;&#039;&#039;ycled &#039;&#039;&#039;I&#039;&#039;&#039;mmediately &#039;&#039;&#039;D&#039;&#039;&#039;ownhill}}&amp;lt;/font&amp;gt; &lt;br /&gt;
# Type I   &#039;&#039;&#039;A&#039;&#039;&#039;naphylaxis&lt;br /&gt;
# Type II  &#039;&#039;&#039;C&#039;&#039;&#039;ytotoxic-mediated&lt;br /&gt;
# Type III &#039;&#039;&#039;I&#039;&#039;&#039;mmune-complex&lt;br /&gt;
# Type IV  &#039;&#039;&#039;D&#039;&#039;&#039;elayed hypersensitivity&lt;br /&gt;
&lt;br /&gt;
==Multiple Endocrine Neoplasia (MEN)==&lt;br /&gt;
Each of the MENs is a disease of &#039;&#039;&#039;three or two letters plus a feature&#039;&#039;&#039;; all are autosomal dominant.&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;MEN I:  3 P&#039;s&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
# &#039;&#039;&#039;P&#039;&#039;&#039;ituitary&lt;br /&gt;
# &#039;&#039;&#039;P&#039;&#039;&#039;arathyroid&lt;br /&gt;
# &#039;&#039;&#039;P&#039;&#039;&#039;ancreas&lt;br /&gt;
# Plus Adrenal cortex&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;MEN II:  2 C&#039;s&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
# &#039;&#039;&#039;C&#039;&#039;&#039;arcinoma of thyroid&lt;br /&gt;
# &#039;&#039;&#039;C&#039;&#039;&#039;atacholamines (pheochromocytoma)&lt;br /&gt;
- MEN IIA: parathyroid&lt;br /&gt;
- MEN IIB (MEN III): mucocutaneous neuromas for&lt;br /&gt;
&lt;br /&gt;
==Acute Pneumonia Infiltrates==&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039;yogenic bacteria: &#039;&#039;&#039;P&#039;&#039;&#039;MN infiltrate&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039;iscellaneous microbes: &#039;&#039;&#039;M&#039;&#039;&#039;ononuclear infiltrate&lt;br /&gt;
&lt;br /&gt;
==Takayasu&#039;s Disease/Pulseless Disease== &lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;When you have Takayasu&#039;s, I can&#039;t Tak&#039;a yu pulse&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==CBC Normal Differential==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;N&#039;&#039;&#039;ever &#039;&#039;&#039;L&#039;&#039;&#039;et &#039;&#039;&#039;M&#039;&#039;&#039;onkeys &#039;&#039;&#039;E&#039;&#039;&#039;at &#039;&#039;&#039;B&#039;&#039;&#039;ananas}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;N&#039;&#039;&#039;ice &#039;&#039;&#039;L&#039;&#039;&#039;adies &#039;&#039;&#039;M&#039;&#039;&#039;ake &#039;&#039;&#039;E&#039;&#039;&#039;aster &#039;&#039;&#039;B&#039;&#039;&#039;read&amp;quot;}}&amp;lt;/font&amp;gt;  &lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;60&#039;&#039;&#039;, &#039;&#039;&#039;30&#039;&#039;&#039;, &#039;&#039;&#039;6&#039;&#039;&#039;, &#039;&#039;&#039;3&#039;&#039;&#039;, &#039;&#039;&#039;1&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
# &#039;&#039;&#039;N&#039;&#039;&#039;eutrophils: &#039;&#039;&#039;60&#039;&#039;&#039;%&lt;br /&gt;
# &#039;&#039;&#039;L&#039;&#039;&#039;ymphocytes: &#039;&#039;&#039;30&#039;&#039;&#039;%&lt;br /&gt;
# &#039;&#039;&#039;M&#039;&#039;&#039;onocytes: &#039;&#039;&#039;6&#039;&#039;&#039;%&lt;br /&gt;
# &#039;&#039;&#039;E&#039;&#039;&#039;osinophils: &#039;&#039;&#039;3&#039;&#039;&#039;%&lt;br /&gt;
# &#039;&#039;&#039;B&#039;&#039;&#039;asophils: &#039;&#039;&#039;1&#039;&#039;&#039;%&lt;br /&gt;
&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;Navy&amp;quot;&amp;gt;&#039;&#039;&#039;10. CAUSES&#039;&#039;&#039;&amp;lt;/font&amp;gt;&lt;br /&gt;
==Metabolic Acidosis Causes==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;MUDPILES&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039;ethanol poisoning&lt;br /&gt;
* &#039;&#039;&#039;U&#039;&#039;&#039;remia&lt;br /&gt;
* &#039;&#039;&#039;D&#039;&#039;&#039;iabetic Keto-acidosis&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039;ara-aldehyde ingestion&lt;br /&gt;
* &#039;&#039;&#039;I&#039;&#039;&#039;schemia&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039;actic Acidosis&lt;br /&gt;
* &#039;&#039;&#039;E&#039;&#039;&#039;thanol poisoning&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039;alicylate ingestion&lt;br /&gt;
&lt;br /&gt;
==Metabolic Acidosis (Normal Anion-Gap) Causes==&lt;br /&gt;
===With Hyperkalemia===&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;RAISE K+&#039;&#039;&#039;}}&amp;lt;/font&amp;gt; &lt;br /&gt;
* RTA type 4&lt;br /&gt;
* Aldosterone or mineralocorticord deficiency&lt;br /&gt;
* Iatrogenic: NH4Cl, HCl&lt;br /&gt;
* &amp;quot;Stenosis&amp;quot;: obstructive uropathy&lt;br /&gt;
* Early uremia &lt;br /&gt;
===With hypokalemia===&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;ReDUCE K+&#039;&#039;&#039;}}&amp;lt;/font&amp;gt; &lt;br /&gt;
* Renal TA type 1 and 2&lt;br /&gt;
* Diarrhoea&lt;br /&gt;
* Urine diversion into gut&lt;br /&gt;
* Carbonate anhydrase inhibitor&lt;br /&gt;
* Ex-hyperventilation&lt;br /&gt;
&lt;br /&gt;
==BUN &amp;amp; Creatinine Elevation Causes==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;ABCD&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;zotremia (pre-renal)&lt;br /&gt;
* &#039;&#039;&#039;B&#039;&#039;&#039; - &#039;&#039;&#039;B&#039;&#039;&#039;leeding (GI)&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039; - &#039;&#039;&#039;C&#039;&#039;&#039;atabolic status&lt;br /&gt;
* &#039;&#039;&#039;D&#039;&#039;&#039; - &#039;&#039;&#039;D&#039;&#039;&#039;iet (high protein parenteral nutrition)&lt;br /&gt;
&lt;br /&gt;
==Hypercalcemia Causes==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;PAM SCHMIDT&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;                       &lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039;aget&#039;s Disease&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;myloid&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039;ultiple Myeloma&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039;arcoid&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039;ancer&lt;br /&gt;
* &#039;&#039;&#039;H&#039;&#039;&#039;ormomal (para-thyroid)&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039;ilk-alkali Syndrome&lt;br /&gt;
* &#039;&#039;&#039;I&#039;&#039;&#039;mmobilization&lt;br /&gt;
* &#039;&#039;&#039;D&#039;&#039;&#039;-vitamin overdose&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039;hyrotoxicosis&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;OR&#039;&#039;&#039;&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;MISHAP&#039;&#039;&#039;}}&amp;lt;/font&amp;gt; &lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039;alignancy&lt;br /&gt;
* &#039;&#039;&#039;I&#039;&#039;&#039;ntoxication (hypervitaminosis)&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039;arcoidosis&lt;br /&gt;
* &#039;&#039;&#039;H&#039;&#039;&#039;yperparathyroidism&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;lkali (Milk) syndrome&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039;aget&#039;s Disease (bone)&lt;br /&gt;
Also consider Addison&#039;s disease, thiazide diuretics and simple lab error&lt;br /&gt;
&lt;br /&gt;
==Acute Pancreatitis Causes==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;GET SMASHED&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
# &#039;&#039;&#039;G&#039;&#039;&#039;all stones&lt;br /&gt;
# &#039;&#039;&#039;E&#039;&#039;&#039;thanol&lt;br /&gt;
# &#039;&#039;&#039;T&#039;&#039;&#039;rauma&lt;br /&gt;
# &#039;&#039;&#039;S&#039;&#039;&#039;teroids&lt;br /&gt;
# &#039;&#039;&#039;M&#039;&#039;&#039;umps&lt;br /&gt;
# &#039;&#039;&#039;A&#039;&#039;&#039;utoimmune disease&lt;br /&gt;
# &#039;&#039;&#039;S&#039;&#039;&#039;corpion venom&lt;br /&gt;
# &#039;&#039;&#039;H&#039;&#039;&#039;yperlipidemia&lt;br /&gt;
# &#039;&#039;&#039;E&#039;&#039;&#039;RCP (dye)&lt;br /&gt;
# &#039;&#039;&#039;D&#039;&#039;&#039;rugs (Azathioprine, Asparginase, Mercaptopurines, Pentamidine)&lt;br /&gt;
Alcohol and Gallstones are the most common causes.&lt;br /&gt;
&lt;br /&gt;
==Back Pain Causes==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;DISK MASS&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;D&#039;&#039;&#039;-&#039;&#039;&#039;D&#039;&#039;&#039;egeneration: DJD, Osteoporosis, spondylosis&lt;br /&gt;
* &#039;&#039;&#039;I&#039;&#039;&#039;-&#039;&#039;&#039;I&#039;&#039;&#039;nfection: UTI, PID, Potts, osteomyelitis, prostatitis, Injury/fracture, compression fracture&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039;-&#039;&#039;&#039;S&#039;&#039;&#039;pondylitis, ankylosing Spondyloarthropathies (rheumatoid arthritis, Reiters,  SLE)&lt;br /&gt;
* &#039;&#039;&#039;K&#039;&#039;&#039;-&#039;&#039;&#039;K&#039;&#039;&#039;idney stones/infarction/infection (pyelo/abscess)&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039;-&#039;&#039;&#039;M&#039;&#039;&#039;ultiple myeloma, &#039;&#039;&#039;M&#039;&#039;&#039;etastasis from breast, prostate, lung, thyroid, kidney CA&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;-&#039;&#039;&#039;A&#039;&#039;&#039;neurysm, &#039;&#039;&#039;A&#039;&#039;&#039;bdominal pain referred to the back (see acute abdominal pain)&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039;-&#039;&#039;&#039;S&#039;&#039;&#039;lipped disk, &#039;&#039;&#039;S&#039;&#039;&#039;pondylolisthesis&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039;-&#039;&#039;&#039;S&#039;&#039;&#039;train, &#039;&#039;&#039;S&#039;&#039;&#039;coliosis/lordosis, &#039;&#039;&#039;S&#039;&#039;&#039;kin: herpes zoster&lt;br /&gt;
&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;Navy&amp;quot;&amp;gt;&#039;&#039;&#039;11. TREATMENT&#039;&#039;&#039;&amp;lt;/font&amp;gt;&lt;br /&gt;
==Syncope Management==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;If the face is red, raise the head!&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;If the face is pale, raise the tail!&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Malignant Hyperthermia Treatment==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Sunday Hot Day, Better Give Iced Fluids Today!&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039;- Stop all triggering agents, give 100% O2&lt;br /&gt;
* &#039;&#039;&#039;H&#039;&#039;&#039;- Hyperventillate&lt;br /&gt;
* &#039;&#039;&#039;D&#039;&#039;&#039;- Dantrolene 2.5 mg/kg&lt;br /&gt;
* &#039;&#039;&#039;B&#039;&#039;&#039;- Bicarbonate&lt;br /&gt;
* &#039;&#039;&#039;G&#039;&#039;&#039;- Glucose and Insulin&lt;br /&gt;
* &#039;&#039;&#039;I&#039;&#039;&#039;- IV Fluids, Cooling Blanket&lt;br /&gt;
* &#039;&#039;&#039;F&#039;&#039;&#039;- Fluid Output; Furosemide&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039;- Tachycardia, be prepared to treat V Tach&lt;br /&gt;
&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;Navy&amp;quot;&amp;gt;&#039;&#039;&#039;12. GENETICS&#039;&#039;&#039;&amp;lt;/font&amp;gt;&lt;br /&gt;
==Down Syndrome Features==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;CHILD HAS PROBLEM!&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039;ongenital heart disease/ &#039;&#039;&#039;C&#039;&#039;&#039;ataracts&lt;br /&gt;
* &#039;&#039;&#039;H&#039;&#039;&#039;ypotonia/ Hypothyroidism&lt;br /&gt;
* &#039;&#039;&#039;I&#039;&#039;&#039;ncure 5th finger/ &#039;&#039;&#039;I&#039;&#039;&#039;ncreased gap between 1st and 2nd toe&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039;eukemia risk x2/ &#039;&#039;&#039;L&#039;&#039;&#039;ung problem&lt;br /&gt;
* &#039;&#039;&#039;D&#039;&#039;&#039;uodenal atresia/ &#039;&#039;&#039;D&#039;&#039;&#039;elayed development &lt;br /&gt;
* &#039;&#039;&#039;H&#039;&#039;&#039;irshsprung&#039;s disease/ &#039;&#039;&#039;H&#039;&#039;&#039;earing loss&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;lzheimer&#039;s disease/ Alantoaxial instability&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039;quint/ Short neck &lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039;rotruding tongue/ &#039;&#039;&#039;P&#039;&#039;&#039;alm crease&lt;br /&gt;
* &#039;&#039;&#039;R&#039;&#039;&#039;ound face/ &#039;&#039;&#039;R&#039;&#039;&#039;olling eye (nystagmus)&lt;br /&gt;
* &#039;&#039;&#039;O&#039;&#039;&#039;cciput flat/ &#039;&#039;&#039;O&#039;&#039;&#039;blique eye fissure&lt;br /&gt;
* &#039;&#039;&#039;B&#039;&#039;&#039;rushfield spot/ &#039;&#039;&#039;B&#039;&#039;&#039;rachycephaly&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039;ow nasal bridge/ &#039;&#039;&#039;L&#039;&#039;&#039;anguage problem&lt;br /&gt;
* &#039;&#039;&#039;E&#039;&#039;&#039;picanthic fold/ &#039;&#039;&#039;E&#039;&#039;&#039;ar folded&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039;ental retardation/ &#039;&#039;&#039;M&#039;&#039;&#039;yoclonus &lt;br /&gt;
&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;DOWN&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;D&#039;&#039;&#039;ecreased alpha-fetoprotein and unconjugated estriol (maternal)&lt;br /&gt;
* &#039;&#039;&#039;O&#039;&#039;&#039;ne extra chromosome twenty-one&lt;br /&gt;
* &#039;&#039;&#039;W&#039;&#039;&#039;omen of advanced age&lt;br /&gt;
* &#039;&#039;&#039;N&#039;&#039;&#039;on-disjunction during maternal meiosis &lt;br /&gt;
&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Drink at 21&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
Chromosome 21&lt;br /&gt;
&lt;br /&gt;
==Patau&#039;s Syndrome - Chromosome 13==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;P&#039;&#039;&#039;uberty at 13}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Edward&#039;s Syndrome - Chromosome 18==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|Election voter at 18}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==DiGeorge (Velocardiofacial) Syndrome==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;CATCH 22&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039;ardiac abnormalities&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;bnormal facies&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039;hymic aplasia&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039;left palate&lt;br /&gt;
* &#039;&#039;&#039;H&#039;&#039;&#039;ypocalcemia&lt;br /&gt;
* &#039;&#039;&#039;22&#039;&#039;&#039;q11 deletion &lt;br /&gt;
&lt;br /&gt;
==Marfan Syndrome Features==&lt;br /&gt;
# &#039;&#039;&#039;M&#039;&#039;&#039;itral valve prolapse - MVP&lt;br /&gt;
# &#039;&#039;&#039;A&#039;&#039;&#039;ortic Aneurysm&lt;br /&gt;
# &#039;&#039;&#039;R&#039;&#039;&#039;etinal detachment&lt;br /&gt;
# &#039;&#039;&#039;F&#039;&#039;&#039;ibrillin&lt;br /&gt;
# &#039;&#039;&#039;A&#039;&#039;&#039;rachnodactyly&lt;br /&gt;
# &#039;&#039;&#039;N&#039;&#039;&#039;egative &#039;&#039;&#039;N&#039;&#039;&#039;itroprusside test (differentiates from homocystinuria) &lt;br /&gt;
&lt;br /&gt;
==Adult Polycystic Kidney Disease==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&amp;quot;Polycystic kidney&amp;quot;&#039; has &#039;&#039;&#039;16 letters&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
Also,  and is due to a defect on chromosome 16.&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;APKD&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
ADult Polycystic Kidney Disease is  Autosomal Dominant&lt;br /&gt;
&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;Navy&amp;quot;&amp;gt;&#039;&#039;&#039;13. PEDIATRICS&#039;&#039;&#039;&amp;lt;/font&amp;gt;&lt;br /&gt;
==APGAR Score==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;APGAR&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;ppearance (color): blue/pale, trunk pink, all pink&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039;ulse (heart rate): 0, &amp;lt;100, 100+&lt;br /&gt;
* &#039;&#039;&#039;G&#039;&#039;&#039;rimace (reflex irritability): 0, grimace, grimace+cough&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;ctivity (muscle tone): limp, some, active&lt;br /&gt;
* &#039;&#039;&#039;R&#039;&#039;&#039;espiration (respiratory effort): 0, irregular, regular&lt;br /&gt;
- Score 0-2 at 1 and 5 minutes in each of 5 categories, being 10 the perfect score.&lt;/div&gt;</summary>
		<author><name>Gonzalo Romero</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=WBR_mnemonics&amp;diff=936896</id>
		<title>WBR mnemonics</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=WBR_mnemonics&amp;diff=936896"/>
		<updated>2014-02-01T00:11:44Z</updated>

		<summary type="html">&lt;p&gt;Gonzalo Romero: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Board review project}}&lt;br /&gt;
[[Image:Main_help_page_small.PNG|100px|link=Help]][[Image:Projects.PNG|100px|link=Projects]][[Image:Editor&#039;s_Tools.PNG|100px|link=Help Menu]]&lt;br /&gt;
&#039;&#039;&#039;Editor-In-Chief:&#039;&#039;&#039; [[User:William J Gibson|Will Gibson]];  {{AE}}  [[User:Gonzalo Romero|Gonzalo A. Romero, M.D.]][mailto:gromero@wikidoc.org];{{Rim}};[[User:Sergekorjian|Serge Korjian]]; [[User:YazanDaaboul|Yazan Daaboul]]; {{VR}}; {{M.P}}; {{AO}}; {{MS}};&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font color=&amp;quot;Navy&amp;quot;&amp;gt;&#039;&#039;&#039;1. ANATOMY&#039;&#039;&#039;&amp;lt;/font&amp;gt;&lt;br /&gt;
==GI Anatomy==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;D&#039;&#039;&#039;ow &#039;&#039;&#039;J&#039;&#039;&#039;ones &#039;&#039;&#039;I&#039;&#039;&#039;ndustrial &#039;&#039;&#039;A&#039;&#039;&#039;verage &#039;&#039;&#039;C&#039;&#039;&#039;losing &#039;&#039;&#039;S&#039;&#039;&#039;tock &#039;&#039;&#039;R&#039;&#039;&#039;eport}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&#039;&#039;From proximal to distal:&#039;&#039;&lt;br /&gt;
# &#039;&#039;&#039;D&#039;&#039;&#039;uodenum&lt;br /&gt;
# &#039;&#039;&#039;J&#039;&#039;&#039;ejunum&lt;br /&gt;
# &#039;&#039;&#039;I&#039;&#039;&#039;leum&lt;br /&gt;
# &#039;&#039;&#039;A&#039;&#039;&#039;ppendix&lt;br /&gt;
# &#039;&#039;&#039;C&#039;&#039;&#039;olon&lt;br /&gt;
# &#039;&#039;&#039;S&#039;&#039;&#039;igmoid&lt;br /&gt;
# &#039;&#039;&#039;R&#039;&#039;&#039;ectum&lt;br /&gt;
&lt;br /&gt;
==Brachial Plexus Organization==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Radical Teachers Drink Cold Beers&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Randy Travis Drinks Cold Beers&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Robert Taylor Drinks Cold Beer&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Red Trucks Drive Cats Nuts&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
# Roots&lt;br /&gt;
# Trunks&lt;br /&gt;
# Divisions&lt;br /&gt;
# Cords&lt;br /&gt;
# Branches&lt;br /&gt;
&lt;br /&gt;
==Cranial Nerves==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;On Old Olympus Towering Tops, A Finn And German Viewed Some Hops&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Our Only Object To Touch And Feel Virgin Girls Vagina And Hymen&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
# I - olfactory&lt;br /&gt;
# II - optic&lt;br /&gt;
# III - oculomotor&lt;br /&gt;
# IV - trochlear&lt;br /&gt;
# V - trigeminal&lt;br /&gt;
# VI - abducens&lt;br /&gt;
# VII - facial&lt;br /&gt;
# VIII - acoustic (vestibulocochlear)&lt;br /&gt;
# IX - glossophrayngeal&lt;br /&gt;
# X - vagus&lt;br /&gt;
# XI - accessory&lt;br /&gt;
# XII - hypoglossal&lt;br /&gt;
&lt;br /&gt;
==Extraocular Muscles Innervation==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;LR6 SO4 3&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;LR 6&#039;&#039;&#039; - &#039;&#039;&#039;L&#039;&#039;&#039;ateral &#039;&#039;&#039;R&#039;&#039;&#039;ectus by the &#039;&#039;&#039;VI&#039;&#039;&#039;  cranial nerve (Abducens)&lt;br /&gt;
* &#039;&#039;&#039;SO 4&#039;&#039;&#039; - &#039;&#039;&#039;S&#039;&#039;&#039;uperior &#039;&#039;&#039;O&#039;&#039;&#039;blique by the &#039;&#039;&#039;IV&#039;&#039;&#039; cranial nerve (Trochlear)&lt;br /&gt;
* &#039;&#039;&#039;3&#039;&#039;&#039; - The remaining by the &#039;&#039;&#039;III&#039;&#039;&#039; cranial nerve (Occulomotor)&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;LAST&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039; - &#039;&#039;&#039;L&#039;&#039;&#039;ateral Rectus&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;bducens Nerve&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039; - &#039;&#039;&#039;S&#039;&#039;&#039;uperior Oblique&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039; - &#039;&#039;&#039;T&#039;&#039;&#039;rochlear Nerve&lt;br /&gt;
&lt;br /&gt;
==Facial Nerve Branches==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Two Zebras Bought My Car&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Two Zebras Bit My Cookie&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;To Zanzibar By Motor Car&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Ten Zulus Buggered My Cat&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
# Temporal&lt;br /&gt;
# Zygomatic&lt;br /&gt;
# Buccal&lt;br /&gt;
# Mandibular&lt;br /&gt;
# Cervical&lt;br /&gt;
&lt;br /&gt;
==Penis Innervation==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;P&#039;&#039;&#039;oint and &#039;&#039;&#039;S&#039;&#039;&#039;hoot}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039;arasympathetic causes erection&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039;ympathetic causes ejaculation&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;S2, 3, 4 keep the penis off the floor&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* Innervation of the penis by branches of the pudendal nerve, derived from spinal cord levels &#039;&#039;&#039;S 2-4&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
==Aorta Branches==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;ABC&#039;S&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;ortic arch gives off the:&lt;br /&gt;
# &#039;&#039;&#039;B&#039;&#039;&#039; - &#039;&#039;&#039;B&#039;&#039;&#039;racheiocephalic trunk&lt;br /&gt;
# &#039;&#039;&#039;C&#039;&#039;&#039; - Left &#039;&#039;&#039;C&#039;&#039;&#039;ommon &#039;&#039;&#039;C&#039;&#039;&#039;arotid&lt;br /&gt;
# &#039;&#039;&#039;S&#039;&#039;&#039; - Left &#039;&#039;&#039;S&#039;&#039;&#039;ubclavian artery&lt;br /&gt;
&lt;br /&gt;
==Femoral Triangle Structures in Order==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;N (AVEL)&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;N&#039;&#039;&#039;erve&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;rtery&lt;br /&gt;
* &#039;&#039;&#039;V&#039;&#039;&#039;ein&lt;br /&gt;
* &#039;&#039;&#039;E&#039;&#039;&#039;mpty space&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039;ymphatics&lt;br /&gt;
- Parenthesis includes things contained in the femoral sheath.&lt;br /&gt;
&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;navy&amp;quot;&amp;gt;&#039;&#039;&#039;2. CELL BIOLOGY&#039;&#039;&#039;&amp;lt;/font&amp;gt;&lt;br /&gt;
==Cell Division Phases==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;People Meet And Talk&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039; - &#039;&#039;&#039;P&#039;&#039;&#039;rophase&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039; - &#039;&#039;&#039;M&#039;&#039;&#039;etaphase&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;naphase&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039; - &#039;&#039;&#039;T&#039;&#039;&#039;elophase&lt;br /&gt;
&lt;br /&gt;
==Cell Cycle Stages==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Go Sally Go! Make Children!&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;G1&#039;&#039;&#039; phase - Growth phase 1&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039; phase - DNA synthesis&lt;br /&gt;
* &#039;&#039;&#039;G2&#039;&#039;&#039; phase - Growth phase 2&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039; phase - Mitosis&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039; phase - Cytokinesis&lt;br /&gt;
&lt;br /&gt;
==Golgi Complex Functions==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Golgi Distributes A SPAM&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;Distributes&#039;&#039;&#039; proteins and lipids from ER&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;dd mannose onto specific lysosome proteins&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039;ulfation of sugars and slected tyrosine&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039;roteoglycan assembly&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;dd O-oligosugars to serine and threnonine&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039;odify N-ologosugars on asparagine&lt;br /&gt;
&lt;br /&gt;
==Collagen==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;COLLAGEN&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039; - &#039;&#039;&#039;C&#039;&#039;&#039;-terminal propeptide (procollagen) / &#039;&#039;&#039;C&#039;&#039;&#039;ovalent &#039;&#039;&#039;C&#039;&#039;&#039;ross links/ &#039;&#039;&#039;C&#039;&#039;&#039; vitamin/ &#039;&#039;&#039;C&#039;&#039;&#039;onnective tissue/ &#039;&#039;&#039;C&#039;&#039;&#039;artilage/&#039;&#039;&#039;C&#039;&#039;&#039;hondroblasts/&#039;&#039;&#039;C&#039;&#039;&#039;opper Cofactor (Covalent Cross linking)&lt;br /&gt;
* &#039;&#039;&#039;O&#039;&#039;&#039; - &#039;&#039;&#039;O&#039;&#039;&#039;utside the cell is where collagen normally functions/ &#039;&#039;&#039;O&#039;&#039;&#039;steoblasts/ &#039;&#039;&#039;O&#039;&#039;&#039;steogenesis imperfecta&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039; - &#039;&#039;&#039;L&#039;&#039;&#039;ysyl hydroxylase / &#039;&#039;&#039;L&#039;&#039;&#039;ysyl oxidase (oxidatively deaminates lysyl and hydroxylysyl residues to form collagen cross links, last biosynthesis step)&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039; - &#039;&#039;&#039;L&#039;&#039;&#039;ong triple helical fibers / &#039;&#039;&#039;L&#039;&#039;&#039;igaments&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;lpha chains / &#039;&#039;&#039;A&#039;&#039;&#039;ttached by H bonds form triple helix / &#039;&#039;&#039;A&#039;&#039;&#039;scorbate for hydroxylation of lysyl and prolyl residues of pro-Alpha chains&lt;br /&gt;
(postranslational modification)&lt;br /&gt;
* &#039;&#039;&#039;G&#039;&#039;&#039; - &#039;&#039;&#039;G&#039;&#039;&#039;ly in every third position / &#039;&#039;&#039;G&#039;&#039;&#039;lycosylation of hydroxyl group of hydroxylysine with &#039;&#039;&#039;G&#039;&#039;&#039;lucose and &#039;&#039;&#039;G&#039;&#039;&#039;alactose;&#039;&#039;&#039;GO&#039;&#039;&#039;lgi allows procollagen to &#039;&#039;&#039;GO&#039;&#039;&#039; outside of cell&lt;br /&gt;
* &#039;&#039;&#039;E&#039;&#039;&#039; - &#039;&#039;&#039;E&#039;&#039;&#039;xtracellular matrix / &#039;&#039;&#039;E&#039;&#039;&#039;ye (cornea, sclera) / &#039;&#039;&#039;E&#039;&#039;&#039;hlers-Danlos Syndrome&lt;br /&gt;
* &#039;&#039;&#039;N&#039;&#039;&#039; - &#039;&#039;&#039;N&#039;&#039;&#039;-terminal propeptide (procollagen) / &#039;&#039;&#039;N&#039;&#039;&#039;onhelical terminal extensions&lt;br /&gt;
&lt;br /&gt;
==Carbon Monoxide: Electron Transport Chain Target==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;CO blocks CO&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
Carbon monoxide &#039;&#039;&#039;(CO)&#039;&#039;&#039; blocks Cytochrome Oxidase &#039;&#039;&#039;(CO)&#039;&#039;&#039; &lt;br /&gt;
&lt;br /&gt;
==Hemoglobin Binding Curve: Right Shift Causes==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;CADET, face right!&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* C = Increase in carbon dioxide&lt;br /&gt;
* A = Acidosis (low ph)&lt;br /&gt;
* D = Increase in 2,3 DPG aka 2,3 BPG&lt;br /&gt;
* E = Exercise&lt;br /&gt;
* T = increase in temperature&lt;br /&gt;
&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;Navy&amp;quot;&amp;gt;&#039;&#039;&#039;3. RECEPTORS&#039;&#039;&#039;&amp;lt;/font&amp;gt;&lt;br /&gt;
==G-proteins Receptors== &lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;QISS &amp;amp; QIQ&amp;quot; (Kiss and Kick)&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
In alphabetical order&lt;br /&gt;
* Q: alpha 1&lt;br /&gt;
* I: alpha 2&lt;br /&gt;
* S: beta 1&lt;br /&gt;
* S: beta 2&lt;br /&gt;
* &amp;amp;&lt;br /&gt;
* Q: M1&lt;br /&gt;
* I: M2&lt;br /&gt;
* Q: M3 &lt;br /&gt;
&lt;br /&gt;
==Adrenaline Mechanism==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;ABC of Adrenaline&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* Adrenaline--&amp;gt; activates&lt;br /&gt;
* Beta receptors--&amp;gt; increases&lt;br /&gt;
* Cyclic AMP&lt;br /&gt;
&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;Navy&amp;quot;&amp;gt;&#039;&#039;&#039;4. BIOCHEMISTRY&#039;&#039;&#039;&amp;lt;/font&amp;gt;&lt;br /&gt;
==Enzymes Classification==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Over The HILL&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;O&#039;&#039;&#039; - &#039;&#039;&#039;O&#039;&#039;&#039;xidoreductases&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039; - &#039;&#039;&#039;T&#039;&#039;&#039;ransferases&lt;br /&gt;
* &#039;&#039;&#039;H&#039;&#039;&#039; - &#039;&#039;&#039;H&#039;&#039;&#039;ydrolases&lt;br /&gt;
* &#039;&#039;&#039;I&#039;&#039;&#039; - &#039;&#039;&#039;I&#039;&#039;&#039;somerases&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039; - &#039;&#039;&#039;L&#039;&#039;&#039;igases&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039; - &#039;&#039;&#039;L&#039;&#039;&#039;yases&lt;br /&gt;
&lt;br /&gt;
==Glycolysis Enzymes==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Hungry Peter Pan And The Growling Pink Panther Eat Pies&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* Hexokinase&lt;br /&gt;
* Phosphohexo isomerase&lt;br /&gt;
* Phosphofructokinase-1 (6-phosphofructo-1 kinase)&lt;br /&gt;
* Aldolase, Triose phosphate isomerase&lt;br /&gt;
* Glyceraldehyde 3-phosphate dehydrogenase&lt;br /&gt;
* Phosphoglycerate kinase&lt;br /&gt;
* Phosphoglycerate mutase&lt;br /&gt;
* Enolase&lt;br /&gt;
* Pyruvate kinase&lt;br /&gt;
&lt;br /&gt;
==Glycolysis Steps==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Goodness Gracious, Father Franklin Did Go By Picking Pumpkins (to) Prepare Pies&#039;&#039;&#039;}}&amp;lt;/font&amp;gt; &lt;br /&gt;
* Glucose&lt;br /&gt;
* Glucose-6-P&lt;br /&gt;
* Fructose-6-P&lt;br /&gt;
* Fructose-1,6-diP&lt;br /&gt;
* Dihydroxyacetone-P&lt;br /&gt;
* Glyceraldehyde-P&lt;br /&gt;
* 1,3-Biphosphoglycerate&lt;br /&gt;
* 3-Phosphoglycerate&lt;br /&gt;
* 2-Phosphoglycerate (to)&lt;br /&gt;
* Phosphoenolpyruvate [PEP] Pyruvate • &#039;Did&#039;, &#039;By&#039; and &#039;Pies&#039; tell you the first part of those three: di-, bi-, and py-. &lt;br /&gt;
• &#039;PrEPare&#039; tells location of PEP in the process. &lt;br /&gt;
&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;Navy&amp;quot;&amp;gt;&#039;&#039;&#039;5. METABOLISM&#039;&#039;&#039;&amp;lt;/font&amp;gt;&lt;br /&gt;
==Metabolism Sites==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Use both arms to HUG&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
# Heme synthesis&lt;br /&gt;
# Urea cycle&lt;br /&gt;
# Gluconeogenesis&lt;br /&gt;
These reactions occur in both cytoplasm and mitochondria&lt;br /&gt;
&lt;br /&gt;
==AcetylCoA and AcetacetylCoA==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;A Lighter Lease (A LyTr LeIs)&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
Amino acids forming them:&lt;br /&gt;
* A=AcetylCoA or Acetoacetyl CoA&lt;br /&gt;
* Ly=Lysine&lt;br /&gt;
* Tr=Tryptophan&lt;br /&gt;
* Le=Leucine&lt;br /&gt;
* Is=Isoleucine &lt;br /&gt;
&lt;br /&gt;
==Citric Acid Cycle Compounds==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Our City Is Kept Safe And Sound From Malice&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* Oxaloacetate&lt;br /&gt;
* Citrate&lt;br /&gt;
* Isocitrate&lt;br /&gt;
* alpha-Ketoglutarate&lt;br /&gt;
* Succinyl-CoA&lt;br /&gt;
* Succinate&lt;br /&gt;
* Fumarate&lt;br /&gt;
* Malate&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Can I Keep Selling Sex For Money, Officer?&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* Citrate&lt;br /&gt;
* Isocitrate&lt;br /&gt;
* alpha-Ketogluterate&lt;br /&gt;
* Succinyl CoA&lt;br /&gt;
* Succinate&lt;br /&gt;
* Fumerate&lt;br /&gt;
* Malate&lt;br /&gt;
* Oxaloacetate&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Oh! Can I Keep Some Succinate For Myself?&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Oh Citric Acid Is Of (course) A SiLly STupid Funny Molecule&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* Oxaloacetate&lt;br /&gt;
* Citrate&lt;br /&gt;
* Isocitrate, alpha-Ketoglutarate&lt;br /&gt;
* Succinyl CoA&lt;br /&gt;
* Succinate&lt;br /&gt;
* Fumarate&lt;br /&gt;
* Malate &lt;br /&gt;
&lt;br /&gt;
==Citric Acid Cycle Enzymes==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Corrupt Anti Intelligence Agent Spoke Slander For Money&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* Citrate synthatase&lt;br /&gt;
* Aconitase&lt;br /&gt;
* Isocitrate dehydrogenase&lt;br /&gt;
* Alpha ketogluturate dehydrogenase&lt;br /&gt;
* Succinyl CoA synthetase&lt;br /&gt;
* Succinate dehydrogenase&lt;br /&gt;
* Fumarase&lt;br /&gt;
* Malate Dehydrogenase&lt;br /&gt;
&lt;br /&gt;
==Essential Amino Acids==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;P&#039;&#039;&#039; ri &#039;&#039;&#039;V&#039;&#039;&#039; a &#039;&#039;&#039;T&#039;&#039;&#039; e   &#039;&#039;&#039;TIM   HALL&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;PVT. TIM HALL&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;&amp;quot;PVT. TIM HALL always argues, never tires&amp;quot;&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039; - &#039;&#039;&#039;P&#039;&#039;&#039;he&lt;br /&gt;
* &#039;&#039;&#039;V&#039;&#039;&#039; - &#039;&#039;&#039;V&#039;&#039;&#039;al&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039; - &#039;&#039;&#039;T&#039;&#039;&#039;hr&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039; - &#039;&#039;&#039;T&#039;&#039;&#039;rp&lt;br /&gt;
* &#039;&#039;&#039;I&#039;&#039;&#039; - &#039;&#039;&#039;I&#039;&#039;&#039;le&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039; - &#039;&#039;&#039;M&#039;&#039;&#039;et&lt;br /&gt;
* &#039;&#039;&#039;H&#039;&#039;&#039; - &#039;&#039;&#039;H&#039;&#039;&#039;is&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;rg&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039; - &#039;&#039;&#039;L&#039;&#039;&#039;eu&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039; - &#039;&#039;&#039;L&#039;&#039;&#039;ys&lt;br /&gt;
* Pvt. is short for Private in the military&lt;br /&gt;
* Arg and His are considered semi-essential&lt;br /&gt;
* Alternatively: &#039;&#039;&#039;MATT VIL PHLy&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
==Creatine Phosphate: Amino Acid Precursors==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Nice GAMs!&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;G&#039;&#039;&#039; - &#039;&#039;&#039;G&#039;&#039;&#039;lycine&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;rginine&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039; - &#039;&#039;&#039;M&#039;&#039;&#039;ethionine&lt;br /&gt;
&lt;br /&gt;
==Branched Chain Amino Acids Catabolism Steps==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Truck hit the Ox to Death&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039; - &#039;&#039;&#039;T&#039;&#039;&#039;ransamination&lt;br /&gt;
* &#039;&#039;&#039;O&#039;&#039;&#039; - &#039;&#039;&#039;O&#039;&#039;&#039;xidative decarboxylation&lt;br /&gt;
* &#039;&#039;&#039;D&#039;&#039;&#039; - &#039;&#039;&#039;D&#039;&#039;&#039;ehydrogenation&lt;br /&gt;
&lt;br /&gt;
==Branched-chain Amino Acids Used by Skeletal Muscle (Fasting State)==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Muscles LIVe fast&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* Leucine&lt;br /&gt;
* Isoleucine&lt;br /&gt;
* Valine&lt;br /&gt;
&lt;br /&gt;
==Urea Cycle==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;O&#039;&#039;&#039;rdinarily &#039;&#039;&#039;C&#039;&#039;&#039;areless &#039;&#039;&#039;C&#039;&#039;&#039;rappers &#039;&#039;&#039;A&#039;&#039;&#039;re &#039;&#039;&#039;A&#039;&#039;&#039;lso &#039;&#039;&#039;F&#039;&#039;&#039;rivolous &#039;&#039;&#039;A&#039;&#039;&#039;bout &#039;&#039;&#039;U&#039;&#039;&#039;rination!}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;O&#039;&#039;&#039; - &#039;&#039;&#039;O&#039;&#039;&#039;rnithine&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039; - &#039;&#039;&#039;C&#039;&#039;&#039;arbamoyl&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039; - &#039;&#039;&#039;C&#039;&#039;&#039;itrulline&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;spartate&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;rginosuccinate&lt;br /&gt;
* &#039;&#039;&#039;F&#039;&#039;&#039; - &#039;&#039;&#039;F&#039;&#039;&#039;umarate&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;rginine&lt;br /&gt;
* &#039;&#039;&#039;U&#039;&#039;&#039; - &#039;&#039;&#039;U&#039;&#039;&#039;rea&lt;br /&gt;
&lt;br /&gt;
==Pyrimidines Nucleotides==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;CUT the PY (pie)&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039;ytosine&lt;br /&gt;
* &#039;&#039;&#039;U&#039;&#039;&#039;racil&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039;hiamine &lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039;he&lt;br /&gt;
* &#039;&#039;&#039;PY&#039;&#039;&#039;rimidines &lt;br /&gt;
&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;Navy&amp;quot;&amp;gt;&#039;&#039;&#039;6. ENZYME DEFICIENCIES&#039;&#039;&#039;&amp;lt;/font&amp;gt;&lt;br /&gt;
==G6PD: Oxidant Drugs Inducing Hemolytic Anemia == &lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;AAA&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* Antibiotic (eg: sufamethoxazole)&lt;br /&gt;
* Antimalarial (eg: primaquine)&lt;br /&gt;
* Antipyretics (eg: acetanilid, but not aspirin or acetaminophen)&lt;br /&gt;
&lt;br /&gt;
==Pompe&#039;s Disease==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Type &amp;quot;Police: Po + lys&amp;quot;&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;PO&#039;&#039;&#039;mpe&#039;s disease is a &#039;&#039;&#039;LYS&#039;&#039;&#039;osomal storage disease (alpha 1,4 glucosidase)&lt;br /&gt;
&lt;br /&gt;
==Galactosemia==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;GALIPUT&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* Galactose 1 Phosphate Uridyl Transferase&lt;br /&gt;
* There is an assay called the Galiput test for this&lt;br /&gt;
&lt;br /&gt;
==Fabry&#039;s Disease==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;FABRY &#039; S&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;F&#039;&#039;&#039; - &#039;&#039;&#039;F&#039;&#039;&#039;oam cells found in glomeruli and tubules / &#039;&#039;&#039;F&#039;&#039;&#039;ebrile episodes&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;lpha galactosidase &#039;&#039;&#039;A&#039;&#039;&#039; deficiency / &#039;&#039;&#039;A&#039;&#039;&#039;ngiokeratomas&lt;br /&gt;
* &#039;&#039;&#039;B&#039;&#039;&#039; - &#039;&#039;&#039;B&#039;&#039;&#039;urning pain in extremities / &#039;&#039;&#039;B&#039;&#039;&#039;UN increased in serum / &#039;&#039;&#039;B&#039;&#039;&#039;oys&lt;br /&gt;
* &#039;&#039;&#039;R&#039;&#039;&#039; - &#039;&#039;&#039;R&#039;&#039;&#039;enal failure&lt;br /&gt;
* &#039;&#039;&#039;Y&#039;&#039;&#039; - &#039;&#039;&#039;Y&#039;&#039;&#039;X genotype (male, X linked recessive)&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039; - &#039;&#039;&#039;S&#039;&#039;&#039;phingolipidoses&lt;br /&gt;
&lt;br /&gt;
==Hurler Syndrome Features== &lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;HURLER&#039;S&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
*&#039;&#039;&#039;H&#039;&#039;&#039;eptosplenomegaly &lt;br /&gt;
*&#039;&#039;&#039;U&#039;&#039;&#039;gly facies &lt;br /&gt;
*&#039;&#039;&#039;R&#039;&#039;&#039;ecessive (AR inheritance) &lt;br /&gt;
*&#039;&#039;&#039;L&#039;&#039;&#039;-iduronidase deficiency (alpha) &lt;br /&gt;
*&#039;&#039;&#039;E&#039;&#039;&#039;yes clouded &lt;br /&gt;
*&#039;&#039;&#039;R&#039;&#039;&#039;etarded &lt;br /&gt;
*&#039;&#039;&#039;S&#039;&#039;&#039;tubby fingers/&#039;&#039;&#039;S&#039;&#039;&#039;hort &lt;br /&gt;
&lt;br /&gt;
==Acute Intermittent Porphyria== &lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;5  P&#039;s &#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039;ain in abdomen&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039;olyneuropathy&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039;sychologial abnormalities&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039;ink urine&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039;recipitated by drugs (eg barbiturates, oral contraceptives, sulpha drugs)&lt;br /&gt;
&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;Navy&amp;quot;&amp;gt;&#039;&#039;&#039;7. VITAMINS&#039;&#039;&#039;&amp;lt;/font&amp;gt;&lt;br /&gt;
==B Vitamins==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;The Rhythm Nearly Proved Contagious&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
In increasing order: &lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039; - &#039;&#039;&#039;T&#039;&#039;&#039;hiamine (B1)&lt;br /&gt;
* &#039;&#039;&#039;R&#039;&#039;&#039; - &#039;&#039;&#039;R&#039;&#039;&#039;iboflavin (B2)&lt;br /&gt;
* &#039;&#039;&#039;N&#039;&#039;&#039; - &#039;&#039;&#039;N&#039;&#039;&#039;iacin (B3)&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039; - &#039;&#039;&#039;P&#039;&#039;&#039;yridoxine (B6)&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039; - &#039;&#039;&#039;C&#039;&#039;&#039;obalamin (B12)&lt;br /&gt;
&lt;br /&gt;
==Niacin Deficiency==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;The famous 4 D&#039;s&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
# Diarrhea&lt;br /&gt;
# Dermatitis&lt;br /&gt;
# Dementia&lt;br /&gt;
# Death (if untreated) &lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;The 3D&#039;s of pellagra&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
Vitamin B3 (niacin, nicotinic acid) deficiency&lt;br /&gt;
# Dermatitis&lt;br /&gt;
# Diarrhea&lt;br /&gt;
# Dementia&lt;br /&gt;
&lt;br /&gt;
==Folate Deficiency Causes==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;A FOLIC DROP&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* Alcoholism&lt;br /&gt;
* Folic acid antagonists&lt;br /&gt;
* Oral contraceptives&lt;br /&gt;
* Low dietary intake&lt;br /&gt;
* Infection with Giardia&lt;br /&gt;
* Celiac sprue&lt;br /&gt;
* Dilatin&lt;br /&gt;
* Relative folate deficiency&lt;br /&gt;
* Old&lt;br /&gt;
* Pregnant &lt;br /&gt;
&lt;br /&gt;
==Fat Soluble Vitamins==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;The FAT cat is in the ADEK (attic)&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
Fat soluble vitamins are &#039;&#039;A,D,E,K.&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
==Hypervitaminosis A==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|Increased Vitamin A makes you &#039;&#039;&#039;HARD&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;H&#039;&#039;&#039; - &#039;&#039;&#039;H&#039;&#039;&#039;eadache / &#039;&#039;&#039;H&#039;&#039;&#039;epatomegaly&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;norexia / &#039;&#039;&#039;A&#039;&#039;&#039;lopecia&lt;br /&gt;
* &#039;&#039;&#039;R&#039;&#039;&#039; - &#039;&#039;&#039;R&#039;&#039;&#039;eally painful bones&lt;br /&gt;
* &#039;&#039;&#039;D&#039;&#039;&#039; - &#039;&#039;&#039;D&#039;&#039;&#039;ry skin / &#039;&#039;&#039;D&#039;&#039;&#039;rowsiness&lt;br /&gt;
&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;Navy&amp;quot;&amp;gt;&#039;&#039;&#039;8. HISTORY TAKING&#039;&#039;&#039;&amp;lt;/font&amp;gt;&lt;br /&gt;
==Alcoholism Screening==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;CAGE&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* Have you ever felt it necessary to &#039;&#039;&#039;C&#039;&#039;&#039;UT DOWN on your drinking?&lt;br /&gt;
* Have you ever been &#039;&#039;&#039;A&#039;&#039;&#039;NNOYED when people suggest you cut down on your drinking?&lt;br /&gt;
* Have you ever felt &#039;&#039;&#039;G&#039;&#039;&#039;UILTY about your drinking?&lt;br /&gt;
* Have you ever felt the need to have a drink in the morning for an &#039;&#039;&#039;E&#039;&#039;&#039;YE OPENER?&lt;br /&gt;
&lt;br /&gt;
==Chief Complaint==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;OPQRST&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;O&#039;&#039;&#039; - &#039;&#039;&#039;O&#039;&#039;&#039;nset of pain:  what was the patient doing when the pain started?&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039; - &#039;&#039;&#039;P&#039;&#039;&#039;alliative or &#039;&#039;&#039;P&#039;&#039;&#039;rovocative factors for the pain&lt;br /&gt;
* &#039;&#039;&#039;Q&#039;&#039;&#039; - &#039;&#039;&#039;Q&#039;&#039;&#039;uality of pain (burning, stabbing, aching, etc.)&lt;br /&gt;
* &#039;&#039;&#039;R&#039;&#039;&#039; - &#039;&#039;&#039;R&#039;&#039;&#039;adiation (up to jaw, down left arm, etc.)&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039; - &#039;&#039;&#039;S&#039;&#039;&#039;everity of pain (usually 1 - 10 scale)&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039; - &#039;&#039;&#039;T&#039;&#039;&#039;iming of pain (eg: after meals, in the morning, how long it lasts, etc.)&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;SOCRATES&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039; - &#039;&#039;&#039;S&#039;&#039;&#039;ite of pain&lt;br /&gt;
* &#039;&#039;&#039;O&#039;&#039;&#039; - &#039;&#039;&#039;O&#039;&#039;&#039;nset of pain&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039; - &#039;&#039;&#039;C&#039;&#039;&#039;haracter of pain: dull, sharp, aching, stabbing, tearing&lt;br /&gt;
* &#039;&#039;&#039;R&#039;&#039;&#039; - &#039;&#039;&#039;R&#039;&#039;&#039;adiation of pain: central abdominal pain radiating to Right Iliac Fossa&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;ssociated factors: eg. nausea/vomiting&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039; - &#039;&#039;&#039;T&#039;&#039;&#039;iming of pain/duration&lt;br /&gt;
* &#039;&#039;&#039;E&#039;&#039;&#039; - &#039;&#039;&#039;E&#039;&#039;&#039;xacerbating/alleviating factors&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039; - &#039;&#039;&#039;S&#039;&#039;&#039;everity of pain (1 - 10 scale)&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;ASCLAST&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;ggravatiing and &#039;&#039;&#039;A&#039;&#039;&#039;lleviating factors&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039; - &#039;&#039;&#039;S&#039;&#039;&#039;everity&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039; - &#039;&#039;&#039;C&#039;&#039;&#039;haracter, quality&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039; - &#039;&#039;&#039;L&#039;&#039;&#039;ocation&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;ssociated symptoms&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039; - &#039;&#039;&#039;S&#039;&#039;&#039;etting&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039; - &#039;&#039;&#039;T&#039;&#039;&#039;iming&lt;br /&gt;
&lt;br /&gt;
NOTE: ASCLAST means let the patient talk first, then ask him/her specific questions.&lt;br /&gt;
&lt;br /&gt;
==Hospital Admission Orders==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;DAVE WILMINGTON&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;D&#039;&#039;&#039;iet&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;ctivity&lt;br /&gt;
* &#039;&#039;&#039;V&#039;&#039;&#039;ital signs: how often to monitor&lt;br /&gt;
* &#039;&#039;&#039;E&#039;&#039;&#039;xcrement: test urine/stool&lt;br /&gt;
* &#039;&#039;&#039;W&#039;&#039;&#039;eight: how often to monitor&lt;br /&gt;
* &#039;&#039;&#039;I&#039;&#039;&#039; / O: monitor input/output&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039;abs: which/how often&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039;eds: which/route/interval&lt;br /&gt;
* &#039;&#039;&#039;I&#039;&#039;&#039; V fluids: what/at what rate&lt;br /&gt;
* &#039;&#039;&#039;N&#039;&#039;&#039;ursing care: e.g. position, wound care, up in chair, ostomy care&lt;br /&gt;
* &#039;&#039;&#039;G&#039;&#039;&#039;eneral care: e.g. physical/respiratory therapy&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039;ests: e.g. X-ray/EKG/EEG&lt;br /&gt;
* &#039;&#039;&#039;O&#039;&#039;&#039;bserve for: reaction/seizure/neuro exams&lt;br /&gt;
* &#039;&#039;&#039;N&#039;&#039;&#039;otify parameters: e.g. Temperature &amp;gt; 100 F / respiration changes&lt;br /&gt;
&lt;br /&gt;
After noting date and time of admission as well as diagnosis and condition (ADC), use the mnemonic to ensure all areas are addressed, but not all apply to every patient.&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;ADC VAAN DIML&#039;&#039;&#039;, pronounced ADC van dim(e)L}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;dmit: 23 hours, full admit, service of attending&lt;br /&gt;
* &#039;&#039;&#039;D&#039;&#039;&#039;iagnosis&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039;ondition: &amp;quot;Stable&amp;quot;/&amp;quot;Guarded&amp;quot;&lt;br /&gt;
* &#039;&#039;&#039;V&#039;&#039;&#039;itals: post-op, routine, q 1 hour&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;llergies&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;ctivities: strict bed rest/fall precautions/ad lib/bathroom privileges&lt;br /&gt;
* &#039;&#039;&#039;N&#039;&#039;&#039;ursing: strict I&amp;amp;O&#039;s/daily weights/call P.R.N.&lt;br /&gt;
* &#039;&#039;&#039;D&#039;&#039;&#039;iet: NPO/regular/clears/advance diet as tolerated/2000 cal ADA/renal&lt;br /&gt;
* &#039;&#039;&#039;I&#039;&#039;&#039;V fluids: D5, 1/2 NS, 20 KCL at 110 ml/hr, LR @ 100 ml/hr&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039;eds: scheduled and PRN&#039;s&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039;abs and X-ray: CBC in AM, PCXR in PACU&lt;br /&gt;
&lt;br /&gt;
Note that IV fluids follows Diet. If one writes NPO, then &#039;&#039;&#039;all&#039;&#039;&#039; such patients get maintenance fluids (use the 4-2-1 rule).&lt;br /&gt;
&lt;br /&gt;
==Post-Op Fever Causes==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Five W&#039;s&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;W&#039;&#039;&#039;ind: pneumonia, atelectasis&lt;br /&gt;
* &#039;&#039;&#039;W&#039;&#039;&#039;ound: wound infections&lt;br /&gt;
* &#039;&#039;&#039;W&#039;&#039;&#039;ater: urinary tract infection&lt;br /&gt;
* &#039;&#039;&#039;W&#039;&#039;&#039;alking: DVT/PE (walking can help reduce DVT/PE)&lt;br /&gt;
* &#039;&#039;&#039;W&#039;&#039;&#039;onderdrugs: especially anesthesia&lt;br /&gt;
&lt;br /&gt;
==Predisposing Conditions for Pulmonary Embolism==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;TOM SCH PREFER&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039; - &#039;&#039;&#039;T&#039;&#039;&#039;rauma&lt;br /&gt;
* &#039;&#039;&#039;O&#039;&#039;&#039; - &#039;&#039;&#039;O&#039;&#039;&#039;besity&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039; - &#039;&#039;&#039;M&#039;&#039;&#039;alignancy&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039; - &#039;&#039;&#039;S&#039;&#039;&#039;urgery&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039; - &#039;&#039;&#039;C&#039;&#039;&#039;ardiac disease&lt;br /&gt;
* &#039;&#039;&#039;H&#039;&#039;&#039; - &#039;&#039;&#039;H&#039;&#039;&#039;ospitalization&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039; - &#039;&#039;&#039;P&#039;&#039;&#039;ast history&lt;br /&gt;
* &#039;&#039;&#039;R&#039;&#039;&#039; - &#039;&#039;&#039;R&#039;&#039;&#039;est (bed-bound)&lt;br /&gt;
* &#039;&#039;&#039;E&#039;&#039;&#039; - &#039;&#039;&#039;E&#039;&#039;&#039;strogen, pregnancy, post-partum&lt;br /&gt;
* &#039;&#039;&#039;F&#039;&#039;&#039; - &#039;&#039;&#039;F&#039;&#039;&#039;racture&lt;br /&gt;
* &#039;&#039;&#039;E&#039;&#039;&#039; - &#039;&#039;&#039;E&#039;&#039;&#039;lderly&lt;br /&gt;
* &#039;&#039;&#039;R&#039;&#039;&#039; - &#039;&#039;&#039;R&#039;&#039;&#039;oad trip&lt;br /&gt;
&lt;br /&gt;
==Compartment Syndrome Signs (Arterial Occlusion)==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;6 P&#039;s&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
# Pain&lt;br /&gt;
# Pale (Pallor)&lt;br /&gt;
# Perishing with Cold (Poikilothermia)&lt;br /&gt;
# Pulseless&lt;br /&gt;
# Paresthesias&lt;br /&gt;
# Paralysis&lt;br /&gt;
&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;Navy&amp;quot;&amp;gt;&#039;&#039;&#039;9. PATHOLOGY&#039;&#039;&#039;&amp;lt;/font&amp;gt;&lt;br /&gt;
==Causes of Diseases==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;VITAMIN C&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
*&#039;&#039;&#039;V&#039;&#039;&#039;ascular&lt;br /&gt;
*&#039;&#039;&#039;I&#039;&#039;&#039;nfectious&lt;br /&gt;
*&#039;&#039;&#039;T&#039;&#039;&#039;rauma&lt;br /&gt;
*&#039;&#039;&#039;A&#039;&#039;&#039;uto-immune&lt;br /&gt;
*&#039;&#039;&#039;M&#039;&#039;&#039;etabolic&lt;br /&gt;
*&#039;&#039;&#039;I&#039;&#039;&#039;diopathic/Iatrogenic&lt;br /&gt;
*&#039;&#039;&#039;N&#039;&#039;&#039;eoplastic&lt;br /&gt;
*&#039;&#039;&#039;C&#039;&#039;&#039;ongenital&lt;br /&gt;
&lt;br /&gt;
==5 Signs of Inflammation==&lt;br /&gt;
# &#039;&#039;&#039;Rubor&#039;&#039;&#039;: redness/erythema&lt;br /&gt;
# &#039;&#039;&#039;Calor&#039;&#039;&#039;: raised temperature&lt;br /&gt;
# &#039;&#039;&#039;Tumor&#039;&#039;&#039;: swelling&lt;br /&gt;
# &#039;&#039;&#039;Dolor&#039;&#039;&#039;: pain&lt;br /&gt;
# &#039;&#039;&#039;Functio Laesa&#039;&#039;&#039;: loss of function&lt;br /&gt;
- Described by Celsus&lt;br /&gt;
&lt;br /&gt;
==Hypersentivity Reactions (Gell &amp;amp; Goombs Classification)==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;ACID&#039;&#039;&#039;}}&amp;lt;/font&amp;gt; &amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;A&#039;&#039;&#039;nna &#039;&#039;&#039;C&#039;&#039;&#039;ycled &#039;&#039;&#039;I&#039;&#039;&#039;mmediately &#039;&#039;&#039;D&#039;&#039;&#039;ownhill}}&amp;lt;/font&amp;gt; &lt;br /&gt;
# Type I   &#039;&#039;&#039;A&#039;&#039;&#039;naphylaxis&lt;br /&gt;
# Type II  &#039;&#039;&#039;C&#039;&#039;&#039;ytotoxic-mediated&lt;br /&gt;
# Type III &#039;&#039;&#039;I&#039;&#039;&#039;mmune-complex&lt;br /&gt;
# Type IV  &#039;&#039;&#039;D&#039;&#039;&#039;elayed hypersensitivity&lt;br /&gt;
&lt;br /&gt;
==Multiple Endocrine Neoplasia (MEN)==&lt;br /&gt;
Each of the MENs is a disease of &#039;&#039;&#039;three or two letters plus a feature&#039;&#039;&#039;; all are autosomal dominant.&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;MEN I:  3 P&#039;s&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
# &#039;&#039;&#039;P&#039;&#039;&#039;ituitary&lt;br /&gt;
# &#039;&#039;&#039;P&#039;&#039;&#039;arathyroid&lt;br /&gt;
# &#039;&#039;&#039;P&#039;&#039;&#039;ancreas&lt;br /&gt;
# Plus Adrenal cortex&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;MEN II:  2 C&#039;s&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
# &#039;&#039;&#039;C&#039;&#039;&#039;arcinoma of thyroid&lt;br /&gt;
# &#039;&#039;&#039;C&#039;&#039;&#039;atacholamines (pheochromocytoma)&lt;br /&gt;
- MEN IIA: parathyroid&lt;br /&gt;
- MEN IIB (MEN III): mucocutaneous neuromas for&lt;br /&gt;
&lt;br /&gt;
==Acute Pneumonia Infiltrates==&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039;yogenic bacteria: &#039;&#039;&#039;P&#039;&#039;&#039;MN infiltrate&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039;iscellaneous microbes: &#039;&#039;&#039;M&#039;&#039;&#039;ononuclear infiltrate&lt;br /&gt;
&lt;br /&gt;
==Takayasu&#039;s Disease/Pulseless Disease== &lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;When you have Takayasu&#039;s, I can&#039;t Tak&#039;a yu pulse&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==CBC Normal Differential==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;N&#039;&#039;&#039;ever &#039;&#039;&#039;L&#039;&#039;&#039;et &#039;&#039;&#039;M&#039;&#039;&#039;onkeys &#039;&#039;&#039;E&#039;&#039;&#039;at &#039;&#039;&#039;B&#039;&#039;&#039;ananas}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;N&#039;&#039;&#039;ice &#039;&#039;&#039;L&#039;&#039;&#039;adies &#039;&#039;&#039;M&#039;&#039;&#039;ake &#039;&#039;&#039;E&#039;&#039;&#039;aster &#039;&#039;&#039;B&#039;&#039;&#039;read&amp;quot;}}&amp;lt;/font&amp;gt;  &lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;60&#039;&#039;&#039;, &#039;&#039;&#039;30&#039;&#039;&#039;, &#039;&#039;&#039;6&#039;&#039;&#039;, &#039;&#039;&#039;3&#039;&#039;&#039;, &#039;&#039;&#039;1&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
# &#039;&#039;&#039;N&#039;&#039;&#039;eutrophils: &#039;&#039;&#039;60&#039;&#039;&#039;%&lt;br /&gt;
# &#039;&#039;&#039;L&#039;&#039;&#039;ymphocytes: &#039;&#039;&#039;30&#039;&#039;&#039;%&lt;br /&gt;
# &#039;&#039;&#039;M&#039;&#039;&#039;onocytes: &#039;&#039;&#039;6&#039;&#039;&#039;%&lt;br /&gt;
# &#039;&#039;&#039;E&#039;&#039;&#039;osinophils: &#039;&#039;&#039;3&#039;&#039;&#039;%&lt;br /&gt;
# &#039;&#039;&#039;B&#039;&#039;&#039;asophils: &#039;&#039;&#039;1&#039;&#039;&#039;%&lt;br /&gt;
&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;Navy&amp;quot;&amp;gt;&#039;&#039;&#039;10. CAUSES&#039;&#039;&#039;&amp;lt;/font&amp;gt;&lt;br /&gt;
==Metabolic Acidosis Causes==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;MUDPILES&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039;ethanol poisoning&lt;br /&gt;
* &#039;&#039;&#039;U&#039;&#039;&#039;remia&lt;br /&gt;
* &#039;&#039;&#039;D&#039;&#039;&#039;iabetic Keto-acidosis&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039;ara-aldehyde ingestion&lt;br /&gt;
* &#039;&#039;&#039;I&#039;&#039;&#039;schemia&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039;actic Acidosis&lt;br /&gt;
* &#039;&#039;&#039;E&#039;&#039;&#039;thanol poisoning&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039;alicylate ingestion&lt;br /&gt;
&lt;br /&gt;
==Metabolic Acidosis (Normal Anion-Gap) Causes==&lt;br /&gt;
===With Hyperkalemia===&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;RAISE K+&#039;&#039;&#039;}}&amp;lt;/font&amp;gt; &lt;br /&gt;
* RTA type 4&lt;br /&gt;
* Aldosterone or mineralocorticord deficiency&lt;br /&gt;
* Iatrogenic: NH4Cl, HCl&lt;br /&gt;
* &amp;quot;Stenosis&amp;quot;: obstructive uropathy&lt;br /&gt;
* Early uremia &lt;br /&gt;
===With hypokalemia===&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;ReDUCE K+&#039;&#039;&#039;}}&amp;lt;/font&amp;gt; &lt;br /&gt;
* Renal TA type 1 and 2&lt;br /&gt;
* Diarrhoea&lt;br /&gt;
* Urine diversion into gut&lt;br /&gt;
* Carbonate anhydrase inhibitor&lt;br /&gt;
* Ex-hyperventilation&lt;br /&gt;
&lt;br /&gt;
==BUN &amp;amp; Creatinine Elevation Causes==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;ABCD&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;zotremia (pre-renal)&lt;br /&gt;
* &#039;&#039;&#039;B&#039;&#039;&#039; - &#039;&#039;&#039;B&#039;&#039;&#039;leeding (GI)&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039; - &#039;&#039;&#039;C&#039;&#039;&#039;atabolic status&lt;br /&gt;
* &#039;&#039;&#039;D&#039;&#039;&#039; - &#039;&#039;&#039;D&#039;&#039;&#039;iet (high protein parenteral nutrition)&lt;br /&gt;
&lt;br /&gt;
==Hypercalcemia Causes==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;PAM SCHMIDT&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;                       &lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039;aget&#039;s Disease&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;myloid&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039;ultiple Myeloma&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039;arcoid&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039;ancer&lt;br /&gt;
* &#039;&#039;&#039;H&#039;&#039;&#039;ormomal (para-thyroid)&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039;ilk-alkali Syndrome&lt;br /&gt;
* &#039;&#039;&#039;I&#039;&#039;&#039;mmobilization&lt;br /&gt;
* &#039;&#039;&#039;D&#039;&#039;&#039;-vitamin overdose&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039;hyrotoxicosis&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;OR&#039;&#039;&#039;&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;MISHAP&#039;&#039;&#039;}}&amp;lt;/font&amp;gt; &lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039;alignancy&lt;br /&gt;
* &#039;&#039;&#039;I&#039;&#039;&#039;ntoxication (hypervitaminosis)&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039;arcoidosis&lt;br /&gt;
* &#039;&#039;&#039;H&#039;&#039;&#039;yperparathyroidism&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;lkali (Milk) syndrome&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039;aget&#039;s Disease (bone)&lt;br /&gt;
Also consider Addison&#039;s disease, thiazide diuretics and simple lab error&lt;br /&gt;
&lt;br /&gt;
==Acute Pancreatitis Causes==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;GET SMASHED&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
# &#039;&#039;&#039;G&#039;&#039;&#039;all stones&lt;br /&gt;
# &#039;&#039;&#039;E&#039;&#039;&#039;thanol&lt;br /&gt;
# &#039;&#039;&#039;T&#039;&#039;&#039;rauma&lt;br /&gt;
# &#039;&#039;&#039;S&#039;&#039;&#039;teroids&lt;br /&gt;
# &#039;&#039;&#039;M&#039;&#039;&#039;umps&lt;br /&gt;
# &#039;&#039;&#039;A&#039;&#039;&#039;utoimmune disease&lt;br /&gt;
# &#039;&#039;&#039;S&#039;&#039;&#039;corpion venom&lt;br /&gt;
# &#039;&#039;&#039;H&#039;&#039;&#039;yperlipidemia&lt;br /&gt;
# &#039;&#039;&#039;E&#039;&#039;&#039;RCP (dye)&lt;br /&gt;
# &#039;&#039;&#039;D&#039;&#039;&#039;rugs (Azathioprine, Asparginase, Mercaptopurines, Pentamidine)&lt;br /&gt;
Alcohol and Gallstones are the most common causes.&lt;br /&gt;
&lt;br /&gt;
==Back Pain Causes==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;DISK MASS&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;D&#039;&#039;&#039;-&#039;&#039;&#039;D&#039;&#039;&#039;egeneration: DJD, Osteoporosis, spondylosis&lt;br /&gt;
* &#039;&#039;&#039;I&#039;&#039;&#039;-&#039;&#039;&#039;I&#039;&#039;&#039;nfection: UTI, PID, Potts, osteomyelitis, prostatitis, Injury/fracture, compression fracture&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039;-&#039;&#039;&#039;S&#039;&#039;&#039;pondylitis, ankylosing Spondyloarthropathies (rheumatoid arthritis, Reiters,  SLE)&lt;br /&gt;
* &#039;&#039;&#039;K&#039;&#039;&#039;-&#039;&#039;&#039;K&#039;&#039;&#039;idney stones/infarction/infection (pyelo/abscess)&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039;-&#039;&#039;&#039;M&#039;&#039;&#039;ultiple myeloma, &#039;&#039;&#039;M&#039;&#039;&#039;etastasis from breast, prostate, lung, thyroid, kidney CA&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;-&#039;&#039;&#039;A&#039;&#039;&#039;neurysm, &#039;&#039;&#039;A&#039;&#039;&#039;bdominal pain referred to the back (see acute abdominal pain)&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039;-&#039;&#039;&#039;S&#039;&#039;&#039;lipped disk, &#039;&#039;&#039;S&#039;&#039;&#039;pondylolisthesis&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039;-&#039;&#039;&#039;S&#039;&#039;&#039;train, &#039;&#039;&#039;S&#039;&#039;&#039;coliosis/lordosis, &#039;&#039;&#039;S&#039;&#039;&#039;kin: herpes zoster&lt;br /&gt;
&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;Navy&amp;quot;&amp;gt;&#039;&#039;&#039;11. TREATMENT&#039;&#039;&#039;&amp;lt;/font&amp;gt;&lt;br /&gt;
==Syncope Management==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;If the face is red, raise the head!&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;If the face is pale, raise the tail!&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Malignant Hyperthermia Treatment==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Sunday Hot Day, Better Give Iced Fluids Today!&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039;- Stop all triggering agents, give 100% O2&lt;br /&gt;
* &#039;&#039;&#039;H&#039;&#039;&#039;- Hyperventillate&lt;br /&gt;
* &#039;&#039;&#039;D&#039;&#039;&#039;- Dantrolene 2.5 mg/kg&lt;br /&gt;
* &#039;&#039;&#039;B&#039;&#039;&#039;- Bicarbonate&lt;br /&gt;
* &#039;&#039;&#039;G&#039;&#039;&#039;- Glucose and Insulin&lt;br /&gt;
* &#039;&#039;&#039;I&#039;&#039;&#039;- IV Fluids, Cooling Blanket&lt;br /&gt;
* &#039;&#039;&#039;F&#039;&#039;&#039;- Fluid Output; Furosemide&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039;- Tachycardia, be prepared to treat V Tach&lt;br /&gt;
&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;Navy&amp;quot;&amp;gt;&#039;&#039;&#039;12. GENETICS&#039;&#039;&#039;&amp;lt;/font&amp;gt;&lt;br /&gt;
==Down Syndrome Features==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;CHILD HAS PROBLEM!&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039;ongenital heart disease/ &#039;&#039;&#039;C&#039;&#039;&#039;ataracts&lt;br /&gt;
* &#039;&#039;&#039;H&#039;&#039;&#039;ypotonia/ Hypothyroidism&lt;br /&gt;
* &#039;&#039;&#039;I&#039;&#039;&#039;ncure 5th finger/ &#039;&#039;&#039;I&#039;&#039;&#039;ncreased gap between 1st and 2nd toe&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039;eukemia risk x2/ &#039;&#039;&#039;L&#039;&#039;&#039;ung problem&lt;br /&gt;
* &#039;&#039;&#039;D&#039;&#039;&#039;uodenal atresia/ &#039;&#039;&#039;D&#039;&#039;&#039;elayed development &lt;br /&gt;
* &#039;&#039;&#039;H&#039;&#039;&#039;irshsprung&#039;s disease/ &#039;&#039;&#039;H&#039;&#039;&#039;earing loss&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;lzheimer&#039;s disease/ Alantoaxial instability&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039;quint/ Short neck &lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039;rotruding tongue/ &#039;&#039;&#039;P&#039;&#039;&#039;alm crease&lt;br /&gt;
* &#039;&#039;&#039;R&#039;&#039;&#039;ound face/ &#039;&#039;&#039;R&#039;&#039;&#039;olling eye (nystagmus)&lt;br /&gt;
* &#039;&#039;&#039;O&#039;&#039;&#039;cciput flat/ &#039;&#039;&#039;O&#039;&#039;&#039;blique eye fissure&lt;br /&gt;
* &#039;&#039;&#039;B&#039;&#039;&#039;rushfield spot/ &#039;&#039;&#039;B&#039;&#039;&#039;rachycephaly&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039;ow nasal bridge/ &#039;&#039;&#039;L&#039;&#039;&#039;anguage problem&lt;br /&gt;
* &#039;&#039;&#039;E&#039;&#039;&#039;picanthic fold/ &#039;&#039;&#039;E&#039;&#039;&#039;ar folded&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039;ental retardation/ &#039;&#039;&#039;M&#039;&#039;&#039;yoclonus &lt;br /&gt;
&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;DOWN&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;D&#039;&#039;&#039;ecreased alpha-fetoprotein and unconjugated estriol (maternal)&lt;br /&gt;
* &#039;&#039;&#039;O&#039;&#039;&#039;ne extra chromosome twenty-one&lt;br /&gt;
* &#039;&#039;&#039;W&#039;&#039;&#039;omen of advanced age&lt;br /&gt;
* &#039;&#039;&#039;N&#039;&#039;&#039;on-disjunction during maternal meiosis &lt;br /&gt;
&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Drink at 21&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
Chromosome 21&lt;br /&gt;
&lt;br /&gt;
==Patau&#039;s Syndrome - Chromosome 13==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;P&#039;&#039;&#039;uberty at 13}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Edward&#039;s Syndrome - Chromosome 18==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|Election voter at 18}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==DiGeorge (Velocardiofacial) Syndrome==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;CATCH 22&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039;ardiac abnormalities&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;bnormal facies&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039;hymic aplasia&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039;left palate&lt;br /&gt;
* &#039;&#039;&#039;H&#039;&#039;&#039;ypocalcemia&lt;br /&gt;
* &#039;&#039;&#039;22&#039;&#039;&#039;q11 deletion &lt;br /&gt;
&lt;br /&gt;
==Marfan Syndrome Features==&lt;br /&gt;
# &#039;&#039;&#039;M&#039;&#039;&#039;itral valve prolapse - MVP&lt;br /&gt;
# &#039;&#039;&#039;A&#039;&#039;&#039;ortic Aneurysm&lt;br /&gt;
# &#039;&#039;&#039;R&#039;&#039;&#039;etinal detachment&lt;br /&gt;
# &#039;&#039;&#039;F&#039;&#039;&#039;ibrillin&lt;br /&gt;
# &#039;&#039;&#039;A&#039;&#039;&#039;rachnodactyly&lt;br /&gt;
# &#039;&#039;&#039;N&#039;&#039;&#039;egative &#039;&#039;&#039;N&#039;&#039;&#039;itroprusside test (differentiates from homocystinuria) &lt;br /&gt;
&lt;br /&gt;
==Adult Polycystic Kidney Disease==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&amp;quot;Polycystic kidney&amp;quot;&#039; has &#039;&#039;&#039;16 letters&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
Also,  and is due to a defect on chromosome 16.&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;APKD&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
ADult Polycystic Kidney Disease is  Autosomal Dominant&lt;br /&gt;
&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;Navy&amp;quot;&amp;gt;&#039;&#039;&#039;13. PEDIATRICS&#039;&#039;&#039;&amp;lt;/font&amp;gt;&lt;br /&gt;
==APGAR Score==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;APGAR&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;ppearance (color): blue/pale, trunk pink, all pink&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039;ulse (heart rate): 0, &amp;lt;100, 100+&lt;br /&gt;
* &#039;&#039;&#039;G&#039;&#039;&#039;rimace (reflex irritability): 0, grimace, grimace+cough&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;ctivity (muscle tone): limp, some, active&lt;br /&gt;
* &#039;&#039;&#039;R&#039;&#039;&#039;espiration (respiratory effort): 0, irregular, regular&lt;br /&gt;
- Score 0-2 at 1 and 5 minutes in each of 5 categories, being 10 the perfect score.&lt;/div&gt;</summary>
		<author><name>Gonzalo Romero</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=WBR_mnemonics&amp;diff=936895</id>
		<title>WBR mnemonics</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=WBR_mnemonics&amp;diff=936895"/>
		<updated>2014-02-01T00:01:39Z</updated>

		<summary type="html">&lt;p&gt;Gonzalo Romero: /* Adrenaline Mechanism */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Board review project}}&lt;br /&gt;
[[Image:Main_help_page_small.PNG|100px|link=Help]][[Image:Projects.PNG|100px|link=Projects]][[Image:Editor&#039;s_Tools.PNG|100px|link=Help Menu]]&lt;br /&gt;
&#039;&#039;&#039;Editor-In-Chief:&#039;&#039;&#039; [[User:William J Gibson|Will Gibson]];  {{AE}}  [[User:Gonzalo Romero|Gonzalo A. Romero, M.D.]][mailto:gromero@wikidoc.org];{{Rim}};[[User:Sergekorjian|Serge Korjian]]; [[User:YazanDaaboul|Yazan Daaboul]]; {{VR}}; {{M.P}}; {{AO}}; {{MS}};&lt;br /&gt;
&lt;br /&gt;
==ANATOMY==&lt;br /&gt;
==GI Anatomy==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;D&#039;&#039;&#039;ow &#039;&#039;&#039;J&#039;&#039;&#039;ones &#039;&#039;&#039;I&#039;&#039;&#039;ndustrial &#039;&#039;&#039;A&#039;&#039;&#039;verage &#039;&#039;&#039;C&#039;&#039;&#039;losing &#039;&#039;&#039;S&#039;&#039;&#039;tock &#039;&#039;&#039;R&#039;&#039;&#039;eport}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&#039;&#039;From proximal to distal:&#039;&#039;&lt;br /&gt;
# &#039;&#039;&#039;D&#039;&#039;&#039;uodenum&lt;br /&gt;
# &#039;&#039;&#039;J&#039;&#039;&#039;ejunum&lt;br /&gt;
# &#039;&#039;&#039;I&#039;&#039;&#039;leum&lt;br /&gt;
# &#039;&#039;&#039;A&#039;&#039;&#039;ppendix&lt;br /&gt;
# &#039;&#039;&#039;C&#039;&#039;&#039;olon&lt;br /&gt;
# &#039;&#039;&#039;S&#039;&#039;&#039;igmoid&lt;br /&gt;
# &#039;&#039;&#039;R&#039;&#039;&#039;ectum&lt;br /&gt;
&lt;br /&gt;
==Brachial Plexus Organization==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Radical Teachers Drink Cold Beers&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Randy Travis Drinks Cold Beers&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Robert Taylor Drinks Cold Beer&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Red Trucks Drive Cats Nuts&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
# Roots&lt;br /&gt;
# Trunks&lt;br /&gt;
# Divisions&lt;br /&gt;
# Cords&lt;br /&gt;
# Branches&lt;br /&gt;
&lt;br /&gt;
==Cranial Nerves==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;On Old Olympus Towering Tops, A Finn And German Viewed Some Hops&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Our Only Object To Touch And Feel Virgin Girls Vagina And Hymen&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
# I - olfactory&lt;br /&gt;
# II - optic&lt;br /&gt;
# III - oculomotor&lt;br /&gt;
# IV - trochlear&lt;br /&gt;
# V - trigeminal&lt;br /&gt;
# VI - abducens&lt;br /&gt;
# VII - facial&lt;br /&gt;
# VIII - acoustic (vestibulocochlear)&lt;br /&gt;
# IX - glossophrayngeal&lt;br /&gt;
# X - vagus&lt;br /&gt;
# XI - accessory&lt;br /&gt;
# XII - hypoglossal&lt;br /&gt;
&lt;br /&gt;
==Extraocular Muscles Innervation==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;LR6 SO4 3&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;LR 6&#039;&#039;&#039; - &#039;&#039;&#039;L&#039;&#039;&#039;ateral &#039;&#039;&#039;R&#039;&#039;&#039;ectus by the &#039;&#039;&#039;VI&#039;&#039;&#039;  cranial nerve (Abducens)&lt;br /&gt;
* &#039;&#039;&#039;SO 4&#039;&#039;&#039; - &#039;&#039;&#039;S&#039;&#039;&#039;uperior &#039;&#039;&#039;O&#039;&#039;&#039;blique by the &#039;&#039;&#039;IV&#039;&#039;&#039; cranial nerve (Trochlear)&lt;br /&gt;
* &#039;&#039;&#039;3&#039;&#039;&#039; - The remaining by the &#039;&#039;&#039;III&#039;&#039;&#039; cranial nerve (Occulomotor)&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;LAST&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039; - &#039;&#039;&#039;L&#039;&#039;&#039;ateral Rectus&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;bducens Nerve&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039; - &#039;&#039;&#039;S&#039;&#039;&#039;uperior Oblique&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039; - &#039;&#039;&#039;T&#039;&#039;&#039;rochlear Nerve&lt;br /&gt;
&lt;br /&gt;
==Facial Nerve Branches==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Two Zebras Bought My Car&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Two Zebras Bit My Cookie&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;To Zanzibar By Motor Car&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Ten Zulus Buggered My Cat&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
# Temporal&lt;br /&gt;
# Zygomatic&lt;br /&gt;
# Buccal&lt;br /&gt;
# Mandibular&lt;br /&gt;
# Cervical&lt;br /&gt;
&lt;br /&gt;
==Penis Innervation==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;P&#039;&#039;&#039;oint and &#039;&#039;&#039;S&#039;&#039;&#039;hoot}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039;arasympathetic causes erection&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039;ympathetic causes ejaculation&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;S2, 3, 4 keep the penis off the floor&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* Innervation of the penis by branches of the pudendal nerve, derived from spinal cord levels &#039;&#039;&#039;S 2-4&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
==Aorta Branches==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;ABC&#039;S&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;ortic arch gives off the:&lt;br /&gt;
# &#039;&#039;&#039;B&#039;&#039;&#039; - &#039;&#039;&#039;B&#039;&#039;&#039;racheiocephalic trunk&lt;br /&gt;
# &#039;&#039;&#039;C&#039;&#039;&#039; - Left &#039;&#039;&#039;C&#039;&#039;&#039;ommon &#039;&#039;&#039;C&#039;&#039;&#039;arotid&lt;br /&gt;
# &#039;&#039;&#039;S&#039;&#039;&#039; - Left &#039;&#039;&#039;S&#039;&#039;&#039;ubclavian artery&lt;br /&gt;
&lt;br /&gt;
==Femoral Triangle Structures in Order==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;N (AVEL)&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;N&#039;&#039;&#039;erve&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;rtery&lt;br /&gt;
* &#039;&#039;&#039;V&#039;&#039;&#039;ein&lt;br /&gt;
* &#039;&#039;&#039;E&#039;&#039;&#039;mpty space&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039;ymphatics&lt;br /&gt;
- Parenthesis includes things contained in the femoral sheath.&lt;br /&gt;
&lt;br /&gt;
==CELL BIOLOGY==&lt;br /&gt;
==Cell Division Phases==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;People Meet And Talk&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039; - &#039;&#039;&#039;P&#039;&#039;&#039;rophase&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039; - &#039;&#039;&#039;M&#039;&#039;&#039;etaphase&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;naphase&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039; - &#039;&#039;&#039;T&#039;&#039;&#039;elophase&lt;br /&gt;
&lt;br /&gt;
==Cell Cycle Stages==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Go Sally Go! Make Children!&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;G1&#039;&#039;&#039; phase - Growth phase 1&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039; phase - DNA synthesis&lt;br /&gt;
* &#039;&#039;&#039;G2&#039;&#039;&#039; phase - Growth phase 2&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039; phase - Mitosis&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039; phase - Cytokinesis&lt;br /&gt;
&lt;br /&gt;
==Golgi Complex Functions==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Golgi Distributes A SPAM&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;Distributes&#039;&#039;&#039; proteins and lipids from ER&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;dd mannose onto specific lysosome proteins&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039;ulfation of sugars and slected tyrosine&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039;roteoglycan assembly&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;dd O-oligosugars to serine and threnonine&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039;odify N-ologosugars on asparagine&lt;br /&gt;
&lt;br /&gt;
==Collagen==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;COLLAGEN&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039; - &#039;&#039;&#039;C&#039;&#039;&#039;-terminal propeptide (procollagen) / &#039;&#039;&#039;C&#039;&#039;&#039;ovalent &#039;&#039;&#039;C&#039;&#039;&#039;ross links/ &#039;&#039;&#039;C&#039;&#039;&#039; vitamin/ &#039;&#039;&#039;C&#039;&#039;&#039;onnective tissue/ &#039;&#039;&#039;C&#039;&#039;&#039;artilage/&#039;&#039;&#039;C&#039;&#039;&#039;hondroblasts/&#039;&#039;&#039;C&#039;&#039;&#039;opper Cofactor (Covalent Cross linking)&lt;br /&gt;
* &#039;&#039;&#039;O&#039;&#039;&#039; - &#039;&#039;&#039;O&#039;&#039;&#039;utside the cell is where collagen normally functions/ &#039;&#039;&#039;O&#039;&#039;&#039;steoblasts/ &#039;&#039;&#039;O&#039;&#039;&#039;steogenesis imperfecta&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039; - &#039;&#039;&#039;L&#039;&#039;&#039;ysyl hydroxylase / &#039;&#039;&#039;L&#039;&#039;&#039;ysyl oxidase (oxidatively deaminates lysyl and hydroxylysyl residues to form collagen cross links, last biosynthesis step)&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039; - &#039;&#039;&#039;L&#039;&#039;&#039;ong triple helical fibers / &#039;&#039;&#039;L&#039;&#039;&#039;igaments&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;lpha chains / &#039;&#039;&#039;A&#039;&#039;&#039;ttached by H bonds form triple helix / &#039;&#039;&#039;A&#039;&#039;&#039;scorbate for hydroxylation of lysyl and prolyl residues of pro-Alpha chains&lt;br /&gt;
(postranslational modification)&lt;br /&gt;
* &#039;&#039;&#039;G&#039;&#039;&#039; - &#039;&#039;&#039;G&#039;&#039;&#039;ly in every third position / &#039;&#039;&#039;G&#039;&#039;&#039;lycosylation of hydroxyl group of hydroxylysine with &#039;&#039;&#039;G&#039;&#039;&#039;lucose and &#039;&#039;&#039;G&#039;&#039;&#039;alactose;&#039;&#039;&#039;GO&#039;&#039;&#039;lgi allows procollagen to &#039;&#039;&#039;GO&#039;&#039;&#039; outside of cell&lt;br /&gt;
* &#039;&#039;&#039;E&#039;&#039;&#039; - &#039;&#039;&#039;E&#039;&#039;&#039;xtracellular matrix / &#039;&#039;&#039;E&#039;&#039;&#039;ye (cornea, sclera) / &#039;&#039;&#039;E&#039;&#039;&#039;hlers-Danlos Syndrome&lt;br /&gt;
* &#039;&#039;&#039;N&#039;&#039;&#039; - &#039;&#039;&#039;N&#039;&#039;&#039;-terminal propeptide (procollagen) / &#039;&#039;&#039;N&#039;&#039;&#039;onhelical terminal extensions&lt;br /&gt;
&lt;br /&gt;
==Carbon Monoxide: Electron Transport Chain Target==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;CO blocks CO&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
Carbon monoxide &#039;&#039;&#039;(CO)&#039;&#039;&#039; blocks Cytochrome Oxidase &#039;&#039;&#039;(CO)&#039;&#039;&#039; &lt;br /&gt;
&lt;br /&gt;
==Hemoglobin Binding Curve: Right Shift Causes==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;CADET, face right!&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* C = Increase in carbon dioxide&lt;br /&gt;
* A = Acidosis (low ph)&lt;br /&gt;
* D = Increase in 2,3 DPG aka 2,3 BPG&lt;br /&gt;
* E = Exercise&lt;br /&gt;
* T = increase in temperature&lt;br /&gt;
&lt;br /&gt;
==RECEPTORS==&lt;br /&gt;
==G-proteins Receptors== &lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;QISS &amp;amp; QIQ&amp;quot; (Kiss and Kick)&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
In alphabetical order&lt;br /&gt;
* Q: alpha 1&lt;br /&gt;
* I: alpha 2&lt;br /&gt;
* S: beta 1&lt;br /&gt;
* S: beta 2&lt;br /&gt;
* &amp;amp;&lt;br /&gt;
* Q: M1&lt;br /&gt;
* I: M2&lt;br /&gt;
* Q: M3 &lt;br /&gt;
&lt;br /&gt;
==Adrenaline Mechanism==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;ABC of Adrenaline&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* Adrenaline--&amp;gt; activates&lt;br /&gt;
* Beta receptors--&amp;gt; increases&lt;br /&gt;
* Cyclic AMP&lt;br /&gt;
&lt;br /&gt;
==BIOCHEMISTRY==&lt;br /&gt;
==Enzymes Classification==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Over The HILL&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;O&#039;&#039;&#039; - &#039;&#039;&#039;O&#039;&#039;&#039;xidoreductases&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039; - &#039;&#039;&#039;T&#039;&#039;&#039;ransferases&lt;br /&gt;
* &#039;&#039;&#039;H&#039;&#039;&#039; - &#039;&#039;&#039;H&#039;&#039;&#039;ydrolases&lt;br /&gt;
* &#039;&#039;&#039;I&#039;&#039;&#039; - &#039;&#039;&#039;I&#039;&#039;&#039;somerases&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039; - &#039;&#039;&#039;L&#039;&#039;&#039;igases&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039; - &#039;&#039;&#039;L&#039;&#039;&#039;yases&lt;br /&gt;
&lt;br /&gt;
==Glycolysis Enzymes==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Hungry Peter Pan And The Growling Pink Panther Eat Pies&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* Hexokinase&lt;br /&gt;
* Phosphohexo isomerase&lt;br /&gt;
* Phosphofructokinase-1 (6-phosphofructo-1 kinase)&lt;br /&gt;
* Aldolase, Triose phosphate isomerase&lt;br /&gt;
* Glyceraldehyde 3-phosphate dehydrogenase&lt;br /&gt;
* Phosphoglycerate kinase&lt;br /&gt;
* Phosphoglycerate mutase&lt;br /&gt;
* Enolase&lt;br /&gt;
* Pyruvate kinase&lt;br /&gt;
&lt;br /&gt;
==Glycolysis Steps==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Goodness Gracious, Father Franklin Did Go By Picking Pumpkins (to) Prepare Pies&#039;&#039;&#039;}}&amp;lt;/font&amp;gt; &lt;br /&gt;
* Glucose&lt;br /&gt;
* Glucose-6-P&lt;br /&gt;
* Fructose-6-P&lt;br /&gt;
* Fructose-1,6-diP&lt;br /&gt;
* Dihydroxyacetone-P&lt;br /&gt;
* Glyceraldehyde-P&lt;br /&gt;
* 1,3-Biphosphoglycerate&lt;br /&gt;
* 3-Phosphoglycerate&lt;br /&gt;
* 2-Phosphoglycerate (to)&lt;br /&gt;
* Phosphoenolpyruvate [PEP] Pyruvate • &#039;Did&#039;, &#039;By&#039; and &#039;Pies&#039; tell you the first part of those three: di-, bi-, and py-. &lt;br /&gt;
• &#039;PrEPare&#039; tells location of PEP in the process. &lt;br /&gt;
&lt;br /&gt;
==METABOLISM==&lt;br /&gt;
==Metabolism Sites==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Use both arms to HUG&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
# Heme synthesis&lt;br /&gt;
# Urea cycle&lt;br /&gt;
# Gluconeogenesis&lt;br /&gt;
These reactions occur in both cytoplasm and mitochondria&lt;br /&gt;
&lt;br /&gt;
==AcetylCoA and AcetacetylCoA==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;A Lighter Lease (A LyTr LeIs)&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
Amino acids forming them:&lt;br /&gt;
* A=AcetylCoA or Acetoacetyl CoA&lt;br /&gt;
* Ly=Lysine&lt;br /&gt;
* Tr=Tryptophan&lt;br /&gt;
* Le=Leucine&lt;br /&gt;
* Is=Isoleucine &lt;br /&gt;
&lt;br /&gt;
==Citric Acid Cycle Compounds==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Our City Is Kept Safe And Sound From Malice&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* Oxaloacetate&lt;br /&gt;
* Citrate&lt;br /&gt;
* Isocitrate&lt;br /&gt;
* alpha-Ketoglutarate&lt;br /&gt;
* Succinyl-CoA&lt;br /&gt;
* Succinate&lt;br /&gt;
* Fumarate&lt;br /&gt;
* Malate&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Can I Keep Selling Sex For Money, Officer?&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* Citrate&lt;br /&gt;
* Isocitrate&lt;br /&gt;
* alpha-Ketogluterate&lt;br /&gt;
* Succinyl CoA&lt;br /&gt;
* Succinate&lt;br /&gt;
* Fumerate&lt;br /&gt;
* Malate&lt;br /&gt;
* Oxaloacetate&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Oh! Can I Keep Some Succinate For Myself?&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Oh Citric Acid Is Of (course) A SiLly STupid Funny Molecule&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* Oxaloacetate&lt;br /&gt;
* Citrate&lt;br /&gt;
* Isocitrate, alpha-Ketoglutarate&lt;br /&gt;
* Succinyl CoA&lt;br /&gt;
* Succinate&lt;br /&gt;
* Fumarate&lt;br /&gt;
* Malate &lt;br /&gt;
&lt;br /&gt;
==Citric Acid Cycle Enzymes==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Corrupt Anti Intelligence Agent Spoke Slander For Money&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* Citrate synthatase&lt;br /&gt;
* Aconitase&lt;br /&gt;
* Isocitrate dehydrogenase&lt;br /&gt;
* Alpha ketogluturate dehydrogenase&lt;br /&gt;
* Succinyl CoA synthetase&lt;br /&gt;
* Succinate dehydrogenase&lt;br /&gt;
* Fumarase&lt;br /&gt;
* Malate Dehydrogenase&lt;br /&gt;
&lt;br /&gt;
==Essential Amino Acids==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;P&#039;&#039;&#039; ri &#039;&#039;&#039;V&#039;&#039;&#039; a &#039;&#039;&#039;T&#039;&#039;&#039; e   &#039;&#039;&#039;TIM   HALL&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;PVT. TIM HALL&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;&amp;quot;PVT. TIM HALL always argues, never tires&amp;quot;&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039; - &#039;&#039;&#039;P&#039;&#039;&#039;he&lt;br /&gt;
* &#039;&#039;&#039;V&#039;&#039;&#039; - &#039;&#039;&#039;V&#039;&#039;&#039;al&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039; - &#039;&#039;&#039;T&#039;&#039;&#039;hr&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039; - &#039;&#039;&#039;T&#039;&#039;&#039;rp&lt;br /&gt;
* &#039;&#039;&#039;I&#039;&#039;&#039; - &#039;&#039;&#039;I&#039;&#039;&#039;le&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039; - &#039;&#039;&#039;M&#039;&#039;&#039;et&lt;br /&gt;
* &#039;&#039;&#039;H&#039;&#039;&#039; - &#039;&#039;&#039;H&#039;&#039;&#039;is&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;rg&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039; - &#039;&#039;&#039;L&#039;&#039;&#039;eu&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039; - &#039;&#039;&#039;L&#039;&#039;&#039;ys&lt;br /&gt;
* Pvt. is short for Private in the military&lt;br /&gt;
* Arg and His are considered semi-essential&lt;br /&gt;
* Alternatively: &#039;&#039;&#039;MATT VIL PHLy&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
==Creatine Phosphate: Amino Acid Precursors==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Nice GAMs!&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;G&#039;&#039;&#039; - &#039;&#039;&#039;G&#039;&#039;&#039;lycine&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;rginine&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039; - &#039;&#039;&#039;M&#039;&#039;&#039;ethionine&lt;br /&gt;
&lt;br /&gt;
==Branched Chain Amino Acids Catabolism Steps==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Truck hit the Ox to Death&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039; - &#039;&#039;&#039;T&#039;&#039;&#039;ransamination&lt;br /&gt;
* &#039;&#039;&#039;O&#039;&#039;&#039; - &#039;&#039;&#039;O&#039;&#039;&#039;xidative decarboxylation&lt;br /&gt;
* &#039;&#039;&#039;D&#039;&#039;&#039; - &#039;&#039;&#039;D&#039;&#039;&#039;ehydrogenation&lt;br /&gt;
&lt;br /&gt;
==Branched-chain Amino Acids Used by Skeletal Muscle (Fasting State)==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Muscles LIVe fast&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* Leucine&lt;br /&gt;
* Isoleucine&lt;br /&gt;
* Valine&lt;br /&gt;
&lt;br /&gt;
==Urea Cycle==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;O&#039;&#039;&#039;rdinarily &#039;&#039;&#039;C&#039;&#039;&#039;areless &#039;&#039;&#039;C&#039;&#039;&#039;rappers &#039;&#039;&#039;A&#039;&#039;&#039;re &#039;&#039;&#039;A&#039;&#039;&#039;lso &#039;&#039;&#039;F&#039;&#039;&#039;rivolous &#039;&#039;&#039;A&#039;&#039;&#039;bout &#039;&#039;&#039;U&#039;&#039;&#039;rination!}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;O&#039;&#039;&#039; - &#039;&#039;&#039;O&#039;&#039;&#039;rnithine&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039; - &#039;&#039;&#039;C&#039;&#039;&#039;arbamoyl&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039; - &#039;&#039;&#039;C&#039;&#039;&#039;itrulline&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;spartate&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;rginosuccinate&lt;br /&gt;
* &#039;&#039;&#039;F&#039;&#039;&#039; - &#039;&#039;&#039;F&#039;&#039;&#039;umarate&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;rginine&lt;br /&gt;
* &#039;&#039;&#039;U&#039;&#039;&#039; - &#039;&#039;&#039;U&#039;&#039;&#039;rea&lt;br /&gt;
&lt;br /&gt;
==Pyrimidines Nucleotides==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;CUT the PY (pie)&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039;ytosine&lt;br /&gt;
* &#039;&#039;&#039;U&#039;&#039;&#039;racil&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039;hiamine &lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039;he&lt;br /&gt;
* &#039;&#039;&#039;PY&#039;&#039;&#039;rimidines &lt;br /&gt;
&lt;br /&gt;
==ENZYME DEFICIENCIES==&lt;br /&gt;
==G6PD: Oxidant Drugs Inducing Hemolytic Anemia == &lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;AAA&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* Antibiotic (eg: sufamethoxazole)&lt;br /&gt;
* Antimalarial (eg: primaquine)&lt;br /&gt;
* Antipyretics (eg: acetanilid, but not aspirin or acetaminophen)&lt;br /&gt;
&lt;br /&gt;
==Pompe&#039;s Disease==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Type &amp;quot;Police: Po + lys&amp;quot;&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;PO&#039;&#039;&#039;mpe&#039;s disease is a &#039;&#039;&#039;LYS&#039;&#039;&#039;osomal storage disease (alpha 1,4 glucosidase)&lt;br /&gt;
&lt;br /&gt;
==Galactosemia==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;GALIPUT&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* Galactose 1 Phosphate Uridyl Transferase&lt;br /&gt;
* There is an assay called the Galiput test for this&lt;br /&gt;
&lt;br /&gt;
==Fabry&#039;s Disease==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;FABRY &#039; S&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;F&#039;&#039;&#039; - &#039;&#039;&#039;F&#039;&#039;&#039;oam cells found in glomeruli and tubules / &#039;&#039;&#039;F&#039;&#039;&#039;ebrile episodes&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;lpha galactosidase &#039;&#039;&#039;A&#039;&#039;&#039; deficiency / &#039;&#039;&#039;A&#039;&#039;&#039;ngiokeratomas&lt;br /&gt;
* &#039;&#039;&#039;B&#039;&#039;&#039; - &#039;&#039;&#039;B&#039;&#039;&#039;urning pain in extremities / &#039;&#039;&#039;B&#039;&#039;&#039;UN increased in serum / &#039;&#039;&#039;B&#039;&#039;&#039;oys&lt;br /&gt;
* &#039;&#039;&#039;R&#039;&#039;&#039; - &#039;&#039;&#039;R&#039;&#039;&#039;enal failure&lt;br /&gt;
* &#039;&#039;&#039;Y&#039;&#039;&#039; - &#039;&#039;&#039;Y&#039;&#039;&#039;X genotype (male, X linked recessive)&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039; - &#039;&#039;&#039;S&#039;&#039;&#039;phingolipidoses&lt;br /&gt;
&lt;br /&gt;
==Hurler Syndrome Features== &lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;HURLER&#039;S&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
*&#039;&#039;&#039;H&#039;&#039;&#039;eptosplenomegaly &lt;br /&gt;
*&#039;&#039;&#039;U&#039;&#039;&#039;gly facies &lt;br /&gt;
*&#039;&#039;&#039;R&#039;&#039;&#039;ecessive (AR inheritance) &lt;br /&gt;
*&#039;&#039;&#039;L&#039;&#039;&#039;-iduronidase deficiency (alpha) &lt;br /&gt;
*&#039;&#039;&#039;E&#039;&#039;&#039;yes clouded &lt;br /&gt;
*&#039;&#039;&#039;R&#039;&#039;&#039;etarded &lt;br /&gt;
*&#039;&#039;&#039;S&#039;&#039;&#039;tubby fingers/&#039;&#039;&#039;S&#039;&#039;&#039;hort &lt;br /&gt;
&lt;br /&gt;
==Acute Intermittent Porphyria== &lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;5  P&#039;s &#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039;ain in abdomen&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039;olyneuropathy&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039;sychologial abnormalities&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039;ink urine&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039;recipitated by drugs (eg barbiturates, oral contraceptives, sulpha drugs)&lt;br /&gt;
&lt;br /&gt;
==VITAMINS==&lt;br /&gt;
==B Vitamins==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;The Rhythm Nearly Proved Contagious&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
In increasing order: &lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039; - &#039;&#039;&#039;T&#039;&#039;&#039;hiamine (B1)&lt;br /&gt;
* &#039;&#039;&#039;R&#039;&#039;&#039; - &#039;&#039;&#039;R&#039;&#039;&#039;iboflavin (B2)&lt;br /&gt;
* &#039;&#039;&#039;N&#039;&#039;&#039; - &#039;&#039;&#039;N&#039;&#039;&#039;iacin (B3)&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039; - &#039;&#039;&#039;P&#039;&#039;&#039;yridoxine (B6)&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039; - &#039;&#039;&#039;C&#039;&#039;&#039;obalamin (B12)&lt;br /&gt;
&lt;br /&gt;
==Niacin Deficiency==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;The famous 4 D&#039;s&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
# Diarrhea&lt;br /&gt;
# Dermatitis&lt;br /&gt;
# Dementia&lt;br /&gt;
# Death (if untreated) &lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;The 3D&#039;s of pellagra&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
Vitamin B3 (niacin, nicotinic acid) deficiency&lt;br /&gt;
# Dermatitis&lt;br /&gt;
# Diarrhea&lt;br /&gt;
# Dementia&lt;br /&gt;
&lt;br /&gt;
==Folate Deficiency Causes==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;A FOLIC DROP&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* Alcoholism&lt;br /&gt;
* Folic acid antagonists&lt;br /&gt;
* Oral contraceptives&lt;br /&gt;
* Low dietary intake&lt;br /&gt;
* Infection with Giardia&lt;br /&gt;
* Celiac sprue&lt;br /&gt;
* Dilatin&lt;br /&gt;
* Relative folate deficiency&lt;br /&gt;
* Old&lt;br /&gt;
* Pregnant &lt;br /&gt;
&lt;br /&gt;
==Fat Soluble Vitamins==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;The FAT cat is in the ADEK (attic)&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
Fat soluble vitamins are &#039;&#039;A,D,E,K.&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
==Hypervitaminosis A==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|Increased Vitamin A makes you &#039;&#039;&#039;HARD&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;H&#039;&#039;&#039; - &#039;&#039;&#039;H&#039;&#039;&#039;eadache / &#039;&#039;&#039;H&#039;&#039;&#039;epatomegaly&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;norexia / &#039;&#039;&#039;A&#039;&#039;&#039;lopecia&lt;br /&gt;
* &#039;&#039;&#039;R&#039;&#039;&#039; - &#039;&#039;&#039;R&#039;&#039;&#039;eally painful bones&lt;br /&gt;
* &#039;&#039;&#039;D&#039;&#039;&#039; - &#039;&#039;&#039;D&#039;&#039;&#039;ry skin / &#039;&#039;&#039;D&#039;&#039;&#039;rowsiness&lt;br /&gt;
&lt;br /&gt;
==HISTORY TAKING==&lt;br /&gt;
==Alcoholism Screening==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;CAGE&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* Have you ever felt it necessary to &#039;&#039;&#039;C&#039;&#039;&#039;UT DOWN on your drinking?&lt;br /&gt;
* Have you ever been &#039;&#039;&#039;A&#039;&#039;&#039;NNOYED when people suggest you cut down on your drinking?&lt;br /&gt;
* Have you ever felt &#039;&#039;&#039;G&#039;&#039;&#039;UILTY about your drinking?&lt;br /&gt;
* Have you ever felt the need to have a drink in the morning for an &#039;&#039;&#039;E&#039;&#039;&#039;YE OPENER?&lt;br /&gt;
&lt;br /&gt;
==Chief Complaint==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;OPQRST&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;O&#039;&#039;&#039; - &#039;&#039;&#039;O&#039;&#039;&#039;nset of pain:  what was the patient doing when the pain started?&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039; - &#039;&#039;&#039;P&#039;&#039;&#039;alliative or &#039;&#039;&#039;P&#039;&#039;&#039;rovocative factors for the pain&lt;br /&gt;
* &#039;&#039;&#039;Q&#039;&#039;&#039; - &#039;&#039;&#039;Q&#039;&#039;&#039;uality of pain (burning, stabbing, aching, etc.)&lt;br /&gt;
* &#039;&#039;&#039;R&#039;&#039;&#039; - &#039;&#039;&#039;R&#039;&#039;&#039;adiation (up to jaw, down left arm, etc.)&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039; - &#039;&#039;&#039;S&#039;&#039;&#039;everity of pain (usually 1 - 10 scale)&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039; - &#039;&#039;&#039;T&#039;&#039;&#039;iming of pain (eg: after meals, in the morning, how long it lasts, etc.)&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;SOCRATES&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039; - &#039;&#039;&#039;S&#039;&#039;&#039;ite of pain&lt;br /&gt;
* &#039;&#039;&#039;O&#039;&#039;&#039; - &#039;&#039;&#039;O&#039;&#039;&#039;nset of pain&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039; - &#039;&#039;&#039;C&#039;&#039;&#039;haracter of pain: dull, sharp, aching, stabbing, tearing&lt;br /&gt;
* &#039;&#039;&#039;R&#039;&#039;&#039; - &#039;&#039;&#039;R&#039;&#039;&#039;adiation of pain: central abdominal pain radiating to Right Iliac Fossa&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;ssociated factors: eg. nausea/vomiting&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039; - &#039;&#039;&#039;T&#039;&#039;&#039;iming of pain/duration&lt;br /&gt;
* &#039;&#039;&#039;E&#039;&#039;&#039; - &#039;&#039;&#039;E&#039;&#039;&#039;xacerbating/alleviating factors&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039; - &#039;&#039;&#039;S&#039;&#039;&#039;everity of pain (1 - 10 scale)&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;ASCLAST&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;ggravatiing and &#039;&#039;&#039;A&#039;&#039;&#039;lleviating factors&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039; - &#039;&#039;&#039;S&#039;&#039;&#039;everity&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039; - &#039;&#039;&#039;C&#039;&#039;&#039;haracter, quality&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039; - &#039;&#039;&#039;L&#039;&#039;&#039;ocation&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;ssociated symptoms&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039; - &#039;&#039;&#039;S&#039;&#039;&#039;etting&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039; - &#039;&#039;&#039;T&#039;&#039;&#039;iming&lt;br /&gt;
&lt;br /&gt;
NOTE: ASCLAST means let the patient talk first, then ask him/her specific questions.&lt;br /&gt;
&lt;br /&gt;
==Hospital Admission Orders==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;DAVE WILMINGTON&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;D&#039;&#039;&#039;iet&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;ctivity&lt;br /&gt;
* &#039;&#039;&#039;V&#039;&#039;&#039;ital signs: how often to monitor&lt;br /&gt;
* &#039;&#039;&#039;E&#039;&#039;&#039;xcrement: test urine/stool&lt;br /&gt;
* &#039;&#039;&#039;W&#039;&#039;&#039;eight: how often to monitor&lt;br /&gt;
* &#039;&#039;&#039;I&#039;&#039;&#039; / O: monitor input/output&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039;abs: which/how often&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039;eds: which/route/interval&lt;br /&gt;
* &#039;&#039;&#039;I&#039;&#039;&#039; V fluids: what/at what rate&lt;br /&gt;
* &#039;&#039;&#039;N&#039;&#039;&#039;ursing care: e.g. position, wound care, up in chair, ostomy care&lt;br /&gt;
* &#039;&#039;&#039;G&#039;&#039;&#039;eneral care: e.g. physical/respiratory therapy&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039;ests: e.g. X-ray/EKG/EEG&lt;br /&gt;
* &#039;&#039;&#039;O&#039;&#039;&#039;bserve for: reaction/seizure/neuro exams&lt;br /&gt;
* &#039;&#039;&#039;N&#039;&#039;&#039;otify parameters: e.g. Temperature &amp;gt; 100 F / respiration changes&lt;br /&gt;
&lt;br /&gt;
After noting date and time of admission as well as diagnosis and condition (ADC), use the mnemonic to ensure all areas are addressed, but not all apply to every patient.&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;ADC VAAN DIML&#039;&#039;&#039;, pronounced ADC van dim(e)L}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;dmit: 23 hours, full admit, service of attending&lt;br /&gt;
* &#039;&#039;&#039;D&#039;&#039;&#039;iagnosis&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039;ondition: &amp;quot;Stable&amp;quot;/&amp;quot;Guarded&amp;quot;&lt;br /&gt;
* &#039;&#039;&#039;V&#039;&#039;&#039;itals: post-op, routine, q 1 hour&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;llergies&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;ctivities: strict bed rest/fall precautions/ad lib/bathroom privileges&lt;br /&gt;
* &#039;&#039;&#039;N&#039;&#039;&#039;ursing: strict I&amp;amp;O&#039;s/daily weights/call P.R.N.&lt;br /&gt;
* &#039;&#039;&#039;D&#039;&#039;&#039;iet: NPO/regular/clears/advance diet as tolerated/2000 cal ADA/renal&lt;br /&gt;
* &#039;&#039;&#039;I&#039;&#039;&#039;V fluids: D5, 1/2 NS, 20 KCL at 110 ml/hr, LR @ 100 ml/hr&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039;eds: scheduled and PRN&#039;s&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039;abs and X-ray: CBC in AM, PCXR in PACU&lt;br /&gt;
&lt;br /&gt;
Note that IV fluids follows Diet. If one writes NPO, then &#039;&#039;&#039;all&#039;&#039;&#039; such patients get maintenance fluids (use the 4-2-1 rule).&lt;br /&gt;
&lt;br /&gt;
==Post-Op Fever Causes==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Five W&#039;s&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;W&#039;&#039;&#039;ind: pneumonia, atelectasis&lt;br /&gt;
* &#039;&#039;&#039;W&#039;&#039;&#039;ound: wound infections&lt;br /&gt;
* &#039;&#039;&#039;W&#039;&#039;&#039;ater: urinary tract infection&lt;br /&gt;
* &#039;&#039;&#039;W&#039;&#039;&#039;alking: DVT/PE (walking can help reduce DVT/PE)&lt;br /&gt;
* &#039;&#039;&#039;W&#039;&#039;&#039;onderdrugs: especially anesthesia&lt;br /&gt;
&lt;br /&gt;
==Predisposing Conditions for Pulmonary Embolism==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;TOM SCH PREFER&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039; - &#039;&#039;&#039;T&#039;&#039;&#039;rauma&lt;br /&gt;
* &#039;&#039;&#039;O&#039;&#039;&#039; - &#039;&#039;&#039;O&#039;&#039;&#039;besity&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039; - &#039;&#039;&#039;M&#039;&#039;&#039;alignancy&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039; - &#039;&#039;&#039;S&#039;&#039;&#039;urgery&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039; - &#039;&#039;&#039;C&#039;&#039;&#039;ardiac disease&lt;br /&gt;
* &#039;&#039;&#039;H&#039;&#039;&#039; - &#039;&#039;&#039;H&#039;&#039;&#039;ospitalization&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039; - &#039;&#039;&#039;P&#039;&#039;&#039;ast history&lt;br /&gt;
* &#039;&#039;&#039;R&#039;&#039;&#039; - &#039;&#039;&#039;R&#039;&#039;&#039;est (bed-bound)&lt;br /&gt;
* &#039;&#039;&#039;E&#039;&#039;&#039; - &#039;&#039;&#039;E&#039;&#039;&#039;strogen, pregnancy, post-partum&lt;br /&gt;
* &#039;&#039;&#039;F&#039;&#039;&#039; - &#039;&#039;&#039;F&#039;&#039;&#039;racture&lt;br /&gt;
* &#039;&#039;&#039;E&#039;&#039;&#039; - &#039;&#039;&#039;E&#039;&#039;&#039;lderly&lt;br /&gt;
* &#039;&#039;&#039;R&#039;&#039;&#039; - &#039;&#039;&#039;R&#039;&#039;&#039;oad trip&lt;br /&gt;
&lt;br /&gt;
==Compartment Syndrome Signs (Arterial Occlusion)==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;6 P&#039;s&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
# Pain&lt;br /&gt;
# Pale (Pallor)&lt;br /&gt;
# Perishing with Cold (Poikilothermia)&lt;br /&gt;
# Pulseless&lt;br /&gt;
# Paresthesias&lt;br /&gt;
# Paralysis&lt;br /&gt;
&lt;br /&gt;
==PATHOLOGY==&lt;br /&gt;
==Causes of Diseases==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;VITAMIN C&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
*&#039;&#039;&#039;V&#039;&#039;&#039;ascular&lt;br /&gt;
*&#039;&#039;&#039;I&#039;&#039;&#039;nfectious&lt;br /&gt;
*&#039;&#039;&#039;T&#039;&#039;&#039;rauma&lt;br /&gt;
*&#039;&#039;&#039;A&#039;&#039;&#039;uto-immune&lt;br /&gt;
*&#039;&#039;&#039;M&#039;&#039;&#039;etabolic&lt;br /&gt;
*&#039;&#039;&#039;I&#039;&#039;&#039;diopathic/Iatrogenic&lt;br /&gt;
*&#039;&#039;&#039;N&#039;&#039;&#039;eoplastic&lt;br /&gt;
*&#039;&#039;&#039;C&#039;&#039;&#039;ongenital&lt;br /&gt;
&lt;br /&gt;
==5 Signs of Inflammation==&lt;br /&gt;
# &#039;&#039;&#039;Rubor&#039;&#039;&#039;: redness/erythema&lt;br /&gt;
# &#039;&#039;&#039;Calor&#039;&#039;&#039;: raised temperature&lt;br /&gt;
# &#039;&#039;&#039;Tumor&#039;&#039;&#039;: swelling&lt;br /&gt;
# &#039;&#039;&#039;Dolor&#039;&#039;&#039;: pain&lt;br /&gt;
# &#039;&#039;&#039;Functio Laesa&#039;&#039;&#039;: loss of function&lt;br /&gt;
- Described by Celsus&lt;br /&gt;
&lt;br /&gt;
==Hypersentivity Reactions (Gell &amp;amp; Goombs Classification)==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;ACID&#039;&#039;&#039;}}&amp;lt;/font&amp;gt; &amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;A&#039;&#039;&#039;nna &#039;&#039;&#039;C&#039;&#039;&#039;ycled &#039;&#039;&#039;I&#039;&#039;&#039;mmediately &#039;&#039;&#039;D&#039;&#039;&#039;ownhill}}&amp;lt;/font&amp;gt; &lt;br /&gt;
# Type I   &#039;&#039;&#039;A&#039;&#039;&#039;naphylaxis&lt;br /&gt;
# Type II  &#039;&#039;&#039;C&#039;&#039;&#039;ytotoxic-mediated&lt;br /&gt;
# Type III &#039;&#039;&#039;I&#039;&#039;&#039;mmune-complex&lt;br /&gt;
# Type IV  &#039;&#039;&#039;D&#039;&#039;&#039;elayed hypersensitivity&lt;br /&gt;
&lt;br /&gt;
==Multiple Endocrine Neoplasia (MEN)==&lt;br /&gt;
Each of the MENs is a disease of &#039;&#039;&#039;three or two letters plus a feature&#039;&#039;&#039;; all are autosomal dominant.&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;MEN I:  3 P&#039;s&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
# &#039;&#039;&#039;P&#039;&#039;&#039;ituitary&lt;br /&gt;
# &#039;&#039;&#039;P&#039;&#039;&#039;arathyroid&lt;br /&gt;
# &#039;&#039;&#039;P&#039;&#039;&#039;ancreas&lt;br /&gt;
# Plus Adrenal cortex&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;MEN II:  2 C&#039;s&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
# &#039;&#039;&#039;C&#039;&#039;&#039;arcinoma of thyroid&lt;br /&gt;
# &#039;&#039;&#039;C&#039;&#039;&#039;atacholamines (pheochromocytoma)&lt;br /&gt;
- MEN IIA: parathyroid&lt;br /&gt;
- MEN IIB (MEN III): mucocutaneous neuromas for&lt;br /&gt;
&lt;br /&gt;
==Acute Pneumonia Infiltrates==&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039;yogenic bacteria: &#039;&#039;&#039;P&#039;&#039;&#039;MN infiltrate&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039;iscellaneous microbes: &#039;&#039;&#039;M&#039;&#039;&#039;ononuclear infiltrate&lt;br /&gt;
&lt;br /&gt;
==Takayasu&#039;s Disease/Pulseless Disease== &lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;When you have Takayasu&#039;s, I can&#039;t Tak&#039;a yu pulse&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==CBC Normal Differential==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;N&#039;&#039;&#039;ever &#039;&#039;&#039;L&#039;&#039;&#039;et &#039;&#039;&#039;M&#039;&#039;&#039;onkeys &#039;&#039;&#039;E&#039;&#039;&#039;at &#039;&#039;&#039;B&#039;&#039;&#039;ananas}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;N&#039;&#039;&#039;ice &#039;&#039;&#039;L&#039;&#039;&#039;adies &#039;&#039;&#039;M&#039;&#039;&#039;ake &#039;&#039;&#039;E&#039;&#039;&#039;aster &#039;&#039;&#039;B&#039;&#039;&#039;read&amp;quot;}}&amp;lt;/font&amp;gt;  &lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;60&#039;&#039;&#039;, &#039;&#039;&#039;30&#039;&#039;&#039;, &#039;&#039;&#039;6&#039;&#039;&#039;, &#039;&#039;&#039;3&#039;&#039;&#039;, &#039;&#039;&#039;1&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
# &#039;&#039;&#039;N&#039;&#039;&#039;eutrophils: &#039;&#039;&#039;60&#039;&#039;&#039;%&lt;br /&gt;
# &#039;&#039;&#039;L&#039;&#039;&#039;ymphocytes: &#039;&#039;&#039;30&#039;&#039;&#039;%&lt;br /&gt;
# &#039;&#039;&#039;M&#039;&#039;&#039;onocytes: &#039;&#039;&#039;6&#039;&#039;&#039;%&lt;br /&gt;
# &#039;&#039;&#039;E&#039;&#039;&#039;osinophils: &#039;&#039;&#039;3&#039;&#039;&#039;%&lt;br /&gt;
# &#039;&#039;&#039;B&#039;&#039;&#039;asophils: &#039;&#039;&#039;1&#039;&#039;&#039;%&lt;br /&gt;
&lt;br /&gt;
==CAUSES==&lt;br /&gt;
==Metabolic Acidosis Causes==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;MUDPILES&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039;ethanol poisoning&lt;br /&gt;
* &#039;&#039;&#039;U&#039;&#039;&#039;remia&lt;br /&gt;
* &#039;&#039;&#039;D&#039;&#039;&#039;iabetic Keto-acidosis&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039;ara-aldehyde ingestion&lt;br /&gt;
* &#039;&#039;&#039;I&#039;&#039;&#039;schemia&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039;actic Acidosis&lt;br /&gt;
* &#039;&#039;&#039;E&#039;&#039;&#039;thanol poisoning&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039;alicylate ingestion&lt;br /&gt;
&lt;br /&gt;
==Metabolic Acidosis (Normal Anion-Gap) Causes==&lt;br /&gt;
===With Hyperkalemia===&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;RAISE K+&#039;&#039;&#039;}}&amp;lt;/font&amp;gt; &lt;br /&gt;
* RTA type 4&lt;br /&gt;
* Aldosterone or mineralocorticord deficiency&lt;br /&gt;
* Iatrogenic: NH4Cl, HCl&lt;br /&gt;
* &amp;quot;Stenosis&amp;quot;: obstructive uropathy&lt;br /&gt;
* Early uremia &lt;br /&gt;
===With hypokalemia===&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;ReDUCE K+&#039;&#039;&#039;}}&amp;lt;/font&amp;gt; &lt;br /&gt;
* Renal TA type 1 and 2&lt;br /&gt;
* Diarrhoea&lt;br /&gt;
* Urine diversion into gut&lt;br /&gt;
* Carbonate anhydrase inhibitor&lt;br /&gt;
* Ex-hyperventilation&lt;br /&gt;
&lt;br /&gt;
==BUN &amp;amp; Creatinine Elevation Causes==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;ABCD&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;zotremia (pre-renal)&lt;br /&gt;
* &#039;&#039;&#039;B&#039;&#039;&#039; - &#039;&#039;&#039;B&#039;&#039;&#039;leeding (GI)&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039; - &#039;&#039;&#039;C&#039;&#039;&#039;atabolic status&lt;br /&gt;
* &#039;&#039;&#039;D&#039;&#039;&#039; - &#039;&#039;&#039;D&#039;&#039;&#039;iet (high protein parenteral nutrition)&lt;br /&gt;
&lt;br /&gt;
==Hypercalcemia Causes==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;PAM SCHMIDT&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;                       &lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039;aget&#039;s Disease&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;myloid&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039;ultiple Myeloma&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039;arcoid&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039;ancer&lt;br /&gt;
* &#039;&#039;&#039;H&#039;&#039;&#039;ormomal (para-thyroid)&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039;ilk-alkali Syndrome&lt;br /&gt;
* &#039;&#039;&#039;I&#039;&#039;&#039;mmobilization&lt;br /&gt;
* &#039;&#039;&#039;D&#039;&#039;&#039;-vitamin overdose&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039;hyrotoxicosis&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;OR&#039;&#039;&#039;&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;MISHAP&#039;&#039;&#039;}}&amp;lt;/font&amp;gt; &lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039;alignancy&lt;br /&gt;
* &#039;&#039;&#039;I&#039;&#039;&#039;ntoxication (hypervitaminosis)&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039;arcoidosis&lt;br /&gt;
* &#039;&#039;&#039;H&#039;&#039;&#039;yperparathyroidism&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;lkali (Milk) syndrome&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039;aget&#039;s Disease (bone)&lt;br /&gt;
Also consider Addison&#039;s disease, thiazide diuretics and simple lab error&lt;br /&gt;
&lt;br /&gt;
==Acute Pancreatitis Causes==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;GET SMASHED&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
# &#039;&#039;&#039;G&#039;&#039;&#039;all stones&lt;br /&gt;
# &#039;&#039;&#039;E&#039;&#039;&#039;thanol&lt;br /&gt;
# &#039;&#039;&#039;T&#039;&#039;&#039;rauma&lt;br /&gt;
# &#039;&#039;&#039;S&#039;&#039;&#039;teroids&lt;br /&gt;
# &#039;&#039;&#039;M&#039;&#039;&#039;umps&lt;br /&gt;
# &#039;&#039;&#039;A&#039;&#039;&#039;utoimmune disease&lt;br /&gt;
# &#039;&#039;&#039;S&#039;&#039;&#039;corpion venom&lt;br /&gt;
# &#039;&#039;&#039;H&#039;&#039;&#039;yperlipidemia&lt;br /&gt;
# &#039;&#039;&#039;E&#039;&#039;&#039;RCP (dye)&lt;br /&gt;
# &#039;&#039;&#039;D&#039;&#039;&#039;rugs (Azathioprine, Asparginase, Mercaptopurines, Pentamidine)&lt;br /&gt;
Alcohol and Gallstones are the most common causes.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Back Pain Causes==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;DISK MASS&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;D&#039;&#039;&#039;-&#039;&#039;&#039;D&#039;&#039;&#039;egeneration: DJD, Osteoporosis, spondylosis&lt;br /&gt;
* &#039;&#039;&#039;I&#039;&#039;&#039;-&#039;&#039;&#039;I&#039;&#039;&#039;nfection: UTI, PID, Potts, osteomyelitis, prostatitis, Injury/fracture, compression fracture&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039;-&#039;&#039;&#039;S&#039;&#039;&#039;pondylitis, ankylosing Spondyloarthropathies (rheumatoid arthritis, Reiters,  SLE)&lt;br /&gt;
* &#039;&#039;&#039;K&#039;&#039;&#039;-&#039;&#039;&#039;K&#039;&#039;&#039;idney stones/infarction/infection (pyelo/abscess)&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039;-&#039;&#039;&#039;M&#039;&#039;&#039;ultiple myeloma, &#039;&#039;&#039;M&#039;&#039;&#039;etastasis from breast, prostate, lung, thyroid, kidney CA&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;-&#039;&#039;&#039;A&#039;&#039;&#039;neurysm, &#039;&#039;&#039;A&#039;&#039;&#039;bdominal pain referred to the back (see acute abdominal pain)&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039;-&#039;&#039;&#039;S&#039;&#039;&#039;lipped disk, &#039;&#039;&#039;S&#039;&#039;&#039;pondylolisthesis&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039;-&#039;&#039;&#039;S&#039;&#039;&#039;train, &#039;&#039;&#039;S&#039;&#039;&#039;coliosis/lordosis, &#039;&#039;&#039;S&#039;&#039;&#039;kin: herpes zoster&lt;br /&gt;
&lt;br /&gt;
==TREATMENT==&lt;br /&gt;
==Syncope Management==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;If the face is red, raise the head!&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;If the face is pale, raise the tail!&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Malignant Hyperthermia Treatment==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Sunday Hot Day, Better Give Iced Fluids Today!&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039;- Stop all triggering agents, give 100% O2&lt;br /&gt;
* &#039;&#039;&#039;H&#039;&#039;&#039;- Hyperventillate&lt;br /&gt;
* &#039;&#039;&#039;D&#039;&#039;&#039;- Dantrolene 2.5 mg/kg&lt;br /&gt;
* &#039;&#039;&#039;B&#039;&#039;&#039;- Bicarbonate&lt;br /&gt;
* &#039;&#039;&#039;G&#039;&#039;&#039;- Glucose and Insulin&lt;br /&gt;
* &#039;&#039;&#039;I&#039;&#039;&#039;- IV Fluids, Cooling Blanket&lt;br /&gt;
* &#039;&#039;&#039;F&#039;&#039;&#039;- Fluid Output; Furosemide&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039;- Tachycardia, be prepared to treat V Tach&lt;br /&gt;
&lt;br /&gt;
==GENETICS==&lt;br /&gt;
==Down Syndrome Features==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;CHILD HAS PROBLEM!&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039;ongenital heart disease/ &#039;&#039;&#039;C&#039;&#039;&#039;ataracts&lt;br /&gt;
* &#039;&#039;&#039;H&#039;&#039;&#039;ypotonia/ Hypothyroidism&lt;br /&gt;
* &#039;&#039;&#039;I&#039;&#039;&#039;ncure 5th finger/ &#039;&#039;&#039;I&#039;&#039;&#039;ncreased gap between 1st and 2nd toe&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039;eukemia risk x2/ &#039;&#039;&#039;L&#039;&#039;&#039;ung problem&lt;br /&gt;
* &#039;&#039;&#039;D&#039;&#039;&#039;uodenal atresia/ &#039;&#039;&#039;D&#039;&#039;&#039;elayed development &lt;br /&gt;
* &#039;&#039;&#039;H&#039;&#039;&#039;irshsprung&#039;s disease/ &#039;&#039;&#039;H&#039;&#039;&#039;earing loss&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;lzheimer&#039;s disease/ Alantoaxial instability&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039;quint/ Short neck &lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039;rotruding tongue/ &#039;&#039;&#039;P&#039;&#039;&#039;alm crease&lt;br /&gt;
* &#039;&#039;&#039;R&#039;&#039;&#039;ound face/ &#039;&#039;&#039;R&#039;&#039;&#039;olling eye (nystagmus)&lt;br /&gt;
* &#039;&#039;&#039;O&#039;&#039;&#039;cciput flat/ &#039;&#039;&#039;O&#039;&#039;&#039;blique eye fissure&lt;br /&gt;
* &#039;&#039;&#039;B&#039;&#039;&#039;rushfield spot/ &#039;&#039;&#039;B&#039;&#039;&#039;rachycephaly&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039;ow nasal bridge/ &#039;&#039;&#039;L&#039;&#039;&#039;anguage problem&lt;br /&gt;
* &#039;&#039;&#039;E&#039;&#039;&#039;picanthic fold/ &#039;&#039;&#039;E&#039;&#039;&#039;ar folded&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039;ental retardation/ &#039;&#039;&#039;M&#039;&#039;&#039;yoclonus &lt;br /&gt;
&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;DOWN&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;D&#039;&#039;&#039;ecreased alpha-fetoprotein and unconjugated estriol (maternal)&lt;br /&gt;
* &#039;&#039;&#039;O&#039;&#039;&#039;ne extra chromosome twenty-one&lt;br /&gt;
* &#039;&#039;&#039;W&#039;&#039;&#039;omen of advanced age&lt;br /&gt;
* &#039;&#039;&#039;N&#039;&#039;&#039;on-disjunction during maternal meiosis &lt;br /&gt;
&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Drink at 21&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
Chromosome 21&lt;br /&gt;
&lt;br /&gt;
==Patau&#039;s Syndrome - Chromosome 13==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;P&#039;&#039;&#039;uberty at 13}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Edward&#039;s Syndrome - Chromosome 18==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|Election voter at 18}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==DiGeorge (Velocardiofacial) Syndrome==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;CATCH 22&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039;ardiac abnormalities&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;bnormal facies&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039;hymic aplasia&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039;left palate&lt;br /&gt;
* &#039;&#039;&#039;H&#039;&#039;&#039;ypocalcemia&lt;br /&gt;
* &#039;&#039;&#039;22&#039;&#039;&#039;q11 deletion &lt;br /&gt;
&lt;br /&gt;
==Marfan Syndrome Features==&lt;br /&gt;
# &#039;&#039;&#039;M&#039;&#039;&#039;itral valve prolapse - MVP&lt;br /&gt;
# &#039;&#039;&#039;A&#039;&#039;&#039;ortic Aneurysm&lt;br /&gt;
# &#039;&#039;&#039;R&#039;&#039;&#039;etinal detachment&lt;br /&gt;
# &#039;&#039;&#039;F&#039;&#039;&#039;ibrillin&lt;br /&gt;
# &#039;&#039;&#039;A&#039;&#039;&#039;rachnodactyly&lt;br /&gt;
# &#039;&#039;&#039;N&#039;&#039;&#039;egative &#039;&#039;&#039;N&#039;&#039;&#039;itroprusside test (differentiates from homocystinuria) &lt;br /&gt;
&lt;br /&gt;
==Adult Polycystic Kidney Disease==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&amp;quot;Polycystic kidney&amp;quot;&#039; has &#039;&#039;&#039;16 letters&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
Also,  and is due to a defect on chromosome 16.&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;APKD&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
ADult Polycystic Kidney Disease is  Autosomal Dominant&lt;br /&gt;
&lt;br /&gt;
==PEDIATRICS==&lt;br /&gt;
==APGAR Score==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;APGAR&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;ppearance (color): blue/pale, trunk pink, all pink&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039;ulse (heart rate): 0, &amp;lt;100, 100+&lt;br /&gt;
* &#039;&#039;&#039;G&#039;&#039;&#039;rimace (reflex irritability): 0, grimace, grimace+cough&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;ctivity (muscle tone): limp, some, active&lt;br /&gt;
* &#039;&#039;&#039;R&#039;&#039;&#039;espiration (respiratory effort): 0, irregular, regular&lt;br /&gt;
- Score 0-2 at 1 and 5 minutes in each of 5 categories, being 10 the perfect score.&lt;/div&gt;</summary>
		<author><name>Gonzalo Romero</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=WBR_mnemonics&amp;diff=936894</id>
		<title>WBR mnemonics</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=WBR_mnemonics&amp;diff=936894"/>
		<updated>2014-01-31T23:59:10Z</updated>

		<summary type="html">&lt;p&gt;Gonzalo Romero: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Board review project}}&lt;br /&gt;
[[Image:Main_help_page_small.PNG|100px|link=Help]][[Image:Projects.PNG|100px|link=Projects]][[Image:Editor&#039;s_Tools.PNG|100px|link=Help Menu]]&lt;br /&gt;
&#039;&#039;&#039;Editor-In-Chief:&#039;&#039;&#039; [[User:William J Gibson|Will Gibson]];  {{AE}}  [[User:Gonzalo Romero|Gonzalo A. Romero, M.D.]][mailto:gromero@wikidoc.org];{{Rim}};[[User:Sergekorjian|Serge Korjian]]; [[User:YazanDaaboul|Yazan Daaboul]]; {{VR}}; {{M.P}}; {{AO}}; {{MS}};&lt;br /&gt;
&lt;br /&gt;
==ANATOMY==&lt;br /&gt;
==GI Anatomy==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;D&#039;&#039;&#039;ow &#039;&#039;&#039;J&#039;&#039;&#039;ones &#039;&#039;&#039;I&#039;&#039;&#039;ndustrial &#039;&#039;&#039;A&#039;&#039;&#039;verage &#039;&#039;&#039;C&#039;&#039;&#039;losing &#039;&#039;&#039;S&#039;&#039;&#039;tock &#039;&#039;&#039;R&#039;&#039;&#039;eport}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&#039;&#039;From proximal to distal:&#039;&#039;&lt;br /&gt;
# &#039;&#039;&#039;D&#039;&#039;&#039;uodenum&lt;br /&gt;
# &#039;&#039;&#039;J&#039;&#039;&#039;ejunum&lt;br /&gt;
# &#039;&#039;&#039;I&#039;&#039;&#039;leum&lt;br /&gt;
# &#039;&#039;&#039;A&#039;&#039;&#039;ppendix&lt;br /&gt;
# &#039;&#039;&#039;C&#039;&#039;&#039;olon&lt;br /&gt;
# &#039;&#039;&#039;S&#039;&#039;&#039;igmoid&lt;br /&gt;
# &#039;&#039;&#039;R&#039;&#039;&#039;ectum&lt;br /&gt;
&lt;br /&gt;
==Brachial Plexus Organization==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Radical Teachers Drink Cold Beers&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Randy Travis Drinks Cold Beers&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Robert Taylor Drinks Cold Beer&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Red Trucks Drive Cats Nuts&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
# Roots&lt;br /&gt;
# Trunks&lt;br /&gt;
# Divisions&lt;br /&gt;
# Cords&lt;br /&gt;
# Branches&lt;br /&gt;
&lt;br /&gt;
==Cranial Nerves==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;On Old Olympus Towering Tops, A Finn And German Viewed Some Hops&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Our Only Object To Touch And Feel Virgin Girls Vagina And Hymen&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
# I - olfactory&lt;br /&gt;
# II - optic&lt;br /&gt;
# III - oculomotor&lt;br /&gt;
# IV - trochlear&lt;br /&gt;
# V - trigeminal&lt;br /&gt;
# VI - abducens&lt;br /&gt;
# VII - facial&lt;br /&gt;
# VIII - acoustic (vestibulocochlear)&lt;br /&gt;
# IX - glossophrayngeal&lt;br /&gt;
# X - vagus&lt;br /&gt;
# XI - accessory&lt;br /&gt;
# XII - hypoglossal&lt;br /&gt;
&lt;br /&gt;
==Extraocular Muscles Innervation==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;LR6 SO4 3&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;LR 6&#039;&#039;&#039; - &#039;&#039;&#039;L&#039;&#039;&#039;ateral &#039;&#039;&#039;R&#039;&#039;&#039;ectus by the &#039;&#039;&#039;VI&#039;&#039;&#039;  cranial nerve (Abducens)&lt;br /&gt;
* &#039;&#039;&#039;SO 4&#039;&#039;&#039; - &#039;&#039;&#039;S&#039;&#039;&#039;uperior &#039;&#039;&#039;O&#039;&#039;&#039;blique by the &#039;&#039;&#039;IV&#039;&#039;&#039; cranial nerve (Trochlear)&lt;br /&gt;
* &#039;&#039;&#039;3&#039;&#039;&#039; - The remaining by the &#039;&#039;&#039;III&#039;&#039;&#039; cranial nerve (Occulomotor)&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;LAST&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039; - &#039;&#039;&#039;L&#039;&#039;&#039;ateral Rectus&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;bducens Nerve&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039; - &#039;&#039;&#039;S&#039;&#039;&#039;uperior Oblique&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039; - &#039;&#039;&#039;T&#039;&#039;&#039;rochlear Nerve&lt;br /&gt;
&lt;br /&gt;
==Facial Nerve Branches==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Two Zebras Bought My Car&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Two Zebras Bit My Cookie&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;To Zanzibar By Motor Car&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Ten Zulus Buggered My Cat&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
# Temporal&lt;br /&gt;
# Zygomatic&lt;br /&gt;
# Buccal&lt;br /&gt;
# Mandibular&lt;br /&gt;
# Cervical&lt;br /&gt;
&lt;br /&gt;
==Penis Innervation==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;P&#039;&#039;&#039;oint and &#039;&#039;&#039;S&#039;&#039;&#039;hoot}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039;arasympathetic causes erection&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039;ympathetic causes ejaculation&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;S2, 3, 4 keep the penis off the floor&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* Innervation of the penis by branches of the pudendal nerve, derived from spinal cord levels &#039;&#039;&#039;S 2-4&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
==Aorta Branches==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;ABC&#039;S&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;ortic arch gives off the:&lt;br /&gt;
# &#039;&#039;&#039;B&#039;&#039;&#039; - &#039;&#039;&#039;B&#039;&#039;&#039;racheiocephalic trunk&lt;br /&gt;
# &#039;&#039;&#039;C&#039;&#039;&#039; - Left &#039;&#039;&#039;C&#039;&#039;&#039;ommon &#039;&#039;&#039;C&#039;&#039;&#039;arotid&lt;br /&gt;
# &#039;&#039;&#039;S&#039;&#039;&#039; - Left &#039;&#039;&#039;S&#039;&#039;&#039;ubclavian artery&lt;br /&gt;
&lt;br /&gt;
==Femoral Triangle Structures in Order==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;N (AVEL)&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;N&#039;&#039;&#039;erve&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;rtery&lt;br /&gt;
* &#039;&#039;&#039;V&#039;&#039;&#039;ein&lt;br /&gt;
* &#039;&#039;&#039;E&#039;&#039;&#039;mpty space&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039;ymphatics&lt;br /&gt;
- Parenthesis includes things contained in the femoral sheath.&lt;br /&gt;
&lt;br /&gt;
==CELL BIOLOGY==&lt;br /&gt;
==Cell Division Phases==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;People Meet And Talk&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039; - &#039;&#039;&#039;P&#039;&#039;&#039;rophase&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039; - &#039;&#039;&#039;M&#039;&#039;&#039;etaphase&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;naphase&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039; - &#039;&#039;&#039;T&#039;&#039;&#039;elophase&lt;br /&gt;
&lt;br /&gt;
==Cell Cycle Stages==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Go Sally Go! Make Children!&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;G1&#039;&#039;&#039; phase - Growth phase 1&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039; phase - DNA synthesis&lt;br /&gt;
* &#039;&#039;&#039;G2&#039;&#039;&#039; phase - Growth phase 2&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039; phase - Mitosis&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039; phase - Cytokinesis&lt;br /&gt;
&lt;br /&gt;
==Golgi Complex Functions==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Golgi Distributes A SPAM&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;Distributes&#039;&#039;&#039; proteins and lipids from ER&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;dd mannose onto specific lysosome proteins&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039;ulfation of sugars and slected tyrosine&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039;roteoglycan assembly&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;dd O-oligosugars to serine and threnonine&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039;odify N-ologosugars on asparagine&lt;br /&gt;
&lt;br /&gt;
==Collagen==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;COLLAGEN&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039; - &#039;&#039;&#039;C&#039;&#039;&#039;-terminal propeptide (procollagen) / &#039;&#039;&#039;C&#039;&#039;&#039;ovalent &#039;&#039;&#039;C&#039;&#039;&#039;ross links/ &#039;&#039;&#039;C&#039;&#039;&#039; vitamin/ &#039;&#039;&#039;C&#039;&#039;&#039;onnective tissue/ &#039;&#039;&#039;C&#039;&#039;&#039;artilage/&#039;&#039;&#039;C&#039;&#039;&#039;hondroblasts/&#039;&#039;&#039;C&#039;&#039;&#039;opper Cofactor (Covalent Cross linking)&lt;br /&gt;
* &#039;&#039;&#039;O&#039;&#039;&#039; - &#039;&#039;&#039;O&#039;&#039;&#039;utside the cell is where collagen normally functions/ &#039;&#039;&#039;O&#039;&#039;&#039;steoblasts/ &#039;&#039;&#039;O&#039;&#039;&#039;steogenesis imperfecta&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039; - &#039;&#039;&#039;L&#039;&#039;&#039;ysyl hydroxylase / &#039;&#039;&#039;L&#039;&#039;&#039;ysyl oxidase (oxidatively deaminates lysyl and hydroxylysyl residues to form collagen cross links, last biosynthesis step)&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039; - &#039;&#039;&#039;L&#039;&#039;&#039;ong triple helical fibers / &#039;&#039;&#039;L&#039;&#039;&#039;igaments&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;lpha chains / &#039;&#039;&#039;A&#039;&#039;&#039;ttached by H bonds form triple helix / &#039;&#039;&#039;A&#039;&#039;&#039;scorbate for hydroxylation of lysyl and prolyl residues of pro-Alpha chains&lt;br /&gt;
(postranslational modification)&lt;br /&gt;
* &#039;&#039;&#039;G&#039;&#039;&#039; - &#039;&#039;&#039;G&#039;&#039;&#039;ly in every third position / &#039;&#039;&#039;G&#039;&#039;&#039;lycosylation of hydroxyl group of hydroxylysine with &#039;&#039;&#039;G&#039;&#039;&#039;lucose and &#039;&#039;&#039;G&#039;&#039;&#039;alactose;&#039;&#039;&#039;GO&#039;&#039;&#039;lgi allows procollagen to &#039;&#039;&#039;GO&#039;&#039;&#039; outside of cell&lt;br /&gt;
* &#039;&#039;&#039;E&#039;&#039;&#039; - &#039;&#039;&#039;E&#039;&#039;&#039;xtracellular matrix / &#039;&#039;&#039;E&#039;&#039;&#039;ye (cornea, sclera) / &#039;&#039;&#039;E&#039;&#039;&#039;hlers-Danlos Syndrome&lt;br /&gt;
* &#039;&#039;&#039;N&#039;&#039;&#039; - &#039;&#039;&#039;N&#039;&#039;&#039;-terminal propeptide (procollagen) / &#039;&#039;&#039;N&#039;&#039;&#039;onhelical terminal extensions&lt;br /&gt;
&lt;br /&gt;
==Carbon Monoxide: Electron Transport Chain Target==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;CO blocks CO&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
Carbon monoxide &#039;&#039;&#039;(CO)&#039;&#039;&#039; blocks Cytochrome Oxidase &#039;&#039;&#039;(CO)&#039;&#039;&#039; &lt;br /&gt;
&lt;br /&gt;
==Hemoglobin Binding Curve: Right Shift Causes==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;CADET, face right!&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* C = Increase in carbon dioxide&lt;br /&gt;
* A = Acidosis (low ph)&lt;br /&gt;
* D = Increase in 2,3 DPG aka 2,3 BPG&lt;br /&gt;
* E = Exercise&lt;br /&gt;
* T = increase in temperature&lt;br /&gt;
&lt;br /&gt;
==RECEPTORS==&lt;br /&gt;
==G-proteins Receptors== &lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;QISS &amp;amp; QIQ&amp;quot; (Kiss and Kick)&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
In alphabetical order&lt;br /&gt;
* Q: alpha 1&lt;br /&gt;
* I: alpha 2&lt;br /&gt;
* S: beta 1&lt;br /&gt;
* S: beta 2&lt;br /&gt;
* &amp;amp;&lt;br /&gt;
* Q: M1&lt;br /&gt;
* I: M2&lt;br /&gt;
* Q: M3 &lt;br /&gt;
&lt;br /&gt;
==Adrenaline Mechanism==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;ABC of Adrenaline&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* Adrenaline--&amp;gt; activates&lt;br /&gt;
* Beta receptors--&amp;gt; increases&lt;br /&gt;
* Cyclic AMP &lt;br /&gt;
&lt;br /&gt;
==BIOCHEMISTRY==&lt;br /&gt;
==Enzymes Classification==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Over The HILL&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;O&#039;&#039;&#039; - &#039;&#039;&#039;O&#039;&#039;&#039;xidoreductases&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039; - &#039;&#039;&#039;T&#039;&#039;&#039;ransferases&lt;br /&gt;
* &#039;&#039;&#039;H&#039;&#039;&#039; - &#039;&#039;&#039;H&#039;&#039;&#039;ydrolases&lt;br /&gt;
* &#039;&#039;&#039;I&#039;&#039;&#039; - &#039;&#039;&#039;I&#039;&#039;&#039;somerases&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039; - &#039;&#039;&#039;L&#039;&#039;&#039;igases&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039; - &#039;&#039;&#039;L&#039;&#039;&#039;yases&lt;br /&gt;
&lt;br /&gt;
==Glycolysis Enzymes==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Hungry Peter Pan And The Growling Pink Panther Eat Pies&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* Hexokinase&lt;br /&gt;
* Phosphohexo isomerase&lt;br /&gt;
* Phosphofructokinase-1 (6-phosphofructo-1 kinase)&lt;br /&gt;
* Aldolase, Triose phosphate isomerase&lt;br /&gt;
* Glyceraldehyde 3-phosphate dehydrogenase&lt;br /&gt;
* Phosphoglycerate kinase&lt;br /&gt;
* Phosphoglycerate mutase&lt;br /&gt;
* Enolase&lt;br /&gt;
* Pyruvate kinase&lt;br /&gt;
&lt;br /&gt;
==Glycolysis Steps==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Goodness Gracious, Father Franklin Did Go By Picking Pumpkins (to) Prepare Pies&#039;&#039;&#039;}}&amp;lt;/font&amp;gt; &lt;br /&gt;
* Glucose&lt;br /&gt;
* Glucose-6-P&lt;br /&gt;
* Fructose-6-P&lt;br /&gt;
* Fructose-1,6-diP&lt;br /&gt;
* Dihydroxyacetone-P&lt;br /&gt;
* Glyceraldehyde-P&lt;br /&gt;
* 1,3-Biphosphoglycerate&lt;br /&gt;
* 3-Phosphoglycerate&lt;br /&gt;
* 2-Phosphoglycerate (to)&lt;br /&gt;
* Phosphoenolpyruvate [PEP] Pyruvate • &#039;Did&#039;, &#039;By&#039; and &#039;Pies&#039; tell you the first part of those three: di-, bi-, and py-. &lt;br /&gt;
• &#039;PrEPare&#039; tells location of PEP in the process. &lt;br /&gt;
&lt;br /&gt;
==METABOLISM==&lt;br /&gt;
==Metabolism Sites==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Use both arms to HUG&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
# Heme synthesis&lt;br /&gt;
# Urea cycle&lt;br /&gt;
# Gluconeogenesis&lt;br /&gt;
These reactions occur in both cytoplasm and mitochondria&lt;br /&gt;
&lt;br /&gt;
==AcetylCoA and AcetacetylCoA==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;A Lighter Lease (A LyTr LeIs)&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
Amino acids forming them:&lt;br /&gt;
* A=AcetylCoA or Acetoacetyl CoA&lt;br /&gt;
* Ly=Lysine&lt;br /&gt;
* Tr=Tryptophan&lt;br /&gt;
* Le=Leucine&lt;br /&gt;
* Is=Isoleucine &lt;br /&gt;
&lt;br /&gt;
==Citric Acid Cycle Compounds==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Our City Is Kept Safe And Sound From Malice&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* Oxaloacetate&lt;br /&gt;
* Citrate&lt;br /&gt;
* Isocitrate&lt;br /&gt;
* alpha-Ketoglutarate&lt;br /&gt;
* Succinyl-CoA&lt;br /&gt;
* Succinate&lt;br /&gt;
* Fumarate&lt;br /&gt;
* Malate&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Can I Keep Selling Sex For Money, Officer?&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* Citrate&lt;br /&gt;
* Isocitrate&lt;br /&gt;
* alpha-Ketogluterate&lt;br /&gt;
* Succinyl CoA&lt;br /&gt;
* Succinate&lt;br /&gt;
* Fumerate&lt;br /&gt;
* Malate&lt;br /&gt;
* Oxaloacetate&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Oh! Can I Keep Some Succinate For Myself?&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Oh Citric Acid Is Of (course) A SiLly STupid Funny Molecule&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* Oxaloacetate&lt;br /&gt;
* Citrate&lt;br /&gt;
* Isocitrate, alpha-Ketoglutarate&lt;br /&gt;
* Succinyl CoA&lt;br /&gt;
* Succinate&lt;br /&gt;
* Fumarate&lt;br /&gt;
* Malate &lt;br /&gt;
&lt;br /&gt;
==Citric Acid Cycle Enzymes==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Corrupt Anti Intelligence Agent Spoke Slander For Money&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* Citrate synthatase&lt;br /&gt;
* Aconitase&lt;br /&gt;
* Isocitrate dehydrogenase&lt;br /&gt;
* Alpha ketogluturate dehydrogenase&lt;br /&gt;
* Succinyl CoA synthetase&lt;br /&gt;
* Succinate dehydrogenase&lt;br /&gt;
* Fumarase&lt;br /&gt;
* Malate Dehydrogenase&lt;br /&gt;
&lt;br /&gt;
==Essential Amino Acids==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;P&#039;&#039;&#039; ri &#039;&#039;&#039;V&#039;&#039;&#039; a &#039;&#039;&#039;T&#039;&#039;&#039; e   &#039;&#039;&#039;TIM   HALL&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;PVT. TIM HALL&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;&amp;quot;PVT. TIM HALL always argues, never tires&amp;quot;&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039; - &#039;&#039;&#039;P&#039;&#039;&#039;he&lt;br /&gt;
* &#039;&#039;&#039;V&#039;&#039;&#039; - &#039;&#039;&#039;V&#039;&#039;&#039;al&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039; - &#039;&#039;&#039;T&#039;&#039;&#039;hr&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039; - &#039;&#039;&#039;T&#039;&#039;&#039;rp&lt;br /&gt;
* &#039;&#039;&#039;I&#039;&#039;&#039; - &#039;&#039;&#039;I&#039;&#039;&#039;le&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039; - &#039;&#039;&#039;M&#039;&#039;&#039;et&lt;br /&gt;
* &#039;&#039;&#039;H&#039;&#039;&#039; - &#039;&#039;&#039;H&#039;&#039;&#039;is&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;rg&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039; - &#039;&#039;&#039;L&#039;&#039;&#039;eu&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039; - &#039;&#039;&#039;L&#039;&#039;&#039;ys&lt;br /&gt;
* Pvt. is short for Private in the military&lt;br /&gt;
* Arg and His are considered semi-essential&lt;br /&gt;
* Alternatively: &#039;&#039;&#039;MATT VIL PHLy&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
==Creatine Phosphate: Amino Acid Precursors==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Nice GAMs!&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;G&#039;&#039;&#039; - &#039;&#039;&#039;G&#039;&#039;&#039;lycine&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;rginine&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039; - &#039;&#039;&#039;M&#039;&#039;&#039;ethionine&lt;br /&gt;
&lt;br /&gt;
==Branched Chain Amino Acids Catabolism Steps==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Truck hit the Ox to Death&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039; - &#039;&#039;&#039;T&#039;&#039;&#039;ransamination&lt;br /&gt;
* &#039;&#039;&#039;O&#039;&#039;&#039; - &#039;&#039;&#039;O&#039;&#039;&#039;xidative decarboxylation&lt;br /&gt;
* &#039;&#039;&#039;D&#039;&#039;&#039; - &#039;&#039;&#039;D&#039;&#039;&#039;ehydrogenation&lt;br /&gt;
&lt;br /&gt;
==Branched-chain Amino Acids Used by Skeletal Muscle (Fasting State)==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Muscles LIVe fast&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* Leucine&lt;br /&gt;
* Isoleucine&lt;br /&gt;
* Valine&lt;br /&gt;
&lt;br /&gt;
==Urea Cycle==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;O&#039;&#039;&#039;rdinarily &#039;&#039;&#039;C&#039;&#039;&#039;areless &#039;&#039;&#039;C&#039;&#039;&#039;rappers &#039;&#039;&#039;A&#039;&#039;&#039;re &#039;&#039;&#039;A&#039;&#039;&#039;lso &#039;&#039;&#039;F&#039;&#039;&#039;rivolous &#039;&#039;&#039;A&#039;&#039;&#039;bout &#039;&#039;&#039;U&#039;&#039;&#039;rination!}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;O&#039;&#039;&#039; - &#039;&#039;&#039;O&#039;&#039;&#039;rnithine&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039; - &#039;&#039;&#039;C&#039;&#039;&#039;arbamoyl&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039; - &#039;&#039;&#039;C&#039;&#039;&#039;itrulline&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;spartate&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;rginosuccinate&lt;br /&gt;
* &#039;&#039;&#039;F&#039;&#039;&#039; - &#039;&#039;&#039;F&#039;&#039;&#039;umarate&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;rginine&lt;br /&gt;
* &#039;&#039;&#039;U&#039;&#039;&#039; - &#039;&#039;&#039;U&#039;&#039;&#039;rea&lt;br /&gt;
&lt;br /&gt;
==Pyrimidines Nucleotides==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;CUT the PY (pie)&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039;ytosine&lt;br /&gt;
* &#039;&#039;&#039;U&#039;&#039;&#039;racil&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039;hiamine &lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039;he&lt;br /&gt;
* &#039;&#039;&#039;PY&#039;&#039;&#039;rimidines &lt;br /&gt;
&lt;br /&gt;
==ENZYME DEFICIENCIES==&lt;br /&gt;
==G6PD: Oxidant Drugs Inducing Hemolytic Anemia == &lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;AAA&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* Antibiotic (eg: sufamethoxazole)&lt;br /&gt;
* Antimalarial (eg: primaquine)&lt;br /&gt;
* Antipyretics (eg: acetanilid, but not aspirin or acetaminophen)&lt;br /&gt;
&lt;br /&gt;
==Pompe&#039;s Disease==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Type &amp;quot;Police: Po + lys&amp;quot;&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;PO&#039;&#039;&#039;mpe&#039;s disease is a &#039;&#039;&#039;LYS&#039;&#039;&#039;osomal storage disease (alpha 1,4 glucosidase)&lt;br /&gt;
&lt;br /&gt;
==Galactosemia==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;GALIPUT&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* Galactose 1 Phosphate Uridyl Transferase&lt;br /&gt;
* There is an assay called the Galiput test for this&lt;br /&gt;
&lt;br /&gt;
==Fabry&#039;s Disease==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;FABRY &#039; S&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;F&#039;&#039;&#039; - &#039;&#039;&#039;F&#039;&#039;&#039;oam cells found in glomeruli and tubules / &#039;&#039;&#039;F&#039;&#039;&#039;ebrile episodes&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;lpha galactosidase &#039;&#039;&#039;A&#039;&#039;&#039; deficiency / &#039;&#039;&#039;A&#039;&#039;&#039;ngiokeratomas&lt;br /&gt;
* &#039;&#039;&#039;B&#039;&#039;&#039; - &#039;&#039;&#039;B&#039;&#039;&#039;urning pain in extremities / &#039;&#039;&#039;B&#039;&#039;&#039;UN increased in serum / &#039;&#039;&#039;B&#039;&#039;&#039;oys&lt;br /&gt;
* &#039;&#039;&#039;R&#039;&#039;&#039; - &#039;&#039;&#039;R&#039;&#039;&#039;enal failure&lt;br /&gt;
* &#039;&#039;&#039;Y&#039;&#039;&#039; - &#039;&#039;&#039;Y&#039;&#039;&#039;X genotype (male, X linked recessive)&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039; - &#039;&#039;&#039;S&#039;&#039;&#039;phingolipidoses&lt;br /&gt;
&lt;br /&gt;
==Hurler Syndrome Features== &lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;HURLER&#039;S&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
*&#039;&#039;&#039;H&#039;&#039;&#039;eptosplenomegaly &lt;br /&gt;
*&#039;&#039;&#039;U&#039;&#039;&#039;gly facies &lt;br /&gt;
*&#039;&#039;&#039;R&#039;&#039;&#039;ecessive (AR inheritance) &lt;br /&gt;
*&#039;&#039;&#039;L&#039;&#039;&#039;-iduronidase deficiency (alpha) &lt;br /&gt;
*&#039;&#039;&#039;E&#039;&#039;&#039;yes clouded &lt;br /&gt;
*&#039;&#039;&#039;R&#039;&#039;&#039;etarded &lt;br /&gt;
*&#039;&#039;&#039;S&#039;&#039;&#039;tubby fingers/&#039;&#039;&#039;S&#039;&#039;&#039;hort &lt;br /&gt;
&lt;br /&gt;
==Acute Intermittent Porphyria== &lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;5  P&#039;s &#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039;ain in abdomen&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039;olyneuropathy&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039;sychologial abnormalities&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039;ink urine&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039;recipitated by drugs (eg barbiturates, oral contraceptives, sulpha drugs)&lt;br /&gt;
&lt;br /&gt;
==VITAMINS==&lt;br /&gt;
==B Vitamins==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;The Rhythm Nearly Proved Contagious&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
In increasing order: &lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039; - &#039;&#039;&#039;T&#039;&#039;&#039;hiamine (B1)&lt;br /&gt;
* &#039;&#039;&#039;R&#039;&#039;&#039; - &#039;&#039;&#039;R&#039;&#039;&#039;iboflavin (B2)&lt;br /&gt;
* &#039;&#039;&#039;N&#039;&#039;&#039; - &#039;&#039;&#039;N&#039;&#039;&#039;iacin (B3)&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039; - &#039;&#039;&#039;P&#039;&#039;&#039;yridoxine (B6)&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039; - &#039;&#039;&#039;C&#039;&#039;&#039;obalamin (B12)&lt;br /&gt;
&lt;br /&gt;
==Niacin Deficiency==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;The famous 4 D&#039;s&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
# Diarrhea&lt;br /&gt;
# Dermatitis&lt;br /&gt;
# Dementia&lt;br /&gt;
# Death (if untreated) &lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;The 3D&#039;s of pellagra&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
Vitamin B3 (niacin, nicotinic acid) deficiency&lt;br /&gt;
# Dermatitis&lt;br /&gt;
# Diarrhea&lt;br /&gt;
# Dementia&lt;br /&gt;
&lt;br /&gt;
==Folate Deficiency Causes==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;A FOLIC DROP&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* Alcoholism&lt;br /&gt;
* Folic acid antagonists&lt;br /&gt;
* Oral contraceptives&lt;br /&gt;
* Low dietary intake&lt;br /&gt;
* Infection with Giardia&lt;br /&gt;
* Celiac sprue&lt;br /&gt;
* Dilatin&lt;br /&gt;
* Relative folate deficiency&lt;br /&gt;
* Old&lt;br /&gt;
* Pregnant &lt;br /&gt;
&lt;br /&gt;
==Fat Soluble Vitamins==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;The FAT cat is in the ADEK (attic)&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
Fat soluble vitamins are &#039;&#039;A,D,E,K.&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
==Hypervitaminosis A==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|Increased Vitamin A makes you &#039;&#039;&#039;HARD&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;H&#039;&#039;&#039; - &#039;&#039;&#039;H&#039;&#039;&#039;eadache / &#039;&#039;&#039;H&#039;&#039;&#039;epatomegaly&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;norexia / &#039;&#039;&#039;A&#039;&#039;&#039;lopecia&lt;br /&gt;
* &#039;&#039;&#039;R&#039;&#039;&#039; - &#039;&#039;&#039;R&#039;&#039;&#039;eally painful bones&lt;br /&gt;
* &#039;&#039;&#039;D&#039;&#039;&#039; - &#039;&#039;&#039;D&#039;&#039;&#039;ry skin / &#039;&#039;&#039;D&#039;&#039;&#039;rowsiness&lt;br /&gt;
&lt;br /&gt;
==HISTORY TAKING==&lt;br /&gt;
==Alcoholism Screening==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;CAGE&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* Have you ever felt it necessary to &#039;&#039;&#039;C&#039;&#039;&#039;UT DOWN on your drinking?&lt;br /&gt;
* Have you ever been &#039;&#039;&#039;A&#039;&#039;&#039;NNOYED when people suggest you cut down on your drinking?&lt;br /&gt;
* Have you ever felt &#039;&#039;&#039;G&#039;&#039;&#039;UILTY about your drinking?&lt;br /&gt;
* Have you ever felt the need to have a drink in the morning for an &#039;&#039;&#039;E&#039;&#039;&#039;YE OPENER?&lt;br /&gt;
&lt;br /&gt;
==Chief Complaint==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;OPQRST&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;O&#039;&#039;&#039; - &#039;&#039;&#039;O&#039;&#039;&#039;nset of pain:  what was the patient doing when the pain started?&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039; - &#039;&#039;&#039;P&#039;&#039;&#039;alliative or &#039;&#039;&#039;P&#039;&#039;&#039;rovocative factors for the pain&lt;br /&gt;
* &#039;&#039;&#039;Q&#039;&#039;&#039; - &#039;&#039;&#039;Q&#039;&#039;&#039;uality of pain (burning, stabbing, aching, etc.)&lt;br /&gt;
* &#039;&#039;&#039;R&#039;&#039;&#039; - &#039;&#039;&#039;R&#039;&#039;&#039;adiation (up to jaw, down left arm, etc.)&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039; - &#039;&#039;&#039;S&#039;&#039;&#039;everity of pain (usually 1 - 10 scale)&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039; - &#039;&#039;&#039;T&#039;&#039;&#039;iming of pain (eg: after meals, in the morning, how long it lasts, etc.)&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;SOCRATES&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039; - &#039;&#039;&#039;S&#039;&#039;&#039;ite of pain&lt;br /&gt;
* &#039;&#039;&#039;O&#039;&#039;&#039; - &#039;&#039;&#039;O&#039;&#039;&#039;nset of pain&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039; - &#039;&#039;&#039;C&#039;&#039;&#039;haracter of pain: dull, sharp, aching, stabbing, tearing&lt;br /&gt;
* &#039;&#039;&#039;R&#039;&#039;&#039; - &#039;&#039;&#039;R&#039;&#039;&#039;adiation of pain: central abdominal pain radiating to Right Iliac Fossa&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;ssociated factors: eg. nausea/vomiting&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039; - &#039;&#039;&#039;T&#039;&#039;&#039;iming of pain/duration&lt;br /&gt;
* &#039;&#039;&#039;E&#039;&#039;&#039; - &#039;&#039;&#039;E&#039;&#039;&#039;xacerbating/alleviating factors&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039; - &#039;&#039;&#039;S&#039;&#039;&#039;everity of pain (1 - 10 scale)&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;ASCLAST&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;ggravatiing and &#039;&#039;&#039;A&#039;&#039;&#039;lleviating factors&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039; - &#039;&#039;&#039;S&#039;&#039;&#039;everity&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039; - &#039;&#039;&#039;C&#039;&#039;&#039;haracter, quality&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039; - &#039;&#039;&#039;L&#039;&#039;&#039;ocation&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;ssociated symptoms&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039; - &#039;&#039;&#039;S&#039;&#039;&#039;etting&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039; - &#039;&#039;&#039;T&#039;&#039;&#039;iming&lt;br /&gt;
&lt;br /&gt;
NOTE: ASCLAST means let the patient talk first, then ask him/her specific questions.&lt;br /&gt;
&lt;br /&gt;
==Hospital Admission Orders==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;DAVE WILMINGTON&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;D&#039;&#039;&#039;iet&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;ctivity&lt;br /&gt;
* &#039;&#039;&#039;V&#039;&#039;&#039;ital signs: how often to monitor&lt;br /&gt;
* &#039;&#039;&#039;E&#039;&#039;&#039;xcrement: test urine/stool&lt;br /&gt;
* &#039;&#039;&#039;W&#039;&#039;&#039;eight: how often to monitor&lt;br /&gt;
* &#039;&#039;&#039;I&#039;&#039;&#039; / O: monitor input/output&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039;abs: which/how often&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039;eds: which/route/interval&lt;br /&gt;
* &#039;&#039;&#039;I&#039;&#039;&#039; V fluids: what/at what rate&lt;br /&gt;
* &#039;&#039;&#039;N&#039;&#039;&#039;ursing care: e.g. position, wound care, up in chair, ostomy care&lt;br /&gt;
* &#039;&#039;&#039;G&#039;&#039;&#039;eneral care: e.g. physical/respiratory therapy&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039;ests: e.g. X-ray/EKG/EEG&lt;br /&gt;
* &#039;&#039;&#039;O&#039;&#039;&#039;bserve for: reaction/seizure/neuro exams&lt;br /&gt;
* &#039;&#039;&#039;N&#039;&#039;&#039;otify parameters: e.g. Temperature &amp;gt; 100 F / respiration changes&lt;br /&gt;
&lt;br /&gt;
After noting date and time of admission as well as diagnosis and condition (ADC), use the mnemonic to ensure all areas are addressed, but not all apply to every patient.&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;ADC VAAN DIML&#039;&#039;&#039;, pronounced ADC van dim(e)L}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;dmit: 23 hours, full admit, service of attending&lt;br /&gt;
* &#039;&#039;&#039;D&#039;&#039;&#039;iagnosis&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039;ondition: &amp;quot;Stable&amp;quot;/&amp;quot;Guarded&amp;quot;&lt;br /&gt;
* &#039;&#039;&#039;V&#039;&#039;&#039;itals: post-op, routine, q 1 hour&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;llergies&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;ctivities: strict bed rest/fall precautions/ad lib/bathroom privileges&lt;br /&gt;
* &#039;&#039;&#039;N&#039;&#039;&#039;ursing: strict I&amp;amp;O&#039;s/daily weights/call P.R.N.&lt;br /&gt;
* &#039;&#039;&#039;D&#039;&#039;&#039;iet: NPO/regular/clears/advance diet as tolerated/2000 cal ADA/renal&lt;br /&gt;
* &#039;&#039;&#039;I&#039;&#039;&#039;V fluids: D5, 1/2 NS, 20 KCL at 110 ml/hr, LR @ 100 ml/hr&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039;eds: scheduled and PRN&#039;s&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039;abs and X-ray: CBC in AM, PCXR in PACU&lt;br /&gt;
&lt;br /&gt;
Note that IV fluids follows Diet. If one writes NPO, then &#039;&#039;&#039;all&#039;&#039;&#039; such patients get maintenance fluids (use the 4-2-1 rule).&lt;br /&gt;
&lt;br /&gt;
==Post-Op Fever Causes==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Five W&#039;s&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;W&#039;&#039;&#039;ind: pneumonia, atelectasis&lt;br /&gt;
* &#039;&#039;&#039;W&#039;&#039;&#039;ound: wound infections&lt;br /&gt;
* &#039;&#039;&#039;W&#039;&#039;&#039;ater: urinary tract infection&lt;br /&gt;
* &#039;&#039;&#039;W&#039;&#039;&#039;alking: DVT/PE (walking can help reduce DVT/PE)&lt;br /&gt;
* &#039;&#039;&#039;W&#039;&#039;&#039;onderdrugs: especially anesthesia&lt;br /&gt;
&lt;br /&gt;
==Predisposing Conditions for Pulmonary Embolism==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;TOM SCH PREFER&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039; - &#039;&#039;&#039;T&#039;&#039;&#039;rauma&lt;br /&gt;
* &#039;&#039;&#039;O&#039;&#039;&#039; - &#039;&#039;&#039;O&#039;&#039;&#039;besity&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039; - &#039;&#039;&#039;M&#039;&#039;&#039;alignancy&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039; - &#039;&#039;&#039;S&#039;&#039;&#039;urgery&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039; - &#039;&#039;&#039;C&#039;&#039;&#039;ardiac disease&lt;br /&gt;
* &#039;&#039;&#039;H&#039;&#039;&#039; - &#039;&#039;&#039;H&#039;&#039;&#039;ospitalization&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039; - &#039;&#039;&#039;P&#039;&#039;&#039;ast history&lt;br /&gt;
* &#039;&#039;&#039;R&#039;&#039;&#039; - &#039;&#039;&#039;R&#039;&#039;&#039;est (bed-bound)&lt;br /&gt;
* &#039;&#039;&#039;E&#039;&#039;&#039; - &#039;&#039;&#039;E&#039;&#039;&#039;strogen, pregnancy, post-partum&lt;br /&gt;
* &#039;&#039;&#039;F&#039;&#039;&#039; - &#039;&#039;&#039;F&#039;&#039;&#039;racture&lt;br /&gt;
* &#039;&#039;&#039;E&#039;&#039;&#039; - &#039;&#039;&#039;E&#039;&#039;&#039;lderly&lt;br /&gt;
* &#039;&#039;&#039;R&#039;&#039;&#039; - &#039;&#039;&#039;R&#039;&#039;&#039;oad trip&lt;br /&gt;
&lt;br /&gt;
==Compartment Syndrome Signs (Arterial Occlusion)==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;6 P&#039;s&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
# Pain&lt;br /&gt;
# Pale (Pallor)&lt;br /&gt;
# Perishing with Cold (Poikilothermia)&lt;br /&gt;
# Pulseless&lt;br /&gt;
# Paresthesias&lt;br /&gt;
# Paralysis&lt;br /&gt;
&lt;br /&gt;
==PATHOLOGY==&lt;br /&gt;
==Causes of Diseases==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;VITAMIN C&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
*&#039;&#039;&#039;V&#039;&#039;&#039;ascular&lt;br /&gt;
*&#039;&#039;&#039;I&#039;&#039;&#039;nfectious&lt;br /&gt;
*&#039;&#039;&#039;T&#039;&#039;&#039;rauma&lt;br /&gt;
*&#039;&#039;&#039;A&#039;&#039;&#039;uto-immune&lt;br /&gt;
*&#039;&#039;&#039;M&#039;&#039;&#039;etabolic&lt;br /&gt;
*&#039;&#039;&#039;I&#039;&#039;&#039;diopathic/Iatrogenic&lt;br /&gt;
*&#039;&#039;&#039;N&#039;&#039;&#039;eoplastic&lt;br /&gt;
*&#039;&#039;&#039;C&#039;&#039;&#039;ongenital&lt;br /&gt;
&lt;br /&gt;
==5 Signs of Inflammation==&lt;br /&gt;
# &#039;&#039;&#039;Rubor&#039;&#039;&#039;: redness/erythema&lt;br /&gt;
# &#039;&#039;&#039;Calor&#039;&#039;&#039;: raised temperature&lt;br /&gt;
# &#039;&#039;&#039;Tumor&#039;&#039;&#039;: swelling&lt;br /&gt;
# &#039;&#039;&#039;Dolor&#039;&#039;&#039;: pain&lt;br /&gt;
# &#039;&#039;&#039;Functio Laesa&#039;&#039;&#039;: loss of function&lt;br /&gt;
- Described by Celsus&lt;br /&gt;
&lt;br /&gt;
==Hypersentivity Reactions (Gell &amp;amp; Goombs Classification)==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;ACID&#039;&#039;&#039;}}&amp;lt;/font&amp;gt; &amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;A&#039;&#039;&#039;nna &#039;&#039;&#039;C&#039;&#039;&#039;ycled &#039;&#039;&#039;I&#039;&#039;&#039;mmediately &#039;&#039;&#039;D&#039;&#039;&#039;ownhill}}&amp;lt;/font&amp;gt; &lt;br /&gt;
# Type I   &#039;&#039;&#039;A&#039;&#039;&#039;naphylaxis&lt;br /&gt;
# Type II  &#039;&#039;&#039;C&#039;&#039;&#039;ytotoxic-mediated&lt;br /&gt;
# Type III &#039;&#039;&#039;I&#039;&#039;&#039;mmune-complex&lt;br /&gt;
# Type IV  &#039;&#039;&#039;D&#039;&#039;&#039;elayed hypersensitivity&lt;br /&gt;
&lt;br /&gt;
==Multiple Endocrine Neoplasia (MEN)==&lt;br /&gt;
Each of the MENs is a disease of &#039;&#039;&#039;three or two letters plus a feature&#039;&#039;&#039;; all are autosomal dominant.&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;MEN I:  3 P&#039;s&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
# &#039;&#039;&#039;P&#039;&#039;&#039;ituitary&lt;br /&gt;
# &#039;&#039;&#039;P&#039;&#039;&#039;arathyroid&lt;br /&gt;
# &#039;&#039;&#039;P&#039;&#039;&#039;ancreas&lt;br /&gt;
# Plus Adrenal cortex&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;MEN II:  2 C&#039;s&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
# &#039;&#039;&#039;C&#039;&#039;&#039;arcinoma of thyroid&lt;br /&gt;
# &#039;&#039;&#039;C&#039;&#039;&#039;atacholamines (pheochromocytoma)&lt;br /&gt;
- MEN IIA: parathyroid&lt;br /&gt;
- MEN IIB (MEN III): mucocutaneous neuromas for&lt;br /&gt;
&lt;br /&gt;
==Acute Pneumonia Infiltrates==&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039;yogenic bacteria: &#039;&#039;&#039;P&#039;&#039;&#039;MN infiltrate&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039;iscellaneous microbes: &#039;&#039;&#039;M&#039;&#039;&#039;ononuclear infiltrate&lt;br /&gt;
&lt;br /&gt;
==Takayasu&#039;s Disease/Pulseless Disease== &lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;When you have Takayasu&#039;s, I can&#039;t Tak&#039;a yu pulse&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==CBC Normal Differential==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;N&#039;&#039;&#039;ever &#039;&#039;&#039;L&#039;&#039;&#039;et &#039;&#039;&#039;M&#039;&#039;&#039;onkeys &#039;&#039;&#039;E&#039;&#039;&#039;at &#039;&#039;&#039;B&#039;&#039;&#039;ananas}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;N&#039;&#039;&#039;ice &#039;&#039;&#039;L&#039;&#039;&#039;adies &#039;&#039;&#039;M&#039;&#039;&#039;ake &#039;&#039;&#039;E&#039;&#039;&#039;aster &#039;&#039;&#039;B&#039;&#039;&#039;read&amp;quot;}}&amp;lt;/font&amp;gt;  &lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;60&#039;&#039;&#039;, &#039;&#039;&#039;30&#039;&#039;&#039;, &#039;&#039;&#039;6&#039;&#039;&#039;, &#039;&#039;&#039;3&#039;&#039;&#039;, &#039;&#039;&#039;1&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
# &#039;&#039;&#039;N&#039;&#039;&#039;eutrophils: &#039;&#039;&#039;60&#039;&#039;&#039;%&lt;br /&gt;
# &#039;&#039;&#039;L&#039;&#039;&#039;ymphocytes: &#039;&#039;&#039;30&#039;&#039;&#039;%&lt;br /&gt;
# &#039;&#039;&#039;M&#039;&#039;&#039;onocytes: &#039;&#039;&#039;6&#039;&#039;&#039;%&lt;br /&gt;
# &#039;&#039;&#039;E&#039;&#039;&#039;osinophils: &#039;&#039;&#039;3&#039;&#039;&#039;%&lt;br /&gt;
# &#039;&#039;&#039;B&#039;&#039;&#039;asophils: &#039;&#039;&#039;1&#039;&#039;&#039;%&lt;br /&gt;
&lt;br /&gt;
==CAUSES==&lt;br /&gt;
==Metabolic Acidosis Causes==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;MUDPILES&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039;ethanol poisoning&lt;br /&gt;
* &#039;&#039;&#039;U&#039;&#039;&#039;remia&lt;br /&gt;
* &#039;&#039;&#039;D&#039;&#039;&#039;iabetic Keto-acidosis&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039;ara-aldehyde ingestion&lt;br /&gt;
* &#039;&#039;&#039;I&#039;&#039;&#039;schemia&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039;actic Acidosis&lt;br /&gt;
* &#039;&#039;&#039;E&#039;&#039;&#039;thanol poisoning&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039;alicylate ingestion&lt;br /&gt;
&lt;br /&gt;
==Metabolic Acidosis (Normal Anion-Gap) Causes==&lt;br /&gt;
===With Hyperkalemia===&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;RAISE K+&#039;&#039;&#039;}}&amp;lt;/font&amp;gt; &lt;br /&gt;
* RTA type 4&lt;br /&gt;
* Aldosterone or mineralocorticord deficiency&lt;br /&gt;
* Iatrogenic: NH4Cl, HCl&lt;br /&gt;
* &amp;quot;Stenosis&amp;quot;: obstructive uropathy&lt;br /&gt;
* Early uremia &lt;br /&gt;
===With hypokalemia===&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;ReDUCE K+&#039;&#039;&#039;}}&amp;lt;/font&amp;gt; &lt;br /&gt;
* Renal TA type 1 and 2&lt;br /&gt;
* Diarrhoea&lt;br /&gt;
* Urine diversion into gut&lt;br /&gt;
* Carbonate anhydrase inhibitor&lt;br /&gt;
* Ex-hyperventilation&lt;br /&gt;
&lt;br /&gt;
==BUN &amp;amp; Creatinine Elevation Causes==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;ABCD&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;zotremia (pre-renal)&lt;br /&gt;
* &#039;&#039;&#039;B&#039;&#039;&#039; - &#039;&#039;&#039;B&#039;&#039;&#039;leeding (GI)&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039; - &#039;&#039;&#039;C&#039;&#039;&#039;atabolic status&lt;br /&gt;
* &#039;&#039;&#039;D&#039;&#039;&#039; - &#039;&#039;&#039;D&#039;&#039;&#039;iet (high protein parenteral nutrition)&lt;br /&gt;
&lt;br /&gt;
==Hypercalcemia Causes==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;PAM SCHMIDT&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;                       &lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039;aget&#039;s Disease&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;myloid&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039;ultiple Myeloma&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039;arcoid&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039;ancer&lt;br /&gt;
* &#039;&#039;&#039;H&#039;&#039;&#039;ormomal (para-thyroid)&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039;ilk-alkali Syndrome&lt;br /&gt;
* &#039;&#039;&#039;I&#039;&#039;&#039;mmobilization&lt;br /&gt;
* &#039;&#039;&#039;D&#039;&#039;&#039;-vitamin overdose&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039;hyrotoxicosis&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;OR&#039;&#039;&#039;&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;MISHAP&#039;&#039;&#039;}}&amp;lt;/font&amp;gt; &lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039;alignancy&lt;br /&gt;
* &#039;&#039;&#039;I&#039;&#039;&#039;ntoxication (hypervitaminosis)&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039;arcoidosis&lt;br /&gt;
* &#039;&#039;&#039;H&#039;&#039;&#039;yperparathyroidism&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;lkali (Milk) syndrome&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039;aget&#039;s Disease (bone)&lt;br /&gt;
Also consider Addison&#039;s disease, thiazide diuretics and simple lab error&lt;br /&gt;
&lt;br /&gt;
==Acute Pancreatitis Causes==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;GET SMASHED&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
# &#039;&#039;&#039;G&#039;&#039;&#039;all stones&lt;br /&gt;
# &#039;&#039;&#039;E&#039;&#039;&#039;thanol&lt;br /&gt;
# &#039;&#039;&#039;T&#039;&#039;&#039;rauma&lt;br /&gt;
# &#039;&#039;&#039;S&#039;&#039;&#039;teroids&lt;br /&gt;
# &#039;&#039;&#039;M&#039;&#039;&#039;umps&lt;br /&gt;
# &#039;&#039;&#039;A&#039;&#039;&#039;utoimmune disease&lt;br /&gt;
# &#039;&#039;&#039;S&#039;&#039;&#039;corpion venom&lt;br /&gt;
# &#039;&#039;&#039;H&#039;&#039;&#039;yperlipidemia&lt;br /&gt;
# &#039;&#039;&#039;E&#039;&#039;&#039;RCP (dye)&lt;br /&gt;
# &#039;&#039;&#039;D&#039;&#039;&#039;rugs (Azathioprine, Asparginase, Mercaptopurines, Pentamidine)&lt;br /&gt;
Alcohol and Gallstones are the most common causes.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Back Pain Causes==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;DISK MASS&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;D&#039;&#039;&#039;-&#039;&#039;&#039;D&#039;&#039;&#039;egeneration: DJD, Osteoporosis, spondylosis&lt;br /&gt;
* &#039;&#039;&#039;I&#039;&#039;&#039;-&#039;&#039;&#039;I&#039;&#039;&#039;nfection: UTI, PID, Potts, osteomyelitis, prostatitis, Injury/fracture, compression fracture&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039;-&#039;&#039;&#039;S&#039;&#039;&#039;pondylitis, ankylosing Spondyloarthropathies (rheumatoid arthritis, Reiters,  SLE)&lt;br /&gt;
* &#039;&#039;&#039;K&#039;&#039;&#039;-&#039;&#039;&#039;K&#039;&#039;&#039;idney stones/infarction/infection (pyelo/abscess)&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039;-&#039;&#039;&#039;M&#039;&#039;&#039;ultiple myeloma, &#039;&#039;&#039;M&#039;&#039;&#039;etastasis from breast, prostate, lung, thyroid, kidney CA&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;-&#039;&#039;&#039;A&#039;&#039;&#039;neurysm, &#039;&#039;&#039;A&#039;&#039;&#039;bdominal pain referred to the back (see acute abdominal pain)&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039;-&#039;&#039;&#039;S&#039;&#039;&#039;lipped disk, &#039;&#039;&#039;S&#039;&#039;&#039;pondylolisthesis&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039;-&#039;&#039;&#039;S&#039;&#039;&#039;train, &#039;&#039;&#039;S&#039;&#039;&#039;coliosis/lordosis, &#039;&#039;&#039;S&#039;&#039;&#039;kin: herpes zoster&lt;br /&gt;
&lt;br /&gt;
==TREATMENT==&lt;br /&gt;
==Syncope Management==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;If the face is red, raise the head!&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;If the face is pale, raise the tail!&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Malignant Hyperthermia Treatment==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Sunday Hot Day, Better Give Iced Fluids Today!&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039;- Stop all triggering agents, give 100% O2&lt;br /&gt;
* &#039;&#039;&#039;H&#039;&#039;&#039;- Hyperventillate&lt;br /&gt;
* &#039;&#039;&#039;D&#039;&#039;&#039;- Dantrolene 2.5 mg/kg&lt;br /&gt;
* &#039;&#039;&#039;B&#039;&#039;&#039;- Bicarbonate&lt;br /&gt;
* &#039;&#039;&#039;G&#039;&#039;&#039;- Glucose and Insulin&lt;br /&gt;
* &#039;&#039;&#039;I&#039;&#039;&#039;- IV Fluids, Cooling Blanket&lt;br /&gt;
* &#039;&#039;&#039;F&#039;&#039;&#039;- Fluid Output; Furosemide&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039;- Tachycardia, be prepared to treat V Tach&lt;br /&gt;
&lt;br /&gt;
==GENETICS==&lt;br /&gt;
==Down Syndrome Features==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;CHILD HAS PROBLEM!&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039;ongenital heart disease/ &#039;&#039;&#039;C&#039;&#039;&#039;ataracts&lt;br /&gt;
* &#039;&#039;&#039;H&#039;&#039;&#039;ypotonia/ Hypothyroidism&lt;br /&gt;
* &#039;&#039;&#039;I&#039;&#039;&#039;ncure 5th finger/ &#039;&#039;&#039;I&#039;&#039;&#039;ncreased gap between 1st and 2nd toe&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039;eukemia risk x2/ &#039;&#039;&#039;L&#039;&#039;&#039;ung problem&lt;br /&gt;
* &#039;&#039;&#039;D&#039;&#039;&#039;uodenal atresia/ &#039;&#039;&#039;D&#039;&#039;&#039;elayed development &lt;br /&gt;
* &#039;&#039;&#039;H&#039;&#039;&#039;irshsprung&#039;s disease/ &#039;&#039;&#039;H&#039;&#039;&#039;earing loss&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;lzheimer&#039;s disease/ Alantoaxial instability&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039;quint/ Short neck &lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039;rotruding tongue/ &#039;&#039;&#039;P&#039;&#039;&#039;alm crease&lt;br /&gt;
* &#039;&#039;&#039;R&#039;&#039;&#039;ound face/ &#039;&#039;&#039;R&#039;&#039;&#039;olling eye (nystagmus)&lt;br /&gt;
* &#039;&#039;&#039;O&#039;&#039;&#039;cciput flat/ &#039;&#039;&#039;O&#039;&#039;&#039;blique eye fissure&lt;br /&gt;
* &#039;&#039;&#039;B&#039;&#039;&#039;rushfield spot/ &#039;&#039;&#039;B&#039;&#039;&#039;rachycephaly&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039;ow nasal bridge/ &#039;&#039;&#039;L&#039;&#039;&#039;anguage problem&lt;br /&gt;
* &#039;&#039;&#039;E&#039;&#039;&#039;picanthic fold/ &#039;&#039;&#039;E&#039;&#039;&#039;ar folded&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039;ental retardation/ &#039;&#039;&#039;M&#039;&#039;&#039;yoclonus &lt;br /&gt;
&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;DOWN&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;D&#039;&#039;&#039;ecreased alpha-fetoprotein and unconjugated estriol (maternal)&lt;br /&gt;
* &#039;&#039;&#039;O&#039;&#039;&#039;ne extra chromosome twenty-one&lt;br /&gt;
* &#039;&#039;&#039;W&#039;&#039;&#039;omen of advanced age&lt;br /&gt;
* &#039;&#039;&#039;N&#039;&#039;&#039;on-disjunction during maternal meiosis &lt;br /&gt;
&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Drink at 21&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
Chromosome 21&lt;br /&gt;
&lt;br /&gt;
==Patau&#039;s Syndrome - Chromosome 13==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;P&#039;&#039;&#039;uberty at 13}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Edward&#039;s Syndrome - Chromosome 18==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|Election voter at 18}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==DiGeorge (Velocardiofacial) Syndrome==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;CATCH 22&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039;ardiac abnormalities&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;bnormal facies&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039;hymic aplasia&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039;left palate&lt;br /&gt;
* &#039;&#039;&#039;H&#039;&#039;&#039;ypocalcemia&lt;br /&gt;
* &#039;&#039;&#039;22&#039;&#039;&#039;q11 deletion &lt;br /&gt;
&lt;br /&gt;
==Marfan Syndrome Features==&lt;br /&gt;
# &#039;&#039;&#039;M&#039;&#039;&#039;itral valve prolapse - MVP&lt;br /&gt;
# &#039;&#039;&#039;A&#039;&#039;&#039;ortic Aneurysm&lt;br /&gt;
# &#039;&#039;&#039;R&#039;&#039;&#039;etinal detachment&lt;br /&gt;
# &#039;&#039;&#039;F&#039;&#039;&#039;ibrillin&lt;br /&gt;
# &#039;&#039;&#039;A&#039;&#039;&#039;rachnodactyly&lt;br /&gt;
# &#039;&#039;&#039;N&#039;&#039;&#039;egative &#039;&#039;&#039;N&#039;&#039;&#039;itroprusside test (differentiates from homocystinuria) &lt;br /&gt;
&lt;br /&gt;
==Adult Polycystic Kidney Disease==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&amp;quot;Polycystic kidney&amp;quot;&#039; has &#039;&#039;&#039;16 letters&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
Also,  and is due to a defect on chromosome 16.&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;APKD&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
ADult Polycystic Kidney Disease is  Autosomal Dominant&lt;br /&gt;
&lt;br /&gt;
==PEDIATRICS==&lt;br /&gt;
==APGAR Score==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;APGAR&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;ppearance (color): blue/pale, trunk pink, all pink&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039;ulse (heart rate): 0, &amp;lt;100, 100+&lt;br /&gt;
* &#039;&#039;&#039;G&#039;&#039;&#039;rimace (reflex irritability): 0, grimace, grimace+cough&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;ctivity (muscle tone): limp, some, active&lt;br /&gt;
* &#039;&#039;&#039;R&#039;&#039;&#039;espiration (respiratory effort): 0, irregular, regular&lt;br /&gt;
- Score 0-2 at 1 and 5 minutes in each of 5 categories, being 10 the perfect score.&lt;/div&gt;</summary>
		<author><name>Gonzalo Romero</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=WBR_mnemonics&amp;diff=936893</id>
		<title>WBR mnemonics</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=WBR_mnemonics&amp;diff=936893"/>
		<updated>2014-01-31T23:43:57Z</updated>

		<summary type="html">&lt;p&gt;Gonzalo Romero: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Board review project}}&lt;br /&gt;
[[Image:Main_help_page_small.PNG|100px|link=Help]][[Image:Projects.PNG|100px|link=Projects]][[Image:Editor&#039;s_Tools.PNG|100px|link=Help Menu]]&lt;br /&gt;
&#039;&#039;&#039;Editor-In-Chief:&#039;&#039;&#039; [[User:William J Gibson|Will Gibson]];  {{AE}}  [[User:Gonzalo Romero|Gonzalo A. Romero, M.D.]][mailto:gromero@wikidoc.org];{{Rim}};[[User:Sergekorjian|Serge Korjian]]; [[User:YazanDaaboul|Yazan Daaboul]]; {{VR}}; {{M.P}}; {{AO}}; {{MS}};&lt;br /&gt;
&lt;br /&gt;
==GI==&lt;br /&gt;
==GI Anatomy==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;D&#039;&#039;&#039;ow &#039;&#039;&#039;J&#039;&#039;&#039;ones &#039;&#039;&#039;I&#039;&#039;&#039;ndustrial &#039;&#039;&#039;A&#039;&#039;&#039;verage &#039;&#039;&#039;C&#039;&#039;&#039;losing &#039;&#039;&#039;S&#039;&#039;&#039;tock &#039;&#039;&#039;R&#039;&#039;&#039;eport}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&#039;&#039;From proximal to distal:&#039;&#039;&lt;br /&gt;
# &#039;&#039;&#039;D&#039;&#039;&#039;uodenum&lt;br /&gt;
# &#039;&#039;&#039;J&#039;&#039;&#039;ejunum&lt;br /&gt;
# &#039;&#039;&#039;I&#039;&#039;&#039;leum&lt;br /&gt;
# &#039;&#039;&#039;A&#039;&#039;&#039;ppendix&lt;br /&gt;
# &#039;&#039;&#039;C&#039;&#039;&#039;olon&lt;br /&gt;
# &#039;&#039;&#039;S&#039;&#039;&#039;igmoid&lt;br /&gt;
# &#039;&#039;&#039;R&#039;&#039;&#039;ectum&lt;br /&gt;
&lt;br /&gt;
==Acute Pancreatitis Causes==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;GET SMASHED&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
# &#039;&#039;&#039;G&#039;&#039;&#039;all stones&lt;br /&gt;
# &#039;&#039;&#039;E&#039;&#039;&#039;thanol&lt;br /&gt;
# &#039;&#039;&#039;T&#039;&#039;&#039;rauma&lt;br /&gt;
# &#039;&#039;&#039;S&#039;&#039;&#039;teroids&lt;br /&gt;
# &#039;&#039;&#039;M&#039;&#039;&#039;umps&lt;br /&gt;
# &#039;&#039;&#039;A&#039;&#039;&#039;utoimmune disease&lt;br /&gt;
# &#039;&#039;&#039;S&#039;&#039;&#039;corpion venom&lt;br /&gt;
# &#039;&#039;&#039;H&#039;&#039;&#039;yperlipidemia&lt;br /&gt;
# &#039;&#039;&#039;E&#039;&#039;&#039;RCP (dye)&lt;br /&gt;
# &#039;&#039;&#039;D&#039;&#039;&#039;rugs (Azathioprine, Asparginase, Mercaptopurines, Pentamidine)&lt;br /&gt;
Alcohol and Gallstones are the most common causes.&lt;br /&gt;
&lt;br /&gt;
==ANATOMY====Brachial Plexus Organization==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Radical Teachers Drink Cold Beers&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Randy Travis Drinks Cold Beers&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Robert Taylor Drinks Cold Beer&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Red Trucks Drive Cats Nuts&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
# Roots&lt;br /&gt;
# Trunks&lt;br /&gt;
# Divisions&lt;br /&gt;
# Cords&lt;br /&gt;
# Branches&lt;br /&gt;
&lt;br /&gt;
==Cranial Nerves==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;On Old Olympus Towering Tops, A Finn And German Viewed Some Hops&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Our Only Object To Touch And Feel Virgin Girls Vagina And Hymen&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
# I - olfactory&lt;br /&gt;
# II - optic&lt;br /&gt;
# III - oculomotor&lt;br /&gt;
# IV - trochlear&lt;br /&gt;
# V - trigeminal&lt;br /&gt;
# VI - abducens&lt;br /&gt;
# VII - facial&lt;br /&gt;
# VIII - acoustic (vestibulocochlear)&lt;br /&gt;
# IX - glossophrayngeal&lt;br /&gt;
# X - vagus&lt;br /&gt;
# XI - accessory&lt;br /&gt;
# XII - hypoglossal&lt;br /&gt;
&lt;br /&gt;
==Extraocular Muscles Innervation==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;LR6 SO4 3&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;LR 6&#039;&#039;&#039; - &#039;&#039;&#039;L&#039;&#039;&#039;ateral &#039;&#039;&#039;R&#039;&#039;&#039;ectus by the &#039;&#039;&#039;VI&#039;&#039;&#039;  cranial nerve (Abducens)&lt;br /&gt;
* &#039;&#039;&#039;SO 4&#039;&#039;&#039; - &#039;&#039;&#039;S&#039;&#039;&#039;uperior &#039;&#039;&#039;O&#039;&#039;&#039;blique by the &#039;&#039;&#039;IV&#039;&#039;&#039; cranial nerve (Trochlear)&lt;br /&gt;
* &#039;&#039;&#039;3&#039;&#039;&#039; - The remaining by the &#039;&#039;&#039;III&#039;&#039;&#039; cranial nerve (Occulomotor)&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;LAST&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039; - &#039;&#039;&#039;L&#039;&#039;&#039;ateral Rectus&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;bducens Nerve&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039; - &#039;&#039;&#039;S&#039;&#039;&#039;uperior Oblique&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039; - &#039;&#039;&#039;T&#039;&#039;&#039;rochlear Nerve&lt;br /&gt;
&lt;br /&gt;
==Facial Nerve Branches==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Two Zebras Bought My Car&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Two Zebras Bit My Cookie&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;To Zanzibar By Motor Car&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Ten Zulus Buggered My Cat&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
# Temporal&lt;br /&gt;
# Zygomatic&lt;br /&gt;
# Buccal&lt;br /&gt;
# Mandibular&lt;br /&gt;
# Cervical&lt;br /&gt;
&lt;br /&gt;
==Penis Innervation==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;P&#039;&#039;&#039;oint and &#039;&#039;&#039;S&#039;&#039;&#039;hoot}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039;arasympathetic causes erection&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039;ympathetic causes ejaculation&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;S2, 3, 4 keep the penis off the floor&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* Innervation of the penis by branches of the pudendal nerve, derived from spinal cord levels &#039;&#039;&#039;S 2-4&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
==Aorta Branches==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;ABC&#039;S&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;ortic arch gives off the:&lt;br /&gt;
# &#039;&#039;&#039;B&#039;&#039;&#039; - &#039;&#039;&#039;B&#039;&#039;&#039;racheiocephalic trunk&lt;br /&gt;
# &#039;&#039;&#039;C&#039;&#039;&#039; - Left &#039;&#039;&#039;C&#039;&#039;&#039;ommon &#039;&#039;&#039;C&#039;&#039;&#039;arotid&lt;br /&gt;
# &#039;&#039;&#039;S&#039;&#039;&#039; - Left &#039;&#039;&#039;S&#039;&#039;&#039;ubclavian artery&lt;br /&gt;
&lt;br /&gt;
==Femoral Triangle Structures in Order==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;N (AVEL)&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;N&#039;&#039;&#039;erve&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;rtery&lt;br /&gt;
* &#039;&#039;&#039;V&#039;&#039;&#039;ein&lt;br /&gt;
* &#039;&#039;&#039;E&#039;&#039;&#039;mpty space&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039;ymphatics&lt;br /&gt;
- Parenthesis includes things contained in the femoral sheath.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==PEDIATRICS==&lt;br /&gt;
==APGAR Score==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;APGAR&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;ppearance (color): blue/pale, trunk pink, all pink&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039;ulse (heart rate): 0, &amp;lt;100, 100+&lt;br /&gt;
* &#039;&#039;&#039;G&#039;&#039;&#039;rimace (reflex irritability): 0, grimace, grimace+cough&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;ctivity (muscle tone): limp, some, active&lt;br /&gt;
* &#039;&#039;&#039;R&#039;&#039;&#039;espiration (respiratory effort): 0, irregular, regular&lt;br /&gt;
- Score 0-2 at 1 and 5 minutes in each of 5 categories, being 10 the perfect score.&lt;br /&gt;
&lt;br /&gt;
==HISTORY TAKING==&lt;br /&gt;
==Alcoholism Screening==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;CAGE&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* Have you ever felt it necessary to &#039;&#039;&#039;C&#039;&#039;&#039;UT DOWN on your drinking?&lt;br /&gt;
* Have you ever been &#039;&#039;&#039;A&#039;&#039;&#039;NNOYED when people suggest you cut down on your drinking?&lt;br /&gt;
* Have you ever felt &#039;&#039;&#039;G&#039;&#039;&#039;UILTY about your drinking?&lt;br /&gt;
* Have you ever felt the need to have a drink in the morning for an &#039;&#039;&#039;E&#039;&#039;&#039;YE OPENER?&lt;br /&gt;
&lt;br /&gt;
==Chief Complaint==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;OPQRST&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;O&#039;&#039;&#039; - &#039;&#039;&#039;O&#039;&#039;&#039;nset of pain:  what was the patient doing when the pain started?&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039; - &#039;&#039;&#039;P&#039;&#039;&#039;alliative or &#039;&#039;&#039;P&#039;&#039;&#039;rovocative factors for the pain&lt;br /&gt;
* &#039;&#039;&#039;Q&#039;&#039;&#039; - &#039;&#039;&#039;Q&#039;&#039;&#039;uality of pain (burning, stabbing, aching, etc.)&lt;br /&gt;
* &#039;&#039;&#039;R&#039;&#039;&#039; - &#039;&#039;&#039;R&#039;&#039;&#039;adiation (up to jaw, down left arm, etc.)&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039; - &#039;&#039;&#039;S&#039;&#039;&#039;everity of pain (usually 1 - 10 scale)&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039; - &#039;&#039;&#039;T&#039;&#039;&#039;iming of pain (eg: after meals, in the morning, how long it lasts, etc.)&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;SOCRATES&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039; - &#039;&#039;&#039;S&#039;&#039;&#039;ite of pain&lt;br /&gt;
* &#039;&#039;&#039;O&#039;&#039;&#039; - &#039;&#039;&#039;O&#039;&#039;&#039;nset of pain&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039; - &#039;&#039;&#039;C&#039;&#039;&#039;haracter of pain: dull, sharp, aching, stabbing, tearing&lt;br /&gt;
* &#039;&#039;&#039;R&#039;&#039;&#039; - &#039;&#039;&#039;R&#039;&#039;&#039;adiation of pain: central abdominal pain radiating to Right Iliac Fossa&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;ssociated factors: eg. nausea/vomiting&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039; - &#039;&#039;&#039;T&#039;&#039;&#039;iming of pain/duration&lt;br /&gt;
* &#039;&#039;&#039;E&#039;&#039;&#039; - &#039;&#039;&#039;E&#039;&#039;&#039;xacerbating/alleviating factors&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039; - &#039;&#039;&#039;S&#039;&#039;&#039;everity of pain (1 - 10 scale)&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;ASCLAST&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;ggravatiing and &#039;&#039;&#039;A&#039;&#039;&#039;lleviating factors&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039; - &#039;&#039;&#039;S&#039;&#039;&#039;everity&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039; - &#039;&#039;&#039;C&#039;&#039;&#039;haracter, quality&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039; - &#039;&#039;&#039;L&#039;&#039;&#039;ocation&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;ssociated symptoms&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039; - &#039;&#039;&#039;S&#039;&#039;&#039;etting&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039; - &#039;&#039;&#039;T&#039;&#039;&#039;iming&lt;br /&gt;
&lt;br /&gt;
NOTE: ASCLAST means let the patient talk first, then ask him/her specific questions.&lt;br /&gt;
&lt;br /&gt;
==Hospital Admission Orders==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;DAVE WILMINGTON&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;D&#039;&#039;&#039;iet&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;ctivity&lt;br /&gt;
* &#039;&#039;&#039;V&#039;&#039;&#039;ital signs: how often to monitor&lt;br /&gt;
* &#039;&#039;&#039;E&#039;&#039;&#039;xcrement: test urine/stool&lt;br /&gt;
* &#039;&#039;&#039;W&#039;&#039;&#039;eight: how often to monitor&lt;br /&gt;
* &#039;&#039;&#039;I&#039;&#039;&#039; / O: monitor input/output&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039;abs: which/how often&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039;eds: which/route/interval&lt;br /&gt;
* &#039;&#039;&#039;I&#039;&#039;&#039; V fluids: what/at what rate&lt;br /&gt;
* &#039;&#039;&#039;N&#039;&#039;&#039;ursing care: e.g. position, wound care, up in chair, ostomy care&lt;br /&gt;
* &#039;&#039;&#039;G&#039;&#039;&#039;eneral care: e.g. physical/respiratory therapy&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039;ests: e.g. X-ray/EKG/EEG&lt;br /&gt;
* &#039;&#039;&#039;O&#039;&#039;&#039;bserve for: reaction/seizure/neuro exams&lt;br /&gt;
* &#039;&#039;&#039;N&#039;&#039;&#039;otify parameters: e.g. Temperature &amp;gt; 100 F / respiration changes&lt;br /&gt;
&lt;br /&gt;
After noting date and time of admission as well as diagnosis and condition (ADC), use the mnemonic to ensure all areas are addressed, but not all apply to every patient.&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;ADC VAAN DIML&#039;&#039;&#039;, pronounced ADC van dim(e)L}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;dmit: 23 hours, full admit, service of attending&lt;br /&gt;
* &#039;&#039;&#039;D&#039;&#039;&#039;iagnosis&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039;ondition: &amp;quot;Stable&amp;quot;/&amp;quot;Guarded&amp;quot;&lt;br /&gt;
* &#039;&#039;&#039;V&#039;&#039;&#039;itals: post-op, routine, q 1 hour&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;llergies&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;ctivities: strict bed rest/fall precautions/ad lib/bathroom privileges&lt;br /&gt;
* &#039;&#039;&#039;N&#039;&#039;&#039;ursing: strict I&amp;amp;O&#039;s/daily weights/call P.R.N.&lt;br /&gt;
* &#039;&#039;&#039;D&#039;&#039;&#039;iet: NPO/regular/clears/advance diet as tolerated/2000 cal ADA/renal&lt;br /&gt;
* &#039;&#039;&#039;I&#039;&#039;&#039;V fluids: D5, 1/2 NS, 20 KCL at 110 ml/hr, LR @ 100 ml/hr&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039;eds: scheduled and PRN&#039;s&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039;abs and X-ray: CBC in AM, PCXR in PACU&lt;br /&gt;
&lt;br /&gt;
Note that IV fluids follows Diet. If one writes NPO, then &#039;&#039;&#039;all&#039;&#039;&#039; such patients get maintenance fluids (use the 4-2-1 rule).&lt;br /&gt;
&lt;br /&gt;
==Post-Op Fever Causes==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Five W&#039;s&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;W&#039;&#039;&#039;ind: pneumonia, atelectasis&lt;br /&gt;
* &#039;&#039;&#039;W&#039;&#039;&#039;ound: wound infections&lt;br /&gt;
* &#039;&#039;&#039;W&#039;&#039;&#039;ater: urinary tract infection&lt;br /&gt;
* &#039;&#039;&#039;W&#039;&#039;&#039;alking: DVT/PE (walking can help reduce DVT/PE)&lt;br /&gt;
* &#039;&#039;&#039;W&#039;&#039;&#039;onderdrugs: especially anesthesia&lt;br /&gt;
&lt;br /&gt;
==Predisposing Conditions for Pulmonary Embolism==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;TOM SCH PREFER&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039; - &#039;&#039;&#039;T&#039;&#039;&#039;rauma&lt;br /&gt;
* &#039;&#039;&#039;O&#039;&#039;&#039; - &#039;&#039;&#039;O&#039;&#039;&#039;besity&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039; - &#039;&#039;&#039;M&#039;&#039;&#039;alignancy&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039; - &#039;&#039;&#039;S&#039;&#039;&#039;urgery&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039; - &#039;&#039;&#039;C&#039;&#039;&#039;ardiac disease&lt;br /&gt;
* &#039;&#039;&#039;H&#039;&#039;&#039; - &#039;&#039;&#039;H&#039;&#039;&#039;ospitalization&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039; - &#039;&#039;&#039;P&#039;&#039;&#039;ast history&lt;br /&gt;
* &#039;&#039;&#039;R&#039;&#039;&#039; - &#039;&#039;&#039;R&#039;&#039;&#039;est (bed-bound)&lt;br /&gt;
* &#039;&#039;&#039;E&#039;&#039;&#039; - &#039;&#039;&#039;E&#039;&#039;&#039;strogen, pregnancy, post-partum&lt;br /&gt;
* &#039;&#039;&#039;F&#039;&#039;&#039; - &#039;&#039;&#039;F&#039;&#039;&#039;racture&lt;br /&gt;
* &#039;&#039;&#039;E&#039;&#039;&#039; - &#039;&#039;&#039;E&#039;&#039;&#039;lderly&lt;br /&gt;
* &#039;&#039;&#039;R&#039;&#039;&#039; - &#039;&#039;&#039;R&#039;&#039;&#039;oad trip&lt;br /&gt;
&lt;br /&gt;
==Compartment Syndrome Signs (Arterial Occlusion)==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;6 P&#039;s&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
# Pain&lt;br /&gt;
# Pale (Pallor)&lt;br /&gt;
# Perishing with Cold (Poikilothermia)&lt;br /&gt;
# Pulseless&lt;br /&gt;
# Paresthesias&lt;br /&gt;
# Paralysis&lt;br /&gt;
&lt;br /&gt;
==PATHOLOGY==&lt;br /&gt;
==Causes of Diseases==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;VITAMIN C&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
*&#039;&#039;&#039;V&#039;&#039;&#039;ascular&lt;br /&gt;
*&#039;&#039;&#039;I&#039;&#039;&#039;nfectious&lt;br /&gt;
*&#039;&#039;&#039;T&#039;&#039;&#039;rauma&lt;br /&gt;
*&#039;&#039;&#039;A&#039;&#039;&#039;uto-immune&lt;br /&gt;
*&#039;&#039;&#039;M&#039;&#039;&#039;etabolic&lt;br /&gt;
*&#039;&#039;&#039;I&#039;&#039;&#039;diopathic/Iatrogenic&lt;br /&gt;
*&#039;&#039;&#039;N&#039;&#039;&#039;eoplastic&lt;br /&gt;
*&#039;&#039;&#039;C&#039;&#039;&#039;ongenital&lt;br /&gt;
&lt;br /&gt;
==5 Signs of Inflammation==&lt;br /&gt;
# &#039;&#039;&#039;Rubor&#039;&#039;&#039;: redness/erythema&lt;br /&gt;
# &#039;&#039;&#039;Calor&#039;&#039;&#039;: raised temperature&lt;br /&gt;
# &#039;&#039;&#039;Tumor&#039;&#039;&#039;: swelling&lt;br /&gt;
# &#039;&#039;&#039;Dolor&#039;&#039;&#039;: pain&lt;br /&gt;
# &#039;&#039;&#039;Functio Laesa&#039;&#039;&#039;: loss of function&lt;br /&gt;
- Described by Celsus&lt;br /&gt;
&lt;br /&gt;
==Hypersentivity Reactions (Gell &amp;amp; Goombs Classification)==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;ACID&#039;&#039;&#039;}}&amp;lt;/font&amp;gt; &amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;A&#039;&#039;&#039;nna &#039;&#039;&#039;C&#039;&#039;&#039;ycled &#039;&#039;&#039;I&#039;&#039;&#039;mmediately &#039;&#039;&#039;D&#039;&#039;&#039;ownhill}}&amp;lt;/font&amp;gt; &lt;br /&gt;
# Type I   &#039;&#039;&#039;A&#039;&#039;&#039;naphylaxis&lt;br /&gt;
# Type II  &#039;&#039;&#039;C&#039;&#039;&#039;ytotoxic-mediated&lt;br /&gt;
# Type III &#039;&#039;&#039;I&#039;&#039;&#039;mmune-complex&lt;br /&gt;
# Type IV  &#039;&#039;&#039;D&#039;&#039;&#039;elayed hypersensitivity&lt;br /&gt;
&lt;br /&gt;
==Multiple Endocrine Neoplasia (MEN)==&lt;br /&gt;
Each of the MENs is a disease of &#039;&#039;&#039;three or two letters plus a feature&#039;&#039;&#039;; all are autosomal dominant.&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;MEN I:  3 P&#039;s&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
# &#039;&#039;&#039;P&#039;&#039;&#039;ituitary&lt;br /&gt;
# &#039;&#039;&#039;P&#039;&#039;&#039;arathyroid&lt;br /&gt;
# &#039;&#039;&#039;P&#039;&#039;&#039;ancreas&lt;br /&gt;
# Plus Adrenal cortex&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;MEN II:  2 C&#039;s&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
# &#039;&#039;&#039;C&#039;&#039;&#039;arcinoma of thyroid&lt;br /&gt;
# &#039;&#039;&#039;C&#039;&#039;&#039;atacholamines (pheochromocytoma)&lt;br /&gt;
- MEN IIA: parathyroid&lt;br /&gt;
- MEN IIB (MEN III): mucocutaneous neuromas for&lt;br /&gt;
&lt;br /&gt;
==Acute Pneumonia Infiltrates==&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039;yogenic bacteria: &#039;&#039;&#039;P&#039;&#039;&#039;MN infiltrate&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039;iscellaneous microbes: &#039;&#039;&#039;M&#039;&#039;&#039;ononuclear infiltrate&lt;br /&gt;
&lt;br /&gt;
==Takayasu&#039;s Disease/Pulseless Disease== &lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;When you have Takayasu&#039;s, I can&#039;t Tak&#039;a yu pulse&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==CBC Normal Differential==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;N&#039;&#039;&#039;ever &#039;&#039;&#039;L&#039;&#039;&#039;et &#039;&#039;&#039;M&#039;&#039;&#039;onkeys &#039;&#039;&#039;E&#039;&#039;&#039;at &#039;&#039;&#039;B&#039;&#039;&#039;ananas}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;N&#039;&#039;&#039;ice &#039;&#039;&#039;L&#039;&#039;&#039;adies &#039;&#039;&#039;M&#039;&#039;&#039;ake &#039;&#039;&#039;E&#039;&#039;&#039;aster &#039;&#039;&#039;B&#039;&#039;&#039;read&amp;quot;}}&amp;lt;/font&amp;gt;  &lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;60&#039;&#039;&#039;, &#039;&#039;&#039;30&#039;&#039;&#039;, &#039;&#039;&#039;6&#039;&#039;&#039;, &#039;&#039;&#039;3&#039;&#039;&#039;, &#039;&#039;&#039;1&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
# &#039;&#039;&#039;N&#039;&#039;&#039;eutrophils: &#039;&#039;&#039;60&#039;&#039;&#039;%&lt;br /&gt;
# &#039;&#039;&#039;L&#039;&#039;&#039;ymphocytes: &#039;&#039;&#039;30&#039;&#039;&#039;%&lt;br /&gt;
# &#039;&#039;&#039;M&#039;&#039;&#039;onocytes: &#039;&#039;&#039;6&#039;&#039;&#039;%&lt;br /&gt;
# &#039;&#039;&#039;E&#039;&#039;&#039;osinophils: &#039;&#039;&#039;3&#039;&#039;&#039;%&lt;br /&gt;
# &#039;&#039;&#039;B&#039;&#039;&#039;asophils: &#039;&#039;&#039;1&#039;&#039;&#039;%&lt;br /&gt;
&lt;br /&gt;
==Metabolic Acidosis Causes==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;MUDPILES&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039;ethanol poisoning&lt;br /&gt;
* &#039;&#039;&#039;U&#039;&#039;&#039;remia&lt;br /&gt;
* &#039;&#039;&#039;D&#039;&#039;&#039;iabetic Keto-acidosis&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039;ara-aldehyde ingestion&lt;br /&gt;
* &#039;&#039;&#039;I&#039;&#039;&#039;schemia&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039;actic Acidosis&lt;br /&gt;
* &#039;&#039;&#039;E&#039;&#039;&#039;thanol poisoning&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039;alicylate ingestion&lt;br /&gt;
&lt;br /&gt;
==Metabolic Acidosis (Normal Anion-Gap) Causes==&lt;br /&gt;
===With Hyperkalemia===&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;RAISE K+&#039;&#039;&#039;}}&amp;lt;/font&amp;gt; &lt;br /&gt;
* RTA type 4&lt;br /&gt;
* Aldosterone or mineralocorticord deficiency&lt;br /&gt;
* Iatrogenic: NH4Cl, HCl&lt;br /&gt;
* &amp;quot;Stenosis&amp;quot;: obstructive uropathy&lt;br /&gt;
* Early uremia &lt;br /&gt;
===With hypokalemia===&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;ReDUCE K+&#039;&#039;&#039;}}&amp;lt;/font&amp;gt; &lt;br /&gt;
* Renal TA type 1 and 2&lt;br /&gt;
* Diarrhoea&lt;br /&gt;
* Urine diversion into gut&lt;br /&gt;
* Carbonate anhydrase inhibitor&lt;br /&gt;
* Ex-hyperventilation&lt;br /&gt;
&lt;br /&gt;
==BUN &amp;amp; Creatinine Elevation==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;ABCD&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;zotremia (pre-renal)&lt;br /&gt;
* &#039;&#039;&#039;B&#039;&#039;&#039; - &#039;&#039;&#039;B&#039;&#039;&#039;leeding (GI)&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039; - &#039;&#039;&#039;C&#039;&#039;&#039;atabolic status&lt;br /&gt;
* &#039;&#039;&#039;D&#039;&#039;&#039; - &#039;&#039;&#039;D&#039;&#039;&#039;iet (high protein parenteral nutrition)&lt;br /&gt;
&lt;br /&gt;
==Hypercalcemia Causes==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;PAM SCHMIDT&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;                       &lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039;aget&#039;s Disease&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;myloid&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039;ultiple Myeloma&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039;arcoid&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039;ancer&lt;br /&gt;
* &#039;&#039;&#039;H&#039;&#039;&#039;ormomal (para-thyroid)&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039;ilk-alkali Syndrome&lt;br /&gt;
* &#039;&#039;&#039;I&#039;&#039;&#039;mmobilization&lt;br /&gt;
* &#039;&#039;&#039;D&#039;&#039;&#039;-vitamin overdose&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039;hyrotoxicosis&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;OR&#039;&#039;&#039;&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;MISHAP&#039;&#039;&#039;}}&amp;lt;/font&amp;gt; &lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039;alignancy&lt;br /&gt;
* &#039;&#039;&#039;I&#039;&#039;&#039;ntoxication (hypervitaminosis)&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039;arcoidosis&lt;br /&gt;
* &#039;&#039;&#039;H&#039;&#039;&#039;yperparathyroidism&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;lkali (Milk) syndrome&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039;aget&#039;s Disease (bone)&lt;br /&gt;
Also consider Addison&#039;s disease, thiazide diuretics and simple lab error&lt;br /&gt;
&lt;br /&gt;
==Malignant Hyperthermia Treatment==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Sunday Hot Day, Better Give Iced Fluids Today!&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039;- Stop all triggering agents, give 100% O2&lt;br /&gt;
* &#039;&#039;&#039;H&#039;&#039;&#039;- Hyperventillate&lt;br /&gt;
* &#039;&#039;&#039;D&#039;&#039;&#039;- Dantrolene 2.5 mg/kg&lt;br /&gt;
* &#039;&#039;&#039;B&#039;&#039;&#039;- Bicarbonate&lt;br /&gt;
* &#039;&#039;&#039;G&#039;&#039;&#039;- Glucose and Insulin&lt;br /&gt;
* &#039;&#039;&#039;I&#039;&#039;&#039;- IV Fluids, Cooling Blanket&lt;br /&gt;
* &#039;&#039;&#039;F&#039;&#039;&#039;- Fluid Output; Furosemide&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039;- Tachycardia, be prepared to treat V Tach&lt;br /&gt;
&lt;br /&gt;
==Back Pain Causes==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;DISK MASS&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;D&#039;&#039;&#039;-&#039;&#039;&#039;D&#039;&#039;&#039;egeneration: DJD, Osteoporosis, spondylosis&lt;br /&gt;
* &#039;&#039;&#039;I&#039;&#039;&#039;-&#039;&#039;&#039;I&#039;&#039;&#039;nfection: UTI, PID, Potts, osteomyelitis, prostatitis, Injury/fracture, compression fracture&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039;-&#039;&#039;&#039;S&#039;&#039;&#039;pondylitis, ankylosing Spondyloarthropathies (rheumatoid arthritis, Reiters,  SLE)&lt;br /&gt;
* &#039;&#039;&#039;K&#039;&#039;&#039;-&#039;&#039;&#039;K&#039;&#039;&#039;idney stones/infarction/infection (pyelo/abscess)&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039;-&#039;&#039;&#039;M&#039;&#039;&#039;ultiple myeloma, &#039;&#039;&#039;M&#039;&#039;&#039;etastasis from breast, prostate, lung, thyroid, kidney CA&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;-&#039;&#039;&#039;A&#039;&#039;&#039;neurysm, &#039;&#039;&#039;A&#039;&#039;&#039;bdominal pain referred to the back (see acute abdominal pain)&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039;-&#039;&#039;&#039;S&#039;&#039;&#039;lipped disk, &#039;&#039;&#039;S&#039;&#039;&#039;pondylolisthesis&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039;-&#039;&#039;&#039;S&#039;&#039;&#039;train, &#039;&#039;&#039;S&#039;&#039;&#039;coliosis/lordosis, &#039;&#039;&#039;S&#039;&#039;&#039;kin: herpes zoster&lt;br /&gt;
&lt;br /&gt;
==Syncope Management==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;If the face is red, raise the head!&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;If the face is pale, raise the tail!&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==GENETICS==&lt;br /&gt;
==Down Syndrome Features==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;CHILD HAS PROBLEM!&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039;ongenital heart disease/ &#039;&#039;&#039;C&#039;&#039;&#039;ataracts&lt;br /&gt;
* &#039;&#039;&#039;H&#039;&#039;&#039;ypotonia/ Hypothyroidism&lt;br /&gt;
* &#039;&#039;&#039;I&#039;&#039;&#039;ncure 5th finger/ &#039;&#039;&#039;I&#039;&#039;&#039;ncreased gap between 1st and 2nd toe&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039;eukemia risk x2/ &#039;&#039;&#039;L&#039;&#039;&#039;ung problem&lt;br /&gt;
* &#039;&#039;&#039;D&#039;&#039;&#039;uodenal atresia/ &#039;&#039;&#039;D&#039;&#039;&#039;elayed development &lt;br /&gt;
* &#039;&#039;&#039;H&#039;&#039;&#039;irshsprung&#039;s disease/ &#039;&#039;&#039;H&#039;&#039;&#039;earing loss&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;lzheimer&#039;s disease/ Alantoaxial instability&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039;quint/ Short neck &lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039;rotruding tongue/ &#039;&#039;&#039;P&#039;&#039;&#039;alm crease&lt;br /&gt;
* &#039;&#039;&#039;R&#039;&#039;&#039;ound face/ &#039;&#039;&#039;R&#039;&#039;&#039;olling eye (nystagmus)&lt;br /&gt;
* &#039;&#039;&#039;O&#039;&#039;&#039;cciput flat/ &#039;&#039;&#039;O&#039;&#039;&#039;blique eye fissure&lt;br /&gt;
* &#039;&#039;&#039;B&#039;&#039;&#039;rushfield spot/ &#039;&#039;&#039;B&#039;&#039;&#039;rachycephaly&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039;ow nasal bridge/ &#039;&#039;&#039;L&#039;&#039;&#039;anguage problem&lt;br /&gt;
* &#039;&#039;&#039;E&#039;&#039;&#039;picanthic fold/ &#039;&#039;&#039;E&#039;&#039;&#039;ar folded&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039;ental retardation/ &#039;&#039;&#039;M&#039;&#039;&#039;yoclonus &lt;br /&gt;
&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;DOWN&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;D&#039;&#039;&#039;ecreased alpha-fetoprotein and unconjugated estriol (maternal)&lt;br /&gt;
* &#039;&#039;&#039;O&#039;&#039;&#039;ne extra chromosome twenty-one&lt;br /&gt;
* &#039;&#039;&#039;W&#039;&#039;&#039;omen of advanced age&lt;br /&gt;
* &#039;&#039;&#039;N&#039;&#039;&#039;on-disjunction during maternal meiosis &lt;br /&gt;
&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Drink at 21&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
Chromosome 21&lt;br /&gt;
&lt;br /&gt;
==Patau&#039;s Syndrome - Chromosome 13==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;P&#039;&#039;&#039;uberty at 13}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Edward&#039;s Syndrome - Chromosome 18==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|Election voter at 18}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Hurler Syndrome Features== &lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;HURLER&#039;S&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
*&#039;&#039;&#039;H&#039;&#039;&#039;eptosplenomegaly &lt;br /&gt;
*&#039;&#039;&#039;U&#039;&#039;&#039;gly facies &lt;br /&gt;
*&#039;&#039;&#039;R&#039;&#039;&#039;ecessive (AR inheritance) &lt;br /&gt;
*&#039;&#039;&#039;L&#039;&#039;&#039;-iduronidase deficiency (alpha) &lt;br /&gt;
*&#039;&#039;&#039;E&#039;&#039;&#039;yes clouded &lt;br /&gt;
*&#039;&#039;&#039;R&#039;&#039;&#039;etarded &lt;br /&gt;
*&#039;&#039;&#039;S&#039;&#039;&#039;tubby fingers/&#039;&#039;&#039;S&#039;&#039;&#039;hort &lt;br /&gt;
&lt;br /&gt;
==DiGeorge (Velocardiofacial) Syndrome==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;CATCH 22&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039;ardiac abnormalities&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;bnormal facies&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039;hymic aplasia&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039;left palate&lt;br /&gt;
* &#039;&#039;&#039;H&#039;&#039;&#039;ypocalcemia&lt;br /&gt;
* &#039;&#039;&#039;22&#039;&#039;&#039;q11 deletion &lt;br /&gt;
&lt;br /&gt;
==MARFAN Syndrome Features==&lt;br /&gt;
# &#039;&#039;&#039;M&#039;&#039;&#039;itral valve prolapse - MVP&lt;br /&gt;
# &#039;&#039;&#039;A&#039;&#039;&#039;ortic Aneurysm&lt;br /&gt;
# &#039;&#039;&#039;R&#039;&#039;&#039;etinal detachment&lt;br /&gt;
# &#039;&#039;&#039;F&#039;&#039;&#039;ibrillin&lt;br /&gt;
# &#039;&#039;&#039;A&#039;&#039;&#039;rachnodactyly&lt;br /&gt;
# &#039;&#039;&#039;N&#039;&#039;&#039;egative &#039;&#039;&#039;N&#039;&#039;&#039;itroprusside test (differentiates from homocystinuria) &lt;br /&gt;
&lt;br /&gt;
==Adult Polycystic Kidney Disease==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&amp;quot;Polycystic kidney&amp;quot;&#039; has &#039;&#039;&#039;16 letters&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
Also,  and is due to a defect on chromosome 16.&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;APKD&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
ADult Polycystic Kidney Disease is  Autosomal Dominant&lt;br /&gt;
&lt;br /&gt;
==Essential Amino Acids==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;P&#039;&#039;&#039; ri &#039;&#039;&#039;V&#039;&#039;&#039; a &#039;&#039;&#039;T&#039;&#039;&#039; e   &#039;&#039;&#039;TIM   HALL&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;PVT. TIM HALL&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;&amp;quot;PVT. TIM HALL always argues, never tires&amp;quot;&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039; - &#039;&#039;&#039;P&#039;&#039;&#039;he&lt;br /&gt;
* &#039;&#039;&#039;V&#039;&#039;&#039; - &#039;&#039;&#039;V&#039;&#039;&#039;al&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039; - &#039;&#039;&#039;T&#039;&#039;&#039;hr&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039; - &#039;&#039;&#039;T&#039;&#039;&#039;rp&lt;br /&gt;
* &#039;&#039;&#039;I&#039;&#039;&#039; - &#039;&#039;&#039;I&#039;&#039;&#039;le&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039; - &#039;&#039;&#039;M&#039;&#039;&#039;et&lt;br /&gt;
* &#039;&#039;&#039;H&#039;&#039;&#039; - &#039;&#039;&#039;H&#039;&#039;&#039;is&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;rg&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039; - &#039;&#039;&#039;L&#039;&#039;&#039;eu&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039; - &#039;&#039;&#039;L&#039;&#039;&#039;ys&lt;br /&gt;
* Pvt. is short for Private in the military&lt;br /&gt;
* Arg and His are considered semi-essential&lt;br /&gt;
* Alternatively: &#039;&#039;&#039;MATT VIL PHLy&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
==Urea Cycle==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;O&#039;&#039;&#039;rdinarily &#039;&#039;&#039;C&#039;&#039;&#039;areless &#039;&#039;&#039;C&#039;&#039;&#039;rappers &#039;&#039;&#039;A&#039;&#039;&#039;re &#039;&#039;&#039;A&#039;&#039;&#039;lso &#039;&#039;&#039;F&#039;&#039;&#039;rivolous &#039;&#039;&#039;A&#039;&#039;&#039;bout &#039;&#039;&#039;U&#039;&#039;&#039;rination!}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;O&#039;&#039;&#039; - &#039;&#039;&#039;O&#039;&#039;&#039;rnithine&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039; - &#039;&#039;&#039;C&#039;&#039;&#039;arbamoyl&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039; - &#039;&#039;&#039;C&#039;&#039;&#039;itrulline&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;spartate&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;rginosuccinate&lt;br /&gt;
* &#039;&#039;&#039;F&#039;&#039;&#039; - &#039;&#039;&#039;F&#039;&#039;&#039;umarate&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;rginine&lt;br /&gt;
* &#039;&#039;&#039;U&#039;&#039;&#039; - &#039;&#039;&#039;U&#039;&#039;&#039;rea&lt;br /&gt;
&lt;br /&gt;
==CELL BIOLOGY==&lt;br /&gt;
==Cell Division Phases==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;People Meet And Talk&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039; - &#039;&#039;&#039;P&#039;&#039;&#039;rophase&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039; - &#039;&#039;&#039;M&#039;&#039;&#039;etaphase&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;naphase&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039; - &#039;&#039;&#039;T&#039;&#039;&#039;elophase&lt;br /&gt;
&lt;br /&gt;
==Cell Cycle Stages==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Go Sally Go! Make Children!&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;G1&#039;&#039;&#039; phase - Growth phase 1&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039; phase - DNA synthesis&lt;br /&gt;
* &#039;&#039;&#039;G2&#039;&#039;&#039; phase - Growth phase 2&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039; phase - Mitosis&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039; phase - Cytokinesis&lt;br /&gt;
&lt;br /&gt;
==Golgi Complex Functions==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Golgi Distributes A SPAM&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;Distributes&#039;&#039;&#039; proteins and lipids from ER&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;dd mannose onto specific lysosome proteins&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039;ulfation of sugars and slected tyrosine&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039;roteoglycan assembly&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039;dd O-oligosugars to serine and threnonine&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039;odify N-ologosugars on asparagine&lt;br /&gt;
&lt;br /&gt;
==Collagen==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;COLLAGEN&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039; - &#039;&#039;&#039;C&#039;&#039;&#039;-terminal propeptide (procollagen) / &#039;&#039;&#039;C&#039;&#039;&#039;ovalent &#039;&#039;&#039;C&#039;&#039;&#039;ross links/ &#039;&#039;&#039;C&#039;&#039;&#039; vitamin/ &#039;&#039;&#039;C&#039;&#039;&#039;onnective tissue/ &#039;&#039;&#039;C&#039;&#039;&#039;artilage/ &#039;&#039;&#039;C&#039;&#039;&#039;hondroblasts/&#039;&#039;&#039;C&#039;&#039;&#039;opper Cofactor (Covalent Cross linking)&lt;br /&gt;
* &#039;&#039;&#039;O&#039;&#039;&#039; - &#039;&#039;&#039;O&#039;&#039;&#039;utside the cell is where collagen normally functions/ &#039;&#039;&#039;O&#039;&#039;&#039;steoblasts/ &#039;&#039;&#039;O&#039;&#039;&#039;steogenesis imperfecta&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039; - &#039;&#039;&#039;L&#039;&#039;&#039;ysyl hydroxylase / &#039;&#039;&#039;L&#039;&#039;&#039;ysyl oxidase (oxidatively deaminates lysyl and hydroxylysyl residues to form collagen cross links, last biosynthesis step)&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039; - &#039;&#039;&#039;L&#039;&#039;&#039;ong triple helical fibers / &#039;&#039;&#039;L&#039;&#039;&#039;igaments&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;lpha chains / &#039;&#039;&#039;A&#039;&#039;&#039;ttached by H bonds form triple helix / &#039;&#039;&#039;A&#039;&#039;&#039;scorbate for hydroxylation of lysyl and prolyl residues of pro-Alpha chains&lt;br /&gt;
(postranslational modification)&lt;br /&gt;
* &#039;&#039;&#039;G&#039;&#039;&#039; - &#039;&#039;&#039;G&#039;&#039;&#039;ly in every third position / &#039;&#039;&#039;G&#039;&#039;&#039;lycosylation of hydroxyl group of hydroxylysine with &#039;&#039;&#039;G&#039;&#039;&#039;lucose and &#039;&#039;&#039;G&#039;&#039;&#039;alactose; &#039;&#039;&#039;GO&#039;&#039;&#039;lgi allows procollagen to &#039;&#039;&#039;GO&#039;&#039;&#039; outside of cell&lt;br /&gt;
* &#039;&#039;&#039;E&#039;&#039;&#039; - &#039;&#039;&#039;E&#039;&#039;&#039;xtracellular matrix / &#039;&#039;&#039;E&#039;&#039;&#039;ye (cornea, sclera) / &#039;&#039;&#039;E&#039;&#039;&#039;hlers-Danlos Syndrome&lt;br /&gt;
* &#039;&#039;&#039;N&#039;&#039;&#039; - &#039;&#039;&#039;N&#039;&#039;&#039;-terminal propeptide (procollagen) / &#039;&#039;&#039;N&#039;&#039;&#039;onhelical terminal extensions&lt;br /&gt;
&lt;br /&gt;
==Acute Intermittent Porphyria== &lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;5  P&#039;s &#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039;ain in abdomen&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039;olyneuropathy&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039;sychologial abnormalities&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039;ink urine&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039;recipitated by drugs (eg barbiturates, oral contraceptives, sulpha drugs)&lt;br /&gt;
&lt;br /&gt;
==G6PD: Oxidant Drugs Inducing Hemolytic Anemia == &lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;AAA&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* Antibiotic (eg: sufamethoxazole)&lt;br /&gt;
* Antimalarial (eg: primaquine)&lt;br /&gt;
* Antipyretics (eg: acetanilid, but not aspirin or acetaminophen)&lt;br /&gt;
&lt;br /&gt;
==Pompe&#039;s Disease==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Type &amp;quot;Police: Po + lys&amp;quot;&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;PO&#039;&#039;&#039;mpe&#039;s disease is a &#039;&#039;&#039;LYS&#039;&#039;&#039;osomal storage disease (alpha 1,4 glucosidase)&lt;br /&gt;
&lt;br /&gt;
==Galactosemia==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;GALIPUT&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* Galactose 1 Phosphate Uridyl Transferase&lt;br /&gt;
* There is an assay called the Galiput test for this&lt;br /&gt;
&lt;br /&gt;
==G-proteins Receptors== &lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;QISS &amp;amp; QIQ&amp;quot; (Kiss and Kick)&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
In alphabetical order&lt;br /&gt;
* Q: alpha 1&lt;br /&gt;
* I: alpha 2&lt;br /&gt;
* S: beta 1&lt;br /&gt;
* S: beta 2&lt;br /&gt;
* &amp;amp;&lt;br /&gt;
* Q: M1&lt;br /&gt;
* I: M2&lt;br /&gt;
* Q: M3 &lt;br /&gt;
&lt;br /&gt;
==Adrenaline Mechanism==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;ABC of Adrenaline&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* Adrenaline--&amp;gt; activates&lt;br /&gt;
* Beta receptors--&amp;gt; increases&lt;br /&gt;
* Cyclic AMP &lt;br /&gt;
&lt;br /&gt;
==Carbon Monoxide: Electron Transport Chain Target==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;CO blocks CO&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
Carbon monoxide &#039;&#039;&#039;(CO)&#039;&#039;&#039; blocks Cytochrome Oxidase &#039;&#039;&#039;(CO)&#039;&#039;&#039; &lt;br /&gt;
&lt;br /&gt;
==Hemoglobin Binding Curve: Right Shift Causes==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;CADET, face right!&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* C = Increase in carbon dioxide&lt;br /&gt;
* A = Acidosis (low ph)&lt;br /&gt;
* D = Increase in 2,3 DPG aka 2,3 BPG&lt;br /&gt;
* E = Exercise&lt;br /&gt;
* T = increase in temperature&lt;br /&gt;
&lt;br /&gt;
==BIOCHEMISTRY==&lt;br /&gt;
==Enzymes Classification==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Over The HILL&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;O&#039;&#039;&#039; - &#039;&#039;&#039;O&#039;&#039;&#039;xidoreductases&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039; - &#039;&#039;&#039;T&#039;&#039;&#039;ransferases&lt;br /&gt;
* &#039;&#039;&#039;H&#039;&#039;&#039; - &#039;&#039;&#039;H&#039;&#039;&#039;ydrolases&lt;br /&gt;
* &#039;&#039;&#039;I&#039;&#039;&#039; - &#039;&#039;&#039;I&#039;&#039;&#039;somerases&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039; - &#039;&#039;&#039;L&#039;&#039;&#039;igases&lt;br /&gt;
* &#039;&#039;&#039;L&#039;&#039;&#039; - &#039;&#039;&#039;L&#039;&#039;&#039;yases&lt;br /&gt;
&lt;br /&gt;
==AcetylCoA and AcetacetylCoA==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;A Lighter Lease (A LyTr LeIs)&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
Amino acids forming them:&lt;br /&gt;
* A=AcetylCoA or Acetoacetyl CoA&lt;br /&gt;
* Ly=Lysine&lt;br /&gt;
* Tr=Tryptophan&lt;br /&gt;
* Le=Leucine&lt;br /&gt;
* Is=Isoleucine &lt;br /&gt;
&lt;br /&gt;
==Branched-chain Amino Acids Used by Skeletal Muscle (Fasting State)==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Muscles LIVe fast&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* Leucine&lt;br /&gt;
* Isoleucine&lt;br /&gt;
* Valine&lt;br /&gt;
&lt;br /&gt;
==Glycolysis Steps==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Goodness Gracious, Father Franklin Did Go By Picking Pumpkins (to) Prepare Pies&#039;&#039;&#039;}}&amp;lt;/font&amp;gt; &lt;br /&gt;
* Glucose&lt;br /&gt;
* Glucose-6-P&lt;br /&gt;
* Fructose-6-P&lt;br /&gt;
* Fructose-1,6-diP&lt;br /&gt;
* Dihydroxyacetone-P&lt;br /&gt;
* Glyceraldehyde-P&lt;br /&gt;
* 1,3-Biphosphoglycerate&lt;br /&gt;
* 3-Phosphoglycerate&lt;br /&gt;
* 2-Phosphoglycerate (to)&lt;br /&gt;
* Phosphoenolpyruvate [PEP] Pyruvate • &#039;Did&#039;, &#039;By&#039; and &#039;Pies&#039; tell you the first part of those three: di-, bi-, and py-. &lt;br /&gt;
• &#039;PrEPare&#039; tells location of PEP in the process. &lt;br /&gt;
&lt;br /&gt;
==METABOLISM==&lt;br /&gt;
==Metabolism Sites==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Use both arms to HUG&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
# Heme synthesis&lt;br /&gt;
# Urea cycle&lt;br /&gt;
# Gluconeogenesis&lt;br /&gt;
These reactions occur in both cytoplasm and mitochondria&lt;br /&gt;
&lt;br /&gt;
==Glycolysis Enzymes==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Hungry Peter Pan And The Growling Pink Panther Eat Pies&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* Hexokinase&lt;br /&gt;
* Phosphohexo isomerase&lt;br /&gt;
* Phosphofructokinase-1 (6-phosphofructo-1 kinase)&lt;br /&gt;
* Aldolase, Triose phosphate isomerase&lt;br /&gt;
* Glyceraldehyde 3-phosphate dehydrogenase&lt;br /&gt;
* Phosphoglycerate kinase&lt;br /&gt;
* Phosphoglycerate mutase&lt;br /&gt;
* Enolase&lt;br /&gt;
* Pyruvate kinase&lt;br /&gt;
&lt;br /&gt;
==Citric Acid Cycle Compounds==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Our City Is Kept Safe And Sound From Malice&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* Oxaloacetate&lt;br /&gt;
* Citrate&lt;br /&gt;
* Isocitrate&lt;br /&gt;
* alpha-Ketoglutarate&lt;br /&gt;
* Succinyl-CoA&lt;br /&gt;
* Succinate&lt;br /&gt;
* Fumarate&lt;br /&gt;
* Malate&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Can I Keep Selling Sex For Money, Officer?&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* Citrate&lt;br /&gt;
* Isocitrate&lt;br /&gt;
* alpha-Ketogluterate&lt;br /&gt;
* Succinyl CoA&lt;br /&gt;
* Succinate&lt;br /&gt;
* Fumerate&lt;br /&gt;
* Malate&lt;br /&gt;
* Oxaloacetate&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Oh! Can I Keep Some Succinate For Myself?&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Oh Citric Acid Is Of (course) A SiLly STupid Funny Molecule&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* Oxaloacetate&lt;br /&gt;
* Citrate&lt;br /&gt;
* Isocitrate, alpha-Ketoglutarate&lt;br /&gt;
* Succinyl CoA&lt;br /&gt;
* Succinate&lt;br /&gt;
* Fumarate&lt;br /&gt;
* Malate &lt;br /&gt;
&lt;br /&gt;
==Citric Acid Cycle Enzymes==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Corrupt Anti Intelligence Agent Spoke Slander For Money&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* Citrate synthatase&lt;br /&gt;
* Aconitase&lt;br /&gt;
* Isocitrate dehydrogenase&lt;br /&gt;
* Alpha ketogluturate dehydrogenase&lt;br /&gt;
* Succinyl CoA synthetase&lt;br /&gt;
* Succinate dehydrogenase&lt;br /&gt;
* Fumarase&lt;br /&gt;
* Malate Dehydrogenase&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==B Vitamins==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;The Rhythm Nearly Proved Contagious&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
In increasing order: &lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039; - &#039;&#039;&#039;T&#039;&#039;&#039;hiamine (B1)&lt;br /&gt;
* &#039;&#039;&#039;R&#039;&#039;&#039; - &#039;&#039;&#039;R&#039;&#039;&#039;iboflavin (B2)&lt;br /&gt;
* &#039;&#039;&#039;N&#039;&#039;&#039; - &#039;&#039;&#039;N&#039;&#039;&#039;iacin (B3)&lt;br /&gt;
* &#039;&#039;&#039;P&#039;&#039;&#039; - &#039;&#039;&#039;P&#039;&#039;&#039;yridoxine (B6)&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039; - &#039;&#039;&#039;C&#039;&#039;&#039;obalamin (B12)&lt;br /&gt;
&lt;br /&gt;
==Niacin Deficiency==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;The famous 4 D&#039;s&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
# Diarrhea&lt;br /&gt;
# Dermatitis&lt;br /&gt;
# Dementia&lt;br /&gt;
# Death (if untreated) &lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;The 3D&#039;s of pellagra&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
Vitamin B3 (niacin, nicotinic acid) deficiency&lt;br /&gt;
# Dermatitis&lt;br /&gt;
# Diarrhea&lt;br /&gt;
# Dementia&lt;br /&gt;
&lt;br /&gt;
==Folate Deficiency Causes==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;A FOLIC DROP&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* Alcoholism&lt;br /&gt;
* Folic acid antagonists&lt;br /&gt;
* Oral contraceptives&lt;br /&gt;
* Low dietary intake&lt;br /&gt;
* Infection with Giardia&lt;br /&gt;
* Celiac sprue&lt;br /&gt;
* Dilatin&lt;br /&gt;
* Relative folate deficiency&lt;br /&gt;
* Old&lt;br /&gt;
* Pregnant &lt;br /&gt;
&lt;br /&gt;
==Fat Soluble Vitamins==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;The FAT cat is in the ADEK (attic)&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
Fat soluble vitamins are &#039;&#039;A,D,E,K.&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
==Hypervitaminosis A==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|Increased Vitamin A makes you &#039;&#039;&#039;HARD&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;H&#039;&#039;&#039; - &#039;&#039;&#039;H&#039;&#039;&#039;eadache / &#039;&#039;&#039;H&#039;&#039;&#039;epatomegaly&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;norexia / &#039;&#039;&#039;A&#039;&#039;&#039;lopecia&lt;br /&gt;
* &#039;&#039;&#039;R&#039;&#039;&#039; - &#039;&#039;&#039;R&#039;&#039;&#039;eally painful bones&lt;br /&gt;
* &#039;&#039;&#039;D&#039;&#039;&#039; - &#039;&#039;&#039;D&#039;&#039;&#039;ry skin / &#039;&#039;&#039;D&#039;&#039;&#039;rowsiness&lt;br /&gt;
&lt;br /&gt;
==Branched Chain Amino Acids Catabolism Steps==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Truck hit the Ox to Death&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039; - &#039;&#039;&#039;T&#039;&#039;&#039;ransamination&lt;br /&gt;
* &#039;&#039;&#039;O&#039;&#039;&#039; - &#039;&#039;&#039;O&#039;&#039;&#039;xidative decarboxylation&lt;br /&gt;
* &#039;&#039;&#039;D&#039;&#039;&#039; - &#039;&#039;&#039;D&#039;&#039;&#039;ehydrogenation&lt;br /&gt;
&lt;br /&gt;
==Creatine Phosphate: Amino Acid Precursors==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;Nice GAMs!&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;G&#039;&#039;&#039; - &#039;&#039;&#039;G&#039;&#039;&#039;lycine&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;rginine&lt;br /&gt;
* &#039;&#039;&#039;M&#039;&#039;&#039; - &#039;&#039;&#039;M&#039;&#039;&#039;ethionine&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Pyrimidines Nucleotides==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;CUT the PY (pie)&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;C&#039;&#039;&#039;ytosine&lt;br /&gt;
* &#039;&#039;&#039;U&#039;&#039;&#039;racil&lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039;hiamine &lt;br /&gt;
* &#039;&#039;&#039;T&#039;&#039;&#039;he&lt;br /&gt;
* &#039;&#039;&#039;PY&#039;&#039;&#039;rimidines &lt;br /&gt;
&lt;br /&gt;
==Fabry&#039;s Disease==&lt;br /&gt;
&amp;lt;font color=&amp;quot;red&amp;quot;&amp;gt;{{cquote|&#039;&#039;&#039;FABRY &#039; S&#039;&#039;&#039;}}&amp;lt;/font&amp;gt;&lt;br /&gt;
* &#039;&#039;&#039;F&#039;&#039;&#039; - &#039;&#039;&#039;F&#039;&#039;&#039;oam cells found in glomeruli and tubules / &#039;&#039;&#039;F&#039;&#039;&#039;ebrile episodes&lt;br /&gt;
* &#039;&#039;&#039;A&#039;&#039;&#039; - &#039;&#039;&#039;A&#039;&#039;&#039;lpha galactosidase &#039;&#039;&#039;A&#039;&#039;&#039; deficiency / &#039;&#039;&#039;A&#039;&#039;&#039;ngiokeratomas&lt;br /&gt;
* &#039;&#039;&#039;B&#039;&#039;&#039; - &#039;&#039;&#039;B&#039;&#039;&#039;urning pain in extremities / &#039;&#039;&#039;B&#039;&#039;&#039;UN increased in serum / &#039;&#039;&#039;B&#039;&#039;&#039;oys&lt;br /&gt;
* &#039;&#039;&#039;R&#039;&#039;&#039; - &#039;&#039;&#039;R&#039;&#039;&#039;enal failure&lt;br /&gt;
* &#039;&#039;&#039;Y&#039;&#039;&#039; - &#039;&#039;&#039;Y&#039;&#039;&#039;X genotype (male, X linked recessive)&lt;br /&gt;
* &#039;&#039;&#039;S&#039;&#039;&#039; - &#039;&#039;&#039;S&#039;&#039;&#039;phingolipidoses&lt;/div&gt;</summary>
		<author><name>Gonzalo Romero</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=WBR_team&amp;diff=936887</id>
		<title>WBR team</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=WBR_team&amp;diff=936887"/>
		<updated>2014-01-31T23:10:04Z</updated>

		<summary type="html">&lt;p&gt;Gonzalo Romero: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Board review project}}&lt;br /&gt;
[[Image:Main_help_page_small.PNG|100px|link=Help]][[Image:Projects.PNG|100px|link=Projects]][[Image:Editor&#039;s_Tools.PNG|100px|link=Help Menu]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Editor-In-Chief:&#039;&#039;&#039; [[User:William J Gibson|Will Gibson]];  {{AE}}  [[User:Gonzalo Romero|Gonzalo A. Romero, M.D.]][mailto:gromero@wikidoc.org];{{Rim}};[[User:Sergekorjian|Serge Korjian]]; [[User:YazanDaaboul|Yazan Daaboul]]; {{VR}}; {{CP}}; {{AN}}; {{RT}}; {{M.P}}; {{AO}}; {{MS}};&lt;br /&gt;
&lt;br /&gt;
==Meet the Wiki Board Review Team==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Deputy Editors-In-Chief, WikiDoc:&#039;&#039;&#039;&lt;br /&gt;
*[[User:William J Gibson|William Gibson, B.S.]]&lt;br /&gt;
*[[User:Rim Halaby|Rim Halaby, M.D.]]&lt;br /&gt;
*[[User:Sergekorjian|Serge Korjian]]&lt;br /&gt;
*[[User:YazanDaaboul|Yazan Daaboul]]&lt;br /&gt;
*[[User:Gonzalo Romero|Gonzalo Romero, M.D.]]&lt;br /&gt;
*[[User:Vendhan Ramanujam|Vendhan Ramanujam, M.B.B.S.]]&lt;br /&gt;
*[[User:Mugilan Poongkunran|Mugilan Poongkunran, M.B.B.S.]]&lt;br /&gt;
*[[User:Kristin Feeney|Kristin Feeney, B.S.]]&lt;br /&gt;
*[[User:Hardik Patel|Hardik Patel, M.B.B.S.]]&lt;br /&gt;
*[[User:Ochuko Ajari|Ochuko Ajari, M.B.B.S., M.S.]]&lt;br /&gt;
*[[User:Mahmoud Sakr|Mahmoud Sakr, M.D.]]&lt;br /&gt;
*[[User:Ayokunle Olubaniyi|Ayokunle Olubaniyi M.B.B.S.]]&lt;br /&gt;
*[[User:Sapan Patel|Sapan Patel, M.B.B.S.]]&lt;br /&gt;
&lt;br /&gt;
{| width=&amp;quot;60%&amp;quot; style=&amp;quot;border: solid 1px #cedff2&amp;quot; cellpadding=&amp;quot;4&amp;quot; cellspacing=&amp;quot;1&amp;quot; Font&lt;br /&gt;
|- style=&amp;quot;color:#000; font-size:130%; vertical-align:top; width:20%&amp;quot;&lt;br /&gt;
|  bgcolor=&amp;quot;#cedff2&amp;quot; style=&amp;quot;border: solid 1px #cedff2&amp;quot; colspan=&amp;quot;2&amp;quot; align=&amp;quot;left&amp;quot; | &#039;&#039;&#039;Deputy Editors-In-Chief on Site&#039;&#039;&#039;&lt;br /&gt;
|- style=&amp;quot;color:#000; font-size:100%; vertical-align:top; width:50%&amp;quot;&lt;br /&gt;
| bgcolor=&amp;quot;#f5fffa;&#039;&#039; width=&amp;quot;20%&amp;quot; align=&amp;quot;left&amp;quot; | [[Image:Will_Gibson.jpg|200px]]&lt;br /&gt;
| bgcolor=&amp;quot;#cedff2&amp;quot; width=&amp;quot;80%&amp;quot; align=&amp;quot;left&amp;quot; |&lt;br /&gt;
&#039;&#039;&#039;[[User:William J Gibson|William Gibson, B.S.]]&#039;&#039;&#039;&lt;br /&gt;
&#039;&#039;&#039;Contact:&#039;&#039;&#039; wgibson@mit.edu&lt;br /&gt;
*&#039;&#039;&#039;Deputy Editor-In-Chief at PERFUSE Study Group&#039;&#039;&#039;&lt;br /&gt;
*&#039;&#039;&#039;Beth Israel Deaconess Medical Center, Harvard Medical School&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
*&#039;&#039;&#039;M.D., Ph.D. candidate from Harvard Medical School&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
|- style=&amp;quot;color:#000; font-size:100%; vertical-align:top; width:50%&amp;quot;&lt;br /&gt;
| bgcolor=&amp;quot;#f5fffa;&#039;&#039; width=&amp;quot;20%&amp;quot; align=&amp;quot;left&amp;quot; | [[Image:Rim.jpg|200px]]&lt;br /&gt;
| bgcolor=&amp;quot;#cedff2&amp;quot; width=&amp;quot;80%&amp;quot; align=&amp;quot;left&amp;quot; |&lt;br /&gt;
&#039;&#039;&#039;[[User:Rim Halaby|Rim Halaby, M.D.]]&#039;&#039;&#039;&lt;br /&gt;
&#039;&#039;&#039;Contact:&#039;&#039;&#039; rim.halaby@wikidoc.org  &#039;&#039;&#039;Phone:&#039;&#039;&#039; 617-632-7590&lt;br /&gt;
*&#039;&#039;&#039;Research Fellow at PERFUSE Study Group&#039;&#039;&#039;&lt;br /&gt;
*&#039;&#039;&#039;Beth Israel Deaconess Medical Center, Harvard Medical School&#039;&#039;&#039;&lt;br /&gt;
*&#039;&#039;&#039;Senior Manager of Deputy Editors, WikiDoc&#039;&#039;&#039;&lt;br /&gt;
&#039;&#039;&#039;Interests:&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
|- style=&amp;quot;color:#000; font-size:100%; vertical-align:top; width:50%&amp;quot;&lt;br /&gt;
| bgcolor=&amp;quot;#f5fffa;&#039;&#039; width=&amp;quot;20%&amp;quot; align=&amp;quot;left&amp;quot; | Picture 9&lt;br /&gt;
| bgcolor=&amp;quot;#cedff2&amp;quot; width=&amp;quot;80%&amp;quot; align=&amp;quot;left&amp;quot; |&lt;br /&gt;
&#039;&#039;&#039;Gerald Chi, M.D.&#039;&#039;&#039;&lt;br /&gt;
&#039;&#039;&#039;Contact:&#039;&#039;&#039; gchi@wikidoc.org&lt;br /&gt;
*&#039;&#039;&#039;Research Fellow at PERFUSE Study Group&#039;&#039;&#039;&lt;br /&gt;
*&#039;&#039;&#039;Beth Israel Deaconess Medical Center, Harvard Medical School&#039;&#039;&#039;&lt;br /&gt;
&#039;&#039;&#039;Interests:&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
|- style=&amp;quot;color:#000; font-size:100%; vertical-align:top; width:50%&amp;quot;&lt;br /&gt;
| bgcolor=&amp;quot;#f5fffa;&#039;&#039; width=&amp;quot;20%&amp;quot; align=&amp;quot;left&amp;quot; | [[Image:Vendhan.jpg|200px]]&lt;br /&gt;
| bgcolor=&amp;quot;#cedff2&amp;quot; width=&amp;quot;80%&amp;quot; align=&amp;quot;left&amp;quot; |&lt;br /&gt;
&#039;&#039;&#039;[[User:Vendhan Ramanujam|Vendhan Ramanujam, M.B.B.S.]]&#039;&#039;&#039;&lt;br /&gt;
&#039;&#039;&#039;Contact:&#039;&#039;&#039; vendhan.r@wikidoc.org&lt;br /&gt;
*&#039;&#039;&#039;Research Fellow at PERFUSE Study Group&lt;br /&gt;
*&#039;&#039;&#039;Beth Israel Deaconess Medical Center, Harvard Medical School&lt;br /&gt;
&#039;&#039;&#039;Interests:&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
|- valign=&amp;quot;bottom&amp;quot; style=&amp;quot;color:#000; font-size:100%; vertical-align:top; width:50%&amp;quot;&lt;br /&gt;
| bgcolor=&amp;quot;#f5fffa;&#039;&#039; width=&amp;quot;20%&amp;quot; align=&amp;quot;left&amp;quot; | [[Image:Hardik.jpg|200px]]&lt;br /&gt;
| bgcolor=&amp;quot;#cedff2&amp;quot; width=&amp;quot;80%&amp;quot; align=&amp;quot;left&amp;quot; | &lt;br /&gt;
&#039;&#039;&#039;[[User:Hardik Patel|Hardik Patel, M.B.B.S.]]&#039;&#039;&#039;&lt;br /&gt;
&#039;&#039;&#039;Contact:&#039;&#039;&#039; hardikp@wikidoc.org&lt;br /&gt;
*&#039;&#039;&#039;Research Fellow at PERFUSE Study Group&#039;&#039;&#039;&lt;br /&gt;
*&#039;&#039;&#039;Beth Israel Deaconess Medical Center, Harvard Medical School&#039;&#039;&#039;&lt;br /&gt;
&#039;&#039;&#039;Interests:&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
|- style=&amp;quot;color:#000; font-size:100%; vertical-align:top; width:50%&amp;quot;&lt;br /&gt;
| bgcolor=&amp;quot;#f5fffa;&#039;&#039; width=&amp;quot;20%&amp;quot; align=&amp;quot;left&amp;quot; | [[Image:Ochuko.jpg|200px]]&lt;br /&gt;
| bgcolor=&amp;quot;#cedff2&amp;quot; width=&amp;quot;80%&amp;quot; align=&amp;quot;left&amp;quot; |&lt;br /&gt;
&#039;&#039;&#039;[[User:Ochuko Ajari|Ochuko Ajari, M.B.B.S., M.S.]]&#039;&#039;&#039; &lt;br /&gt;
&#039;&#039;&#039;Contact:&#039;&#039;&#039; oajari@wikidoc.org&lt;br /&gt;
*&#039;&#039;&#039;Postdoctoral Research Fellow at PERFUSE Study Group&#039;&#039;&#039;&lt;br /&gt;
*&#039;&#039;&#039;Beth Israel Deaconess Medical Center, Harvard Medical School&#039;&#039;&#039;&lt;br /&gt;
*&#039;&#039;&#039;Senior Manager of Deputy Editors, WikiDoc&#039;&#039;&#039;&lt;br /&gt;
&#039;&#039;&#039;Interests:&#039;&#039;&#039;&lt;br /&gt;
*&#039;&#039;&#039;Cardiology&#039;&#039;&#039;&lt;br /&gt;
*&#039;&#039;&#039;Infectious Diseases&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
|- style=&amp;quot;color:#000; font-size:100%; vertical-align:top; width:50%&amp;quot;&lt;br /&gt;
| bgcolor=&amp;quot;#f5fffa;&#039;&#039; width=&amp;quot;20%&amp;quot; align=&amp;quot;left&amp;quot; | [[Image:Gonzalo.jpg|200px]]&lt;br /&gt;
| bgcolor=&amp;quot;#cedff2&amp;quot; width=&amp;quot;80%&amp;quot; align=&amp;quot;left&amp;quot; |  &lt;br /&gt;
&#039;&#039;&#039;[[User:Gonzalo Romero|Gonzalo Romero, M.D.]]&#039;&#039;&#039;&lt;br /&gt;
&#039;&#039;&#039;Contact:&#039;&#039;&#039; gromero@wikidoc.org&lt;br /&gt;
*&#039;&#039;&#039;Clinical Research Fellow at PERFUSE Study Group&#039;&#039;&#039;&lt;br /&gt;
*&#039;&#039;&#039;Beth Israel Deaconess Medical Center, Harvard Medical School&#039;&#039;&#039;&lt;br /&gt;
*&#039;&#039;&#039;Principles and Practice of Clinical Research Fellow, Harvard Medical School&#039;&#039;&#039;&lt;br /&gt;
&#039;&#039;&#039;Interests:&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
|- style=&amp;quot;color:#000; font-size:100%; vertical-align:top; width:50%&amp;quot;&lt;br /&gt;
| bgcolor=&amp;quot;#f5fffa;&#039;&#039; width=&amp;quot;20%&amp;quot; align=&amp;quot;left&amp;quot; | [[Image:Mugilan.JPG|200px]]&lt;br /&gt;
| bgcolor=&amp;quot;#cedff2&amp;quot; width=&amp;quot;80%&amp;quot; align=&amp;quot;left&amp;quot; |&lt;br /&gt;
&#039;&#039;&#039;[[User:Mugilan Poongkunran|Mugilan Poongkunran, M.B.B.S.]]&#039;&#039;&#039;&lt;br /&gt;
&#039;&#039;&#039;Contact:&#039;&#039;&#039; mugilan.p@wikidoc.org&lt;br /&gt;
*&#039;&#039;&#039;Research Fellow at PERFUSE Study Group&#039;&#039;&#039;&lt;br /&gt;
*&#039;&#039;&#039;Beth Israel Deaconess Medical Center, Harvard Medical School&#039;&#039;&#039;&lt;br /&gt;
&#039;&#039;&#039;Interests:&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
|- style=&amp;quot;color:#000; font-size:100%; vertical-align:top; width:50%&amp;quot;&lt;br /&gt;
| bgcolor=&amp;quot;#f5fffa;&#039;&#039; width=&amp;quot;20%&amp;quot; align=&amp;quot;left&amp;quot; | Picture 13&lt;br /&gt;
| bgcolor=&amp;quot;#cedff2&amp;quot; width=&amp;quot;80%&amp;quot; align=&amp;quot;left&amp;quot; |&lt;br /&gt;
&#039;&#039;&#039;[[User:Mahmoud Sakr|Mahmoud Sakr, M.D.]]&#039;&#039;&#039;&lt;br /&gt;
&#039;&#039;&#039;Contact:&#039;&#039;&#039; msakr@wikidoc.org&lt;br /&gt;
*&#039;&#039;&#039;Research Fellow at PERFUSE Study Group&#039;&#039;&#039;&lt;br /&gt;
*&#039;&#039;&#039;Beth Israel Deaconess Medical Center, Harvard Medical School&#039;&#039;&#039;&lt;br /&gt;
&#039;&#039;&#039;Interests:&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
|- style=&amp;quot;color:#000; font-size:100%; vertical-align:top; width:50%&amp;quot;&lt;br /&gt;
| bgcolor=&amp;quot;#f5fffa;&#039;&#039; width=&amp;quot;20%&amp;quot; align=&amp;quot;left&amp;quot; | Picture 15&lt;br /&gt;
| bgcolor=&amp;quot;#cedff2&amp;quot; width=&amp;quot;80%&amp;quot; align=&amp;quot;left&amp;quot; |&lt;br /&gt;
&#039;&#039;&#039;[[User:Farman Khan|Farman Khan, M.D., M.R.C.P.]]&#039;&#039;&#039;&lt;br /&gt;
&#039;&#039;&#039;Contact:&#039;&#039;&#039; fkhan@wikidoc.org&lt;br /&gt;
*&#039;&#039;&#039;Research Fellow at PERFUSE Study Group&lt;br /&gt;
*&#039;&#039;&#039;Beth Israel Deaconess Medical Center, Harvard Medical School&lt;br /&gt;
&#039;&#039;&#039;Interests:&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Gonzalo Romero</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=Template:Board_review_project&amp;diff=936884</id>
		<title>Template:Board review project</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=Template:Board_review_project&amp;diff=936884"/>
		<updated>2014-01-31T23:08:41Z</updated>

		<summary type="html">&lt;p&gt;Gonzalo Romero: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{| style=&amp;quot;margin: 0 0 1em 1em; border: 2px solid #696969; float: right; width:12em&amp;quot; cellpadding=&amp;quot;10&amp;quot; cellspacing=&amp;quot;20&amp;quot;; &lt;br /&gt;
! style=&amp;quot;padding: 1 7px; font-size: 120%; background:MidnightBlue&amp;quot; align=center | {{fontcolor|#FFFFFF|WikiDoc Board Review}}&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;font-size: 90%; padding: 0 10px; background: #DCDCDC&amp;quot; align=left | &#039;&#039;&#039;[[Board review project|The Project]]&#039;&#039;&#039;&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;font-size: 90%; padding: 0 10px; background: #DCDCDC&amp;quot; align=left | &#039;&#039;&#039;[[WBR team|The Team]]&#039;&#039;&#039;&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;font-size: 90%; padding: 0 10px; background: #DCDCDC&amp;quot; align=left | &#039;&#039;&#039;[[How to create a board review project|Guidelines]]&#039;&#039;&#039;&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;font-size: 90%; padding: 0 10px; background: #DCDCDC&amp;quot; align=left | &#039;&#039;&#039;[[WBR|Question List]]&#039;&#039;&#039;&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;font-size: 90%; padding: 0 10px; background: #DCDCDC&amp;quot; align=left | &#039;&#039;&#039;[[WBR quality checklist|Quality Checklist]]&#039;&#039;&#039;&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;font-size: 90%; padding: 0 10px; background: #DCDCDC&amp;quot; align=left | &#039;&#039;&#039;[[WBR medical illustrations|Medical Illustrations]]&#039;&#039;&#039;&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;font-size: 90%; padding: 0 10px; background: #DCDCDC&amp;quot; align=left | &#039;&#039;&#039;[[WBR template questions|Question Template]]&#039;&#039;&#039;&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;font-size: 90%; padding: 0 10px; background: #DCDCDC&amp;quot; align=left | &#039;&#039;&#039;[[WBR high yield|High Yield!]]&#039;&#039;&#039;&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;font-size: 90%; padding: 0 10px; background: #DCDCDC&amp;quot; align=left | &#039;&#039;&#039;[[WBR labs|Normal Labs]]&#039;&#039;&#039;&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;font-size: 90%; padding: 0 10px; background: #DCDCDC&amp;quot; align=left | &#039;&#039;&#039;[[WBR mnemonics|Mnemonics]]&#039;&#039;&#039;&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;font-size: 90%; padding: 0 10px; background: #DCDCDC&amp;quot; align=left | &#039;&#039;&#039;[[Test taking strategies|Test Taking Tips]]&#039;&#039;&#039;&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
[[Category:Projects]]&lt;/div&gt;</summary>
		<author><name>Gonzalo Romero</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=Board_review_project&amp;diff=936877</id>
		<title>Board review project</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=Board_review_project&amp;diff=936877"/>
		<updated>2014-01-31T23:05:32Z</updated>

		<summary type="html">&lt;p&gt;Gonzalo Romero: /* Links */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Board review project}}&lt;br /&gt;
[[Image:Main_help_page_small.PNG|100px|link=Help]][[Image:Projects.PNG|100px|link=Projects]][[Image:Editor&#039;s_Tools.PNG|100px|link=Help Menu]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Editor-In-Chief:&#039;&#039;&#039; [[User:William J Gibson|Will Gibson]];  {{AE}}  [[User:Gonzalo Romero|Gonzalo A. Romero, M.D.]][mailto:gromero@wikidoc.org]; {{Rim}};[[User:Sergekorjian|Serge Korjian]]; [[User:YazanDaaboul|Yazan Daaboul]]; {{VR}}; {{M.P}}; {{AO}}; {{MS}};&lt;br /&gt;
&lt;br /&gt;
==Overview==&lt;br /&gt;
The goal of the Board Review Questions Project is to create a universally accessible free repository of Board Review Questions which are targeted at multiple educational levels. All questions must be original and cannot violate WikiDoc&#039;s strict policies regarding [[plagiarism]].  Liability related to copyright violations regarding board review questions rests with the person who prepared the question. Please notify WikiDoc in writing if you feel that there has been a copyright violation regarding a board review question.  Board review questions are reviewed and discussed by the [[WikiDoc Scholars]] on Monday mornings at 10:30 AM Eastern time.  After creating the questions, the editor must quality check his or her own work using the following &#039;&#039;&#039;WBR quality checklist&#039;&#039;&#039;.  Board review questions must be approved by the peer-review process prior to uploading them onto WikiDoc.&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
==Statement of Need==&lt;br /&gt;
* Current board review sites charge exorbitant fees for access to the content which may represent an undue financial burden and barrier to participation for medical school and residency applicants alike.&lt;br /&gt;
&lt;br /&gt;
==How Can WikiDoc Meet Those Needs?==&lt;br /&gt;
WikiDoc scholars board review project has several goals, and some of those are:&lt;br /&gt;
&lt;br /&gt;
* Provide a robust resource for medical students and graduates preparing for the boards&lt;br /&gt;
* Provide opportunities for WikiDoc scholars on campus to exchange knowledge, strategies and test-taking skills&lt;br /&gt;
&lt;br /&gt;
==How Can You Help WikiDoc Meet Those Needs?==&lt;br /&gt;
*WikiDoc encourages medical students, interns, residents, fellows, and attending level faculty members to submit board review questions.&lt;br /&gt;
*The &#039;&#039;&#039;WikiDoc Board Review Team&#039;&#039;&#039; meets every Monday at 10:30 AM in the Longwood Medical Area.  The meeting is led by [[User:William J Gibson|Will Gibson]], an M.D., Ph.D. candidate from Harvard Medical School.  For more details, you can send an email to &#039;&#039;&#039;[mailto:willjgibson@gmail.com willjgibson@gmail.com]&#039;&#039;&#039;.  You can join the WikiDoc Board Review Meeting on Skype by connecting to the Skype username &#039;&#039;&#039;wikidocscholars&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
==Resources==&lt;br /&gt;
===WikiDoc Resources===&lt;br /&gt;
* [[MCAT]]&lt;br /&gt;
* [[USMLE Step 1]]&lt;br /&gt;
* [[USMLE Step 2-CK]]&lt;br /&gt;
* [[USMLE Step 2 Clinical Skills]]&lt;br /&gt;
* [[USMLE Step 3]]&lt;br /&gt;
* [[COMLEX-USA]]&lt;br /&gt;
* http://www.wikidoc.org/index.php/How_to_upload_USMLE_II_Images&lt;br /&gt;
&lt;br /&gt;
===External Resources===&lt;br /&gt;
* http://www.usmle.org/pdfs/step-1/2013content_step1.pdf&lt;br /&gt;
* http://www.usmle.org/pdfs/step-2-ck/2012--13_FINAL_S2_GSI.pdf&lt;br /&gt;
* http://www.usmle.org/pdfs/step-3/2013content_step3.pdf&lt;br /&gt;
* http://www.nbme.org/&lt;br /&gt;
* http://www.nbome.org/&lt;br /&gt;
* http://www.ecfmg.org/&lt;br /&gt;
* http://www.osteopathic.org/Pages/default.aspx&lt;br /&gt;
&lt;br /&gt;
[[Category:Help]]&lt;br /&gt;
[[Category:Projects]]&lt;br /&gt;
&lt;br /&gt;
{{WH}}&lt;br /&gt;
{{WS}}&lt;/div&gt;</summary>
		<author><name>Gonzalo Romero</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=WBR_medical_illustrations&amp;diff=936876</id>
		<title>WBR medical illustrations</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=WBR_medical_illustrations&amp;diff=936876"/>
		<updated>2014-01-31T23:04:50Z</updated>

		<summary type="html">&lt;p&gt;Gonzalo Romero: /* Examples of WBR Medical Illustrations */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Board review project}}&lt;br /&gt;
[[Image:Main_help_page_small.PNG|100px|link=Help]][[Image:Projects.PNG|100px|link=Projects]][[Image:Editor&#039;s_Tools.PNG|100px|link=Help Menu]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Editor-In-Chief:&#039;&#039;&#039; [[User:William J Gibson|Will Gibson]];  {{AE}}  [[User:Sergekorjian|Serge Korjian]]; {{Rim}}; [[User:YazanDaaboul|Yazan Daaboul]]; [[User:Gonzalo Romero|Gonzalo A. Romero, M.D.]][mailto:gromero@wikidoc.org]; {{VR}}; {{M.P}}; {{AO}}; {{MS}}&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Medical Illustrations==&lt;br /&gt;
The &#039;&#039;&#039;Wiki Board Review Team&#039;&#039;&#039; is constantly trying to improve the quality of their questions. To date, we have an initiative in order to incorporate &#039;&#039;&#039;medical illustrations&#039;&#039;&#039; made by our editors into the questions.  These images have outstanding quality and are copyleft, therefore are allowed to be used.&lt;br /&gt;
&lt;br /&gt;
Should you have any particular interest in a board relevant illustration to be created; please email us to &#039;&#039;&#039;[mailto:medicalillustration@wikidoc.org medicalillustration@wikidoc.org]&#039;&#039;&#039;. Our team will he happy to create images upon petition.&lt;br /&gt;
&lt;br /&gt;
==Examples of WBR Medical Illustrations==&lt;br /&gt;
{|style=&amp;quot;width:70%; height:100px&amp;quot; border=&amp;quot;1&amp;quot; align=center &lt;br /&gt;
|style=&amp;quot;height:100px&amp;quot;; style=&amp;quot;width:75%&amp;quot; border=&amp;quot;1&amp;quot; bgcolor=&amp;quot;DodgerBlue&amp;quot; align=center | &#039;&#039;&#039;Illustration&#039;&#039;&#039;&lt;br /&gt;
|style=&amp;quot;height:100px&amp;quot;; style=&amp;quot;width:25%&amp;quot; border=&amp;quot;1&amp;quot; bgcolor=&amp;quot;SandyBrown&amp;quot; align=center | &#039;&#039;&#039;Topic&#039;&#039;&#039; &lt;br /&gt;
&lt;br /&gt;
|-bgcolor=&amp;quot;AliceBlue&amp;quot;&lt;br /&gt;
| [[File:Aphasia-types.gif|400px|center]]&lt;br /&gt;
|bgcolor=&amp;quot;Cornsilk&amp;quot; align=center | [[Aphasia]]&lt;br /&gt;
&lt;br /&gt;
|-bgcolor=&amp;quot;AliceBlue&amp;quot;&lt;br /&gt;
| [[File:WBR551 prompt.jpg|400px|center]]&lt;br /&gt;
|bgcolor=&amp;quot;Cornsilk&amp;quot; align=center | [[Brachial plexus]]&lt;br /&gt;
&lt;br /&gt;
|-bgcolor=&amp;quot;AliceBlue&amp;quot;&lt;br /&gt;
| [[File:Syringomyelia spinal cord.gif|400px|center]]&lt;br /&gt;
|bgcolor=&amp;quot;Cornsilk&amp;quot; align=center | [[Syringomyelia]]&lt;br /&gt;
&lt;br /&gt;
|-bgcolor=&amp;quot;AliceBlue&amp;quot;&lt;br /&gt;
| [[File:MS.gif|400px|center]]&lt;br /&gt;
|bgcolor=&amp;quot;Cornsilk&amp;quot; align=center | [[Multiple sclerosis]]&lt;br /&gt;
&lt;br /&gt;
|-bgcolor=&amp;quot;AliceBlue&amp;quot;&lt;br /&gt;
| [[File:Dorsal-Columns.gif|400px|center]]&lt;br /&gt;
|bgcolor=&amp;quot;Cornsilk&amp;quot; align=center | [[Tabes Dorsalis]]&lt;br /&gt;
&lt;br /&gt;
|-bgcolor=&amp;quot;AliceBlue&amp;quot;&lt;br /&gt;
| [[File:Anterior-horn.gif|400px|center]]&lt;br /&gt;
|bgcolor=&amp;quot;Cornsilk&amp;quot; align=center | [[Polio]]&lt;br /&gt;
&lt;br /&gt;
|-bgcolor=&amp;quot;AliceBlue&amp;quot;&lt;br /&gt;
| [[ File:ALS.gif|400px|center]]&lt;br /&gt;
|bgcolor=&amp;quot;Cornsilk&amp;quot; align=center | [[ALS]]&lt;br /&gt;
&lt;br /&gt;
|-bgcolor=&amp;quot;AliceBlue&amp;quot;&lt;br /&gt;
| [[File:Shoulder motion with rotator cuff (supraspinatus).gif|400px|center]]&lt;br /&gt;
|bgcolor=&amp;quot;Cornsilk&amp;quot; align=center | [[Rotator cuff]]&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Gonzalo Romero</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=WBR_template_questions&amp;diff=936873</id>
		<title>WBR template questions</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=WBR_template_questions&amp;diff=936873"/>
		<updated>2014-01-31T22:58:21Z</updated>

		<summary type="html">&lt;p&gt;Gonzalo Romero: /* Examples of WBR High Quality Questions */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Board review project}}&lt;br /&gt;
[[Image:Main_help_page_small.PNG|100px|link=Help]][[Image:Projects.PNG|100px|link=Projects]][[Image:Editor&#039;s_Tools.PNG|100px|link=Help Menu]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Editor-In-Chief:&#039;&#039;&#039; [[User:William J Gibson|Will Gibson]];  {{AE}}  [[User:Gonzalo Romero|Gonzalo A. Romero, M.D.]][mailto:gromero@wikidoc.org];{{Rim}};[[User:Sergekorjian|Serge Korjian]]; [[User:YazanDaaboul|Yazan Daaboul]]; {{VR}}; {{M.P}}; {{AO}}; {{MS}};&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Examples of WBR High Quality Questions==&lt;br /&gt;
{|style=&amp;quot;width:30%; height:100px&amp;quot; border=&amp;quot;0&amp;quot; align=center&lt;br /&gt;
|style=&amp;quot;height:100px&amp;quot;; style=&amp;quot;width:50%&amp;quot; border=&amp;quot;1&amp;quot; bgcolor=&amp;quot;DodgerBlue&amp;quot; align=center | &#039;&#039;&#039;High Quality Question Type&#039;&#039;&#039;&lt;br /&gt;
|style=&amp;quot;height:100px&amp;quot;; style=&amp;quot;width:15%&amp;quot; border=&amp;quot;1&amp;quot; bgcolor=&amp;quot;SandyBrown&amp;quot; align=center | &#039;&#039;&#039;Example&#039;&#039;&#039; &lt;br /&gt;
|-bgcolor=&amp;quot;AliceBlue&amp;quot;&lt;br /&gt;
| align=center| &#039;&#039;&#039;Illustration Sample&#039;&#039;&#039;&lt;br /&gt;
| bgcolor=&amp;quot;Cornsilk&amp;quot;|[[WBR0570]]&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;AliceBlue&amp;quot;&lt;br /&gt;
| align=center|&#039;&#039;&#039;Diagram Sample&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Cornsilk&amp;quot;|[[WBR0553]]&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;AliceBlue&amp;quot;&lt;br /&gt;
| align=center| &#039;&#039;&#039;Table Sample&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Cornsilk&amp;quot;|[[WBR question template]]&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;AliceBlue&amp;quot;&lt;br /&gt;
| align=center| &#039;&#039;&#039;Animation Sample&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Cornsilk&amp;quot;|[[WBR0551]]&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;AliceBlue&amp;quot;&lt;br /&gt;
| align=center| &#039;&#039;&#039;Picture Sample&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Cornsilk&amp;quot;|&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Gonzalo Romero</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=WBR_team&amp;diff=936865</id>
		<title>WBR team</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=WBR_team&amp;diff=936865"/>
		<updated>2014-01-31T22:49:02Z</updated>

		<summary type="html">&lt;p&gt;Gonzalo Romero: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Board review project}}&lt;br /&gt;
[[Image:Main_help_page_small.PNG|100px|link=Help]][[Image:Projects.PNG|100px|link=Projects]][[Image:Editor&#039;s_Tools.PNG|100px|link=Help Menu]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Editor-In-Chief:&#039;&#039;&#039; [[User:William J Gibson|Will Gibson]];  {{AE}}  [[User:Gonzalo Romero|Gonzalo A. Romero, M.D.]][mailto:gromero@wikidoc.org];{{Rim}};[[User:Sergekorjian|Serge Korjian]]; [[User:YazanDaaboul|Yazan Daaboul]]; {{VR}}; {{CP}}; {{AN}}; {{RT}}; {{M.P}}; {{AO}}; {{MS}};&lt;br /&gt;
&lt;br /&gt;
==Meet the Wiki Board Review Team==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Deputy Editors-In-Chief, WikiDoc:&#039;&#039;&#039;&lt;br /&gt;
*[[User:William J Gibson|William Gibson, B.S.]]&lt;br /&gt;
*[[User:Rim Halaby|Rim Halaby, M.D.]]&lt;br /&gt;
*[[User:Sergekorjian|Serge Korjian]]&lt;br /&gt;
*[[User:YazanDaaboul|Yazan Daaboul]]&lt;br /&gt;
*[[User:Gonzalo Romero|Gonzalo Romero, M.D.]]&lt;br /&gt;
*[[User:Vendhan Ramanujam|Vendhan Ramanujam, M.B.B.S.]]&lt;br /&gt;
*[[User:Mugilan Poongkunran|Mugilan Poongkunran, M.B.B.S.]]&lt;br /&gt;
*[[User:Kristin Feeney|Kristin Feeney, B.S.]]&lt;br /&gt;
*[[User:Hardik Patel|Hardik Patel, M.B.B.S.]]&lt;br /&gt;
*[[User:Ochuko Ajari|Ochuko Ajari, M.B.B.S., M.S.]]&lt;br /&gt;
*[[User:Mahmoud Sakr|Mahmoud Sakr, M.D.]]&lt;br /&gt;
*[[User:Ayokunle Olubaniyi|Ayokunle Olubaniyi M.B.B.S.]]&lt;br /&gt;
*[[User:Sapan Patel|Sapan Patel, M.B.B.S.]]&lt;br /&gt;
&lt;br /&gt;
{| width=&amp;quot;60%&amp;quot; style=&amp;quot;border: solid 1px #cedff2&amp;quot; cellpadding=&amp;quot;4&amp;quot; cellspacing=&amp;quot;1&amp;quot; Font&lt;br /&gt;
|- style=&amp;quot;color:#000; font-size:130%; vertical-align:top; width:20%&amp;quot;&lt;br /&gt;
|  bgcolor=&amp;quot;#cedff2&amp;quot; style=&amp;quot;border: solid 1px #cedff2&amp;quot; colspan=&amp;quot;2&amp;quot; align=&amp;quot;left&amp;quot; | &#039;&#039;&#039;Deputy Editors-In-Chief on Site&#039;&#039;&#039;&lt;br /&gt;
|- style=&amp;quot;color:#000; font-size:100%; vertical-align:top; width:50%&amp;quot;&lt;br /&gt;
| bgcolor=&amp;quot;#f5fffa;&#039;&#039; width=&amp;quot;20%&amp;quot; align=&amp;quot;left&amp;quot; | [[Image:Will_Gibson.jpg|200px]]&lt;br /&gt;
| bgcolor=&amp;quot;#cedff2&amp;quot; width=&amp;quot;80%&amp;quot; align=&amp;quot;left&amp;quot; |&lt;br /&gt;
&#039;&#039;&#039;[[User:William J Gibson|William Gibson, B.S.]]&#039;&#039;&#039;&lt;br /&gt;
&#039;&#039;&#039;Contact:&#039;&#039;&#039; wgibson@mit.edu&lt;br /&gt;
*&#039;&#039;&#039;Deputy Editor-In-Chief at PERFUSE Study Group&#039;&#039;&#039;&lt;br /&gt;
*&#039;&#039;&#039;Beth Israel Deaconess Medical Center, Harvard Medical School&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
|- style=&amp;quot;color:#000; font-size:100%; vertical-align:top; width:50%&amp;quot;&lt;br /&gt;
| bgcolor=&amp;quot;#f5fffa;&#039;&#039; width=&amp;quot;20%&amp;quot; align=&amp;quot;left&amp;quot; | [[Image:Rim.jpg|200px]]&lt;br /&gt;
| bgcolor=&amp;quot;#cedff2&amp;quot; width=&amp;quot;80%&amp;quot; align=&amp;quot;left&amp;quot; |&lt;br /&gt;
&#039;&#039;&#039;[[User:Rim Halaby|Rim Halaby, M.D.]]&#039;&#039;&#039;&lt;br /&gt;
&#039;&#039;&#039;Contact:&#039;&#039;&#039; rim.halaby@wikidoc.org  &#039;&#039;&#039;Phone:&#039;&#039;&#039; 617-632-7590&lt;br /&gt;
*&#039;&#039;&#039;Research Fellow at PERFUSE Study Group&#039;&#039;&#039;&lt;br /&gt;
*&#039;&#039;&#039;Beth Israel Deaconess Medical Center, Harvard Medical School&#039;&#039;&#039;&lt;br /&gt;
*&#039;&#039;&#039;Senior Manager of Deputy Editors, WikiDoc&#039;&#039;&#039;&lt;br /&gt;
&#039;&#039;&#039;Interests:&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
|- style=&amp;quot;color:#000; font-size:100%; vertical-align:top; width:50%&amp;quot;&lt;br /&gt;
| bgcolor=&amp;quot;#f5fffa;&#039;&#039; width=&amp;quot;20%&amp;quot; align=&amp;quot;left&amp;quot; | Picture 9&lt;br /&gt;
| bgcolor=&amp;quot;#cedff2&amp;quot; width=&amp;quot;80%&amp;quot; align=&amp;quot;left&amp;quot; |&lt;br /&gt;
&#039;&#039;&#039;Gerald Chi, M.D.&#039;&#039;&#039;&lt;br /&gt;
&#039;&#039;&#039;Contact:&#039;&#039;&#039; gchi@wikidoc.org&lt;br /&gt;
*&#039;&#039;&#039;Research Fellow at PERFUSE Study Group&#039;&#039;&#039;&lt;br /&gt;
*&#039;&#039;&#039;Beth Israel Deaconess Medical Center, Harvard Medical School&#039;&#039;&#039;&lt;br /&gt;
&#039;&#039;&#039;Interests:&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
|- style=&amp;quot;color:#000; font-size:100%; vertical-align:top; width:50%&amp;quot;&lt;br /&gt;
| bgcolor=&amp;quot;#f5fffa;&#039;&#039; width=&amp;quot;20%&amp;quot; align=&amp;quot;left&amp;quot; | [[Image:Vendhan.jpg|200px]]&lt;br /&gt;
| bgcolor=&amp;quot;#cedff2&amp;quot; width=&amp;quot;80%&amp;quot; align=&amp;quot;left&amp;quot; |&lt;br /&gt;
&#039;&#039;&#039;[[User:Vendhan Ramanujam|Vendhan Ramanujam, M.B.B.S.]]&#039;&#039;&#039;&lt;br /&gt;
&#039;&#039;&#039;Contact:&#039;&#039;&#039; vendhan.r@wikidoc.org&lt;br /&gt;
*&#039;&#039;&#039;Research Fellow at PERFUSE Study Group&lt;br /&gt;
*&#039;&#039;&#039;Beth Israel Deaconess Medical Center, Harvard Medical School&lt;br /&gt;
&#039;&#039;&#039;Interests:&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
|- valign=&amp;quot;bottom&amp;quot; style=&amp;quot;color:#000; font-size:100%; vertical-align:top; width:50%&amp;quot;&lt;br /&gt;
| bgcolor=&amp;quot;#f5fffa;&#039;&#039; width=&amp;quot;20%&amp;quot; align=&amp;quot;left&amp;quot; | [[Image:Hardik.jpg|200px]]&lt;br /&gt;
| bgcolor=&amp;quot;#cedff2&amp;quot; width=&amp;quot;80%&amp;quot; align=&amp;quot;left&amp;quot; | &lt;br /&gt;
&#039;&#039;&#039;[[User:Hardik Patel|Hardik Patel, M.B.B.S.]]&#039;&#039;&#039;&lt;br /&gt;
&#039;&#039;&#039;Contact:&#039;&#039;&#039; hardikp@wikidoc.org&lt;br /&gt;
*&#039;&#039;&#039;Research Fellow at PERFUSE Study Group&#039;&#039;&#039;&lt;br /&gt;
*&#039;&#039;&#039;Beth Israel Deaconess Medical Center, Harvard Medical School&#039;&#039;&#039;&lt;br /&gt;
&#039;&#039;&#039;Interests:&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
|- style=&amp;quot;color:#000; font-size:100%; vertical-align:top; width:50%&amp;quot;&lt;br /&gt;
| bgcolor=&amp;quot;#f5fffa;&#039;&#039; width=&amp;quot;20%&amp;quot; align=&amp;quot;left&amp;quot; | [[Image:Ochuko.jpg|200px]]&lt;br /&gt;
| bgcolor=&amp;quot;#cedff2&amp;quot; width=&amp;quot;80%&amp;quot; align=&amp;quot;left&amp;quot; |&lt;br /&gt;
&#039;&#039;&#039;[[User:Ochuko Ajari|Ochuko Ajari, M.B.B.S., M.S.]]&#039;&#039;&#039; &lt;br /&gt;
&#039;&#039;&#039;Contact:&#039;&#039;&#039; oajari@wikidoc.org&lt;br /&gt;
*&#039;&#039;&#039;Postdoctoral Research Fellow at PERFUSE Study Group&#039;&#039;&#039;&lt;br /&gt;
*&#039;&#039;&#039;Beth Israel Deaconess Medical Center, Harvard Medical School&#039;&#039;&#039;&lt;br /&gt;
*&#039;&#039;&#039;Senior Manager of Deputy Editors, WikiDoc&#039;&#039;&#039;&lt;br /&gt;
&#039;&#039;&#039;Interests:&#039;&#039;&#039;&lt;br /&gt;
*&#039;&#039;&#039;Cardiology&#039;&#039;&#039;&lt;br /&gt;
*&#039;&#039;&#039;Infectious Diseases&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
|- style=&amp;quot;color:#000; font-size:100%; vertical-align:top; width:50%&amp;quot;&lt;br /&gt;
| bgcolor=&amp;quot;#f5fffa;&#039;&#039; width=&amp;quot;20%&amp;quot; align=&amp;quot;left&amp;quot; | [[Image:Gonzalo.jpg|200px]]&lt;br /&gt;
| bgcolor=&amp;quot;#cedff2&amp;quot; width=&amp;quot;80%&amp;quot; align=&amp;quot;left&amp;quot; |  &lt;br /&gt;
&#039;&#039;&#039;[[User:Gonzalo Romero|Gonzalo Romero, M.D.]]&#039;&#039;&#039;&lt;br /&gt;
&#039;&#039;&#039;Contact:&#039;&#039;&#039; gromero@wikidoc.org&lt;br /&gt;
*&#039;&#039;&#039;Clinical Research Fellow at PERFUSE Study Group&#039;&#039;&#039;&lt;br /&gt;
*&#039;&#039;&#039;Beth Israel Deaconess Medical Center, Harvard Medical School&#039;&#039;&#039;&lt;br /&gt;
*&#039;&#039;&#039;Principles and Practice of Clinical Research Fellow, Harvard Medical School&#039;&#039;&#039;&lt;br /&gt;
&#039;&#039;&#039;Interests:&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
|- style=&amp;quot;color:#000; font-size:100%; vertical-align:top; width:50%&amp;quot;&lt;br /&gt;
| bgcolor=&amp;quot;#f5fffa;&#039;&#039; width=&amp;quot;20%&amp;quot; align=&amp;quot;left&amp;quot; | [[Image:Mugilan.JPG|200px]]&lt;br /&gt;
| bgcolor=&amp;quot;#cedff2&amp;quot; width=&amp;quot;80%&amp;quot; align=&amp;quot;left&amp;quot; |&lt;br /&gt;
&#039;&#039;&#039;[[User:Mugilan Poongkunran|Mugilan Poongkunran, M.B.B.S.]]&#039;&#039;&#039;&lt;br /&gt;
&#039;&#039;&#039;Contact:&#039;&#039;&#039; mugilan.p@wikidoc.org&lt;br /&gt;
*&#039;&#039;&#039;Research Fellow at PERFUSE Study Group&#039;&#039;&#039;&lt;br /&gt;
*&#039;&#039;&#039;Beth Israel Deaconess Medical Center, Harvard Medical School&#039;&#039;&#039;&lt;br /&gt;
&#039;&#039;&#039;Interests:&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
|- style=&amp;quot;color:#000; font-size:100%; vertical-align:top; width:50%&amp;quot;&lt;br /&gt;
| bgcolor=&amp;quot;#f5fffa;&#039;&#039; width=&amp;quot;20%&amp;quot; align=&amp;quot;left&amp;quot; | Picture 13&lt;br /&gt;
| bgcolor=&amp;quot;#cedff2&amp;quot; width=&amp;quot;80%&amp;quot; align=&amp;quot;left&amp;quot; |&lt;br /&gt;
&#039;&#039;&#039;[[User:Mahmoud Sakr|Mahmoud Sakr, M.D.]]&#039;&#039;&#039;&lt;br /&gt;
&#039;&#039;&#039;Contact:&#039;&#039;&#039; msakr@wikidoc.org&lt;br /&gt;
*&#039;&#039;&#039;Research Fellow at PERFUSE Study Group&#039;&#039;&#039;&lt;br /&gt;
*&#039;&#039;&#039;Beth Israel Deaconess Medical Center, Harvard Medical School&#039;&#039;&#039;&lt;br /&gt;
&#039;&#039;&#039;Interests:&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
|- style=&amp;quot;color:#000; font-size:100%; vertical-align:top; width:50%&amp;quot;&lt;br /&gt;
| bgcolor=&amp;quot;#f5fffa;&#039;&#039; width=&amp;quot;20%&amp;quot; align=&amp;quot;left&amp;quot; | Picture 15&lt;br /&gt;
| bgcolor=&amp;quot;#cedff2&amp;quot; width=&amp;quot;80%&amp;quot; align=&amp;quot;left&amp;quot; |&lt;br /&gt;
&#039;&#039;&#039;[[User:Farman Khan|Farman Khan, M.D., M.R.C.P.]]&#039;&#039;&#039;&lt;br /&gt;
&#039;&#039;&#039;Contact:&#039;&#039;&#039; fkhan@wikidoc.org&lt;br /&gt;
*&#039;&#039;&#039;Research Fellow at PERFUSE Study Group&lt;br /&gt;
*&#039;&#039;&#039;Beth Israel Deaconess Medical Center, Harvard Medical School&lt;br /&gt;
&#039;&#039;&#039;Interests:&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Gonzalo Romero</name></author>
	</entry>
</feed>